• SHOP
  • COMBOS
  • TESTIMONIALS
  • CART
  • INGREDIENTS
    • 2-DEOXY-D-GLUCOSE (2DG)
    • ACACIA CYANOPHYLLA FLOWER
    • ACORI GRAMINEI RHIZOMA
    • AEGLE MARMELOS CORREA
    • AGARICUS BLAZEI
    • AGED GARLIC EXTRACT
    • AFRAMOMUM MELEGUETA
    • ALOE ARBORESCENS
    • ALBIZIA
    • ALPINIA OFFICINARUM
    • ALTERNANTHERA SESSILIS
    • AMERICAN GINSENG
    • AMYGDALIN
    • ANACYCLUS PYRETHRUM
    • ANGELICA ARCHANGELICA
    • ANGELICA SINENSIS
    • ANTRODIA
    • ARTICHOKE LEAF
    • ARTOCARPIN
    • AJUGA TURKESTANICA
    • ASHWAGANDHA
    • ASPALATHIN
    • ASTRAGALUS COMPLANATUS
    • AVENA SATIVA
    • BACOPA MONNIERI
    • BAVACHIN
    • BEE POLLEN
    • BETULINIC ACID
    • BOSWELLIC ACID
    • BREVILIN A
    • CAMPESTEROL
    • CAPSAICIN
    • CARCININE
    • CASTICIN
    • CHRYSIN
    • CIANIDANOL
    • CINNAMOMUM ZEYLANICUM
    • CITRULLUS COLOCYNTHIS
    • CITRUS RETICULATA PEEL
    • CODONOPSIS
    • CONJUGATED LINOLEIC ACID
    • COSTUNOLIDE
    • CYANIDIN
    • CUCURBITACIN D
    • DAIDZEIN
    • DECURSIN
    • DELPHINIDIN
    • DIGITALIS PURPREA (DIGOXIN)
    • DIOSMIN
    • Ecklonia Cava
    • Ellagic Acid
    • EMBELIN
    • ERIODICTYOL
    • GALLIC ACID
    • GLYCITEIN
    • GLYCYRRHIZIN
    • HYPERFORIN
    • ICARIIN
    • ISORHAMNETIN
    • ISOORIENTIN
    • ISOVITEXIN
    • JACEOSIDIN
    • KAEMPFEROL
    • KIGELIA AFRICANA
    • KURARINONE
    • LEMON BALM
    • LICORICIDIN
    • LIPOIC ACID
    • LUPEOL
    • MAGNOLOL
    • MENAQUINONE 4
    • MULBERRY LEAF
    • NARINGENIN
    • NOBILETIN
    • OLEACEIN
    • OLEANOLIC ACID
    • OLIVE OIL
    • ORIDONIN
    • PARTHENOLIDE
    • PHLOROGLUCINOL
    • PHLORIZIN
    • PICEATANNOL
    • PRISTIMERIN
    • PROANTHOCYANIDINS
    • PROCYANIDIN B3
    • PSEUDOLARIC ACID B
    • PTEROSTILBENE
    • RUTIN
    • SOLIDAGO VIRGAUREA
    • TANGERETIN
    • TARAXASTEROL
    • TRICHOSTATIN A
    • WEDELOLACTONE
    • WOGONIN
    • YERBA MATE
  • ABOUT
  • SCIENTIFIC STUDIES
    • ADAPTOGENS
    • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
    • ADDICTION & THE BRAIN
    • ADDICTION & STRESS
    • ADDICTION WITHDRAWAL
    • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
    • ADIPOCYTE DIFFERENTIATION
    • ADROPIN
    • ALLERGIES & CYTOKINES
    • ALDOSTERONE & OBESITY/HYPERTENSION
    • ALZHEIMER’S, DEMENTIA, PARKINSON’S
    • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
    • ADVANCED GLYCATION END PRODUCTS (AGES)
    • ADDICTION TREATMENT
    • ADDICTION & DOPAMINE
    • AMPK
    • ANTI AGING
    • ANTIAGING EFFECTS OF COFFEE
    • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
    • ANTI-APOPTOTIC PATHWAYS
    • ANTI ATHEROGENIC
    • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
    • ANTI CARIOGENIC (Protecting From Tooth Decay)
    • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
    • ANTI GLYCATIVE
    • ANTI GLYCATION AGENTS
    • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
    • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
    • ANTI WRINKLE AGENTS
    • ANXIOGENIC
    • ANXIOLYTIC
    • APOPTOSIS
    • APOPTOSIS IN 3T3-L1
    • AUTOPHAGY
    • BCL-2
    • BCL-W
    • BCL-XL
    • BDNF
    • BECLIN-1 & AUTOPHAGY
    • BH3 MIMETICS
    • BIM aka BCL2L11
    • BIOMIMETIC HYDROXYAPATITE
    • BMI-1
    • BPA & OBESITY
    • BRASSINOSTEROIDS
    • CALORIE RESTRICTION
    • CALORIE RESTRICTION & LIFESPAN EXTENSION
    • CARBAMYLATION
    • CARBONYL SCAVENGER
    • CARBONYL STRESS
    • CARDIOPROTECTIVE AGENTS
    • CARDIAC GLYCOSIDES
    • CATALASE
    • CELL CYCLE ARREST
    • CENTENARIANS
    • CDK5
    • CHOLESTEROL EFFLUX
    • COGNITIVE ENHANCEMENT
    • COLD SHOCK PROTEINS
    • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
    • CONDITIONED PLACE PREFERENCE
    • CORTICOTROPIN RELEASING FACTOR
    • COSMECEUTICAL
    • CRYOTHERAPY
    • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
    • CYP2E1
    • CYTOKINES IN PAIN, INFLAMMATION & AGING
    • DAF-16
    • DEPERSONALIZATION
    • DIABETES & CANCER
    • DIHYDROTESTOSTERONE (DHT)
    • DNA METHYLATION & AGING
    • DNA REPAIR
    • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
    • DRY FASTING AND FLUID RESTRICTION FASTING
    • DYNORPHIN
    • ELLAGITANNINS
    • ENDOCRINE DISRUPTING CHEMICALS
    • ENLARGED HEART AND CARDIOMEGALY
    • EPIGENETIC ALTERATIONS
    • EPIGENETIC MODIFIERS
    • EPINEPHRINE
    • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
    • EXCITOXICITY & THE BRAIN
    • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
    • EXTRACELLULAR MICROVESICLES
    • EXTENDS LIFESPAN
    • EXTINCTION TRAINING
    • FASTING & THE BRAIN
    • FASTING & CANCER
    • FASTING MIMICKING DIET
    • FEAR EXTINCTION
    • FGF21
    • FLAVONES
    • GABA (γ-AMINOBUTYRIC ACID)
    • GALLOTANNINS
    • GLUCONEOGENESIS
    • GLUCOCORTICOID RECEPTOR ACTIVATION
    • GLUTAMATE & BRAIN
    • GLYCATION
    • GUT BRAIN AXIS
    • GYPENOSIDE
    • KLOTHO
    • K OPIOD RECEPTOR & ADDICTION
    • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
    • FGF21
    • FOXO3
    • FOXO4
    • HALLMARKS OF AGING
    • HAIR GROWTH
    • HAIR REGENERATION
    • HAIR REPIGMENTATION
    • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
    • HMGB1
    • HORMESIS
    • HPA AXIS
    • HSP70, THE ANTI-AGING PROTEIN
    • HSP90 INHIBITORS
    • HYPERGLYCEMIA
    • HYPERALGESIA
    • HYPERINSULINEMIA
    • HYPOTHALAMIC PITUITARY ADRENAL HPA AXIS
    • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
    • HYPOCRETIN OREXIN
    • IKK
    • IL-6/STAT3
    • IRISIN
    • ISOFLAVONES
    • IMMUNOSENESCENCE
    • INHIBITION OF ADVANCED GLYCATION END PRODUCTS
    • INCREASE PROTEIN SYNTHESIS
    • INCREASES SPERMATOGENESIS
    • INFECTOBESITY
    • INFLAMMATION & ANXIETY
    • INFLAMMATION & CANCER
    • INFLAMMATION & DEPRESSION
    • INFLAMMATION & OBESITY
    • INFLAMMAGING
    • INHIBITION OF RENAL GLUCOSE REABSORPTION
    • INSULIN & AGING
    • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
    • INSULIN & MTOR
    • INSULIN & OBESITY
    • INSULIN OXIDATIVE STRESS
    • INTERMITTENT FASTING
    • JAK INHIBITION ALLEVIATES SASP
    • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
    • KETONE BODIES
    • KETOGENIC DIET
    • LACTOBACILLUS REUTERI
    • LACTOFERRIN
    • LEYDIG CELL STEROIDOGENESIS
    • LIFESPAN EXTENSION
    • LIVER REGENERATION
    • LIPOLYTIC AGENTS
    • LIPID DROPLETS
    • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
    • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
    • MATRIX METALLOPROTEINASES (MMPs)
    • MCL-1
    • MDM2 INHIBITION AS SASP INHIBITOR
    • MEDICINAL MUSHROOMS
    • MEDITERRANEAN DIET
    • METABOLIC REPROGRAMMING
    • METABOLIC SYNDROME
    • METHIONINE RESTRICTION
    • MITOCHONDRIAL UNCOUPLING
    • MONKEYPOX
    • MSG (MONOSOSODIUM GLUTAMATE)
    • MUSCLE FORCE PRODUCTION
    • MUSCLE ATROPHY (PREVENTING)
    • MYOGENESIS
    • MYOSTATIN INHIBITION
    • MYOSTATIN INHIBITION PRESERVES MUSCLE
    • mTORC2
    • mTOR: THE RAPID AGING PATHWAY
    • NATURAL ANTICOAGULANTS
    • NATURAL AROMATASE INHIBITORS
    • NEUROGENESIS (GROWING NEW BRAIN CELLS)
    • NEUROCHEMISTRY OF ADDICTION
    • NEUROPLASTICITY
    • NEUROINFLAMMATION
    • NEUROPROTECTIVE AGENTS
    • NEUTRALIZING OXIDATIVE STRESS WITH MEDICINAL PLANTS
    • NMDA & ANXIETY & DEPRESSION
    • NMDA RECEPTOR & FEAR
    • NON OPIOD ANALGESICS
    • NOOTROPICS
    • NORADRENERGIC
    • NOREPINEPHRINE
    • NRF2: MASTER REGULATOR OF THE AGING PROCESS
    • NF-KB
    • NUTRACEUTICAL
    • OBESOGENS
    • ONCOGENE ACTIVATION INDUCED SENESCENCE
    • ORGANOTINS
    • OVERNUTRITION
    • OXIDATIVE STRESS & AGING
    • P16INK4A
    • P38MAPK
    • P53: TUMOR SUPRESSOR
    • PERIODONTITIS
    • PHOSPHATIDYLINOSITOL 3 KINASE
    • PHYTOCHEMICALS
    • PHYTOSTEROLS
    • PHYTOSTANOLS
    • PHYTOECDYSTEROIDS
    • PROANTHOCYANIDINS
    • PROTEIN CARBONYLATION
    • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
    • POLYPHENOLS AS COVID-19 TREATMENT & PREVENTION
    • PPARY2
    • PREMATURE SENESCENCE
    • PREVENTING SKIN AGING
    • PUFAS
    • PURGATIVES
    • RADIATION EXTRACT
    • RAPAMYCIN (MTOR INHIBITION)
    • RED WINE
    • RENAL (KIDNEY) PROTECTIVE AGENTS
    • REMINERALIZATION OF TEETH
    • REMYELINATION
    • REPAIR OF DNA BREAKS “DOUBLE STRAND”
    • RESTORE INSULIN SENSITIVITY
    • REVERSAL OF OBESITY
    • SASP & ADIPOSE TISSUE
    • SEX HORMONE BINDING GLOBULIN
    • SENESCENT CELLS, SASP & SENOLYTICS
    • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
    • SGLT2 INHIBITORS
    • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
    • SHBG
    • SIRT1
    • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
    • SKIN ELASTICITY
    • SKIN PHOTOAGING (Preventing & Repairing)
    • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
    • SIRT1 & LONGEVITY
    • SMALLPOX
    • SUGAR & AGING
    • STAR PROTEIN
    • STAT3
    • STEM CELL EXHAUSTION
    • STEM CELL REGENERATION
    • STEM CELL THERAPY
    • STIMULATED LIPOLYSYS
    • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
    • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
    • STRESS & AGING
    • STRESS & THE BRAIN
    • TELOMERE SHORTENING & PREMATURE AGING
    • TIME RESTRICTED FEEDING
    • THROMBOLYTICS (PLANT BASED)
    • TRAUMATIC BRAIN INJURY (HEALING)
    • TRYPTOPHAN HYDROXYLASE 2
    • VISCERAL ADIPOSITY
    • XENOBIOTICS
    • XENOESTROGEN
  • HOME
  • CONTACT
  • TELEGRAM PORTAL
  • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
  • The Ultimate Dry Fasting Resource
  • MY ACCOUNT
  • RESET PASSWORD
0
blank
Oleacein
February 19, 2020
blank
RULES FOR 30LBS IN 5 DAYS CHALLENGE
February 19, 2020
  1. … -(5-methylpyridin-2-yl)− 1H-pyrazol-5-yl) pyrazolo [1, 5-a] pyrimidine-3-carboxamide as a new potential PET agent for imaging of IRAK4 enzyme in neuroinflammation
  2. … -1 gp120 and Methamphetamine-mediated Induction of Proinflammatory Cytokines/chemokines and Oxidative Stress in Astrocytes: Implications in neuroinflammation
  3. … -19 MRI at 21.1 T: enhanced spin–lattice relaxation of perfluoro-15-crown-5-ether and sensitivity as demonstrated in ex vivo murine neuroinflammation
  4. … -19 MRI sensitivity using a cryogenic radiofrequency probe: technical developments and ex vivo demonstration in a mouse model of neuroinflammation
  5. … -276: MAPKAP kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity: Relevance to neuroinflammation in a transgenic …
  6. … -activated receptor-γ agonist benefited propionic acid induced autism-like behavioral phenotypes in rats by attenuation of neuroinflammation and oxidative stress
  7. … -analytic studies of the glial cell marker TSPO in psychosis–a question of apples and pears?: A commentary on ‘neuroinflammation in schizophrenia: metaanalysis of …
  8. … -cinnamaldehyde, an essential oil in cinnamon powder, ameliorates cerebral ischemia-induced brain injury via inhibition of neuroinflammation through attenuation of …
  9. … -glu-PAL is neuroprotective in a chronic Parkinson’s disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation
  10. … -induced reward and striatal dopaminergic denervation without changing the expression of dopamine D1 and D2 receptors: implications for neuroinflammation
  11. … -low dose naloxone attenuates morphine tolerance in rats via attenuation of NMDA receptor neurotransmission and suppression of neuroinflammation in the spinal …
  12. … -rich ethanol extract from the leaves of Diospyros kaki attenuates cognitive deficits, amyloid-beta production, oxidative stress, and neuroinflammation in APP/PS1 …
  13. … -Tetrahydrocannabinol Suppresses Human Monocyte Activation and Monocyte-Mediated Astrocyte Inflammation: Implications for HIV-Associated neuroinflammation
  14. … ‐specific patterns of carboxyterminally truncated Aβ peptides 1–37/38/39 in addition to 1–40/42 in Alzheimer’s disease and in patients with chronic neuroinflammation
  15. … , an inhibitor of 5alpha-reductase enzyme, induces long-lasting effects on depressive-like behavior, hippocampal neurogenesis, neuroinflammation and gut microbiota …
  16. … , and Lonicera japonica Thunb. protect against cognitive dysfunction and energy and glucose dysregulation by reducing neuroinflammation and hippocampal insulin …
  17. … , based on the paper entitled” The inhibitory effect of manganese on acetylcholinesterase activity enhances oxidative stress and neuroinflammation in the brain” by …
  18. … , Ravikanth, ElBakoush, Abdelmeneim, Fiebich, Bernd L. and Olajide, Olumayokun A. Antimalarial drug artemether inhibits neuroinflammation in BV2 microglia …
  19. … , Renal, and Metabolic Diseases: Nutrient-sensing mechanisms in hypothalamic cell models: neuropeptide regulation and neuroinflammation in male-and …
  20. … (Cannabis sativa L.) seed phenylpropionamides composition and effects on memory dysfunction and biomarkers of neuroinflammation induced by lipopolysaccharide …
  21. … [(4‐methoxyphenyl)carbamoyl]amino}‐N‐{[1‐(5‐methoxypyridin‐2‐yl)cyclohexyl]methyl}propanamide: An Attempt to Visualize Brain Formyl Peptide Receptors in Mouse Models of neuroinflammation
  22. … [1,5-a]pyrimidines as Translocator Protein 18 kDa (TSPO) Ligands: Synthesis, in Vitro Biological Evaluation, [18F]-Labeling, and in Vivo neuroinflammation PET …
  23. … ]-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s disease
  24. … /maob inhibitor ory2001 prevents the development of the memory deficit in samp8 mice through induction of neuronal plasticity and reduction of neuroinflammation
  25. … 2 Deficiency in Microglia Inhibits Pro-inflammatory Mediator Release and Resultant Neurotoxicity RELEVANCE TO neuroinflammation IN A TRANSGENIC …
  26. … 25-methoxy hispidol A isolated from Poncirus trifoliate against bacteria-induced anxiety and depression by targeting neuroinflammation, oxidative stress and …
  27. … 3170 The TLR2/4 antagonist (+)-naltrexone blocks contextual long-term memory deficits in experimental autoimmune encephalitis and associated neuroinflammation …
  28. … a novel regulator of amphetamine-induced striatal gliosis and cognitive impairment: evidence for a stimulus-dependent regulation of neuroinflammation by midkine/M …
  29. … abrogate chronic restraint stress-induced behavioral deficits: implication of oxido-nitrosative, endoplasmic reticulum stress cascade, and neuroinflammation
  30. … acid produces antidepressant‐like effects in a chronic unpredictable stress model of depression via attenuation of neuroinflammation, oxido‐nitrosative stress, and …
  31. … ACTIVATION OF PROAPOPTOTIC KINASE PKCδ IN DOPAMINERGIC NEURONS BY TNFα DEATH RECEPTOR SIGNALING AND neuroinflammation
  32. … administration of neural stem cells after hypoxia–ischemia reduces sensorimotor deficits, cerebral lesion size, and neuroinflammation in neonatal mice
  33. … administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque …
  34. … after intracerebroventricular streptozotocin injection improves cognitive dysfunction in rats by modulating oxidative stress, cholinergic functions and neuroinflammation
  35. … against 72-h sleep deprivation induced anxiety like behavior: possible roles of oxidative stress, mitochondrial dysfunction and neuroinflammation
  36. … against intrahippocampal aβ-induced long-term memory dysfunction; upregulation of effective neurogenesis with the abrogated apoptosis and neuroinflammation
  37. … AJ, 2012. A hematopoietic contribution to microhemorrhage formation during antiviral CD8 T cell-initiated blood-brain barrier disruption. Journal of neuroinflammation …
  38. … Alterations Reveal Key Role of Prostaglandin Synthase and Cyclooxygenase 1 and 2 in Traumatic Brain Injury–Induced neuroinflammation in the Cerebral Cortex of …
  39. … an antidepressant effect in an unpredictable chronic mild stress model of depression in rats and is associated with the regulation of hippocampal neuroinflammation
  40. … analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation
  41. … and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-κB signaling, oxidative stress and neuroinflammation
  42. … and brain penetrant p38αMAPK inhibitor candidate for neurologic and neuropsychiatric disorders that attenuates neuroinflammation and cognitive dysfunction
  43. … and Cerebrovascular Physiology, Disease, and Signaling Mechanisms: Sex differences in depression-like behavior and neuroinflammation in rats post-MI …
  44. … and N‐acetylcysteine co‐administration markedly inhibit chronic ethanol intake and block relapse binge drinking: Role of neuroinflammation‐oxidative stress self …
  45. … and nitrosative stress biomarkers of depression symptoms in subjects with multiple sclerosis: increased peripheral inflammation but less acute neuroinflammation
  46. … and striatal dopaminergic denervation without changing the expression of dopamine D1 and D2 receptors: Implications for neuroinflammation/M. Vicente-Rodríguez …
  47. … antagonism attenuates the intermittent hypoxia-induced spatial deficits in a murine model of sleep apnea via inhibiting neuroinflammation and oxidative stress
  48. … Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-b Response in HTLV-1-Associated neuroinflammation.
  49. … antiretroviral restriction factor profiling reveals the evolutionary imprint of the ex Vivo and in vivo IFN-β response in HTLV-1-associated neuroinflammation
  50. … are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation
  51. … attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s disease
  52. … based N-formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation
  53. … behaviors and reduces the activation of pro-inflammatory cytokines and the phosphorylation of glucocorticoid receptors at serine 246 induced by neuroinflammation
  54. … benzodiazepine receptor ligand [11C] DAA1106 can be used to image microglia in animal models of Parkinson’s disease and neuroinflammation in vivo using PET.
  55. … between the chemokine receptor CCR5 and microglia in neurological disorders: consequences of targeting CCR5 on neuroinflammation, neuronal death and …
  56. … binds to activated and infected brain macrophages in areas of synaptic degeneration: implications for PET imaging of neuroinflammation in lentiviral encephalitis
  57. … bioavailability curcumin: an anti-inflammatory and neurosupportive bioactive nutrient for neurodegenerative diseases characterized by chronic neuroinflammation
  58. … BioGlue injection in the fetal lamb: a novel model for creation of obstructive congenital hydrocephalus without additional chemically induced neuroinflammation
  59. … cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson’s disease
  60. … cells treated with crude Plasmodium berghei extracts acquire immune‐modulatory properties and suppress the development of autoimmune neuroinflammation
  61. … cerebral ischemia/reperfusion injury in streptozotocin-induced hyperglycemic rats via the inhibition of the cellular apoptosis pathway and neuroinflammation
  62. … changes in neuroinflammatory and arachidonic acid cascade markers with synaptic marker loss in rat lipopolysaccharide infusion model of neuroinflammation
  63. … changes in neuroinflammatory and arachidonic acid cascade markers with synaptic marker loss in rat lipopolysaccharide infusion model of neuroinflammation
  64. … compound Camellikaempferoside B decreases Aβ production, interferes with Aβ aggregation, and prohibits Aβ-mediated neurotoxicity and neuroinflammation
  65. … deficit in a pilocarpine-induced status epilepticus rat model via a decrease in the nuclear factor-κB activation and reduction in microglia neuroinflammation
  66. … deficit induced by energy-dense diet in a rat model of early-Alzheimer’s disease is associated to neurotoxic Aβ species and independent of neuroinflammation
  67. … deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage
  68. … derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer’s disease mouse model through modulation of neuroinflammation
  69. … effect of alendronate against intracerebroventricular streptozotocin induced alteration in neurobehavioral, neuroinflammation and biochemical parameters with …
  70. … EFFECT OF GINSENG AGAINST HALOPERIDOL-INDUCED COGNITIVE IMPAIRMENT, neuroinflammation AND BIOCHEMICAL ALTERATIONS IN …
  71. … effect of interleukin (IL)‐17 secreted by reactive astrocytes is emerged from a high‐level IL‐17‐containing environment during acute neuroinflammation
  72. … effect of mangiferin on early brain injury after subarachnoid hemorrhage by attenuating mitochondria-related apoptosis and neuroinflammation
  73. … effects of indomethacin-loaded nanocapsules against oxygen-glucose deprivation in organotypic hippocampal slice cultures: involvement of neuroinflammation
  74. … effects of intravenous administration of bone marrow stromal cells on sevoflurane-induced neuronal apoptosis and neuroinflammation in neonatal rats
  75. … effects of penta-acetyl geniposide in chronic unpredictable mild stress-induced depression rat model: Involvement of inhibiting neuroinflammation in prefrontal cortex …
  76. … environmental standard impairs neuronal behavior and represses glutamate receptor gene expression and memory-related kinase activation via neuroinflammation …
  77. … epoxide hydrolase and p38 kinase alleviating tau hyperphosphorylation and amyloid neurotoxicity for potential treatment of neuroinflammation in Alzheimer’s disease
  78. … Exacerbates Obesity-Induced Oxidative Stress, Neurovascular Dysfunction, Blood–Brain Barrier Disruption, neuroinflammation, Amyloidogenic Gene Expression …
  79. … exposure activates astroglial hemichannels and pannexons in the hippocampus of adolescent rats: effects on neuroinflammation and astrocyte arborization
  80. … express low levels of D oublecortin, but their proliferation is unaffected by 6‐OHDA‐induced nigral lesion or M inocycline‐mediated inhibition of neuroinflammation
  81. … extract improves learning and memory of chemically-induced aging mice through upregulating neurotrophins BDNF and FGF2 and sequestering neuroinflammation
  82. … extracts of se-enriched Auricularia auricular attenuates D-galactose-induced cognitive deficits, oxidative stress and neuroinflammation via suppressing RAGE/MAPK …
  83. … factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death
  84. … factor receptor-associated death domain mediated neuronal death contributes to the glial activation and subsequent neuroinflammation in Japanese encephalitis
  85. … fatty acid supplementation alleviates doxorubicin-induced depressive-like behaviors and neurotoxicity in rats: involvement of oxidative stress and neuroinflammation
  86. … FGF10 activate neuronal FGFR2/PI3K/Akt signaling and inhibit microglia/macrophages TLR4/NF-κ B-dependent neuroinflammation to improve functional …
  87. … fluid level of Nogo receptor 1 antagonist lateral olfactory tract usher substance (LOTUS) correlates inversely with the extent of neuroinflammation
  88. … GINSENG AGAINST CHRONIC UNPREDICTABLE STRESS-INDUCED COGNITIVE IMPAIRMENT, neuroinflammation, AND BIOCHEMICAL ALTERATIONS
  89. … GLIA SHARE CHARACTERISTICS WITH ANTIGEN PRESENTING CELLS AND MAY ALTER SERUM CHEMOKINE LEVELS DURING neuroinflammation
  90. … growth factor (PDGF)-BB-mediated induction of monocyte chemoattractant protein 1 in human astrocytes: implications for HIV-associated neuroinflammation
  91. … GSK3β-dependent Aβ and p-tau proteins and cognitive loss in young rats: Reduced HB-EGF signaling and downstream neuroinflammation as critical regulators
  92. … high-fat diet-induced obese gerbils but rather elicits neuronal death through increase of abnormal mTOR activation-mediated oxidative stress and neuroinflammation
  93. … hybrid with metal-chelating property ameliorates Cu (II)-induced spatial learning and memory deficits via preventing neuroinflammation and oxido-nitrosative stress in …
  94. … hydrogen sulfide releasing compounds ATB-346 and diallyl trisulfide attenuate streptozotocin-induced cognitive impairment, neuroinflammation, and oxidative stress …
  95. … hyperglycaemia-induced neuronal injury in experimental models of diabetic neuropathy: effects on mitochondrial biogenesis, autophagy and neuroinflammation
  96. … hyperglycaemia-induced neuronal injury in experimental models of diabetic neuropathy: effects on mitochondrial biogenesis, autophagy and neuroinflammation
  97. … identify a new natural-based polyphenol, counteracting Aβ oligomerization in vitro and Aβ oligomer-mediated memory impairment and neuroinflammation in an acute …
  98. … IL-1RA-PEP fusion protein with enhanced brain penetration ameliorates cerebral ischemia-reperfusion injury by inhibition of oxidative stress and neuroinflammation
  99. … immune modulator for the treatment of secondary progressive multiple sclerosis acts directly within the CNS to induce Type I IFN and suppress neuroinflammation (P5 …
  100. … improved Alzheimer disease–like symptoms by potentiating hippocampal insulin signaling and decreasing neuroinflammation and norepinephrine degradation in …
  101. … in molecular biology and proteomics adapted to in vivo peptide phage display define active protein domains as biomarkers in multiple sclerosis neuroinflammation
  102. … in Non-Obese Gerbils, but Results in Neuronal Death in Obese Gerbils by Increasing Abnormal mTOR Activation-Mediated Oxidative Stress and neuroinflammation
  103. … in rats causes long-lasting impairments in impulse control that are differentially sensitive to pharmacotherapeutics and associated with chronic neuroinflammation
  104. … in the acute stage of traumatic brain injury attenuates brain trauma-induced depression-like behavior in rats by reducing neuroinflammation in the hippocampus
  105. … induces human monocytic cell toxicity toward neuronal cells: exploring a possible link between obesity-related metabolic impairments and neuroinflammation
  106. … Inhibition Prevents the Adult Excitatory-Inhibitory Imbalance Induced by the Reciprocal Interaction Between neuroinflammation and Oxidative Stress During …
  107. … inhibitory factor deficiency modulates the immune response and limits autoimmune demyelination: a new role for neurotrophic cytokines in neuroinflammation
  108. … injury‐induced neuronal damage in the somatosensory cortex causes formation of rod‐shaped microglia that promote astrogliosis and persistent neuroinflammation
  109. … investigation of therapeutic mechanisms of exercise in Parkinson’s disease: effects on dopamine release, ventral striatal activity and neuroinflammation
  110. … Levels of Binge Alcohol Reduce Calcium-independent Phospholipase A2 (iPLA2) Levels in Rat Brain: An Unrecognized Initial Sign of neuroinflammation
  111. … lipopolysaccharide-induced cognition impairment and amyloidogenesis by modulating brain-derived neurotropic factor, neuroinflammation and oxido-nitrosative …
  112. … long-term neuroinflammatory responses in a rat encephalopathy model as assessed by multi-parametric MRI: implications for aging-associated neuroinflammation
  113. … Maternal Immune Activation in the Aetiology of Schizophrenia: Establishing a Rat Model with a Focus on Cognitive Symptomology and neuroinflammation.
  114. … Mechanism by which 4-Nonylphenol Accelerates Alzheimer’s Pathogenesis and Induces both Tau-amyloid Mediated Toxicity and neuroinflammation (P1. 9-084)
  115. … Mechanisms in the Neuroprotective Effect of Centella asiatica Against Sleep Deprivation Induced Anxiety Like Behaviour, Oxidative Damage and neuroinflammation
  116. … mechanisms of bone marrow-derived mesenchymal stem cells in the regulation of microglia-mediated neuroinflammation after subarachnoid hemorrhage
  117. … microfluidically supported in vitro model of an endothelial barrier combined with cortical spheroids simulates effects of neuroinflammation in neocortex development
  118. … Modulation of Immune and Central Nervous System Homeostasis: The Role of Diet in Development of neuroinflammation and Neurological Disease
  119. … object discrimination, but not spatial, memory: evidence for selective disruption of specific hippocampus-dependent memory functions during acute neuroinflammation
  120. … odorifera suppresses lipopolysaccharide-induced mouse BV2 microglial cell activation, which protects mouse hippocampal HT22 cells death from neuroinflammation …
  121. … of astrocytic connexin-43, hemichannels, and gap junctions in oxygen-glucose deprivation/reperfusion injury induced neuroinflammation and the possible …
  122. … of cannabinoids, Δ9-tetrahydrocannabinol and cannabidiol, ameliorates experimental multiple sclerosis by suppressing neuroinflammation through regulation of …
  123. … of cerebral dopamine neurotrophic factor transducted BMSCs in contusion spinal cord injury of rats: promotion of nerve regeneration by alleviating neuroinflammation
  124. … of Cnestis ferruginea vahl ex DC (Connaraceae) root extract on kainic acid-induced temporal lobe epilepsy in mice: Role of oxidative stress and neuroinflammation
  125. … of Drug Reward and Reinforcement: Implications of TLR4 Dependent Cocaine and Methamphetamine Induced neuroinflammation on Reward, Relapse …
  126. … of in vivo binding properties of the 18-kDa translocator protein (TSPO) ligands [18F]PBR102 and [18F]PBR111 in a model of excitotoxin-induced neuroinflammation
  127. … of lycopene attenuates lipopolysaccharide-induced amyloidogenesis and cognitive impairments via mediating neuroinflammation and oxidative stress
  128. … of Melanocortin 1 Receptor Attenuates Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage viathe Suppression of neuroinflammation through AMPK/TBK1 …
  129. … of mid-regional proenkephalin A and N-terminal protachykinin A immune reactivity in cerebrospinal fluid of patients with dementia and acute neuroinflammation
  130. … of Neutrophil Gelatinase-Associated Lipocalin Concentration in Canine Cerebrospinal Fluid and Serum and Its Involvement in neuroinflammation
  131. … of peripheral M1 macrophages reverses motor deficits in MPTP-treated mouse by suppressing neuroinflammation and dopaminergic neurodegeneration
  132. … of pro-inflammatory cytokines and the phosphorylation of p38 in the habenula and reverses depressive-like behaviors induced by neuroinflammation
  133. … of salvianolic acid B against cerebral ischemic injury in rats via the CD40/NF-κB pathway associated with suppression of platelets activation and neuroinflammation
  134. … of Th17 cells in the nervous system compartment in multiple sclerosis and experimental autoimmune encephalomyelitis: one possible link between neuroinflammation …
  135. … of the injured sciatic nerve of mice carrying the Wld (S) mutant gene: identification of genes involved in neuroprotection, neuroinflammation, and nerve regeneration
  136. … of β2–adrenoceptor attenuates sepsis–induced hippocampus–dependent cognitive impairments by reversing neuroinflammation and synaptic abnormalities
  137. … of cerebral dopamine neurotrophic factor transducted BMSCs in contusion spinal cord injury of rats: promotion of nerve regeneration by alleviating neuroinflammation
  138. … of Cnestis ferruginea vahl ex DC (Connaraceae) root extract on kainic acid-induced temporal lobe epilepsy in mice: Role of oxidative stress and neuroinflammation
  139. … of Drug Reward and Reinforcement: Implications of TLR4 Dependent Cocaine and Methamphetamine Induced neuroinflammation on Reward, Relapse …
  140. … of in vivo binding properties of the 18-kDa translocator protein (TSPO) ligands [18F]PBR102 and [18F]PBR111 in a model of excitotoxin-induced neuroinflammation
  141. … of lycopene attenuates lipopolysaccharide-induced amyloidogenesis and cognitive impairments via mediating neuroinflammation and oxidative stress
  142. … omega-3 and 6 polyunsaturated fatty acid profile, attenuates glial activation and regulates BDNF function in a rodent model of neuroinflammation induced by central …
  143. … OXIDANT EFFECT OF N-METHANESULFONYLPYRAZOLINYL SUBSTITUTED HETEROSTEROIDS IN AN LPS-INDUCED neuroinflammation MODEL OF MICE
  144. … p53 inactivators pifithrin-μ and pifithrin-α mitigate TBI-induced neuronal damage through regulation of oxidative stress, neuroinflammation, autophagy and mitophagy
  145. … PEPTIDE RECEPTOR 2 (FPR2) AGONISTS WITH NEUROPROTECTIVE PROPERTIES IN MODELS OF neuroinflammation RELATED TO ALZHEIMER’S …
  146. … phospholipase A2 and n− 3 polyunsaturated fatty acid docosahexaenoic acid in prostanoid production in brain: perspectives for protection in neuroinflammation
  147. … platelet activation and inhibits thrombin-induced calcium influx: possible role of copaxone in targeting platelets during autoimmune neuroinflammation
  148. … Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of neuroinflammation
  149. … post-stroke cognitive impairments via inhibition of peri-infarct astroglial and microglial/macrophage P2 purinoceptors-mediated neuroinflammation and …
  150. … pretreated mesenchymal stem cell culture ameliorates mouse lipopolysaccharide-induced cerebral neuroinflammation-histological and immunohistochemical …
  151. … Proenkephalin A and N-terminal Protachykinin A are decreased in the cerebrospinal fluid of patients with dementia disorders and acute neuroinflammation
  152. … profile. Impaired function of the CO2, AQP1, and AQP4 gas channels may cause hypoxia and thus enhance neuroinflammation in autistic individuals
  153. … profiling of cortical gene expression in Alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation
  154. … proliferator-activated receptor-α, ameliorates lipopolysaccharide-induced depressive-like behaviors by preventing neuroinflammation and oxido-nitrosative stress in …
  155. … protected against microglial‐mediated neurotoxicity in SH‐SY5Y and BV2 cocultured cells from LPS–induced neuroinflammation and death by inhibiting MAPK, NF …
  156. … radiotracer 2-(7-butyl-2-(4-(2-([18F] fluoroethoxy) phenyl)-5-methylpyrazolo [1, 5-a] pyrimidin-3-yl)-N, N-diethylacetamide in a preclinical model of neuroinflammation
  157. … regulates the differentiation of CD11b+ Ly-6Chigh monocytes and permeability of blood–brain barrier to galvanize the immune privileged CNS to neuroinflammation
  158. … regulation of ecto-5′-nucleotidase/CD73 and A2AR-mediated adenosine signaling at neurovascular unit: a link between acute and chronic neuroinflammation
  159. … regulation of the major histocompatibility complex class I in the Cns: functional implications for brain aging and sexually dimorphic differences in neuroinflammation
  160. … relapsing experimental allergic encephalomyelitis (CREAE) in plasminogen activator inhibitor‐1 knockout mice: the effect of fibrinolysis during neuroinflammation
  161. … Reticulum Calcium ATPase 1 est induite dans la Maladie d’Alzheimer, promeut le métabolisme amyloïdogène de l’APP et provoque la neuroinflammation.
  162. … Reveals Susceptibilities to Spatial Memory Deficits, Decreased Dopamine Marker Expression and Increased neuroinflammation in the Hippocampus of Male …
  163. … reverses depressive-like behaviors and restores the suppressed FGF2-ERK1/2 signaling and the impaired hippocampal neurogenesis induced by neuroinflammation
  164. … reverses type 2 diabetes-induced cognitive deficits via attenuation of oxidative/nitrosative stress and NF-κB-mediated neuroinflammation in rat hippocampus
  165. … signalling pathway by American ginseng attenuates chronic unpredictable stress-induced cognitive impairment, neuroinflammation, and biochemical alterations
  166. … similar pathogenesis with neurodegenerative diseases: Endosome‐autophagosome‐lysosome pathway dysfunction and microglia‐mediated neuroinflammation
  167. … soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation
  168. … SPLENIC AND PERIPHERAL BLOOD IMMUNE CELL POPULATIONS AND MAY CONTRIBUTE TO neuroinflammation AND NEURODEGENERATION IN …
  169. … stem cells alleviate the early brain injury of subarachnoid hemorrhage partly by suppression of Notch1-dependent neuroinflammation: involvement of Botch
  170. … stromal cells modulate peripheral stress-induced innate immune activation indirectly limiting the emergence of neuroinflammation-driven depressive and anxiety-like …
  171. … sulfate affords neuroprotection in an eclampsia-like model induced in pregnant rats by ameliorating brain edema and neuroinflammation: Immune and inflammatory …
  172. … SYSTEM AND MOTOR IMPAIRMENT IN CRITICAL ILLNESS: Experimental Abdominal Sepsis Induces Persistent neuroinflammation And Microglial Activation
  173. … targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
  174. … Tetrahydroxystilbene-2-O-β-d-glucoside prevention of lipopolysaccharide-induced depressive-like behaviors in mice involves neuroinflammation and oxido-nitrosative …
  175. … thaliana extracts optimized for polyphenols production as potential therapeutics for the APOE-modulated neuroinflammation characteristic of Alzheimer’s …
  176. … the Cognitive Impairment and Depression-Like Behaviors in a Cuprizone Mouse Model by Alleviating Demyelination and neuroinflammation in the Brain
  177. … to As-, Cd-, and Pb-mixture induces Aβ, amyloidogenic APP processing and cognitive impairments via oxidative stress-dependent neuroinflammation in young rats
  178. … tolerance alleviates the intracranial lipopolysaccharide injection-induced neuroinflammation and protects the dopaminergic neurons from neuroinflammation …
  179. … traumatic brain injury in mice promotes functional improvement and acute neuron survival but has little effect on neurogenesis, glial responses or neuroinflammation
  180. … virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation
  181. … Vital M, Sato MDO Adam GP (2016) Depression in Parkinson’s Disease is Associated with a Serotoninergic System Change Secondary to neuroinflammation
  182. ” Effects of exercise on adolescent and adult hypothalamic and hippocampal neuroinflammation“: Corrigendum.
  183. (-)-Phenserine Ameliorates Contusion Volume, neuroinflammation, and Behavioral Impairments Induced by Traumatic Brain Injury in Mice
  184. (-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer’s disease challenged mice
  185. (+)-Sesamin attenuates chronic unpredictable mild stress-induced depressive-like behaviors and memory deficits via suppression of neuroinflammation
  186. (−)-Epicatechin Mitigates Oxidative Stress, neuroinflammation and Hyperphosphorylation of TAU in Hippocampus of Senile Mice
  187. (−)-β-Caryophyllene, a CB2 receptor-selective phytocannabinoid, suppresses motor paralysis and neuroinflammation in a murine model of multiple sclerosis
  188. (161) Peripheral gene expression changes in the chronic constriction injury (CCI) rat model at the sciatic nerve following administration of neuroinflammation-targeted …
  189. (329) PARP inhibition attenuates neuroinflammation and oxidative stress in chronic constriction injury induced peripheral neuropathy
  190. [11C] PK11195 PET IMAGING REVEALS neuroinflammation IN DEMENTIA WITH LEWY BODIES IS NEGATIVELY ASSOCIATED WITH DISEASE SEVERITY …
  191. [11C] PK11195-PET to assess neuroinflammation in multiple sclerosis (MS) patients undergoing an anti-inflammatory therapy
  192. [11C] PK11195-PET to image neuroinflammation in focal epilepsy
  193. [11C] SSR180575: Preliminary evaluation in rodent models of neuroinflammation
  194. [11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson’s disease?
  195. [11C]DAC-PET for Noninvasively Monitoring neuroinflammation and Immunosuppressive Therapy Efficacy in Rat Experimental Autoimmune Encephalomyelitis …
  196. [11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification …
  197. [11C]PBR28 PET Imaging is Sensitive to neuroinflammation in the Aged Rat
  198. [18F] DBT10 as alpha7-nAChR ligand to image stroke-associated neuroinflammation by PET
  199. [18F] FEBMP: positron emission tomography imaging of TSPO in a model of neuroinflammation in rats, and in vitro autoradiograms of the human brain
  200. [18F]DPA-714 PET Imaging Reveals Global neuroinflammation in Zika Virus-Infected Mice
  201. [18F]DPA-714, a potent PET-based radioligand targeted for translocator protein (18kDa) imaging in neuroinflammation: radiolabeling and in vitro evaluation
  202. [18F]DPA‐C5yne, a novel fluorine‐18‐labelled analogue of DPA‐714: radiosynthesis and preliminary evaluation as a radiotracer for imaging neuroinflammation with …
  203. [18F]Fluoromethyl-PBR28 as a Potential Radiotracer for TSPO: Preclinical Comparison with [11C]PBR28 in a Rat Model of neuroinflammation
  204. [53-OR]: Magnesium sulfate (MgSO4) increases seizure threshold via reduced neuroinflammation in a rat model of preeclampsia
  205. # 7-The Role of RNF216/TRIAD3 in neuroinflammation Through Interactions with Toll-Like-Receptors
  206. 0071 Topic: S25-Symposium 27: The role of neuroinflammation and infection in bipolar disorder and schizophrenia Therapeutic Trials of Minocycline, Ondansetron …
  207. 1-Methylnicotinamide attenuates lipopolysaccharide-induced cognitive deficits via targeting neuroinflammation and neuronal apoptosis
  208. 1-Trichloromethyl-1, 2, 3, 4-tetrahydro-beta-carboline (TaClo) Induces the Apoptosis of Dopaminergic Neurons via Oxidative Stress and neuroinflammation
  209. 112. Infiltrating monocytes contribute to neuroinflammation in obese mice with latent herpes simplex virus-1
  210. 117. Imipramine attenuates neuroinflammation and reverses stress-induced social avoidance
  211. 117.1 TSPO in Microglia Activation and “neuroinflammation”: Are We Ready to Go Beyond Metaphors?
  212. 117.4 Pet Imaging of neuroinflammation in Schizophrenia
  213. 11C-DPA-713 versus 18F-GE-180: a preclinical comparison of translocator protein 18 kDa PET tracers to visualize acute and chronic neuroinflammation in a mouse …
  214. 11C-DPA-713 versus 18F-GE-180: A preclinical comparison of TSPO-PET tracers to visualize acute and chronic neuroinflammation in a mouse model of ischemic …
  215. 11C-DPA-713: a novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation
  216. 11C-PK11195 PET for the in vivo evaluation of neuroinflammation in the rat brain after cortical spreading depression
  217. 12: Evidence for the crucial role of estrogen signaling with preterm labor and perinatal neuroinflammation
  218. 12/15 lipoxygenase inhibition suppresses neuroinflammation in a thrombotic permanent cerebral ischemia model
  219. 123. Evaluating the role of neuroinflammation in head and neck cancer-related symptoms
  220. 129. Blockade of L-type voltage dependent calcium channels or ryanodine receptors during chronic neuroinflammation improves spatial memory and reduces …
  221. neuroinflammation&ots=aCTFZjyh_I&sig=OTPft26v4uDCpQNiy_KuGU4t9Ec”>15 Natural Vitamin E Tocotrienol against neuroinflammation and Oxidative Stress
  222. 151. neuroinflammation: An animal model of fatigue induced through interleukin-1 beta
  223. 159 Mitigating Microglial-Mediated neuroinflammation: The Sur1-Trpm4 Channel Regulates Calcium-Sensitive Induction of iNOS.
  224. 16: MECHANISMS OF NANOPARTICLE UPTAKE IN neuroinflammation INDUCED PEDIATRIC BRAIN INJURY
  225. 16. Methylene blue infusion for treatment of traumatic brain injury-associated neuroinflammation and depressive-like behavior
  226. 17 BETA ESTRADIOL AMELIORATES neuroinflammation DRIVEN NEUROPATHIC PAIN IN CHRONIC CONSTRICTION INJURY-INDUCED PERIPHERAL …
  227. 17-Ethynyl-androst-5-ene-3, 7, 17-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and neuroinflammation in a Murine MPTP Model of Parkinson’s …
  228. 17a-Ethynyl-androst-5-ene-3ß, 7ß, 17ß-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and neuroinflammation in a Murine MPTP Model of …
  229. 17α-Ethynyl-androst-5-ene-3β, 7β, 17β-triol (HE3286) Is neuroprotective and reduces motor impairment and neuroinflammation in a murine MPTP Model of …
  230. neuroinflammation_IN_A_SWINE_MODEL_OF.153.aspx”>186: neuroinflammation IN A SWINE MODEL OF PEDIATRIC CARDIAC ARREST
  231. 18F-DPA-714 PET imaging for detecting neuroinflammation in rats with chronic hepatic encephalopathy
  232. 18F-FEAnGA for PET of β-glucuronidase activity in neuroinflammation
  233. 18F-PBR111 PET Imaging in Healthy Controls and Schizophrenia: Test–Retest Reproducibility and Quantification of neuroinflammation
  234. 18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis
  235. 194: IRF8 regulates autophagy and activates microglia to exacerbate neuroinflammation
  236. 1H NMR-Based Metabolomics of Clinacanthus nutans Leaves Extracts in Correlation with Their Anti-neuroinflammation Towards LPS-Induced BV2 Cells
  237. 2-Deoxy-d-glucose attenuates sevoflurane-induced neuroinflammation through nuclear factor-kappa B pathway in vitro
  238. 2‐AG limits Theiler’s virus induced acute neuroinflammation by modulating microglia and promoting MDSCs
  239. 200. neuroinflammation in Individuals at Clinical High Risk for Psychosis: A PET Study With [(18) F]-FEPPA
  240. 2163 Molecular imaging of cardiac and neuroinflammation early after myocardial infarction and in progressive heart failure
  241. 2283: Brain thermometry to detect neuroinflammation in traumatic brain injury
  242. 24. Tumor progression increases neuroinflammation, fatigue and depressive-like behavior without altering muscle function
  243. 241 Tnf-α Induction of Infant Murine Brain Inflammation Via Ikk/Nf Kappa B Signalling: A Potential Model for Paediatric neuroinflammation
  244. 249 Serial 11C-methionine PET detects involvement of astroglia in neuroinflammation following acute myocardial infarction
  245. 27. neuroinflammation mediates the delayed behavioral effects of microembolism
  246. 270: Maternal MgSo4 paradoxically increases fetal brain cytokines associated with neuroinflammation: suggestion for focused Mg use
  247. 28. Early-life viral infection causes neuroinflammation, cognitive deficits, and changes in neurogenesis in the neonatal piglet
  248. 3, 4-DAA, an orally active synthetic tryptophan catabolite, treats established autoimmune neuroinflammation
  249. 3, 6′‐dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation
  250. 40. NEW INSIGHTS ON THE ROLE OF neuroinflammation IN SCHIZOPHRENIA PATHOPHYSIOLOGY FROM POST MORTEM AND ANIMAL STUDIES
  251. 40.4 LOW-DOSE RISPERIDONE TREATMENT IN ADOLESCENCE PREVENTS THE DEVELOPMENT OF neuroinflammation IN THE MATERNAL …
  252. 43: Distinct dictation of Japanese encephalitis virus-induced neuroinflammation and lethality via triggering TLR3 and TLR4 signal pathways
  253. 4Aβ1-15-derived monoclonal antibody reduces more Aβ burdens and neuroinflammation than homologous vaccine in APP/PS1 mice
  254. 5-lipoxygenase inhibitor zileuton attenuates neuroinflammation and brain damage via modulating ERK1/2 signaling pathway in rats of cerebral ischemia
  255. 5-Lipoxygenase-Activating Protein Inhibitors: Promising Drugs for Treating Acute and Chronic neuroinflammation Following Brain Injury
  256. 573. Evidence of both Systemic Inflammation and neuroinflammation in Patients with Chronic Widespread Pain
  257. 5LO GENETIC DELETION ATTENUATES neuroinflammation IN A P301S MOUSE MODEL OF TAUOAPTHY
  258. 6 neuroinflammation
  259. 6-Gingerol attenuates LPS-induced neuroinflammation and cognitive impairment partially via suppressing astrocyte overactivation
  260. 6-O-angeloylplenolin exerts neuroprotection against lipopolysaccharide-induced neuroinflammation in vitro and in vivo
  261. 6-O-galloylpaeoniflorin attenuates cerebral ischemia reperfusion-induced neuroinflammation and oxidative stress via PI3K/Akt/Nrf2 activation
  262. 6-Shogaol, a ginger product, modulates neuroinflammation: a new approach to neuroprotection
  263. 6-Shogaol, an active compound of ginger, protects dopaminergic neurons in Parkinson’s disease models via anti-neuroinflammation
  264. 6-Shogaol, an active constituent of ginger, attenuates neuroinflammation and cognitive deficits in animal models of dementia
  265. 6‐Mer hyaluronan oligosaccharides modulate neuroinflammation and α‐synuclein expression in neuron‐like SH‐SY5Y cells
  266. 6. Crosstalk between mitochondrial dysfunction and neuroinflammation in TBI
  267. 670 Male Vs Female: Structural Susceptibility to neuroinflammation.
  268. 7-Deoxy-trans-dihydronarciclasine Isolated from Lycoris chejuensis Inhibits neuroinflammation in Experimental Models
  269. 7-Fluoro-1, 3-diphenylisoquinoline reverses motor and non-motor symptoms induced by MPTP in mice: role of striatal neuroinflammation
  270. 7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory …
  271. 7‐methoxyflavanone alleviates neuroinflammation in lipopolysaccharide‐stimulated microglial cells by inhibiting TLR4/MyD88/MAPK signalling and activating the Nrf2 …
  272. 778: BBB DISRUPTION AFTER CORTICAL IMPACT: A ROLE FOR FIBRIN IN POST-TBI neuroinflammation?
  273. 9: The role of Nur77 in perinatal neuroinflammation in a preterm labor mouse model
  274. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer’s disease
  275. A blazing landscape: neuroinflammation shapes brain metastasis
  276. A BRAVE NEURO WORLD: UNCOVERING THE ROLE OF RON RECEPTOR TYROSINE KINASE IN neuroinflammation.
  277. A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis
  278. A Central Role for neuroinflammation in Vascular Clearance of Amyloid-Beta
  279. A changing perspective on the role of neuroinflammation in Alzheimer’s disease
  280. A chemical proteomic atlas of brain serine hydrolases identifies cell type-specific pathways regulating neuroinflammation
  281. A combination of resveratrol and curcumin is effective against aluminum chloride-induced neuroinflammation in rats
  282. A commensal bacterial product elicits and modulates migratory capacity of CD39+ CD4 T regulatory subsets in the suppression of neuroinflammation
  283. A common (GT) n repeat polymorphism in the heme oxygenase-1 promoter associates with neuroinflammation and cognitive impairment in HIV infection (S29. 002)
  284. A comparison of neurodegeneration linked with neuroinflammation in different brain areas of rats after intracerebroventricular colchicine injection
  285. A comparison of neuroinflammation to implanted microelectrodes in rat and mouse models
  286. A comparison of the high‐affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)‐PK11195 in rat models of neuroinflammation: implications for PET …
  287. A constraint kinetic modeling approach to quantify [11C] DPA-713 specific binding for PET imaging of neuroinflammation
  288. A decade of research on TLR2 discovering its pivotal role in glial activation and neuroinflammation in neurodegenerative diseases
  289. A Dual Investigation of Questions in Drug Addiction: Exploring the Role of neuroinflammation in Opioid Withdrawal and A Novel Measure of Reward-Seeking …
  290. A dual role for apolipoprotein E in neuroinflammation
  291. A Facile Radiolabeling of [18F]FDPA via Spirocyclic Iodonium Ylides: Preliminary PET Imaging Studies in Preclinical Models of neuroinflammation
  292. A FAS LYMPHOPROLIFERATIVE PHENOTYPE REVEALS NON-APOPTOTIC FAS SIGNALING IN HTLV-1-ASSOCIATED neuroinflammation
  293. A fashi lymphoproliferative phenotype reveals non-apoptotic fas signaling in HTLV-1-associated neuroinflammation
  294. neuroinflammation/”>A Focus on the Effect of L-Theanine on Improving Depression and Cognition in C57BL/J Male Mice Subjected for Chronic Stress Induced neuroinflammation
  295. A genetic and neurochemical analysis of dopamine regulation in drosophila melanogaster of human neurodegenerative disorders and neuroinflammation
  296. A genetically engineered thermally responsive sustained release curcumin depot to treat neuroinflammation
  297. A lack of ovarian function increases neuroinflammation in aged mice
  298. A lincRNA-p21/miR-181 family feedback loop regulates microglial activation during systemic LPS-and MPTP-induced neuroinflammation
  299. A Logic Model of Neuronal-Glial Interaction Suggests Altered Homeostatic Regulation in the Perpetuation of neuroinflammation
  300. A Malva parviflora´ s fraction prevents the deleterious effects resulting from neuroinflammation
  301. A mathematical model of neuroinflammation in severe clinical traumatic brain injury
  302. A mechanistic link between glia and neuronal excitability in acute neuroinflammation
  303. A method for personalized brain mapping of neuroinflammation using 11C-DPA-713 PET
  304. A model of systemic inflammation to study neuroinflammation
  305. neuroinflammation_in_Ovine_Batten_Disease/links/57fc2e5b08ae329c3d498181/A-Molecular-Dissection-of-neuroinflammation-in-Ovine-Batten-Disease.pdf”>A Molecular Dissection of neuroinflammation in Ovine Batten
  306. A mouse model for juvenile, lateral fluid percussion brain injury reveals sex-dependent differences in neuroinflammation and functional recovery
  307. A Multi-Approach Investigation to Evaluate Compounds that Mitigate neuroinflammation.
  308. A Multifunctional Chemical Agent as an Attenuator of Amyloid and Tau Burden and neuroinflammation in Alzheimer’s Disease
  309. A natural variant of the T cell receptor-signaling molecule Vav1 reduces both effector T cell functions and susceptibility to neuroinflammation
  310. A Naturally Occurring Polymorphism in the HIV-1 Tat Basic Domain Inhibits Uptake by Bystander Cells and Leads to Reduced neuroinflammation
  311. A neuroinflammation Inhibitor, Hypoxylon xanthone A, from Soil Fungus Hypoxylon sp.
  312. A new avenue for treating Parkinson’s disease targeted at aggrephagy modulation and neuroinflammation: Insights from in vitro and animal studies
  313. A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
  314. A new mouse model of prostaglandin J2 (PGJ2) induced neuroinflammation and parkinsonism: Validation using μPET and C-11 labeled radiotracers
  315. A new road to neuroinflammation in Parkinson’s disease?
  316. A new therapeutic target for Alzheimer’s disease: effects of palmitoylethanolamide with luteolin association on neuroinflammation pathway (845.10)
  317. A nitric oxide-donating flurbiprofen derivative reduces neuroinflammation without interacting with galantamine in the rat
  318. A Novel and Selective p38 Mitogen-Activated Protein Kinase Inhibitor Attenuates LPS-Induced neuroinflammation in BV2 Microglia and a Mouse Model
  319. A novel animal model for neuroinflammation and white matter degeneration
  320. A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice
  321. A NOVEL CANNABINOID RECEPTOR 1 ANTAGONIST ALLEVIATES METABOLIC DISORDER AND neuroinflammation IN THE MODELS OF ALZHEIMER’S …
  322. A novel immunosuppressor,(5R)-5-hydroxytriptolide, alleviates movement disorder and neuroinflammation in a 6-OHDA hemiparkinsonian rat model
  323. A Novel Marker for neuroinflammation in Diabetic Neuropathy (P03. 195)
  324. A novel perspective on the ApoM-S1P axis, highlighting the metabolism of ApoM and its role in liver fibrosis and neuroinflammation
  325. A novel PET radioligand,[11C] PS13, successfully images COX-1, a potential biomarker for neuroinflammation.
  326. A novel role for earthworm peptide Lumbricusin as a regulator of neuroinflammation
  327. A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation
  328. A novel targeted local analgesia platform to mitigate neuroinflammation and promote neuroregeneration
  329. A NOVEL THERAPEUTIC (NTRX-07) TARGETING neuroinflammation IN ALZHEIMER’S DISEASE IS UNDERGOING PHASE I TRIALS
  330. A novel treatment of neuroinflammation against low back pain by soluble fullerol nanoparticles
  331. A pilot study of high‐dose intravenous immunoglobulin 5% for autism: Impact on autism spectrum and markers of neuroinflammation
  332. A Pivotal Role for Thiamine Deficiency in the Expression of neuroinflammation Markers in Models of Alcohol‐Related Brain Damage
  333. A potential mechanistic role for neuroinflammation in reward processing impairments in autism spectrum disorder
  334. A potential role for the PD1/PD-L1 pathway in the neuroinflammation of Alzheimer’s disease
  335. A Preliminary Model for the Protective Role of the Endocannabinoid 2-Arachydonylglycerol in neuroinflammation
  336. A prenylated xanthone, cudratricusxanthone A, isolated from Cudrania tricuspidata inhibits lipopolysaccharide-induced neuroinflammation through inhibition of NF-κB …
  337. A Primary Neural Cell Culture Model for neuroinflammation
  338. A promising I-123 labeled radioligand for imaging neuroinflammation response by assessment P2X7 receptor expression
  339. A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis
  340. A research update on the potential roles of aquaporin 4 in neuroinflammation
  341. A review of postoperative cognitive dysfunction and neuroinflammation associated with cardiac surgery and anaesthesia
  342. A review of spinal and peripheral neuromodulation and neuroinflammation: lessons learned thus far and future prospects of biotype development
  343. A Role for CRH and HPA Activation in the Regulation of Plasticity Signaling, neuroinflammation and Emotional/Mnesic Behavior Following Global Cerebral …
  344. A role for cyclooxygenase-1 in β-amyloid-induced neuroinflammation
  345. A role for hypertension in CAA, neuroinflammation and neuropathology In Alzheimer’s?
  346. A role for neuronal NF-κB in suppressing neuroinflammation and promoting neuroprotection in the CNS
  347. A role for the non-receptor tyrosine kinase Abl2/Arg in experimental neuroinflammation
  348. A silver lining of neuroinflammation: beneficial effects on myelination
  349. A single dose of trichloroethylene given during development does not substantially alter markers of neuroinflammation in brains of adult mice
  350. A Single Lipopolysaccharide (LPS) Injection to the Rat Brain Induces neuroinflammation Two Months After Treatment
  351. A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation
  352. A sterile animal model for neuroinflammation?
  353. A strategy to passively reduce neuroinflammation surrounding devices implanted chronically in brain tissue by manipulating device surface permeability
  354. A study of the effects of chronic neuroinflammation on cognition and behaviour in the GFAP-IL6 transgenic mouse and investigation of the flavonoid apigenin as a …
  355. A Study of the Endogenous Control of neuroinflammation, A Leading Cause of Morbidity from Traumatic Brain Injury
  356. A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats
  357. A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson’s disease and potential molecular targets
  358. A Systematic review of positron emission tomography of tau, amyloid beta, and neuroinflammation in chronic traumatic encephalopathy: the evidence to date
  359. A TELOscopic view of neuroinflammation
  360. A thin-skull window technique for chronic two-photon in vivo imaging of murine microglia in models of neuroinflammation
  361. A Tip leads cytotoxic T cells to the crime scene in neuroinflammation
  362. A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation
  363. A Zika Virus Primary Isolate Induces neuroinflammation, Compromises the Blood-Brain Barrier, and Upregulates CXCL12 in Adult Macaques
  364. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis
  365. A16 Endoplasmic reticulum stress: an initiator of neuroinflammation in Huntington’s disease?
  366. A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation
  367. A31 The development of translational biomarkers of neuroinflammation in a mouse model of huntington’s disease
  368. AAV-mediated gene delivery attenuates neuroinflammation in feline Sandhoff disease
  369. AAV9-mediated expression of a non-self protein in nonhuman primate central nervous system triggers widespread neuroinflammation driven by antigen …
  370. AB0050 Irf8 Promotes TH17 Differentiation via Activation of Integrin-Mediated Tgfbeta Signaling in neuroinflammation
  371. ABCA1 influences neuroinflammation and neuronal death
  372. Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation
  373. Ablation of the pro-inflammatory master regulator miR-155 does not mitigate neuroinflammation or neurodegeneration in a vertebrate model of Gaucher’s disease
  374. Ablation of the transcription factors E2F1-2 limits neuroinflammation and associated neurological deficits after contusive spinal cord injury
  375. Abnormal increase of neuronal precursor cells and exacerbated neuroinflammation in the corpus callosum in murine model of systemic lupus erythematosus
  376. Absence of galectin-3 attenuates neuroinflammation improving functional recovery after spinal cord injury
  377. Absence of the cellular prion protein exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyelitis
  378. Abstract OT2-05-03: Does minocycline mitigate chemotherapy induced neuroinflammation? A phase II randomized placebo controlled study
  379. Abstract P2-11-04: Chemotherapy Induces neuroinflammation and Cognitive Deficits in Female Mice
  380. Abstract TMP35: CD200-CD200R1 Inhibitory Signaling Attenuates neuroinflammation and Reduces Behavioral Deficits Following Ischemic Stroke
  381. Abstract TP102: Modulation of neuroinflammation by Haptoglobin Reduces Oxidative Stress and Improves ICH Outcomes
  382. Abstract TP141: Mesenchymal Stem Cell Derived Exosomes as a Modulator of neuroinflammation Following Cortical Injury
  383. Abstract TP226: Aging and Smoking Exacerbates Post-Stroke Complement Driven neuroinflammation
  384. Abstract TP279: Brain-Derived Microparticles Mediate neuroinflammation After Stroke
  385. Abstract TP317: Chemokine Production by Microglia Mediates Blood-Derived Monocytes Trafficking in neuroinflammation
  386. Abstract TP337: Microglial Activation and neuroinflammation Are Mediated by Over-Activation of Cofilin After Intracerebral Hemorrhage
  387. Abstract W P250: Food Restriction Ameliorates neuroinflammation and Provides Protection in a Mouse Model of Ischemic Stroke
  388. Abstract W P369: Inhibitory Effect of FTY720 on neuroinflammation in Cerebral Ischemia-reperfusion
  389. Abstract WMP37: Neurovascular Protection by Telmisartan Via Reducing neuroinflammation in SHR-SR Brain After Ischemic Stroke
  390. Abstract WMP73: Discerning How Vascular Inflammation Modulates neuroinflammation Using Novel Vascular Brain Organ-On-A-Chip: Proof-of-Concept Study
  391. Abstract WMP79: Phosphatidylserine-containing Liposomes Pretreatment Attenuates neuroinflammation in a Rat Model of Surgical Brain Injury
  392. Abstract WP142: Targeting VCAM1 to Reduce Acute and Chronic neuroinflammation After Stroke
  393. Abstract WP159: FPS-ZM1 Alleviates neuroinflammation in Focal Cerebral Ischemia Rats via Blocking the RAGE/DIAPH1/NF-kappa B Pathway
  394. Abstract WP418: Mineralocorticoid Receptor Signaling is Associated With neuroinflammation and Changes in Cognitive Function in Angiotensin II-Induced …
  395. Abstract# 1704 Cardiac surgery causes more extended neuroinflammation and cognitive dysfunction compared to abdominal surgery in rats
  396. Abstract# 1736 The role of endothelial IL-1R1 in anxiogenic neuroinflammation
  397. Abstract# 1831 Repeated social defeat stress-induced neuroinflammation contributes to later fear sensitization and impaired extinction recall of fear conditioning in …
  398. Abstract# 3081 Impaired cognition and fatigue; the role of sleep and neuroinflammation for non-specific symptoms in allergy
  399. Abstract# 3113 The role of estrogen in tumor-induced cognitive performance and neuroinflammation
  400. Abstract# 3114 neuroinflammation and chemotherapy-related fatigue
  401. Abstract# 3175 Mycobacterium vaccae immunization protects aged rats from surgery-elicited neuroinflammation and cognitive dysfunction
  402. Abstract# 3182 neuroinflammation and hypertension iteract in the pathogenesis of white matter hyperintensity in subjects with mild cognitive impairment
  403. Acacetin attenuates neuroinflammation via regulation the response to LPS stimuli in vitro and in vivo
  404. Acacetin protects dopaminergic cells against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neuroinflammation in vitro and in vivo
  405. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson’s …
  406. Accelerated neurodegeneration and neuroinflammation in transgenic mice expressing P301L tau mutant and tau-tubulin kinase 1
  407. Accelerated neurodegeneration and phenotypic switch of neuroinflammation in transgenic mice expressing P301L tau-mutant and tau-tubulin kinase 1
  408. Accessible method for the development of novel sterol analogues with dipeptide-like side chains that act as neuroinflammation inhibitors
  409. Accessing neuroinflammation sites: Monocyte/neutrophil-mediated drug delivery for cerebral ischemia
  410. Accumulation of class switched IgD− IgM− memory B cells in the cerebrospinal fluid during neuroinflammation
  411. Accumulation of quinolinic acid with neuroinflammation: does it mean excitotoxicity?
  412. Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine
  413. Acetate supplementation attenuates lipopolysaccharide‐induced neuroinflammation
  414. Acetate supplementation modulates brain adenosine metabolizing enzymes and adenosine A2Areceptor levels in rats subjected to neuroinflammation
  415. Acetate supplementation modulates brain histone acetylation and decreases interleukin-1β expression in a rat model of neuroinflammation
  416. Acetate, an Ethanol Metabolite Increases neuroinflammation and Neuronal Death: Implications in Ethanol Neurodegeneration
  417. Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation
  418. Acetylcholinesterase inhibitors reduce neuroinflammation and-degeneration in the cortex and hippocampus of a surgery stress rat model
  419. Acetylcholinesterase-Inhibitoren reduzieren die neuroinflammation und-degeneration im Cortex und Hippocampus in einem Operations-Stressmodell der adulten …
  420. Acetylpuerarin inhibits oxygen‑glucose deprivation‑induced neuroinflammation of rat primary astrocytes via the suppression of HIF‑1 signaling
  421. Achyranthes bidentata polypeptide k suppresses neuroinflammation in BV2 microglia through Nrf2-dependent mechanism
  422. Acid-sensing ion channels as potential therapeutic targets in neurodegeneration and neuroinflammation
  423. Acorus gramineus inhibits microglia mediated neuroinflammation and prevents neurotoxicity in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced mouse …
  424. Acrolein Scavenger Hydralazine Prevents Streptozotocin‐Induced Painful Diabetic Neuropathy and Spinal neuroinflammation in Rats
  425. Actin filament reorganization in astrocyte networks is a key functional step in neuroinflammation resulting in persistent pain: novel findings on network restoration
  426. Activated microglia targeting dendrimer–minocycline conjugate as therapeutics for neuroinflammation
  427. Activation of adenosine monophosphate–activated protein kinase suppresses neuroinflammation and ameliorates bone cancer paininvolvement of inhibition …
  428. Activation of dopamine D2 receptor suppresses neuroinflammation through αB-crystalline by inhibition of NF-κB nuclear translocation in experimental ICH mice model
  429. Activation of glial α7 nAChR promotes neurogenesis by suppressing Aβ-mediated neuroinflammation in Alzheimer’s disease
  430. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1140-6″>Activation of melanocortin receptor 4 with RO27-3225 attenuates neuroinflammation through AMPK/JNK/p38 MAPK pathway after intracerebral hemorrhage in …
  431. Activation of Melanocortin-4 Receptor by a Synthetic Agonist Inhibits Ethanolinduced neuroinflammation in Rats
  432. Activation of Melanocortin-4 Receptor Inhibits Both neuroinflammation Induced by Early Exposure to Ethanol and Subsequent Voluntary Alcohol Intake in …
  433. Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease
  434. Activation of microglial poly (ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal …
  435. Activation of nicotinic acetylcholine receptors on bone marrow-derived cells relieves neuropathic pain accompanied by peripheral neuroinflammation
  436. Activation of P2X7 receptors in peritoneal and meningeal mast cells detected by uptake of organic dyes: possible purinergic triggers of neuroinflammation in …
  437. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses
  438. Activation of the G Protein-Coupled Estrogen Receptor (GPER) Increases Neurogenesis and Ameliorates neuroinflammation in the Hippocampus of Male …
  439. Activation of the STING-dependent type I interferon response reduces microglial reactivity and neuroinflammation
  440. Acupuncture Resolves Persistent Pain and neuroinflammation in a Mouse Model of Chronic Overlapping Pain Conditions
  441. Acupuncture suppresses stress-induced neuroinflammation in the rat hypothalamus
  442. Acute Alcohol Intoxication is Associated With Sustained neuroinflammation Without Exacerbation of Early Neurobehavioral Outcomes Post Traumatic Brain Injury
  443. Acute alcohol intoxication prolongs neuroinflammation without exacerbating neurobehavioral dysfunction following mild traumatic brain injury
  444. Acute and long-term effects of haloperidol on surgery-induced neuroinflammation and cognitive deficits in aged rats
  445. Acute CSF interleukin-6 trajectories after TBI: associations with neuroinflammation, polytrauma, and outcome
  446. Acute drivers of neuroinflammation in traumatic brain injury
  447. Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury
  448. Acute inhalation of combustion smoke triggers neuroinflammation and persistent anxiety-like behavior in the mouse
  449. Acute Kahweol Treatment Attenuates Traumatic Brain Injury neuroinflammation and Functional Deficits
  450. Acute neuroinflammation and glial reactivity to rebuild neural circuits: Unraveling the role of inflammatory mediators during zebrafish optic nerve regeneration
  451. Acute neuroinflammation and neurogenesis: a role for microglial COX-1
  452. Acute neuroinflammation elicited by TLR-3 systemic activation combined with early life stress induces working memory impairments in male adolescent mice
  453. Acute neuroinflammation exacerbates excitotoxicity in rat hippocampus in vivo
  454. Acute neuroinflammation impairs context discrimination memory and disrupts pattern separation processes in hippocampus
  455. Acute neuroinflammation in a clinically relevant focal cortical ischemic stroke model in rat: longitudinal positron emission tomography and immunofluorescent tracking
  456. Acute neuroinflammation in Lewis rats—a model for acute multiple sclerosis relapses
  457. Acute neuroinflammation induces AIS structural plasticity in a NOX2-dependent manner
  458. Acute neuroinflammation mediates optic nerve regeneration in adult zebrafish
  459. Acute neuroinflammation promotes cell responses to 1800 MHz GSM electromagnetic fields in the rat cerebral cortex
  460. Acute neuroinflammation provokes intracellular acidification in mouse hippocampus
  461. Acute nicotine treatment attenuates lipopolysaccharide-induced cognitive dysfunction by increasing BDNF expression and inhibiting neuroinflammation in the rat …
  462. Acute postoperative pain exacerbates neuroinflammation and related delirium-like cognitive dysfunction in rats
  463. Acute social defeat-induced neuroinflammation in the vmPFC of Syrian hamsters via microglial activation
  464. Acute, chronic, and nonclassical neuroinflammation: Definitions in a changing scientific environment
  465. Acyl ghrelin improves cognition, synaptic plasticity deficits and neuroinflammation following amyloid β (Aβ1‐40) administration in mice
  466. Adalimumab improves cognitive impairment, exerts neuroprotective effects and attenuates neuroinflammation in an Aβ1-40-injected mouse model of Alzheimer’s …
  467. ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia–reperfusion injury
  468. Adaptive brain shut-down counteracts neuroinflammation in the near-term ovine fetus
  469. Adenosine 2A receptor: a crucial neuromodulator with bidirectional effect in neuroinflammation and brain injury
  470. Adenosine A2A receptor involves in neuroinflammation-mediated cognitive decline through activating microglia under acute hypobaric hypoxia
  471. Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction
  472. Adenosine Receptors and neuroinflammation
  473. Adenosine Receptors Modulate Acute Injury and neuroinflammation in Brain Ischemia
  474. Adipocyte cannabinoid CB1 receptor deficiency alleviates high fat diet-induced memory deficit, depressive-like behavior, neuroinflammation and impairment in adult …
  475. Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?
  476. AdipoRon Attenuates neuroinflammation After Intracerebral Hemorrhage Through AdipoR1-AMPK Pathway
  477. Adipose mesenchymal stem cell transplantation alleviates spinal cord injury-induced neuroinflammation partly by suppressing the Jagged1/Notch pathway
  478. Adjudin protects against cerebral ischemia reperfusion injury by inhibition of neuroinflammation and blood-brain barrier disruption
  479. Adolescent traumatic brain injury induces chronic mesolimbic neuroinflammation with concurrent enhancement in the rewarding effects of cocaine in mice during …
  480. neuroinflammation-and-neurodegeneration-in-parki”>Adrenergic Receptors as Pharmacological Targets for neuroinflammation and Neurodegeneration in Parkinson’s Disease
  481. Adult Mice Exposed to Aerosalized Alternaria Exhibit neuroinflammation in the Brainstem but not Rest of Brain
  482. Adult neural stem cells for the treatment of neuroinflammation: Fondazione Centro San Raffaele del Monte Tabor: WO2007015173
  483. Adult neurogenesis, neuroinflammation and therapeutic potential of adult neural stem cells
  484. ADVANCING THERAPEUTICS FOR neuroinflammation IN ALZHEIMER’S DISEASE: CLINICAL DEVELOPMENT CONSIDERATIONS
  485. Agathisflavone isolated from Anacardium occidentale suppresses SIRT1‐mediated neuroinflammation in BV2 microglia and neurotoxicity in APPSwe‐transfected SH …
  486. Age and neuroinflammation: a lifetime of psychoneuroimmune consequences
  487. Age and neuroinflammation: a lifetime of psychoneuroimmune consequences
  488. Age exacerbates surgery-induced cognitive impairment and neuroinflammation in Sprague-Dawley rats: the role of IL-4
  489. Age related macular degeneration and drusen: neuroinflammation in the retina
  490. Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD
  491. AGE-DEPENDENT NEUROPROTECTIVE EFFECTS OF CLUSTERIN IN THE SETTING OF neuroinflammation
  492. AGE-NORMED DIFFUSION BASIS SPECTRUM IMAGING (DBSI) CELL RATIOS TO ASSESS neuroinflammation IN ALZHEIMER’S DISEASE CLINICAL TRIALS
  493. Age-related changes in neuroinflammation and prepulse inhibition in offspring of rats treated with Poly I: C in early gestation
  494. Age-related cognitive impairment is associated with long-term neuroinflammation and oxidative stress in a mouse model of episodic systemic inflammation
  495. Age-related differences in secondary neuroinflammation and amyloid-β deposition in a rat sepsis model
  496. Age-related neuroinflammation and changes in AKT-GSK-3β and WNT/β-CATENIN signaling in rat hippocampus
  497. Age-specific susceptibility to neuroinflammation during post-natal development
  498. Age‐dependent release of high‐mobility group box protein‐1 and cellular neuroinflammation after traumatic brain injury in mice
  499. Aged Mice Lacking Fatty Acid Amide Hydrolase Show Reduced neuroinflammation, Senescence, and Cognitive Impairment
  500. Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice
  501. Ageing, neuroinflammation and neurodegeneration
  502. Aging alters Hv1‐mediated microglial polarization and enhances neuroinflammation after peripheral surgery
  503. Aging and Parkinson’s Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis
  504. Aging differentially affects the loss of neuronal dendritic spine, neuroinflammation and memory impairment at rats after surgery
  505. Aging modulates microglia phenotypes in neuroinflammation of MPTP-PD mice
  506. Aging, Immunity, and neuroinflammation: The Modulatory Potential of Nutrition
  507. Aging, neurogenesis and neuroinflammation in hearing loss and protection
  508. neuroinflammation&ots=Y6qNt5Oc4C&sig=7Evx-84l3x4IzaV8IXiapicy_ew”>Aging, neuroinflammation, and Behavior
  509. AGK2 Alleviates Lipopolysaccharide Induced neuroinflammation through Regulation of Mitogen-Activated Protein Kinase Phosphatase-1
  510. Agmatine Produces Antidepressant Effect via Modulation of neuroinflammation in Chronic Unpredictable Mild Stress Model of Rats: Implication in Inflammatory …
  511. Agomelatine could prevent brain and cerebellum injury against LPS-induced neuroinflammation in rats
  512. Agonism of peroxisome proliferator receptor-gamma may have therapeutic potential for neuroinflammation and Parkinson’s disease
  513. Air pollution & the brain: subchronic diesel exhaust exposure causes neuroinflammation and elevates early markers of neurodegenerative disease
  514. Air pollution, a rising environmental risk factor for cognition, neuroinflammation and neurodegeneration: the clinical impact on children and beyond
  515. Air pollution: mechanisms of neuroinflammation and CNS disease
  516. Akkermansia muciniphila ameliorates depressive symptoms in irritable bowel syndrome via improving neuroinflammation
  517. AKR1B1 upregulation contributes to neuroinflammation and astrocytes proliferation by regulating the energy metabolism in rat spinal cord injury
  518. Alarm or curse? The pain of neuroinflammation
  519. ALCAM regulates BBB integrity and neuroinflammation
  520. ALCAM: cell adhesion molecule or tight junction? The characterization of its role in the context of neuroinflammation
  521. Alcohol abuse enhances neuroinflammation and impairs immune responses in an animal model of human immunodeficiency virus-1 encephalitis
  522. Alcohol and Alzheimer’s Disease—Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, neuroinflammation and Neurodegeneration in Alzheimer’s …
  523. Alcohol brain damage and neuroinflammation: Is there a connection?
  524. Alcohol exposure after mild focal traumatic brain injury impairs neurological recovery and exacerbates localized neuroinflammation
  525. Alcohol shifts gut microbial networks and ameliorates a murine model of neuroinflammation in a sex-specific pattern
  526. Alcohol-Induced neuroinflammation in an Animal Model of FASD and Neuroprotection by Anti-Inflammatory Agents
  527. Alcohol‐induced IL‐1β in the brain is mediated by NLRP3/ASC inflammasome activation that amplifies neuroinflammation
  528. Alcohol, Phospholipase A2-associated neuroinflammation, and ω3 Docosahexaenoic Acid Protection
  529. Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer’s disease related pathology
  530. Alginate-derived oligosaccharide inhibits neuroinflammation and promotes microglial phagocytosis of β-amyloid
  531. All trans retinoic acid attenuates markers of neuroinflammation in rat brain by modulation of SIRT1 and NFκB
  532. All-trans retinoic acid (ATRA) prevents lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment in aged rats
  533. All-Trans-Retinoic Acid Augments the Histopathological Outcome of neuroinflammation and Neurodegeneration in Lupus-Prone MRL/lpr Mice
  534. Alleviation of symptoms of Alzheimer’s disease by diminishing Aβ neurotoxicity and neuroinflammation
  535. Allopregnanolone and neuroinflammation: a focus on multiple sclerosis
  536. Allyl sulfide counteracts 1-bromopropane-induced neurotoxicity by inhibiting neuroinflammation and oxidative stress
  537. Allyl-isothiocynate (AITC) ameliorates LPS induced NF-κB mediated neuroinflammation
  538. Alpha-1 antitrypsin attenuates M1 microglia-mediated neuroinflammation in retinal degeneration
  539. Alpha-chymotrypcin ameliorates neuroinflammation and apoptosis characterizing Alzheimer’s disease-induced in ovarictomized rats
  540. Alpha-lipoic acid attenuates acute neuroinflammation and long-term cognitive impairment after polymicrobial sepsis
  541. Alpha-synuclein stimulation of astrocytes: potential role for neuroinflammation and neuroprotection
  542. Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease
  543. Alpha-tocopherol quinine ameliorates spatial memory deficits by reducing beta-amyloid oligomers, neuroinflammation and oxidative stress in transgenic mice with …
  544. Alpha‐7 nicotinic acetylcholine receptor agonist treatment reduces neuroinflammation, oxidative stress, and brain injury in mice with ischemic stroke and bone fracture
  545. Alteration in nuclear factor-kappaB pathway and functionality of estrogen via receptors promote neuroinflammation in frontal cortex after 1-Methyl-4-Phenyl-1 …
  546. Alteration of Blood Brain Barrier during Cuprizone-Induced neuroinflammation using multi-tracers with PET:[68Ga] EDTA,[11C](R) PK11195, and [11C] DPA713
  547. Alteration of nuclear factor-kappaB pathway promote neuroinflammation depending on the functions of estrogen receptors in substantia nigra after 1-methyl-4-phenyl …
  548. ALTERATIONS IN DNA METHYLATION CONTRIBUTE TO neuroinflammation IN ALZHEIMER’S DISEASE
  549. Alterations in frontal white matter neurochemistry and microstructure in schizophrenia: implications for neuroinflammation
  550. Alterations in immune cells and mediators in the brain: it’s not always neuroinflammation!
  551. Alterations in striatal microRNA-mRNA networks contribute to neuroinflammation in multiple system atrophy
  552. Alterations in the endocannabinoid syste m as a link between unbalanced energy homeostasis, neuroinflammation, and neurological and neuropsychiatric disorders
  553. Alterations in tight junction protein and IgG permeability accompany leukocyte extravasation across the choroid plexus during neuroinflammation
  554. Altered amyloid metabolism in neuroinflammation
  555. Altered filamin A enables amyloid beta-induced tau hyperphosphorylation and neuroinflammation in Alzheimer’s disease
  556. Altered function of neuronal L-type calcium channels in ageing and neuroinflammation: Implications in age-related synaptic dysfunction and cognitive decline
  557. Altered gut microbiome in a mouse model of Gulf War Illness causes neuroinflammation and intestinal injury via leaky gut and TLR4 activation
  558. Altered neuroinflammation and behavior after traumatic brain injury in a mouse model of Alzheimer’s disease
  559. neuroinflammation_and_behavior_following_traumatic_brain_injury_in_a_mouse_model_of_Alzheimer’s_disease/links/561804e108ae044edbad0917/Altered-neuroinflammation-and-behavior-following-traumatic-brain-injury-in-a-mouse-model-of-Alzheimers-disease.pdf”>Altered neuroinflammation and behavior following traumatic brain injury in a mouse model of Alzheimer’s disease
  560. Altered Social Behavior and neuroinflammation in a Mouse Model of Pten Mislocalization
  561. Alternate Activation of Microglia as a Protective Adaptation against Chronic neuroinflammation in Young Rats
  562. Aluminum chloride induces neuroinflammation, loss of neuronal dendritic spine and cognition impairment in developing rat
  563. Alzheimer disease and neuroinflammation
  564. Alzheimer’s disease, neuroinflammation and the influence of different combinations of nutrients
  565. Alzheimer’s disease: recent concepts on the relation of mitochondrial disturbances, excitotoxicity, neuroinflammation, and kynurenines
  566. neuroinflammation_IN_RATS/links/5bf5ed91299bf1124fe4cffb/AMELIORATION-EFFECT-OF-Clinacanthus-nutans-ON-LPS-INDUCED-neuroinflammation-IN-RATS.pdf”>Amelioration effect of Clinacanthus nutans on LPS-induced neuroinflammation in rats
  567. Amelioration of age associated neuroinflammation on long term bacosides treatment
  568. Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein
  569. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-10-36″>Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14· TRAIL
  570. Amelioration of diabetes-induced cognitive deficits by GSK-3β inhibition is attributed to modulation of neurotransmitters and neuroinflammation
  571. Amelioration of neuroinflammation and apoptosis characterizing Alzheimer’s disease by natural products’
  572. neuroinflammation_and_Oxidative_Damage_in_Rats/links/5badada192851ca9ed2b8f7f/Ameliorative-Potential-of-Euphorbia-hirta-Linn-Extract-against-Lipopolysaccharide-Induced-neuroinflammation-and-Oxidative-Damage-in-Rats.pdf”>Ameliorative Potential of Euphorbia hirta (Linn.) Extract against Lipopolysaccharide Induced-neuroinflammation and Oxidative Damage in Rats
  573. Aminochrome decreases NGF, GDNF and induces neuroinflammation in organotypic midbrain slice cultures
  574. Aminopyridazines attenuate hippocampus-dependent behavioral deficits induced by human β-amyloid in a murine model of neuroinflammation
  575. Amitriptyline and bromazepam in the treatment of vibratory angioedema: which role for neuroinflammation?
  576. Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats
  577. neuroinflammation_and.854.aspx”>Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats: A-921
  578. Amitriptyline suppresses neuroinflammation-dependent interleukin-10-p38 mitogen-activated protein kinase-heme oxygenase-1 signaling pathway in chronic …
  579. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1216-3″>Ammoxetine attenuates diabetic neuropathic pain through inhibiting microglial activation and neuroinflammation in the spinal cord
  580. Ampelopsin improves cognitive impairment in Alzheimer’s disease and involvement of neuroinflammation and oxidative stress in the hippocampus.
  581. Amphetamine-Induced Sensitization of Hypertension and Lamina Terminalis neuroinflammation
  582. AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration
  583. AMPK and SIRT1 activation contribute to inhibition of neuroinflammation by thymoquinone in BV2 microglia
  584. Amylin treatment reduces neuroinflammation and ameliorates abnormal patterns of gene expression in the cerebral cortex of an Alzheimer’s disease mouse model
  585. Amyloid burden, neuroinflammation, and links to cognitive decline after ischemic stroke
  586. Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation
  587. Amyloid peptide induced neuroinflammation increases the P2X7R expression in microglial cells impacting to their functionality
  588. Amyloid-associated proteins, neuroinflammation and neurofibrillary degeneration in Alzheimer’s disease and cerebral prion amyloidosis
  589. Amyloid‐β neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK‐3β, tau and neuroinflammation
  590. Amyotrophic lateral sclerosis and multiple sclerosis associated neuroinflammation: nationwide epidemiological studies on etiology, comorbidities, and treatment
  591. Amyotrophic Lateral Sclerosis, neuroinflammation, and Cromolyn
  592. An altered blood–brain barrier contributes to brain iron accumulation and neuroinflammation in the 6-OHDA rat model of Parkinson’s disease
  593. An alternative path to reduce neuroinflammation
  594. An apoE-derived mimic peptide, COG1410, alleviates early brain injury via reducing apoptosis and neuroinflammation in a mouse model of subarachnoid hemorrhage
  595. An aqueous extract of herbal medicine ALWPs enhances cognitive performance and inhibits LPS-induced neuroinflammation via FAK/NF-κB signaling …
  596. An eighteen-month helicobacter infection does not induce amyloid plaques or neuroinflammation in brains of wild type C57BL/6J mice
  597. An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation
  598. An Evaluation of GABAB Receptors on Modulating neuroinflammation in a Non-Transgenic Animal Model of Alzheimer’s Disease
  599. An in vitro experimental model of neuroinflammation: the induction of interleukin‐6 in murine astrocytes infected with Theiler’s murine encephalomyelitis virus, and its …
  600. An integrative approach to neuroinflammation in psychiatric disorders and neuropathic pain
  601. An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling
  602. AN ISOFORM-SPECIFIC ROLE OF FYNT IN ALZHEIMER’S DISEASE AND ITS RELEVANCE IN neuroinflammation
  603. An open-label trial of JAK 1/2 blockade in progressive IFIH1-associated neuroinflammation
  604. Analysis of Aβ and neuroinflammation as a function of brain region and disease progression in the TgCRND8 brain
  605. Analysis of the pain and neuroinflammation after rats with neuropathic pain receive immunoglobulin intervention
  606. Anandamide, acting via CB2 receptors, alleviates LPS-induced neuroinflammation in rat primary microglial cultures
  607. neuroinflammation&ots=RMtS0vhQRl&sig=tmC2_3dV1QU1T0wJHKqMIKEK6wY”>and Their Receptors in neuroinflammation
  608. Andalucin from Artemisia lannta suppresses the neuroinflammation via the promotion of Nrf2-mediated HO-1 levels by blocking the p65–p300 interaction in LPS …
  609. Andrographolide ameliorates intracerebral hemorrhage induced secondary brain injury by inhibiting neuroinflammation induction
  610. Andrographolide does not protect against neuroinflammation in a Parkinsonism model: Focus on tumor necrosis factor alpha
  611. Andrographolide enhances hippocampal BDNF signaling and suppresses neuronal apoptosis, astroglial activation, neuroinflammation, and spatial memory deficits in …
  612. Andrographolide Reduces neuroinflammation and Oxidative Stress in Aged Octodon degus
  613. Anesthesia, surgery and neuroinflammation
  614. Anesthetic immunomodulation of the neuroinflammation in postoperative cognitive dysfunction
  615. Anesthetic modulation of neuroinflammation in Alzheimer’s disease
  616. Aneurysmal subarachnoid hemorrhage and neuroinflammation: a comprehensive review
  617. Angelicae Gigantis Radix Regulates LPS-Induced neuroinflammation in BV2 Microglia by Inhibiting NF-κB and MAPK Activity and Inducing Nrf-2 Activity
  618. Angiotensin II type 1a receptors in the subfornical organ modulate neuroinflammation in the hypothalamic paraventricular nucleus in heart failure rats
  619. Angiotensin II-Induced neuroinflammation Contributes to Sympathetic Overactivity in Hypertensive Rats.
  620. Angiotensin receptor blockade modulates NFκB and STAT3 signaling and inhibits glial activation and neuroinflammation better than angiotensin-converting enzyme …
  621. Angiotensin receptor blocker, losartan ameliorates neuroinflammation and behavioral consequences of lipopolysaccharide injection
  622. Angiotensin type 1 receptor antagonists protect against alpha-synuclein-induced neuroinflammation and dopaminergic neuron death
  623. Angiotensin type 2 receptors: role in aging and neuroinflammation in the substantia nigra
  624. Angiotensin-converting enzyme inhibitor suppresses Type I interferon responses, decreases neuroinflammation and improves depression-like behavior in MRL/lpr …
  625. neuroinflammation&ots=EyPHIMHAMi&sig=wbCgeRHRmnM7Wpc7zM55o8tXisI”>Animal model of Parkinson disease: neuroinflammation and apoptosis in the 6-hydroxydopamine-induced model
  626. Animal models of neuroinflammation secondary to acute insults originated outside the brain
  627. Annexin A1 attenuates neuroinflammation through FPR2/p38/COX‐2 pathway after intracerebral hemorrhage in male mice
  628. Annexin A1 Bioactive Peptide Promotes Resolution of neuroinflammation in an Experimental Model of Exsanguinating Cardiac Arrest Treated by Emergency …
  629. Annexin A2 Deficiency Exacerbates neuroinflammation and Long-Term Neurological Deficits after Traumatic Brain Injury in Mice
  630. Announcement of Special Issues for 2019: Stress and neuroinflammation
  631. Annual research review: the neuroinflammation hypothesis for stress and psychopathology in children–developmental psychoneuroimmunology
  632. Antagonist of the neurokinin-1 receptor curbs neuroinflammation in ex vivo and in vitro models of Lyme neuroborreliosis
  633. Antarctic krill oil diet protects against lipopolysaccharide-induced oxidative stress, neuroinflammation and cognitive impairment
  634. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0752-y”>Anthocyanins abrogate glutamate-induced AMPK activation, oxidative stress, neuroinflammation, and neurodegeneration in postnatal rat brain
  635. Anthocyanins attenuate neuroinflammation through the suppression of MLK3 activation in a mouse model of perioperative neurocognitive disorders
  636. Anthocyanins control neuroinflammation and consequent memory dysfunction in mice exposed to lipopolysaccharide
  637. Anthocyanins from Lycium ruthenicum Murr. Ameliorated d-Galactose-Induced Memory Impairment, Oxidative Stress, and neuroinflammation in Adult Rats
  638. Anthocyanins protect against LPS-induced oxidative stress-mediated neuroinflammation and neurodegeneration in the adult mouse cortex
  639. Anthocyanins reversed D-galactose-induced oxidative stress and neuroinflammation mediated cognitive impairment in adult rats
  640. Anti-allodynic effects of obtusifolin and gluco-obtusifolin against inflammatory and neuropathic pain: Possible mechanism for neuroinflammation
  641. neuroinflammation/”>Anti-inflammatory activity of hydroxytyrosol inhibition of cytokine production in a Parkinson’s model system of neuroinflammation
  642. Anti-Inflammatory and neuroprotective effect of apigenin: Studies in the GFAP-IL6 mouse model of chronic neuroinflammation
  643. Anti-inflammatory effect of afatinib (an EGFR-TKI) on OGD-induced neuroinflammation
  644. Anti-inflammatory Effect of AZD6244 on Acrolein-Induced neuroinflammation
  645. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1361-8″>Anti-inflammatory effects induced by pharmaceutical substances on inflammatory active brain astrocytes—promising treatment of neuroinflammation
  646. Anti-inflammatory Effects of ,-Dihydroxyeudesm-4(15)-ene Isolated from Myrrh on LPS-induced neuroinflammation in BV2 cells
  647. Anti-inflammatory mechanism of Isodon japonicas (Burm) Hara on lipopolysaccharide-induced neuroinflammation
  648. Anti-inflammatory mechanism of lonchocarpine in LPS-or poly (I: C)-induced neuroinflammation
  649. Anti-inflammatory role of microsomal prostaglandin E synthase-1 in a model of neuroinflammation
  650. Anti-inflammatory therapy with simvastatin improves neuroinflammation and CNS function in a mouse model of metachromatic leukodystrophy
  651. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-197″>Anti-inflammatory/anti-amyloidogenic effects of plasmalogens in lipopolysaccharide-induced neuroinflammation in adult mice
  652. Anti-Malarial Drug Artemisinin Extenuates Amyloidogenesis and neuroinflammation in APPswe/PS1dE9 Transgenic Mice Via Inhibition of NF-κB and NLRP3 …
  653. Anti-neuroinflammation activity of acetylpuerarin mediated by a PKC-δ-dependent caspase signaling pathway: in vivo and in vitro studies
  654. Anti-neuroinflammation ameliorates systemic inflammation-induced mitochondrial DNA impairment in the nucleus of the solitary tract and cardiovascular reflex …
  655. Anti-neuroinflammation effect of ginsenoside Rbl in a rat model of Alzheimer disease
  656. Anti-neuroinflammatory effects of DPTP, a novel synthetic clovamide derivative in in vitro and in vivo model of neuroinflammation
  657. Anti-neuroinflammatory effects of Quercetin-3-O-glucuronide isolated from the leaf of Vitis labruscana on LPS-induced neuroinflammation in BV2 cells
  658. Anti-NMDAR encephalitis: demonstration of neuroinflammation and the effect of immunotherapy
  659. Antidepressant activity of crocin-I is associated with amelioration of neuroinflammation and attenuates oxidative damage induced by corticosterone in mice
  660. Antidepressant activity of ω-3 polyunsaturated fatty acids in ovariectomized rats: role of neuroinflammation and microglial polarization
  661. neuroinflammation_in_the_Prefrontal_Cortex_and_Hippocampus/links/5dce4e244585156b351386f0/Antidepressant-and-Anxiolytic-Effect-of-Echium-amoenum-in-Restraint-Stress-Model-The-Role-of-neuroinflammation-in-the-Prefrontal-Cortex-and-Hippocampus.pdf”>Antidepressant and Anxiolytic Effect of Echium amoenum in Restraint Stress Model: The Role of neuroinflammation in the Prefrontal Cortex and Hippocampus
  662. Antidepressant effect of Xingnao Jieyu decoction mediated by alleviating neuroinflammation in a rat model of post-stroke depression
  663. Antidepressant-like activity of Myelophil via attenuation of microglial-mediated neuroinflammation in mice undergoing unpredictable chronic mild stress
  664. Antidepressant-like effect of a new selenium-containing compound is accompanied by a reduction of neuroinflammation and oxidative stress in lipopolysaccharide …
  665. Antidepressant-Like Effect of Bauhinia blakeana Dunn in a neuroinflammation Model in Mice
  666. Antidepressant-like effect of zileuton is accompanied by hippocampal neuroinflammation reduction and CREB/BDNF upregulation in lipopolysaccharide-challenged …
  667. Antidepressants and neuroinflammation: can antidepressants calm glial rage down?
  668. Antigen-independent pathogenic and protective immunity in chronic neuroinflammation
  669. Antihypertensive effects of ACE2 in the paraventricular nucleus: a consequence of reduced neuroinflammation?
  670. Antimalarial drug artemether inhibits neuroinflammation in BV2 microglia through Nrf2-dependent mechanisms
  671. Antimalarial Drug Artemisinin Extenuates Amyloidogenesis and neuroinflammation in APP swe/PS 1dE9 Transgenic Mice via Inhibition of Nuclear Factor‐κ B and …
  672. Antioxidant treatment limits neuroinflammation in experimental glaucoma
  673. Antiparkinson and antioxidant effect of pyridylpyrazolinyl substituted heterosteroids in LPS induced neuroinflammation model of neurodegenerative disorders
  674. Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation
  675. Anxiety, neuroinflammation, cholinergic and GABAergic abnormalities are early markers of Gulf War illness in a mouse model of the disease
  676. Anxiolytic effects of polydatin through the blockade of neuroinflammation in a chronic pain mouse model
  677. Anxiolytic properties of compounds that counteract oxidative stress, neuroinflammation, and glutamatergic dysfunction: a review
  678. Anxiolytic-like effects of the ethanol extract of Magnolia obovata leaves through its effects on GABA-benzodiazepine receptor and neuroinflammation
  679. Apelin attenuates depressive-like behavior and neuroinflammation in rats co-treated with chronic stress and lipopolysaccharide
  680. Apelin-13 suppresses neuroinflammation against cognitive deficit in a streptozotocin-induced rat model of Alzheimer’s disease through activation of BDNF-TrkB …
  681. Apigenin attenuates isoflurane-induced cognitive dysfunction via epigenetic regulation and neuroinflammation in aged rats
  682. Apigetrin from Scutellaria baicalensis Georgi Inhibits neuroinflammation in BV-2 Microglia and Exerts Neuroprotective Effect in HT22 Hippocampal Cells
  683. APOE ISOFORMS DIFFERENTIALLY REGULATE ALZHEIMER’S neuroinflammation
  684. APOE‐modulated Aβ‐induced neuroinflammation in Alzheimer’s disease: current landscape, novel data, and future perspective
  685. Apolipoprotein E alters the association of neuroinflammation with Alzheimer’s disease
  686. Apolipoprotein E Deficiency Aggravates Neuronal Injury by Enhancing neuroinflammation via the JNK/c-Jun Pathway in the Early Phase of Experimental …
  687. Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer’s disease
  688. Apoptosis inhibition can be threatening in Aβ-induced neuroinflammation, through promoting cell proliferation
  689. APP intracellular domain impairs adult neurogenesis in transgenic mice by inducing neuroinflammation
  690. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0755-8″>Appearance of claudin-5+ leukocytes in the central nervous system during neuroinflammation: a novel role for endothelial-derived extracellular vesicles
  691. Application of europium-doped very small iron oxide nanoparticles to visualize neuroinflammation with MRI and fluorescence microscopy
  692. Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer’s disease and mild cognitive impairment
  693. Applying clustering coefficient to the pattern of international author collaboration in neuroimmunology and neuroinflammation
  694. Apurinic/apyrimidinic endonuclease 1 is a key modulator of aluminum-induced neuroinflammation
  695. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-279″>Aquaporin 4: a player in cerebral edema and neuroinflammation
  696. Aquaporin-4 mediates communication between astrocyte and microglia: Implications of neuroinflammation in experimental Parkinson’s disease
  697. Aqueous extract of Dendropanax morbiferus leaves effectively alleviated neuroinflammation and behavioral impediments in MPTP-induced Parkinson’s mouse model
  698. Arctigenin protects focal cerebral ischemia-reperfusion rats through inhibiting neuroinflammation
  699. Are the emergence of affective disturbances in neuropathic pain states contingent on supraspinal neuroinflammation?
  700. Are we ready for successful clinical targeting of neuroinflammation?: major challenges and how to overcome them
  701. neuroinflammation“>Area Postrema Syndrome Secondary to Lupus neuroinflammation
  702. Arginase 1+ microglia reduce Aβ plaque deposition during IL-1β-dependent neuroinflammation
  703. Arginase 2 Deficiency Promotes neuroinflammation and Pain Behaviors Following Nerve Injury in Mice
  704. ARMD 84 AIDS Kaposi’s sarcoma 488 neuroinflammation (M) 12 vitamin E (L) 376
  705. Aromatase and neuroinflammation in rat focal brain ischemia
  706. Aromatic‐turmerone attenuates LPS‐induced neuroinflammation and consequent memory impairment by targeting TLR4‐dependent signaling pathway
  707. Artemisinin B improves learning and memory impairment in AD dementia mice by suppressing neuroinflammation
  708. Arterial input function combined with PET to follow longitudinally neuroinflammation in rats
  709. Asiatic acid attenuates methamphetamine-induced neuroinflammation and neurotoxicity through blocking of NF-kB/STAT3/ERK and mitochondria-mediated …
  710. Asiatic Acid Protects Dopaminergic Neurons from neuroinflammation by Suppressing Mitochondrial ROS Production
  711. Asiatic acid suppresses neuroinflammation in BV2 microglia via modulation of the Sirt1/NF-κB signaling pathway
  712. Assessing neuroinflammation in Obese Individuals Using Diffusion Basis Spectrum Imaging (DBSI)
  713. neuroinflammation&ots=ye2X25E4M4&sig=gDP9amn0dmnrs9IaoyvFwEiUJa0″>Assessing the influence of neuroinflammation on neurogenesis: in vitro models using neural stem cells and microglia as valuable research tools
  714. Assessment of blood-brain barrier integrity and neuroinflammation in preeclampsia
  715. Assessment of neuroinflammation and microglial activation in Alzheimer’s disease with radiolabelled PK11195 and single photon emission computed tomography
  716. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0700-x”>Assessment of neuroinflammation in a mouse model of obesity and β-amyloidosis using PET
  717. Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study
  718. neuroinflammation&ots=lE8867kRDT&sig=wu3qzZI_LuaZcTGZpNJgIorwgso”>Assessment of neuroinflammation in transferred EAE via a translocator protein ligand
  719. Assessment of translocator protein density, as marker of neuroinflammation, in major depressive disorder: a pilot, multicenter, comparative, controlled, brain …
  720. Association between Hippocampal Shape, neuroinflammation, and Cognitive Decline in Alzheimer’s Disease
  721. Association Between Vaccines and neuroinflammation—Reply
  722. Association Between Vaccines and neuroinflammation: Time, Risks, and Benefits
  723. Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosus
  724. Association of high-fat diet with neuroinflammation, anxiety-like defensive behavioral responses, and altered thermoregulatory responses in male rats
  725. Association of long-term atorvastatin with escalated stroke-induced neuroinflammation in rats
  726. Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelination attacks
  727. AST-120 reduces neuroinflammation induced by indoxyl sulfate in glial cells
  728. Astaxanthin ameliorates lipopolysaccharide-induced neuroinflammation, oxidative stress and memory dysfunction through inactivation of the signal …
  729. Astaxanthin attenuates neuroinflammation contributed to the neuropathic pain and motor dysfunction following compression spinal cord injury
  730. Astaxanthin offers neuroprotection and reduces neuroinflammation in experimental subarachnoid hemorrhage
  731. Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson’s disease …
  732. Astragaloside IV ameliorates neuroinflammation-induced depressive-like behaviors in mice via the PPARγ/NF-κB/NLRP3 inflammasome axis
  733. neuroinflammation_and_Cognitive_Impairment_in_Rats/links/5a870988aca272017e5aad15/Astragaloside-IV-Protects-Against-Ab1-42-induced-Oxidative-Stress-neuroinflammation-and-Cognitive-Impairment-in-Rats.pdf”>Astragaloside Ⅳ Protects Against Aβ1-42-induced Oxidative Stress, neuroinflammation and Cognitive Impairment in Rats.
  734. Astragalus membranaceus-polysaccharides ameliorates obesity, hepatic steatosis, neuroinflammation and cognition impairment without affecting amyloid deposition …
  735. Astrocyte and macrophage regulation of YKL‐40 expression and cellular response in neuroinflammation
  736. Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-κB signaling and excitatory amino acid …
  737. Astrocyte gene expression during neuroinflammation: βC/EBPregulates TIMP-1 and other inflammation genes
  738. Astrocyte neuropathology in autism: role of neuroinflammation & glutamatergic signalling
  739. Astrocyte-and endothelial-targeted CCL2 conditional knockout mice: critical tools for studying the pathogenesis of neuroinflammation
  740. Astrocyte-derived CCL2 participates in surgery-induced cognitive dysfunction and neuroinflammation via evoking microglia activation
  741. Astrocyte-derived retinoic acid: a novel regulator of blood–brain barrier function during neuroinflammation in multiple sclerosis
  742. Astrocyte-specific IKK2 activation in mice is sufficient to induce neuroinflammation but does not increase susceptibility to MPTP
  743. Astrocyte‐T cell crosstalk regulates region‐specific neuroinflammation
  744. Astrocyte, reactive astrocytes and self-regulative apoptosis in the neuroinflammation
  745. Astrocyte/microglia cocultures as a model to study neuroinflammation
  746. Astrocytes and neuroinflammation in Alzheimer’s disease
  747. Astrocytes in neuroinflammation and Neuronal Disorders: Shifting the Focus from Neurons
  748. Astrocytes: integrative regulators of neuroinflammation in stroke and other neurological diseases
  749. Astrocytes: key regulators of neuroinflammation
  750. Astrocytic CCAAT/Enhancer-binding protein delta contributes to reactive oxygen species formation in neuroinflammation
  751. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1436-1″>Astrocytic ceramide as possible indicator of neuroinflammation
  752. Astrocytic orosomucoid-2 modulates microglial activation and neuroinflammation
  753. Astrocytic transforming growth factor‐beta signaling reduces subacute neuroinflammation after stroke in mice
  754. Astroglial Connexin 43 Deficiency Protects against LPS-Induced neuroinflammation: A TSPO Brain µPET Study with [18F] FEPPA
  755. Astroglial control of neuroinflammation: TLR3-mediated dsRNA-sensing pathways are in the focus
  756. At the interface of the immune system and the nervous system: how neuroinflammation modulates the fate of neural progenitors in vivo
  757. Atorvastatin Attenuates Cognitive Deficits and neuroinflammation Induced by Aβ1–42 Involving Modulation of TLR4/TRAF6/NF-κB Pathway
  758. Atorvastatin pretreatment attenuates kainic acid-induced hippocampal neuronal death via regulation of lipocalin-2-associated neuroinflammation
  759. Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative 2 stress following amyloid-β1–40 administration in mice: Evidence for …
  760. Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β1–40 administration in mice: Evidence for dissociation …
  761. Atorvastatin prevents neuroinflammation in chronic constriction injury rats through nuclear NFκB downregulation in the dorsal root ganglion and spinal cord
  762. Atp13a2 Deficiency Aggravates Astrocyte‐Mediated neuroinflammation via NLRP3 Inflammasome Activation
  763. Atractylenolide III ameliorates cerebral ischemic injury and neuroinflammation associated with inhibiting JAK2/STAT3/Drp1-dependent mitochondrial fission in …
  764. Atractylodis rhizoma alba attenuates neuroinflammation in BV2 microglia upon LPS stimulation by inducing HO-1 activity and inhibiting NF-κB and MAPK
  765. Atsttrin reduces lipopolysaccharide-induced neuroinflammation by inhibiting the nuclear factor kappa B signaling pathway
  766. Attenuated neurological deficit, cell death and lesion volume in Fas-mutant mice is associated with altered neuroinflammation following traumatic brain injury
  767. Attenuated SIV causes persisting neuroinflammation in the absence of a chronic viral load and neurotoxic antiretroviral therapy
  768. Attenuation of aluminum chloride-induced neuroinflammation and caspase activation through the AKT/GSK-3β pathway by hesperidin in wistar rats
  769. Attenuation of chronic neuroinflammation by a nitric oxide‐releasing derivative of the antioxidant ferulic acid
  770. Attenuation of Ischemic Stroke-Caused Brain Injury by a Monoamine Oxidase Inhibitor Involves Improved Proteostasis and Reduced neuroinflammation
  771. Attenuation of neuroinflammation and Alzheimer’s disease pathology by liver x receptors
  772. Attenuation of neuroinflammation by dexmedetomidine is associated with activation of a cholinergic anti-inflammatory pathway in a rat tibial fracture model
  773. Attenuation of neuroinflammation reverses Adriamycin-induced cognitive impairments
  774. Attenuation of oxidative stress, neuroinflammation, and apoptosis by curcumin prevents cognitive deficits in rats postnatally exposed to ethanol
  775. Attenuation of β-amyloid-induced neuroinflammation by KHG21834 in vivo
  776. Attractylone attenuates sepsis‐associated encephalopathy and cognitive dysfunction by inhibiting microglial activation and neuroinflammation
  777. Aucubin alleviates seizures activity in Li-Pilocarpine-Induced epileptic mice: involvement of inhibition of neuroinflammation and regulation of neurotransmission
  778. Auricular vagus nerve stimulation protects against postoperative cognitive dysfunction by attenuating neuroinflammation and neurodegeneration in aged rats
  779. Author Correction: Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation
  780. Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease
  781. Author Correction: T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation.
  782. Autism spectrum disorders may be due to cerebral toxoplasmosis associated with chronic neuroinflammation causing persistent hypercytokinemia that resulted in an …
  783. Autoantibodies recognizing native MOG are closely associated with active demyelination but not with neuroinflammation in chronic EAE
  784. Autoantibody-mediated neuroinflammation: pathogenesis of neuropsychiatric systemic lupus erythematosus in the NZM88 murine model
  785. Autoimmunity, neuroinflammation, pathogen load: a decisive crosstalk in neuropsychiatric SLE
  786. Automated Production of [18F] FEPPA as a neuroinflammation Imaging Agent
  787. Autophagy and NLRP3 inflammasome crosstalk in neuroinflammation in aged bovine brains
  788. Autophagy itself and/or its anti-neuroinflammation action in hippocampus attenuates postoperative cognitive decline in aged rats undergoing splenectomy
  789. Autophagy Modulators and neuroinflammation
  790. AVE0991, a nonpeptide analogue of Ang-(1-7), attenuates aging-related neuroinflammation
  791. Axl activation attenuates neuroinflammation by inhibiting the TLR/TRAF/NF-κB pathway after MCAO in rats
  792. Axon Guidance Molecules Guiding neuroinflammation
  793. Axonal Injury, neuroinflammation and Amyloid Pathology after Traumatic Brain Injury: Making Connections to Neurodegeneration (I12-1.007)
  794. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes
  795. Axonal regeneration and neuroinflammation: roles for the translocator protein 18 kDa
  796. Axonally derived matrilin-2 induces proinflammatory responses that exacerbate autoimmune neuroinflammation
  797. Aza‐CGP37157‐lipoic hybrids designed as novel Nrf2‐inducers and antioxidants exert neuroprotection against oxidative stress and show neuroinflammation …
  798. B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis
  799. B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation
  800. B2 receptor blockage prevents Aβ-induced cognitive impairment by neuroinflammation inhibition
  801. BACE inhibitor NB-360 reveals strong reduction of amyloid-β generation, robust blockade of amyloid deposition and lowering of neuroinflammation in APP transgenic …
  802. Bacille Calmette-Guérin (BCG) Vaccine in neuroinflammation
  803. BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy
  804. Baicalein administered in the subacute phase ameliorates ischemia-reperfusion-induced brain injury by reducing neuroinflammation and neuronal damage
  805. Baicalein attenuates the neuroinflammation in LPS-activated BV-2 microglial cells through suppression of pro-inflammatory cytokines, COX2/NF-κB expressions and …
  806. Baicalein promotes neuronal and behavioral recovery after intracerebral hemorrhage via suppressing apoptosis, oxidative stress and neuroinflammation
  807. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1474-8″>Baicalin ameliorates neuroinflammation-induced depressive-like behavior through inhibition of toll-like receptor 4 expression via the PI3K/AKT/FoxO1 …
  808. Baicalin attenuates lipopolysaccharide-induced neuroinflammation in cerebral cortex of mice via inhibiting nuclear factor kappa B (NF-κB) activation
  809. Baicalin mitigates cognitive impairment and protects neurons from microglia‐mediated neuroinflammation via suppressing NLRP 3 inflammasomes and TLR 4/NF‐κB …
  810. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1661-7″>BAP31 regulates IRAK1-dependent neuroinflammation in microglia
  811. Basic aspects of the immunology of neuroinflammation
  812. neuroinflammation&ots=JTiCdLlkSN&sig=dPR10XLDFD_DxI7GVmV6EQNLjMc”>Basic Aspects of the Immunology of neuroinflammation
  813. Basic concept of microglia biology and neuroinflammation in relation to psychiatry
  814. BDNF Alleviates neuroinflammation in the Hippocampus of Type 1 Diabetic Mice via Blocking the Aberrant HMGB1/RAGE/NF-κB Pathway
  815. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-020-1704-0″>BDNF promotes activation of astrocytes and microglia contributing to neuroinflammation and mechanical allodynia in cyclophosphamide-induced cystitis
  816. Bee pollen and propolis improve neuroinflammation and dysbiosis induced by propionic acid, a short chain fatty acid in a rodent model of autism
  817. Bee venom acupuncture reduces neuroinflammation modulating microglia/macrophage phenotype polarization in spinal cord injury compression model
  818. Bee venom ameliorates cognitive dysfunction caused by neuroinflammation in an animal model of vascular dementia
  819. Bee venom phospholipase A2 ameliorates amyloidogenesis and neuroinflammation through inhibition of signal transducer and activator of transcription-3 …
  820. Bee venom reduces neuroinflammation in the MPTP-induced model of Parkinson’s disease
  821. Behavioral and biochemical effects of GSM 900MHz in neuroinflammation and gestational inflammation models
  822. Behavioral and ultrastructural changes induced by chronic neuroinflammation in young rats
  823. Behavioural and neurological symptoms accompanied by cellular neuroinflammation in IL-10-deficient mice infected with Plasmodium chabaudi
  824. neuroinflammation.1.aspx”>Behavioural aspects of neuroinflammation
  825. Benefical effects of mediterranean diet in neuroinflammation and related diseases
  826. Beneficial effect of the flavonoid luteolin on neuroinflammation
  827. Beneficial effects of lycopene against haloperidol induced orofacial dyskinesia in rats: Possible neurotransmitters and neuroinflammation modulation
  828. Benzimidazole Containing Acetamide Derivatives Attenuate neuroinflammation and Oxidative Stress in Ethanol-Induced Neurodegeneration
  829. Benzodiazepine-refractory status epilepticus, neuroinflammation, and interneuron neurodegeneration after acute organophosphate intoxication
  830. Berberine alleviates postoperative cognitive dysfunction by suppressing neuroinflammation in aged mice
  831. Beta-amyloid oligomers acutely induce memory deficits in association to tlr4-mediated neuroinflammation
  832. Bexarotent attenuated CCI-induced spinal neuroinflammation and neuropathic pain by targeting MKP-1
  833. Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation
  834. Bibliometric Analysis of the Journal neuroinflammation
  835. Bicuculline reduces neuroinflammation in hippocampus and improves spatial learning and anxiety in hyperammonemic rats. Role of glutamate receptors
  836. Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation
  837. Bidirectional relationship of mast cells-neurovascular unit communication in neuroinflammation and its involvement in POCD
  838. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by …
  839. Biglycan regulates neuroinflammation by promoting M1 microglial activation in early brain injury after experimental subarachnoid hemorrhage
  840. Bilberry anthocyanins improve neuroinflammation and cognitive dysfunction in APP/PSEN1 mice via the CD33/TREM2/TYROBP signaling pathway in microglia
  841. Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation
  842. Bile Acid Metabolism is Altered in Multiple Sclerosis and Supplementation Leads to Amelioration of neuroinflammation (S55. 002)
  843. Bile acid-mediated sphingosine-1-phosphate receptor 2 signaling promotes neuroinflammation during hepatic encephalopathy in mice
  844. Bioaccumulation and neuroinflammation of Gold Nanoparticles in the Central Nervous System
  845. Bioactive components from garlic on brain resiliency against neuroinflammation and neurodegeneration
  846. Bioactive phenols as potential neuroinflammation inhibitors from the leaves of Xanthoceras sorbifolia Bunge
  847. Bioavailable curcumin alleviates lipopolysaccharide-induced neuroinflammation and improves cognition in experimental animals
  848. Biochemical Aspects of neuroinflammation
  849. Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation
  850. Bioengineered 3D glial cell culture systems and applications for neurodegeneration and neuroinflammation
  851. Biology of neuroinflammation: A Common Denominator in Brain Pathologies
  852. Bioluminescence Imaging of neuroinflammation in a Mouse Model of Parkinson’s Disease
  853. neuroinflammation-transgenic-mice-after”>Bioluminescence Imaging of neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils
  854. Biomarkers For neuroinflammation And Satellite Glia Activation In Dry Eye Disease
  855. Biomaterials and glia: Progress on designs to modulate neuroinflammation
  856. Black Ginseng Extract Prevents neuroinflammation and Enhances Learning Behavior in Mice
  857. neuroinflammation/links/573ed6f808ae298602e8de0c/Blockade-of-adenosine-A2A-receptor-confers-neuroprotection-against-retinal-ischemia-reperfusion-injury-through-the-control-of-neuroinflammation.pdf”>Blockade of adenosine A2A receptor confers neuroprotection against retinal ischemia-reperfusion injury through the control of neuroinflammation
  858. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0997-0″>Blocking ATP-sensitive potassium channel alleviates morphine tolerance by inhibiting HSP70-TLR4-NLRP3-mediated neuroinflammation
  859. Blocking endothelin-B receptors rescues retinal ganglion cells from optic nerve injury through suppression of neuroinflammation
  860. Blood brain barrier and neuroinflammation are critical targets of IGF-1-mediated neuroprotection in stroke for middle-aged female rats
  861. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells
  862. Blood-brain barrier at the interface of air pollution-associated neurotoxicity and neuroinflammation
  863. Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults
  864. Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus …
  865. Blood-Brain Barrier Disruption During neuroinflammation
  866. Blood–brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation
  867. Blood–Brain Barrier Transporters and neuroinflammation: Partners in Neuroprotection and in Pathology
  868. Blueberries Improve neuroinflammation and Cognition differentially Depending on Individual Cognitive baseline Status
  869. Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease
  870. BML-111 Reduces neuroinflammation and Cognitive Impairment in Mice With Sepsis via the SIRT1/NF-κB Signaling Pathway
  871. Bombycis excrementum reduces amyloid-β oligomer-induced memory impairments, neurodegeneration, and neuroinflammation in mice
  872. Bone Marrow Chimeras to Study neuroinflammation
  873. Bone marrow mesenchymal stem cells regulate TGF‐β to adjust neuroinflammation in postoperative central inflammatory mice
  874. Bone morphogenetic proteins in multiple sclerosis: role in neuroinflammation
  875. Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke
  876. Botch protects neurons from ischemic insult by antagonizing Notch-mediated neuroinflammation
  877. Botulinum toxin type A ameliorates adjuvant-arthritis pain by inhibiting microglial activation-mediated neuroinflammation and intracellular molecular signaling
  878. Brain and peripheral atypical inflammatory mediators potentiate neuroinflammation and neurodegeneration
  879. Brain aromatase imaging in an acute neuroinflammation model using µPET and 11C-vorozole
  880. Brain barrier breakdown as a cause and consequence of neuroinflammation in sepsis
  881. Brain biopsy findings link major depressive disorder to neuroinflammation, oxidative stress, and neurovascular dysfunction: a case report
  882. Brain Consequences of Spinal Cord Injury with and without Neuropathic Pain: Translating Animal Models of neuroinflammation onto Human Neural Networks …
  883. Brain endothelial IL-1R1 mediates central IL-1 induced neuroinflammation and anxiety-like behavior
  884. Brain energy metabolism and neuroinflammation in ageing APP/PS1-21 mice using longitudinal 18F-FDG and 18F-DPA-714 PET imaging
  885. Brain injury associated with widely abused amphetamines: neuroinflammation, neurogenesis and blood-brain barrier
  886. Brain injury, neuroinflammation and Alzheimer’s disease
  887. Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system
  888. Brain Innate Immunity in the Regulation of neuroinflammation: Therapeutic Strategies by Modulating CD200-CD200R Interaction Involve the Cannabinoid System
  889. Brain interleukin-15 in neuroinflammation and behavior
  890. Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer’s disease
  891. Brain metabolites and peripheral biomarkers associated with neuroinflammation in complex regional pain syndrome using [11C]-(R)-PK11195 positron emission …
  892. Brain Oxidative markers in stress: possible new drug targets against neuroinflammation
  893. Brain pericytes as mediators of neuroinflammation
  894. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0946-y”>Brain ureido degenerative protein modifications are associated with neuroinflammation and proteinopathy in Alzheimer’s disease with cerebrovascular …
  895. Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users
  896. Brain-derived microparticles (BDMPs) contribute to neuroinflammation and Lactadherin reduces BDMP induced neuroinflammation and improves outcome after stroke
  897. Brain-derived microparticles activate microglia/macrophages and induce neuroinflammation
  898. Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation
  899. Brain-immune interactions and neuroinflammation after traumatic brain injury
  900. Brain‐derived neurotrophic factor fused with a collagen‐binding domain inhibits neuroinflammation and promotes neurological recovery of traumatic brain injury mice …
  901. Brazilian green propolis suppresses microglia-mediated neuroinflammation by inhibiting NF-kB activation
  902. Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: boosting autoimmunity to fight-off chronic neuroinflammation
  903. Broken or maladaptive? Altered trajectories in neuroinflammation and behavior after early life adversity
  904. Bushen-Yizhi Formula Alleviates neuroinflammation via Inhibiting NLRP3 Inflammasome Activation in a Mouse Model of Parkinson’s Disease
  905. Butyrate and dietary soluble fiber improve neuroinflammation associated with aging in mice
  906. BV-2 microglial cells used in a model of neuroinflammation
  907. C-reactive protein increases BBB permeability: implications for obesity and neuroinflammation
  908. C-type lectin receptors Mcl and Mincle control development of multiple sclerosis–like neuroinflammation
  909. C/EBPβ and C/EBPδ in neuroinflammation
  910. neuroinflammation_in_Alzheimer’s_Disease_The_Preventive_and_Therapeutic_Potential_of_Polyphenolic_Nutraceuticals/links/5b21b995458515270fc6e189/neuroinflammation-in-Alzheimers-Disease-The-Preventive-and-Therapeutic-Potential-of-Polyphenolic-Nutraceuticals.pdf”>C0550 neuroinflammation in Alzheimer’s Disease: The Preventive and Therapeutic Potential of Polyphenolic Nutraceuticals
  911. C5b-9 complement complex in autoimmune demyelination: dual role in neuroinflammation and neuroprotection
  912. C5b‐9 complement complex in autoimmune demyelination and multiple sclerosis: dual role in neuroinflammation and neuroprotection
  913. Caffeic acid attenuates lipopolysaccharide-induced sickness behaviour and neuroinflammation in mice
  914. Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma
  915. Caffeine and modafinil ameliorate the neuroinflammation and anxious behavior in rats during sleep deprivation by inhibiting the microglia activation
  916. Caffeine attenuates lipopolysaccharide-induced neuroinflammation
  917. Caffeine May Abrogate LPS-Induced Oxidative Stress and neuroinflammation by Regulating Nrf2/TLR4 in Adult Mouse Brains
  918. Caffeine modulates cadmium-induced oxidative stress, neuroinflammation, and cognitive impairments by regulating Nrf-2/HO-1 in vivo and in vitro
  919. neuroinflammation_and_cell_survival_in_retinal_ischemia/links/573ed73908ae9ace84132e62/Caffeine-modulates-retinal-neuroinflammation-and-cell-survival-in-retinal-ischemia”>Caffeine modulates retinal neuroinflammation and cell survival in retinal ischemia
  920. Caffeine prevents d-galactose-induced cognitive deficits, oxidative stress, neuroinflammation and neurodegeneration in the adult rat brain
  921. neuroinflammation%202018%20course%20directors.pdf”>Cajal course on neuroinflammation and how to study it Course directors
  922. neuroinflammation%202018_instructors.pdf”>Cajal course on neuroinflammation and how to study it Instructors
  923. Calcineurin and glial signaling: neuroinflammation and beyond
  924. Calcineurin/nuclear factor-κB signaling mediates isoflurane-induced hippocampal neuroinflammation and subsequent cognitive impairment in aged rats
  925. Calcium dysregulation and neuroinflammation: discrete and integrated mechanisms for age-related synaptic dysfunction
  926. Call for papers: Neurology: Neuroimmunology & neuroinflammation, a new Neurology journal
  927. neuroinflammation/links/5d8195c792851c22d5e09541/CaMKKb-Dependent-Activation-of-AMP-Activated-Protein-Kinase-Is-Critical-to-Suppressive-Effects-of-Hydrogen-Sulfide-on-neuroinflammation.pdf”>CaMKKb-Dependent Activation of AMP-Activated Protein Kinase Is Critical to Suppressive Effects of Hydrogen Sulfide on neuroinflammation
  928. CaMKKβ-dependent activation of AMP-activated protein kinase is critical to suppressive effects of hydrogen sulfide on neuroinflammation
  929. Can cocaine-induced neuroinflammation explain maladaptive cocaine-associated memories?
  930. Can GPCR, such as Kappa Opioid Receptor, be a Viable Therapeutic Target for Reducing or Preventing neuroinflammation
  931. Can neuroinflammation influence the development of autism spectrum disorders?
  932. Can studies of neuroinflammation in a TSPO genetic subgroup (HAB or MAB) be applied to the entire AD cohort?
  933. Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention?
  934. Can the emerging field of immunometabolism provide insights into neuroinflammation?
  935. Caniferolide A, a Macrolide from Streptomyces caniferus, Attenuates neuroinflammation, Oxidative Stress, Amyloid-Beta, and Tau Pathology in Vitro
  936. Cannabidiol in vivo blunts β‐amyloid induced neuroinflammation by suppressing IL‐1β and iNOS expression
  937. Cannabidiol Reduces Ab-Induced neuroinflammation and Promotes Hippocampal
  938. Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement
  939. Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia
  940. Cannabinoid CB2 receptors in a mouse model of Aβ amyloidosis: immunohistochemical analysis and suitability as a PET biomarker of neuroinflammation
  941. Cannabinoid control of neuroinflammation related to multiple sclerosis
  942. Cannabinoid receptor 2 activation mitigates lipopolysaccharide-induced neuroinflammation and sickness behavior in mice
  943. Cannabinoid receptor 2 agonist reduces immune cell migration in neuroinflammation via inhibition of matrix metalloproteinase-9
  944. Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer’s disease mouse model
  945. Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation
  946. Cannabinoid receptor-2 stimulation suppresses neuroinflammation by regulating microglial M1/M2 polarization through the cAMP/PKA pathway in an experimental …
  947. Cannabinoid type 2 (CB2) receptors activation protects against oxidative stress and neuroinflammation associated dopaminergic neurodegeneration in …
  948. Cannabinoids and innate immunity: taking a toll on neuroinflammation
  949. Cannabinoids and neuroinflammation
  950. Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis
  951. Cannabinoids for the treatment of neuroinflammation
  952. Cannabinoids in health and disease: Pharmacological potential in metabolic syndrome and neuroinflammation
  953. neuroinflammation-oxidative-stress-and-neuro-excitotoxicity-2153-2435-1000346.pdfK_b.pdf”>Cannabinoids in neuroinflammation, oxidative stress and neuro excitotoxicity
  954. Cannabis sativa L. constituents and their role in neuroinflammation
  955. Canonical Transient Receptor Potential Channel 3 Contributes to Febrile Seizure Inducing Neuronal Cell Death and neuroinflammation
  956. Canonical wnt signaling in dendritic cells regulates Th1/Th17 responses and suppresses autoimmune neuroinflammation
  957. CAP37: A Marker of neuroinflammation
  958. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1226-1″>Carbon monoxide-releasing molecule-3 protects against ischemic stroke by suppressing neuroinflammation and alleviating blood-brain barrier disruption
  959. Cardiotonic steroids as modulators of neuroinflammation
  960. Care Giving As a Chronic Psychosocial Distress: neuroinflammation Trajectory
  961. Caruifolin D from Artemisia absinthium L. inhibits neuroinflammation via reactive oxygen species-dependent c-jun N-terminal kinase and protein kinase c/NF-κB …
  962. Carvedilol abrogates hypoxia-induced oxidative stress and neuroinflammation in microglial BV2 cells
  963. Cas9 Ribonucleoprotein complex delivery: methods and applications for neuroinflammation
  964. Caspase inhibition in neuroinflammation induced by soluble β amyloid monomer, protects cells from abnormal survival and proliferation, via attenuation of NFқB …
  965. Caspase inhibitors may attenuate opioid-induced hyperalgesia and tolerance via inhibiting microglial activation and neuroinflammation
  966. Caspases playing in the field of neuroinflammation: old and new players
  967. Catechin supressed LPS-induced neuroinflammation in BV-2, C6 and NG108-15 cells by modulating CCL21 through PI3K-Akt
  968. Cathepsin C aggravates neuroinflammation involved in disturbances of behaviour and neurochemistry in acute and chronic stress-induced murine model of …
  969. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1398-3″>Cathepsin C promotes microglia M1 polarization and aggravates neuroinflammation via activation of Ca 2+-dependent PKC/p38MAPK/NF-κB pathway
  970. Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis
  971. Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system
  972. Caveolin1 is required for Th1 cell infiltration, but not tight junction remodeling, at the blood-brain barrier in autoimmune neuroinflammation
  973. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0630-7″>CC motif chemokine ligand 20 regulates neuroinflammation following spinal cord injury via Th17 cell recruitment
  974. CCDC88B is a novel regulator of maturation and effector functions of T cells during pathological inflammationCCDC88B regulates neuroinflammation
  975. CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions
  976. CCL2 disrupts the adherens junction: implications for neuroinflammation
  977. CCR1 Activation Promotes neuroinflammation Through CCR1/TPR1/ERK1/2 Signaling Pathway After Intracerebral Hemorrhage in Mice
  978. CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward
  979. CD11chi Dendritic Cells Regulate Ly-6Chi Monocyte Differentiation to Preserve Immune-privileged CNS in Lethal neuroinflammation
  980. CD200 modulates spinal cord injury neuroinflammation and outcome through CD200R1
  981. CD200 negatively regulates β-amyloid-induced microglial activation and neuroinflammation in vivo and in vitro
  982. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1426-3″>CD200-CD200R1 inhibitory signaling prevents spontaneous bacterial infection and promotes resolution of neuroinflammation and recovery after stroke
  983. CD38 and CD157 Expression: Glial Control of Neurodegeneration and neuroinflammation
  984. CD38 regulation in activated astrocytes: Implications for neuroinflammation and HIV‐1 brain infection
  985. CD38/cyclic ADP-ribose regulates astrocyte calcium signaling: implications for neuroinflammation and HIV-1-associated dementia
  986. CD4+ NKG2D+ T cells exhibit enhanced migratory and encephalitogenic properties in neuroinflammation
  987. CD40-CD40 ligand pathway is a major component of acute neuroinflammation and contributes to long-term cognitive dysfunction after sepsis
  988. CD49d/CD29‐integrin controls the accumulation of plasmacytoid dendritic cells into the CNS during neuroinflammation
  989. CD99L2 deficiency inhibits leukocyte entry into the central nervous system and ameliorates neuroinflammation
  990. Cdk5/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration
  991. Celecoxib Prevents Cognitive Impairment and neuroinflammation
  992. Celecoxib prevents cognitive impairment and neuroinflammation in soluble amyloid β-treated rats
  993. Cell-Derived Microparticles/Exosomes in neuroinflammation
  994. Cell-selective gene ablation as a tool to resolve site-specific roles of CCL2 at the blood-brain barrier during neuroinflammation
  995. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-11-10″>Cell-selective knockout and 3D confocal image analysis reveals separate roles for astrocyte-and endothelial-derived CCL2 in neuroinflammation
  996. Cellular and Molecular Mechanisms of neuroinflammation in Epilepsy
  997. Cellular and molecular mediators of neuroinflammation in Alzheimer disease
  998. Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson’s disease
  999. Cellular aspect of neuroinflammation in Guillain-Barre syndrome: a key to a new therapeutic option?
  1000. Cellular components of neuroinflammation—an introduction
  1001. Cellular imaging at 1.5 T: detecting cells in neuroinflammation using active labeling with superparamagnetic iron oxide
  1002. cellular Inhibitor of Apoptosis Protein2–A critical regulator of neuroinflammation
  1003. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-6-38″>Cellular injury and neuroinflammation in children with chronic intractable epilepsy
  1004. Cellular markers of neuroinflammation and neurogenesis after ischemic brain injury in the long-term survival rat model
  1005. Cellular neuroinflammation in a lateral forceps compression model of spinal cord injury
  1006. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
  1007. Central inhibition of interleukin-6 trans-signaling during peripheral infection reduced neuroinflammation and sickness in aged mice
  1008. Central intracrine DHEA synthesis in ageing-related neuroinflammation and neurodegeneration: therapeutic potential?
  1009. Central modulation of neuroinflammation by neuropeptides and energy-sensing hormones during obesity
  1010. Central nervous system parasitosis and neuroinflammation ameliorated by systemic IL-10 administration in trypanosoma brucei-infected mice
  1011. Central nervous system recruitment of effector memory CD8+ T lymphocytes during neuroinflammation is dependent on α4 integrin
  1012. neuroinflammation&ots=SxGI7SaigW&sig=ZfeE6F6mzkMZfO8QPrJmYqrTjBs”>Central Nervous System Resident Cells in neuroinflammation: A Brave New World
  1013. Central nervous system stromal cells control local CD8+ T cell responses during virus-induced neuroinflammation
  1014. Central neuroinflammation in Cerebral Ischemia: The Role of Glia
  1015. Cerebellum can serve as a pseudo-reference region in Alzheimer disease to detect neuroinflammation measured with PET radioligand binding to translocator protein
  1016. Cerebral dopamine neurotrophic factor protects microglia by combining with AKT and by regulating FoxO1/mTOR signaling during neuroinflammation
  1017. Cerebral FDG PET CT in pediatric neuroinflammation: an exploration in the application of statistical parametric mapping
  1018. Cerebral focal neuroinflammation after acute stroke: Preliminary study with 18F-DPA-714
  1019. Cerebral microglial activation in patients with hepatitis c: in vivo evidence of neuroinflammation
  1020. Cerebral microvascular amyloid β protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic …
  1021. Cerebral transcriptome analysis reveals age-dependent progression of neuroinflammation in P301S mutant tau transgenic male mice
  1022. Cerebral venous congestion promotes blood-brain barrier disruption and neuroinflammation, impairing cognitive function in mice
  1023. Cerebrolysin attenuates hyperalgesia, photophobia, and neuroinflammation in a nitroglycerin-induced migraine model in rats
  1024. Cerebrospinal Fluid Biomarkers of neuroinflammation and Axonal Degeneration in Patients with Multiple Sclerosis
  1025. Cerebrospinal Fluid Markers in neuroinflammation: The Paradigm of Optic Neuritis
  1026. Cerebrospinal fluid markers of extracellular matrix remodelling, synaptic plasticity and neuroinflammation before and after cranial radiotherapy
  1027. Cerebrospinal fluid markers of neuroinflammation in delirium: a role for interleukin-1β in delirium after hip fracture
  1028. Cerebrovascular remodeling and neuroinflammation is a late effect of radiation-induced brain injury in non-human primates
  1029. Cessation of anti-VLA-4 therapy in a focal rat model of multiple sclerosis causes an increase in neuroinflammation
  1030. cGMP signaling pathway in hepatic encephalopathy neuroinflammation and cognition
  1031. Changes in brain oxysterols at different stages of Alzheimer’s disease: Their involvement in neuroinflammation
  1032. Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer’s disease progression: CX3CL1, TREM2, and PPARγ
  1033. Characteristics and pharmacodynamics of severe neuroinflammation in a child with neurolupus
  1034. Characterization and modulation of immunoregulatory molecules in neuroinflammation
  1035. Characterization of 11C-GSK1482160 for targeting the P2X7 receptor as a biomarker for neuroinflammation
  1036. Characterization of a novel acetamidobenzoxazolone‐based PET ligand for translocator protein (18 kDa) imaging of neuroinflammation in the brain
  1037. Characterization of a rat model to study acute neuroinflammation on histopathological, biochemical and functional outcomes
  1038. Characterization of an in vivo model of neuroinflammation and evaluation of the anti-inflammatory and neuroprotective effects of curcumin as a potential lead …
  1039. Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation
  1040. Characterization of MCAM contribution to neuroinflammation using a new murine knockout model
  1041. Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation
  1042. Characterization of neuroinflammation and periphery-to-CNS inflammatory cross-talk in patients with disc herniation and degenerative disc disease
  1043. neuroinflammation_and_periphery-to-CNS_inflammatory_cross-talk_in_patients_with_lumbar_disc_herniation_LDH_and_degenerative_disc_disease_DDD/links/5baa7c1992851ca9ed25d4a3/IASP-World-Congress-2018-Characterization-of-neuroinflammation-and-periphery-to-CNS-inflammatory-cross-talk-in-patients-with-lumbar-disc-herniation-LDH-and-degenerative-disc-disease-DDD.pdf”>Characterization of neuroinflammation and periphery-to-CNS inflammatory cross-talk in patients with lumbar disc herniation (LDH) and degenerative disc …
  1044. Characterization of platelet–monocyte complexes in HIV-1–infected individuals: Possible role in HIV-associated neuroinflammation
  1045. Characterization of rTg4510 mice yields evidence of significant neuroinflammation
  1046. Characterization of the early neuroinflammation after spinal cord injury in mice
  1047. Characterization of the lipopolysaccharide induced model of Parkinson’s disease: Role of oxidative stress and neuroinflammation
  1048. Characterization of the Role of Nicotine and Delta 9-THC in Modulation of neuroinflammation
  1049. Characterizing newly repopulated microglia in the adult mouse: impacts on animal behavior, cell morphology, and neuroinflammation
  1050. Charcot‐Marie‐Tooth disease and neuroinflammation
  1051. Chemerin suppresses neuroinflammation and improves neurological recovery via CaMKK2/AMPK/Nrf2 pathway after germinal matrix hemorrhage in neonatal rats
  1052. Chemical Biology Probes for Extracellular Vesicles Facilitate Studies of neuroinflammation
  1053. Chemical Elements and Oxidative Status in neuroinflammation
  1054. Chemical genetics of neuroinflammation: natural and synthetic compounds as microglial inhibitors
  1055. Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?
  1056. Chemokine receptor expression and function in experimental autoimmune neuroinflammation
  1057. Chemokine receptors in neuroinflammation
  1058. Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning
  1059. Chemokines and chemokine receptors: multipurpose players in neuroinflammation
  1060. Chemokines and cytokines in neuroinflammation leading to neuropathic pain
  1061. Chemokines regulate the migration of neural progenitors to sites of neuroinflammation
  1062. Chemotherapy-induced neuroinflammation is associated with disrupted colonic and bacterial homeostasis in female mice
  1063. CHF5074 reduces biomarkers of neuroinflammation in patients with mild cognitive impairment: a 12-week, double-blind, placebo-controlled study
  1064. Chi3l3 induces oligodendrogenesis in an experimental model of autoimmune neuroinflammation
  1065. Childhood Autoimmune and neuroinflammation-Related Epilepsies
  1066. Chitinases, neuroinflammation and biomarkers in ALS
  1067. Cholinergic protection via α7 nicotinic acetylcholine receptors and PI3K-Akt pathway in LPS-induced neuroinflammation
  1068. Cholinergic system and neuroinflammation: implication in multiple sclerosis
  1069. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1149-x”>Chorioamnionitis, neuroinflammation, and injury: timing is key in the preterm ovine fetus
  1070. Chronic alcohol-induced liver injury correlates with memory deficits: Role for neuroinflammation
  1071. Chronic alcohol-induced microRNA-155 contributes to neuroinflammation in a TLR4-dependent manner in mice
  1072. Chronic behavioral stress exaggerates motor deficit and neuroinflammation in the MPTP mouse model of Parkinson’s disease
  1073. Chronic Binge Alcohol-Associated Differential Brain Region Modulation of Growth Factor Signaling Pathways and neuroinflammation in Simian Immunodeficiency …
  1074. neuroinflammation/links/5490183d0cf2d1800d863b7e/Adenosine-A2A-receptor-blockade-and-caffeine-modulate-retinal-neuroinflammation.pdf”>Chronic caffeine administration prevents retinal neuroinflammation and cell death in a rat retinal ischemia-reperfusion model
  1075. Chronic ethanol exposure combined with high fat diet up-regulates P2X7 receptors that parallels neuroinflammation and neuronal loss in C57BL/6J mice
  1076. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-130″>Chronic ethanol increases systemic TLR3 agonist-induced neuroinflammation and neurodegeneration
  1077. Chronic ethanol increases systemic TLR3 agonist-induced neuroinflammation and neurodegeneration
  1078. Chronic exercise ameliorates the neuroinflammation in mice carrying NSE/htau23
  1079. Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia
  1080. Chronic hM3Dq signaling in microglia ameliorates neuroinflammation in male mice
  1081. Chronic IL-1β-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer’s disease without inducing overt neurodegeneration
  1082. Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in Dark Agouti rats: mechanisms implicated
  1083. Chronic intermittent hypoxia induces chronic low-grade neuroinflammation in the dorsal hippocampus of mice
  1084. Chronic Intermittent Hypoxia-Induced neuroinflammation Undermines Respiratory Motor Plasticity After Chronic Incomplete Cervical Spinal Cord Injury
  1085. Chronic intra-ocular pressure induces neuroinflammation in retina and cerebral structures in an ocular hypertensive rat model
  1086. Chronic intracerebral LPS as a model of neuroinflammation
  1087. Chronic lithium administration attenuates up‐regulated brain arachidonic acid metabolism in a rat model of neuroinflammation
  1088. Chronic minocycline treatment reduces the anxiety-like behaviors induced by repeated restraint stress through modulating neuroinflammation
  1089. Chronic neurodegeneration after traumatic brain injury: Alzheimer disease, chronic traumatic encephalopathy, or persistent neuroinflammation?
  1090. Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signaling (877.1)
  1091. Chronic neuroinflammation impacts the recruitment of adult-born neurons into behaviorally relevant hippocampal networks
  1092. Chronic neuroinflammation in Alzheimer’s disease: new perspectives on animal models and promising candidate drugs
  1093. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer’s disease
  1094. Chronic neuroinflammation underlying pathogenesis of Alzheimer’s disease
  1095. Chronic neuroinflammation: Contribution of IL-1β to Prostaglandin Production and Alzheimer’s Disease Pathology
  1096. Chronic NMDA administration increases neuroinflammatory markers in rat frontal cortex: cross-talk between excitotoxicity and neuroinflammation
  1097. Chronic noise exposure acts cumulatively to exacerbate Alzheimer’s disease-like amyloid-β pathology and neuroinflammation in the rat hippocampus
  1098. Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces neuroinflammation, Oxidative Stress, and Glutamate Levels in A …
  1099. Chronic stress induces transient spinal neuroinflammation, triggering sensory hypersensitivity and long-lasting anxiety-induced hyperalgesia
  1100. Chronic systemic IL-1β exacerbates central neuroinflammation independently of the blood–brain barrier integrity
  1101. Chronic traumatic stress impairs memory in mice: potential roles of acetylcholine, neuroinflammation and corticotropin releasing factor expression in the hippocampus
  1102. Chronic treatment with combined chemotherapeutic agents affects hippocampal micromorphometry and function in mice, independently of neuroinflammation
  1103. Chronic viral neuroinflammation: speculation on underlying mechanisms
  1104. Chrysin restores MPTP induced neuroinflammation, oxidative stress and neurotrophic factors in an acute Parkinson’s disease mouse model
  1105. Ciproxifan improves cholinergic transmission, attenuates neuroinflammation and oxidative stress but does not reduce amyloid level in transgenic mice
  1106. Circadian clock protein Rev-erbα regulates neuroinflammation
  1107. Circadian control of pain and neuroinflammation
  1108. Circadian rhythms, neuroinflammation and Oxidative Stress in the Story of Parkinson’s Disease
  1109. Clarifying the Role of Microglia Versus Macrophages in Facilitating neuroinflammation Surrounding Intracortical Microelectrodes
  1110. CLEC5A regulates Japanese encephalitis virus-induced neuroinflammation and lethality
  1111. Clec7a is a Potential Target to Relieve Neuropathic Pain via Inhibiting neuroinflammation Activation Through Regulating TLR4 Expression
  1112. CLG from Hemp Seed Inhibits LPS-Stimulated neuroinflammation in BV2 Microglia by Regulating NF-κB and Nrf-2 Pathways
  1113. Clinical clues for autoimmunity and neuroinflammation in patients with autistic regression
  1114. Clinical Features and Outcomes of Patients with Status Epilepticus Caused by neuroinflammation (P2. 5-019)
  1115. Clk1 deficiency promotes neuroinflammation and subsequent dopaminergic cell death through regulation of microglial metabolic reprogramming
  1116. Clofibrate, a PPAR‐α agonist, abrogates sodium fluoride‐induced neuroinflammation, oxidative stress, and motor incoordination via modulation of GFAP/Iba‐1/anti …
  1117. CNI-1493 Attenuates neuroinflammation and Dopaminergic Neurodegeneration in the Acute MPTP Mouse Model of Parkinson’s Disease
  1118. CNS immune surveillance and neuroinflammation: endocannabinoids keep control
  1119. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature
  1120. CNS TLR2 mediates innate neuroinflammation but not autoimmune pathogenesis and demyelination
  1121. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation
  1122. Cobalt (II) β-ketoaminato complexes as novel inhibitors of neuroinflammation
  1123. Cocaine mediated neuroinflammation: role of dysregulated autophagy in pericytes
  1124. Cocaine self‐administration is increased after frontal traumatic brain injury and associated with neuroinflammation
  1125. Cofilin Knockdown Attenuates Collagenase-Induced ICH Injury in Mice by Combating Oxidative stress and Modulating neuroinflammation
  1126. Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation?
  1127. Cognitive deficits in experimental autoimmune encephalomyelitis: neuroinflammation and synaptic degeneration
  1128. Cognitive trajectory of patients in the recovery period after ischemic stroke: role of neuroinflammation and structural cerebral factors
  1129. Cold-inducible RNA-binding protein mediates neuroinflammation in cerebral ischemia
  1130. Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease
  1131. Combinations of ketamine and atropine are neuroprotective and reduce neuroinflammation after a toxic status epilepticus in mice
  1132. COMBINED ADMINISTRATION OF AN A2A RECEPTOR ANTAGONIST AND A 5-HT1A/1B RECEPTOR AGONIST REVERSES neuroinflammation IN THE 6 …
  1133. Combined analysis of the glia secretome and the CSF proteome: neuroinflammation and novel biomarkers
  1134. Combining ceftriaxone with doxycycline and daptomycin reduces mortality, neuroinflammation, brain damage, and hearing loss in infant rat pneumococcal meningitis
  1135. Commentary (Complement-Initiated neuroinflammation and Its Role in Early Stage Alzheimer’s Disease)
  1136. neuroinflammation-and-aberration-in-monoamine-levels-in-hypothalamus-are-associated-with-temperature.pdf”>Commentary: Heat stress-induced neuroinflammation and aber-ration in monoamine levels in hypothalamus are associated with temperature dysregulation
  1137. Commentary: Important considerations on bone morphogenetic protein-2 and neuroinflammation
  1138. Commentary: Low-Grade Non-Resolving neuroinflammation: Age Does Matter
  1139. Commentary: Mild endoplasmic reticulum stress ameliorates lpopolysaccharide-induced neuroinflammation and cognitive impairment via regulation of …
  1140. Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study
  1141. Communication between enteric neurons, glia, and nociceptors underlies the effects of tachykinins on neuroinflammation
  1142. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation
  1143. Comparative evaluation of three TSPO PET radiotracers in a LPS-induced model of mild neuroinflammation in rats
  1144. Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys
  1145. Comparison of [18F] FEPPA and [11C] PBR28, novel peripheral benzodiazepine receptor ligands for PET, in a rat model of neuroinflammation
  1146. Comparison of humoral neuroinflammation and adhesion molecule expression in two models of experimental intracerebral hemorrhage
  1147. Comparison of the effect of three licorice varieties on cognitive improvement via an amelioration of neuroinflammation in lipopolysaccharide-induced mice
  1148. Complement activation in autoimmune demyelination: dual role in neuroinflammation and neuroprotection
  1149. Complement activation sustains neuroinflammation and deteriorates adult neurogenesis and spatial memory impairment in rat hippocampus following sleep …
  1150. Complement in neuroinflammation
  1151. Complement in neuroinflammation: Studies in Leprosy and Amyotrophic Lateral Sclerosis
  1152. Complement, neuroinflammation and neuronal degeneration in Alzheimer disease
  1153. Compounds acting on the renin-angiotensin-aldosterone system as potential regulators of autoimmune neuroinflammation
  1154. Comprehensive analysis of the lncRNA-associated ceRNA network identifies neuroinflammation biomarkers for Alzheimer’s disease
  1155. Conditional expression of human β-hexosaminidase in the neurons of Sandhoff disease rescues mice from neurodegeneration but not neuroinflammation
  1156. Connecting metainflammation and neuroinflammation through the PTN-MK-RPTPβ/ζ axis: Relevance in therapeutic development
  1157. Connection between systemic inflammation and neuroinflammation underlies neuroprotective mechanism of several phytochemicals in neurodegenerative diseases
  1158. Connexin43-and pannexin-based channels in neuroinflammation and cerebral neuropathies
  1159. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-15″>Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation
  1160. Construction and optimization of novel recombinant Adeno-Associated Virus rAAV2/5 for targeting microglia to regulate immune responses during neuroinflammation
  1161. Consuming a diet supplemented with resveratrol reduced infection-related neuroinflammation and deficits in working memory in aged mice
  1162. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-1019-y”>Contrasting effect of the latency-reversing agents bryostatin-1 and JQ1 on astrocyte-mediated neuroinflammation and brain neutrophil invasion
  1163. Contribution of C5aR1 to neuroinflammation and Neuronal Dysfunction in Alzheimer’s Disease
  1164. Contribution of Dietary Fat in neuroinflammation
  1165. Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases
  1166. Contribution of microglia‐mediated neuroinflammation to retinal degenerative diseases
  1167. Contribution of neuroinflammation and immunity to brain aging and the mitigating effects of physical and cognitive interventions
  1168. Contribution of neuroinflammation in burning mouth syndrome: indications from benzodiazepine use
  1169. Contribution of neuroinflammation to changes in [11C] flumazenil binding in the rat brain: evaluation of the inflamed pons as reference tissue
  1170. Contribution of neuroinflammation to changes in [11C] flumazenil binding in the rat brain: evaluation of the inflamed pons as reference tissue
  1171. Contribution of neuroinflammation to the development of Alzheimer’s disease-like pathology in OXYS rats
  1172. Contribution of neuroinflammation to the pathogenesis of cancer cachexia
  1173. Contribution of Receptors, Transcription Factors, and Genes in the Induction of neuroinflammation
  1174. Contribution of Schwann cells to remyelination in a naturally occurring canine model of CNS neuroinflammation
  1175. Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders
  1176. Control of neuroinflammation for Therapeutic Gain
  1177. Controlling the activation of the B v8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals
  1178. CONTROLLING THE ACTIVATION OF THE PROKINETICIN SYSTEM REDUCES neuroinflammation AND ABOLISHES PAIN HYPERSENSITIVITY IN …
  1179. Conventional DCs sample and present myelin antigens in the healthy CNS and allow parenchymal T cell entry to initiate neuroinflammation
  1180. Convergence between microglia and peripheral macrophages phenotype during development and neuroinflammation
  1181. Cordycepin (3′-deoxyadenosine) promotes remyelination via suppression of neuroinflammation in a cuprizone-induced mouse model of demyelination
  1182. Core-cross-linked nanoparticles reduce neuroinflammation and improve outcome in a mouse model of traumatic brain injury
  1183. Cornel iridoid glycoside exerts a neuroprotective effect on neuroinflammation in rats with brain injury by inhibiting NF-κB and STAT3
  1184. Correction to Discovery of N-Alkyl Catecholamides as Selective Phosphodiesterase-4 Inhibitors with Anti-neuroinflammation Potential Exhibiting Antidepressant-like …
  1185. Correction to In Vivo Imaging of Human neuroinflammation
  1186. Correction to: Cathepsin C Aggravates neuroinflammation Involved in Disturbances of Behaviour and Neurochemistry in Acute and Chronic Stress-Induced Murine …
  1187. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0979-2″>Correction to: the disruption of mitochondrial axonal transport is an early event in neuroinflammation
  1188. Correction to: TREM2 Attenuates Aβ1-42-Mediated neuroinflammation in BV-2 Cells by Downregulating TLR Signaling.
  1189. Correction: Acetylcholinesterase Inhibitors Reduce neuroinflammation and-Degeneration in the Cortex and Hippocampus of a Surgery Stress Rat Model
  1190. Correction: Derivation of Neural Stem Cells from Human Adult Peripheral CD34+ Cells for an Autologous Model of neuroinflammation
  1191. Correction: Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral …
  1192. Correction: Imatinib Ameliorates neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral …
  1193. Correction: P-Glycoprotein Acts as an Immunomodulator during neuroinflammation
  1194. Correction: Platelets Recognize Brain-Specific Glycolipid Structures, Respond to Neurovascular Damage and Promote neuroinflammation
  1195. Correction: Tau Overexpression Impacts a neuroinflammation Gene Expression Network Perturbed in Alzheimer’s Disease
  1196. Correlation of CSF and plasma antioxidative capacity in patients with different clinical phenotypes of neuroinflammation and clinical and radiological findings
  1197. Correlations between blood–brain barrier disruption and neuroinflammation in an experimental model of penetrating ballistic-like brain injury
  1198. Corrigendum to “Characterization of MCAM contribution to neuroinflammation using a new murine knockout model”[J. Neuroimmunol., 275 (1–2)(2014) 143]
  1199. Corrigendum to’Cordycepin (3′-deoxyadenosine) promotes remyelination via suppression of neuroinflammation in a cuprizone-induced mouse model of …
  1200. Corrigendum to” 6-Shogaol, an active constituent of ginger, attenuates neuroinflammation and cognitive deficits in animal models of dementia”[BBRC 449 (2014) 8-13] …
  1201. Corrigendum to” Anxiety, neuroinflammation, cholinergic and GABAergic abnormalities are early markers of Gulf War illness in a mouse model of the disease”[Brain …
  1202. Corrigendum to” Parkinson’s disease: Autoimmunity and neuroinflammation“[Autoimmun Rev 15 (10)(2016) 1005-1011].
  1203. Corrigendum to” Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder-A combined magnetic resonance imaging and positron emission …
  1204. Corrigendum to” α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a …
  1205. Corrigendum: neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods
  1206. Corrigendum: Versatility of the complement system in neuroinflammation, neurodegeneration, and brain homeostasis
  1207. Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats
  1208. Cortical Neuron-Derived Exosomal MicroRNA-181c-3p Inhibits neuroinflammation by Downregulating CXCL1 in Astrocytes of a Rat Model with Ischemic Brain Injury
  1209. Corticosterone and pyridostigmine/DEET exposure attenuate peripheral cytokine expression: Supporting a dominant role for neuroinflammation in a mouse …
  1210. Corticosterone basal levels and vulnerability to LPS-induced neuroinflammation in the rat brain
  1211. Corticosterone potentiates DFP-induced neuroinflammation and affects high-order diffusion imaging in a rat model of Gulf War Illness
  1212. Could fever and neuroinflammation play a role in the neurobiology of autism? A subject worthy of more research
  1213. Could probiotics be used to mitigate neuroinflammation?
  1214. Could the Combination of Two Non-Psychotropic Cannabinoids Counteract neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
  1215. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1375-2″>Counteracting neuroinflammation in experimental Parkinson’s disease favors recovery of function: effects of Er-NPCs administration
  1216. COX-1 ACTIVITY PRECEDES THE COX-2 INDUCTION IN Aβ INDUCED neuroinflammation
  1217. Cranial irradiation leads to acute and persistent neuroinflammation with delayed increases in T-cell infiltration and CD11c expression in C57BL/6 mouse brain
  1218. Crashing the computer: apoptosis vs. necroptosis in neuroinflammation
  1219. CREB is upregulated in hepatic encephalopathy and contributes to the neuroprotection against neuroinflammation
  1220. Critical function of myeloid SOCS3 is in limiting the neuroinflammation of EAE (147.21)
  1221. Critical role of P2X7 receptors in the neuroinflammation and cognitive dysfunction after surgery
  1222. Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration
  1223. Cross-talk between glia, neurons and mast cells in neuroinflammation associated with Parkinson’s disease
  1224. Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging
  1225. Crosstalk between neurokinin receptor signaling and neuroinflammation in neurological disorders
  1226. Crystallins and neuroinflammation: The glial side of the story
  1227. CSB6B prevents β-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-κB and NLRP3 in microglia cells
  1228. CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
  1229. CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia
  1230. CSF biomarkers related to sleep, cognition and neuroinflammation in patients with Kleine Levin Syndrome
  1231. Cu II (atsm) Attenuates neuroinflammation
  1232. Cues Guiding Leukocyte Transendothelial Migration across the Blood-Brain Barrier in neuroinflammation: Endothelial Heterogeneity, Chemokines, and …
  1233. CuII (atsm) Attenuates neuroinflammation
  1234. Curcumin Alleviates Lipopolysaccharide (LPS)-Activated neuroinflammation via Modulation of miR-199b-5p/IκB Kinase β (IKKβ)/Nuclear Factor Kappa B (NF …
  1235. Curcumin alleviates lipopolysaccharide-induced neuroinflammation in fetal mouse brain
  1236. Curcumin alleviates lumbar radiculopathy by reducing neuroinflammation, oxidative stress and nociceptive factors
  1237. Curcumin ameliorates neuroinflammation, neurodegeneration, and memory deficits in p25 transgenic mouse model that bears hallmarks of Alzheimer’s disease
  1238. Curcumin and Apigenin–novel and promising therapeutics against chronic neuroinflammation in Alzheimer’s disease
  1239. Curcumin attenuates beta-amyloid-induced neuroinflammation via activation of peroxisome proliferator-activated receptor-gamma function in a rat model of …
  1240. Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/TLR4/NF-κB pathways in BV2 cells
  1241. Curcumin prevents acute neuroinflammation and long-term memory impairment induced by systemic lipopolysaccharide in mice
  1242. Curcumin protects axons from degeneration in the setting of local neuroinflammation
  1243. Curcumin reduces neuroinflammation stimulated by Aβ25-35 in primary rat microglial cells
  1244. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer’s disease
  1245. Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases
  1246. Current perspectives on the link between neuroinflammation and neurogenesis
  1247. Current preclinical studies on neuroinflammation and changes in blood–brain barrier integrity by MDMA and methamphetamine
  1248. Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities
  1249. Cutting Edge: IL-27 Attenuates Autoimmune neuroinflammation via Regulatory T Cell/Lag3–Dependent but IL-10–Independent Mechanisms In Vivo
  1250. Cx3cr1‐deficiency exacerbates alpha‐synuclein‐A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson’s disease
  1251. CX3CR1‐dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation
  1252. CXCL12 in control of neuroinflammation
  1253. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1646-6″>CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
  1254. CXCL12-γ expression is inhibited in neuroinflammation
  1255. CXCL12: role in neuroinflammation
  1256. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-11-103″>CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation
  1257. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-93″>CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation
  1258. CXCL5 signaling is a shared pathway of neuroinflammation and blood–brain barrier injury contributing to white matter injury in the immature brain
  1259. CXCL8 gene silencing promotes neuroglial cells activation while inhibiting neuroinflammation through the PI3K/Akt/NF‐κB‐signaling pathway in mice with ischemic …
  1260. CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration.
  1261. CXCR2 is essential for cerebral endothelial activation and leukocyte recruitment during neuroinflammation
  1262. CXCR2 signaling regulates neuroinflammation in models of viral and autoimmune-induced neurodegenerative disease
  1263. CXCR3 promotes cerebellar inflammation but prevents ocular destruction in transgenic mice with a TH1-driven neuroinflammation
  1264. Cyanidin attenuates Aβ 25-35-induced neuroinflammation by suppressing NF-κB activity downstream of TLR4/NOX4 in human neuroblastoma cells
  1265. Cyclic AMP pathway suppress autoimmune neuroinflammation by inhibiting functions of encephalitogenic CD4 T cells and enhancing M2 macrophage …
  1266. Cyclic AMP pathway suppress autoimmune neuroinflammation by inhibiting functions of encephalitogenic CD4 T cells and enhancing M2 macrophage polarization at …
  1267. Cyclin dependent kinase‐11, neuroinflammation and Alzheimer’s disease: a review
  1268. Cyclooxygenase (COX)-1 activity precedes the COX-2 induction in Aβ-induced neuroinflammation
  1269. Cyclooxygenase and neuroinflammation in Parkinson’s disease neurodegeneration
  1270. Cyclooxygenase-1 is involved in the inhibition of hippocampal neurogenesis after lipopolysaccharide-induced neuroinflammation
  1271. Cyclooxygenase-1 null mice show reduced neuroinflammation in response to β-amyloid
  1272. Cyclooxygenase-2-dependent neuroinflammation and oxidative stress in rostral ventrolateral medulla contribute to neurogenic hypertension following chronic …
  1273. CysLT1R downregulation reverses intracerebroventricular streptozotocin-induced memory impairment via modulation of neuroinflammation in mice
  1274. Cystatin F involvement in adenosine A 2A receptor-mediated neuroinflammation in BV2 microglial cells
  1275. Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation
  1276. Cytoglobin attenuates neuroinflammation in lipopolysaccharide-activated primary preoptic area cells via NFkB pathway inhibition
  1277. Cytokine adaptations to repeated ethanol exposure and the role of internal and external cues in ethanol-driven neuroinflammation
  1278. Cytokine Dynamics, Diagnosis and Treatment of neuroinflammation In Chronic Constriction Injury Rat Model
  1279. Cytokine networks in neuroinflammation
  1280. Cytokines and chemokines as biomarkers of ethanol-induced neuroinflammation and anxiety-related behavior: role of TLR4 and TLR2
  1281. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain
  1282. Cytokines as mediators of neuroinflammation in experimental autoimmune encephalomyelitis
  1283. Cytokines in neuroinflammation and Alzheimer’s disease
  1284. Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation
  1285. Cytotoxicity of acute neuroinflammation induced by lipopolysaccharide can be attenuated by ginkgolide B
  1286. CZ2HF mitigates β-amyloid 25-35 fragment-induced learning and memory impairment through inhibition of neuroinflammation and apoptosis in rats
  1287. D-4F increases microRNA-124a and reduces neuroinflammation in diabetic stroke rats
  1288. D27 neuroinflammation and changes in serotonin metabolism in presymptomatic HD gene carriers: a dual tracer positron emission tomography (PET) study
  1289. Daily Administration of Ibuprofen Modifies neuroinflammation Gene Expression, but not Neuroplasticity Gene Expression in Traumatic Brain Injured Rats
  1290. Dampening neuroinflammation
  1291. Dangguishaoyao-san attenuates LPS-induced neuroinflammation via the TLRs/NF-κB signaling pathway
  1292. Danshensu ameliorates the cognitive decline in streptozotocin-induced diabetic mice by attenuating advanced glycation end product-mediated neuroinflammation
  1293. DARS2 protects against neuroinflammation and apoptotic neuronal loss, but is dispensable for myelin producing cells
  1294. Dcf1 deficiency attenuates the role of activated microglia during neuroinflammation
  1295. DE NOVO NAD+ SYNTHESIS RESCUES neuroinflammation AND ALZHEIMER’S DISEASE PHENOTYPES: MODULATING IMMUNE CELL RESPONSES AND …
  1296. Debate:“is increasing neuroinflammation beneficial for neural repair?”
  1297. DECIPHERING THE ROLE OF neuroinflammation IN THE EARLY EVENTS OF ALZHEIMER’S DISEASE
  1298. Decrease in adult neurogenesis and neuroinflammation are involved in spatial memory impairment in the streptozotocin-induced model of sporadic Alzheimer’s …
  1299. Decrease in neuroinflammation after immunisation with synthetic prion peptides in an animal model of scrapie
  1300. Decrease of miR-19b-3p in Brain Microvascular Endothelial Cells Attenuates Meningitic Escherichia coli-Induced neuroinflammation via TNFAIP3-Mediated NF-κB …
  1301. Decreased neuroinflammation and increased brain energy homeostasis following environmental enrichment after mild traumatic brain injury is associated …
  1302. Decreased neuroinflammation correlates to higher vagus nerve activity fluctuations in near-term ovine fetuses: a case for the afferent cholinergic anti …
  1303. Decreased neuronal CD200 expression in IL-4-deficient mice results in increased neuroinflammation in response to lipopolysaccharide
  1304. Decreasing oxidative stress and neuroinflammation with a multifunctional peptide rescues memory deficits in mice with Alzheimer disease
  1305. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1693-z”>Dectin-1/Syk signaling triggers neuroinflammation after ischemic stroke in mice
  1306. Deep brain stimulation does not enhance neuroinflammation in multiple system atrophy
  1307. Deep hypothermia therapy attenuates LPS-induced microglia neuroinflammation via the STAT3 pathway
  1308. Deep sequencing and miRNA profiles in alcohol-induced neuroinflammation and the TLR4 response in mice cerebral cortex
  1309. Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation
  1310. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0238-3″>Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice
  1311. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0740-2″>Deferoxamine regulates neuroinflammation and iron homeostasis in a mouse model of postoperative cognitive dysfunction
  1312. Deferoxamine regulates neuroinflammation and oxidative stress in rats with diabetes-induced cognitive dysfunction
  1313. Deficiency of tenascin-C alleviates neuronal apoptosis and neuroinflammation after experimental subarachnoid hemorrhage in mice
  1314. Deficiency of tPA Exacerbates White Matter Damage, neuroinflammation, Glymphatic Dysfunction and Cognitive Dysfunction in Aging Mice
  1315. Deficiency of TREK-1 potassium channel exacerbates blood-brain barrier damage and neuroinflammation after intracerebral hemorrhage in mice
  1316. Deficiency of α1, 6-fucosyltransferase promotes neuroinflammation by increasing the sensitivity of glial cells to inflammatory mediators
  1317. Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy
  1318. Defining “neuroinflammation” Lessons from MPTP‐and Methamphetamine‐Induced Neurotoxicity
  1319. Defining the contribution of neuroinflammation to Parkinson’s disease in humanized immune system mice
  1320. Defining the role of IL-23 in autoimmune neuroinflammation
  1321. Definition of a 1.06-Mb region linked to neuroinflammation in humans, rats and mice
  1322. Definition of genetic and pathogenic mechanisms regulating neuroinflammation
  1323. Degeneration and regeneration of the peripheral nervous system: from Augustus Waller’s observations to neuroinflammation
  1324. Degenerative joint diseases and neuroinflammation
  1325. Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury
  1326. Deletion of CD38 suppresses glial activation and neuroinflammation in a mouse model of demyelination
  1327. Deletion of Chitinase-3-like 1 accelerates stroke development through enhancement of neuroinflammation by STAT6-dependent M2 microglial inactivation in …
  1328. Deletion of equilibrative nucleoside transporter-2 protects against lipopolysaccharide-induced neuroinflammation and blood-brain barrier dysfunction in mice
  1329. Deletion of monoglyceride lipase in astrocytes attenuates lipopolysaccharide-induced neuroinflammation
  1330. Deletion of μ-Opioid Receptor in Mice Alters the Development of Acute neuroinflammation
  1331. Deletion or inhibition of soluble epoxide hydrolase protects against brain damage and reduces microglia-mediated neuroinflammation in traumatic brain injury
  1332. Delineating neuroinflammation, parasite CNS invasion, and blood-brain barrier dysfunction in an experimental murine model of human African …
  1333. Demyelinating Diseases and neuroinflammation
  1334. Demyelination caused by the copper chelator cuprizone halts T cell mediated autoimmune neuroinflammation
  1335. Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model
  1336. Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration
  1337. Dendrimer-based targeted systemic therapies for neuroinflammation in CNS disorders
  1338. Dendrimer-Fluocinolone Acetonide Nanodevices Supress Retinal neuroinflammation and Are Neuroprotective in RCS Rats
  1339. Dendritic cells as therapeutic targets in neuroinflammation
  1340. Dendritic cells, CD4+ T cells, and α synuclein triangle fuels neuroinflammation in Parkinson’s disease (P3. 053)
  1341. Dental Pulp Stem Cell-Derived Factors Alleviate Subarachnoid Hemorrhage-Induced neuroinflammation and Ischemic Neurological Deficits
  1342. Department of neuroinflammation, Institute of Neurology, Queen Square, London, UK
  1343. Depression comorbid with hyperalgesia: Different roles of neuroinflammation induced by chronic stress and hypercortisolism
  1344. Depression-like behavior, hyperglycemia, oxidative stress, and neuroinflammation presented in diabetic mice are reversed by the administration of 1-methyl-3 …
  1345. Depression-like behaviors and heme oxygenase-1 are regulated by Lycopene in lipopolysaccharide-induced neuroinflammation
  1346. Derivation of neural stem cells from human adult peripheral CD34+ cells for an autologous model of neuroinflammation
  1347. Design of a Novel PAMAM-Based Nanomedicine with Sustained NAC Release for Treatment of neuroinflammation
  1348. Design of antioxidant nanotherapeutics for attenuation of atherogenesis and neuroinflammation
  1349. Design of dual inhibitors of ROCK-I and NOX2 as potential leads for the treatment of neuroinflammation associated with various neurological diseases including …
  1350. Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7
  1351. Designing of multi-target-directed ligands against the enzymes associated with neuroinflammation: an in silico approach
  1352. Detecting neuroinflammation Following Traumatic Brain Injury: Novel Quantitative, Multianalyte Immunoassay Improves Detection
  1353. Detecting neuroinflammation in the brain following chronic alcohol exposure in rats: A comparison between in vivo and in vitro TSPO radioligand binding
  1354. Detecting neuroinflammation with molecular MRI
  1355. Detection of cytotoxic activation of microglia in a rat neuroinflammation model using a novel translocator protein ligand,[18F] FEPPA
  1356. Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180
  1357. Detection of microRNAs in microglia by real-time PCR in normal CNS and during neuroinflammation
  1358. Detection of neuroinflammation before selective neuronal loss appearance after mild focal ischemia using [18 F] DPA-714 imaging
  1359. Detection of neuroinflammation in a Rat Model of Subarachnoid Hemorrhage Using [18F]DPA-714 PET Imaging
  1360. neuroinflammation-through-the-retina-by-means-of-Raman/10.1117/12.921358.short”>Detection of neuroinflammation through the retina by means of Raman spectroscopy and multivariate analysis
  1361. Detection of Zika virus (ZIKV)-induced neuroinflammation in a murine infection model with translocator protein (TSPO) ligand 3H-PK11195
  1362. Determinants of CCL5-driven mononuclear cell migration across the blood–brain barrier. Implications for therapeutically modulating neuroinflammation
  1363. Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-β using BV2 microglial cells and APP/PS1 transgenic mice
  1364. Detrimental effects of HMGB-1 require microglial-astroglial interaction: Implications for the status epilepticus-induced neuroinflammation
  1365. Developing a Novel In-Vitro neuroinflammation Model for Huntington’s Disease
  1366. Development and characterisation of a novel NF-κB reporter cell line for investigation of neuroinflammation
  1367. DEVELOPMENT AND ELUCIDATION OF MECHANISM OF ACTION OF NEW LEADS TO ATTENUATE neuroinflammation IN STROKE MODEL
  1368. Development and Validation of a Targeted Next-Generation Sequencing Gene Panel for Children With neuroinflammation
  1369. Development of a human innervated tissue engineered skin for the study of neuroinflammation
  1370. Development of a methodology for monitoring spinal neuroinflammation mechanisms in the neuropathic rat in vivo
  1371. Development of a novel method for quantification of sterols and oxysterols by UPLC-ESI-HRMS: application to a neuroinflammation rat model
  1372. Development of a positron emission tomography radiotracer for imaging elevated levels of superoxide in neuroinflammation
  1373. Development of an in vitro model of neuroinflammation for studying secondary injury mechanisms in traumatic brain injury
  1374. neuroinflammation&ots=49dOl9Tnx2&sig=idqcBO81Ceicm6IBtebMKuS_Hqs”>Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer’s disease
  1375. Development of highly potent phosphodiesterase 4 inhibitors with anti-neuroinflammation potential: design, synthesis, and structure-activity relationship study of …
  1376. Development of Novel Quinoxaline-Based κ-Opioid Receptor Agonists for the Treatment of neuroinflammation
  1377. Development of PET neuroimaging methods for stroke and neuroinflammation
  1378. Development of rodent in vivo models: neuroinflammation and neurodegeneration relevant to Alzheimer’s disease
  1379. Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination
  1380. Developmental neuroinflammation and schizophrenia
  1381. Dexamethasone sodium phosphate attenuates lipopolysaccharide-induced neuroinflammation in microglia BV2 cells
  1382. Dexmedetomidine Attenuates neuroinflammation In LPS-Stimulated BV2 Microglia Cells Through Upregulation Of miR-340
  1383. Dexmedetomidine Inhibits neuroinflammation by Altering Microglial M1/M2 Polarization Through MAPK/ERK Pathway
  1384. Dexmedetomidine mitigates microglia-mediated neuroinflammation through upregulation of programmed cell death protein 1 in a rat spinal cord injury model
  1385. Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury
  1386. Dexmedetomidine pretreatment inhibits cerebral ischemia/reperfusion‑induced neuroinflammation via activation of AMPK
  1387. Dexmedetomidine reduces lipopolysaccharide induced neuroinflammation, sickness behavior, and anhedonia
  1388. Dexmedetomidine suppresses sevoflurane anesthesia-induced neuroinflammation through activation of the PI3K/Akt/mTOR pathway
  1389. Diabetes insipidus contributes to traumatic brain injury pathology via CD36 neuroinflammation
  1390. neuroinflammation/links/5851255208ae8f3738194d78/DIABETIC-NEUROPATHY-OXIDATIVE-STRESS-AND-neuroinflammation.pdf”>DIABETIC NEUROPATHY: OXIDATIVE STRESS AND neuroinflammation
  1391. Diagnostic approaches and outcomes in patients with neuroinflammation
  1392. Diammonium Glycyrrhizinate Attenuates Aβ1–42‐Induced neuroinflammation and Regulates MAPK and NF‐κB Pathways In Vitro and In Vivo
  1393. DICAM: A novel molecular effector in neuroinflammation
  1394. Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice
  1395. Diesel exhaust activates and primes microglia: air pollution, neuroinflammation, and regulation of dopaminergic neurotoxicity
  1396. Diet induced neuroinflammation and cognitive decline
  1397. Diet-induced cellular neuroinflammation in the hypothalamus: Mechanistic insights from investigation of neurons and microglia
  1398. Diet-Induced neuroinflammation: Microgliosis Due to Binge Eating
  1399. Diet-induced obesity and low testosterone increase neuroinflammation and impair neural function
  1400. Diet-induced obesity and low testosterone interact to increase neuroinflammation and reduce neuron survival
  1401. Diet-induced obesity prolongs neuroinflammation and recruits CCR2+ monocytes to the brain following herpes simplex virus (HSV)-1 latency in mice
  1402. Dietary Acetate Supplementation Attenuates neuroinflammation
  1403. Dietary and donepezil modulation of mTOR signaling and neuroinflammation in the brain
  1404. Dietary broccoli mildly improves neuroinflammation in aged mice but does not reduce lipopolysaccharide-induced sickness behavior
  1405. Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids
  1406. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-014-0156-9″>Dietary intervention rescues maternal obesity induced behavior deficits and neuroinflammation in offspring
  1407. Dietary inulin alters the gut microbiome, enhances systemic metabolism and reduces neuroinflammation in an APOE4 mouse model
  1408. Dietary magnesium and copper affect survival time and neuroinflammation in chronic wasting disease
  1409. Dietary Restriction and neuroinflammation: A Potential Mechanistic Link
  1410. Dietary Saturated Fatty Acids Promote Differentiation of Th1 and Th17 Cells And Aggravate neuroinflammation (P6. 149)
  1411. Dietary Spray-Dried Porcine Plasma Prevents Cognitive Decline in Senescent Mice and Reduces neuroinflammation and Oxidative Stress
  1412. Dietary Supplementation of the Antioxidant Curcumin Halts Systemic LPS-Induced neuroinflammation-Associated Neurodegeneration and Memory/Synaptic …
  1413. Dietary supplementation with α-tocopherol reduces neuroinflammation and neuronal degeneration in the rat brain after kainic acid-induced status epilepticus
  1414. Differences in statin associated neuroprotection corresponds with either decreased production of IL-1β or TNF-α in an in vitro model of neuroinflammation-induced …
  1415. Differential changes in Neuregulin-1 signaling in major brain regions in a lipopolysaccharide-induced neuroinflammation mouse model
  1416. Differential effects of blueberry polyphenols on age-associated neuroinflammation and cognition.
  1417. Differential effects of duration and age on the consequences of neuroinflammation in the hippocampus
  1418. Differential effects of propofol and dexmedetomidine on neuroinflammation induced by systemic endotoxin lipopolysaccharides in adult mice
  1419. Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson’s disease
  1420. Differential local connectivity and neuroinflammation profiles in the medial prefrontal cortex and hippocampus in the valproic acid rat model of autism
  1421. Differential modulation of glial cell mediated neuroinflammation in Plasmodium berghei ANKA infection by TGF β and IL 6
  1422. Differential role of interleukin-1β in neuroinflammation-induced impairment of spatial and nonspatial memory in hyperammonemic rats
  1423. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1545-x”>Differential transcriptional profiles identify microglial-and macrophage-specific gene markers expressed during virus-induced neuroinflammation
  1424. neuroinflammation-and-psychosis-associated-with-chromosome-deletion/2F5C7657FD3577B108B660EEAB6CFC76″>Differential treatment response, neuroinflammation, and psychosis associated with chromosome deletion
  1425. Differentiation and transmigration of CD4 T cells in neuroinflammation and autoimmunity
  1426. Digested raspberries polyphenols for brain health: attenuation of neuroinflammation
  1427. Dihydrolipoic acid protects against lipopolysaccharide-induced behavioral deficits and neuroinflammation via regulation of Nrf2/HO-1/NLRP3 signaling in rat
  1428. Dihydromyricetin exerts a rapid antidepressant-like effect in association with enhancement of BDNF expression and inhibition of neuroinflammation
  1429. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP 3 inflammasome activation in APP/PS 1 transgenic mice
  1430. Dihydromyricetin protects against cerebral ischemia/reperfusion injury via suppressing microglia-mediated neuroinflammation and activation of ERK1/2-CREB …
  1431. Dimethyl fumarate attenuates neuroinflammation and neurobehavioral deficits induced by experimental traumatic brain injury
  1432. Dimethyl fumarate limits neuroinflammation and oxidative stress and improves cognitive impairment after polymicrobial sepsis
  1433. Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?
  1434. Diosmin reduces cerebral Aβ levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice
  1435. Direct Test for neuroinflammation with [11C] DAP-713-PET Scanning
  1436. Direct Test for neuroinflammation with [11C] DPA-713-PET Scanning
  1437. Discovery development of drugs for alzheimers disease neuroinflammation and elucidating their molecular mechanism of action
  1438. Discovery of 2‐(3, 4‐dialkoxyphenyl)‐2‐(substituted pyridazin‐3‐yl) acetonitriles as phosphodiesterase 4 inhibitors with anti‐neuroinflammation potential based on …
  1439. Discovery of coumarin Mannich base derivatives as multifunctional agents against monoamine oxidase B and neuroinflammation for the treatment of Parkinson’s …
  1440. Discovery of N-Alkyl Catecholamides as Selective Phosphodiesterase-4 Inhibitors with Anti-neuroinflammation Potential Exhibiting Antidepressant-like Effects at Non …
  1441. Discovery of trifluoromethyl glycol carbamates as potent and selective covalent monoacylglycerol lipase (MAGL) inhibitors for treatment of neuroinflammation
  1442. Disease-induced neuroinflammation and depression
  1443. Disruption of calcitonin gene-related peptide signaling accelerates muscle denervation and dampens cytotoxic neuroinflammation in SOD1 mutant mice
  1444. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-020-1709-8″>Disruption of Midkine gene reduces traumatic brain injury through the modulation of neuroinflammation
  1445. Dissecting the complex landscape of neuroinflammation at single-cell resolution
  1446. Dissociation of frontotemporal dementia–related deficits and neuroinflammation in progranulin haploinsufficient mice
  1447. Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP/PS1 transgenic mice
  1448. Distinct contributions of astrocytes and pericytes to neuroinflammation identified in a 3D human blood-brain barrier on a chip
  1449. Distinct contributions of hyperglycemia and high-fat feeding in metabolic syndrome-induced neuroinflammation
  1450. Distinct dictation of Japanese encephalitis virus-induced neuroinflammation and lethality via triggering TLR3 and TLR4 signal pathways
  1451. Distinct role of Glutaminyl Cyclases (QCs) in inflammation/neuroinflammation: First results from QC and isoQC knock out mice
  1452. Distribution of different isoforms of receptor protein tyrosine phosphatase γ (Ptprg-RPTP γ) in adult mouse brain: upregulation during neuroinflammation
  1453. Dithiolethione ACDT suppresses neuroinflammation and ameliorates disease severity in experimental autoimmune encephalomyelitis
  1454. Diverse action of lipoteichoic acid and lipopolysaccharide on neuroinflammation, blood-brain barrier disruption, and anxiety in mice
  1455. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia
  1456. Dl-3-n-butylphthalide exerts dopaminergic neuroprotection through inhibition of neuroinflammation
  1457. DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington’s mice (R6/2) reveals neuroinflammation and insulin associations
  1458. DNA Subtraction of In Vivo Selected Phage Repertoires for Efficient Peptide Pathology Biomarker Identification in neuroinflammation Multiple Sclerosis Model
  1459. Docosahexaenoic acid (DHA) in stroke, Alzheimer’s disease, and blinding retinal degenerations: coping with neuroinflammation and sustaining cell survival
  1460. Docosahexaenoic acid decreased neuroinflammation in rat pups after controlled cortical impact
  1461. Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer’s, and other neurodegenerative …
  1462. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0939-x”>Docosahexaenoic acid-containing choline phospholipid modulates LPS-induced neuroinflammation in vivo and in microglia in vitro
  1463. Doenjang, A Korean Traditional Fermented Soybean Paste, Ameliorates neuroinflammation and Neurodegeneration in Mice Fed a High-Fat Diet
  1464. Does Anticholinergic Activity Affect Neuropathology Implication of neuroinflammation in Alzheimer’s Disease
  1465. DOES MEDITERRANEAN DIET CONFER NEUROPROTECTION AGAINST neuroinflammation AND RELATED DISEASES? AN OVERVIEW
  1466. Does neuroinflammation drive the relationship between tau hyperphosphorylation and dementia development following traumatic brain injury?
  1467. Does neuroinflammation fan the flame in neurodegenerative diseases?
  1468. Does neuroinflammation induce systemic aging?
  1469. Does neuroinflammation sustain neurodegeneration in ALS?
  1470. Does neuroinflammation turn on the flame in Alzheimer’s disease? Focus on astrocytes
  1471. Does neuroinflammation turn on the flame in Alzheimer’s disease? Focus on astrocytes
  1472. Does neuroinflammation turn on the flame in Alzheimer’s disease? Focus on astrocytes
  1473. Does the interplay between aging and neuroinflammation modulate Alzheimer’s disease clinical phenotypes? A clinico-pathological perspective
  1474. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1652-8″>Dopamine receptor D3 signalling in astrocytes promotes neuroinflammation
  1475. Dopaminochrome induces neuroinflammation in the substantia nigra of Sprague Dawley rats
  1476. Dorsal raphe neuroinflammation promotes dramatic behavioral stress dysregulation
  1477. Double-negative T cells remarkably promote neuroinflammation after ischemic stroke
  1478. Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
  1479. Downregulated nuclear factor E2-related factor 2 (Nrf2) aggravates cognitive impairments via neuroinflammation and synaptic plasticity in the senescence …
  1480. Doxycycline and meloxicam can treat neuroinflammation by increasing activity of antioxidant enzymes in rat brain.
  1481. Doxycycline counteracts neuroinflammation restoring memory in Alzheimer’s disease mouse models
  1482. Doxycycline for Alzheimer’s disease: fighting β-amyloid oligomers and neuroinflammation
  1483. Drug Abuse-Related neuroinflammation in Human Postmortem Brains: An Immunohistochemical Approach
  1484. Drug development for Alzheimer’s disease: microglia induced neuroinflammation as a target?
  1485. Drug-and cell-based therapies for targeting neuroinflammation in traumatic brain injury
  1486. Ds-HMGB1 and fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1
  1487. Dual bioactivity of resveratrol fatty alcohols: differentiation of neural stem cells and modulation of neuroinflammation
  1488. Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation
  1489. Dual effects of human placenta-derived neural cells on neuroprotection and the inhibition of neuroinflammation in a Rodent model of Parkinson’s disease
  1490. Dual Inhibitors of ROCK I and NOX to Attenuate neuroinflammation in Neurological Disorders High Throughput Virtual and Biological screening
  1491. Dual lentivirus infection potentiates neuroinflammation and neurodegeneration: viral copassage enhances neurovirulence
  1492. Dual role of ALCAM in neuroinflammation and blood–brain barrier homeostasis
  1493. Dual role of vitamin C on the neuroinflammation mediated neurodegeneration and memory impairments in colchicine induced rat model of Alzheimer disease
  1494. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation
  1495. Dual Targeting of Amyloid-beta Clearance and neuroinflammation as a Novel Therapeutic Approach against Alzheimer’s Disease
  1496. Dual therapeutic effects of C-10068, a dextromethorphan derivative, against post-traumatic nonconvulsive seizures and neuroinflammation in a rat model of …
  1497. Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood–brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis
  1498. Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV α …
  1499. Dynamic cross-talk between microglia and peripheral monocytes underlies stress-induced neuroinflammation and behavioral consequences
  1500. Dynamic development of glucocorticoid resistance during autoimmune neuroinflammation
  1501. Dynamic visualization of neuroinflammation in multiple sclerosis animal model with animal positron emission tomography
  1502. Dynamically Monitor neuroinflammation in a Mouse Model of Mo/Hu APPswePS1dE9 Mice with [18F]-DPA714 PET Imaging
  1503. Dynamics of neuroinflammation in the macrosphere model of arterio-arterial embolic focal ischemia: an approximation to human stroke patterns
  1504. Dynamics of Regulatory T Cell-Mediated Control of Antigen Responses and Autoimmune neuroinflammation
  1505. Dysfunction of brain pericytes in chronic neuroinflammation
  1506. Dysfunction of neuronal calcium signalling in neuroinflammation and neurodegeneration
  1507. Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation
  1508. Dysregulation in myelination mediated by persistent neuroinflammation: possible mechanisms in chemotherapy-related cognitive impairment
  1509. Dysregulation of intestinal IL17 signaling & the microbiome exacerbate autoimmune neuroinflammation.
  1510. Dysregulation of neurogenesis by neuroinflammation: key differences in neurodevelopmental and neurological disorders
  1511. neuroinflammation&ots=hOgZ6fGRTT&sig=V1wDaPuMBEbX1NRMdvbDD4nT3LU”>e role of NO/cGMP signaling on neuroinflammation: a new therapeutic opportunity
  1512. Early activation of Egr-1 promotes neuroinflammation and dopaminergic neurodegeneration in an experimental model of Parkinson’s disease
  1513. Early detection of neuroinflammation in p25 inducible mouse model
  1514. Early electroacupuncture treatment ameliorates neuroinflammation in rats with traumatic brain injury
  1515. Early enteral feeding reduces sepsis response and neuroinflammation in a pig model of neonatal bloodstream infection
  1516. Early gene activation initiates neuroinflammation prior to VSV neuroinvasion: Impact on antiviral responses and sleep
  1517. Early hyperbaric oxygen treatment attenuates burn-induced neuroinflammation by inhibiting the galectin-3-dependent toll-like receptor-4 pathway in a rat model
  1518. Early immune response in MPTP-induced neuroinflammation in the mouse myenteric plexus and central nervous system
  1519. Early intervention with ABA prevents neuroinflammation and memory impairment in a triple transgenic mice model of Alzheimer´ s disease
  1520. Early life experience contributes to the developmental programming of depressive-like behaviour, neuroinflammation and oxidative stress
  1521. Early minocycline and late FK506 treatment improves survival and alleviates neuroinflammation, neurodegeneration, and behavioral deficits in prion-infected …
  1522. Early miR-155 upregulation contributes to neuroinflammation in Alzheimer’s disease triple transgenic mouse model
  1523. Early Treatment of Experimental Autoimmune Encephalomyelitis with Cannabidiol Suppresses Tc1 Cells and Reduces neuroinflammation
  1524. Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid β-protein precursor transgenic …
  1525. Eating as a motivated behavior: modulatory effect of high fat diets on energy homeostasis, reward processing and neuroinflammation
  1526. EBI2–Sensor for dihydroxycholesterol gradients in neuroinflammation
  1527. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs
  1528. Edaravone abrogates LPS-induced behavioral anomalies, neuroinflammation and PARP-1
  1529. Editor’s Perspective:“Connecting the Dots” from Blood Brain Barrier Dysfunction to neuroinflammation and Alzheimer’s Disease
  1530. Effect of adenovirus-mediated overexpression of PTEN on brain oxidative damage and neuroinflammation in a rat kindling model of epilepsy
  1531. Effect of agmatine on impairment of hippocampal neurogenesis and neuroinflammation in streptozotocin-induced diabetes in rats
  1532. neuroinflammation_in_Albino_Rats/links/5e1da08ea6fdcc28e9c4c5dc/Effect-of-Annona-Squamosa-Ethanolic-and-Aqueous-Leave-Extracts-on-Aluminum-Chloride-Induced-neuroinflammation-in-Albino-Rats.pdf”>Effect of Annona Squamosa Ethanolic and Aqueous Leave Extracts on Aluminum Chloride-Induced neuroinflammation in Albino Rats
  1533. Effect of anti-dementia drugs on LPS induced neuroinflammation in mice
  1534. Effect of antidepressant treatment on plasma levels of neuroinflammation‐associated molecules in patients with somatic symptom disorder with predominant pain …
  1535. Effect of atorvastatin on behavioral alterations and neuroinflammation during epileptogenesis
  1536. Effect of Cafeteria Diet Induced Obesity on neuroinflammation in the Orbitofrontal Cortex
  1537. Effect of chronic stress in the onset of Parkinson’s disease: possible role of microglial cells in neuroinflammation
  1538. Effect of cigarette smoking on a marker for neuroinflammation: A [11 C] DAA1106 positron emission tomography study
  1539. Effect of Clostridium butyricum against Microglia‐Mediated neuroinflammation in Alzheimer’s Disease via Regulating Gut Microbiota and Metabolites Butyrate
  1540. Effect of dimethyl fumarate on neuroinflammation and apoptosis in pentylenetetrazol kindling model in rats
  1541. Effect of hesperidin on neurobehavioral, neuroinflammation, oxidative stress and lipid alteration in intracerebroventricular streptozotocin induced cognitive impairment …
  1542. Effect of IL-17A on lipopolysaccharide-induced neuroinflammation and fear conditioning test
  1543. Effect of interferon-β on neuroinflammation, brain injury and neurological outcome after experimental subarachnoid hemorrhage
  1544. Effect of Linguizhugan decoction on neuroinflammation and expression disorder of the amyloid β‑related transporters RAGE and LRP‑1 in a rat model of …
  1545. Effect of long-term administration of antiretroviral drugs (Tenofovir and Nevirapine) on neuroinflammation and neuroplasticity in mouse hippocampi
  1546. Effect of low-dose cyclophosphamide, ACTH, and IVIg combination immunotherapy on neuroinflammation in pediatric-onset OMS: a retrospective pilot study
  1547. EFFECT OF MANGOSTEEN EXTRACT ON neuroinflammation IN RAT MODEL OF ACUTE TRAUMATIC BRAIN INJURY
  1548. Effect of melatonin on neuroinflammation and acetylcholinesterase activity induced by LPS in rat brain
  1549. Effect of NAC treatment and physical activity on neuroinflammation in subchronic Parkinsonism; is physical activity essential?
  1550. Effect of NALP1 inflammasome and Lipoxin in methamphetamine-induced on neuroinflammation in rats
  1551. Effect of neuroinflammation on ABC transporters: possible contribution to refractory epilepsy
  1552. neuroinflammation%20on%20cognition.pdf”>Effect of neuroinflammation on cognition and potential mechanisms involved
  1553. Effect of neuroinflammation on Mitochondrial Quality Control Pathways in Parkinson’s Disease–Affected Neurons
  1554. Effect of neuroinflammation on synaptic organization and function in the developing brain: implications for neurodevelopmental and neurodegenerative …
  1555. Effect of Novel ERβ Agonist in Controlling neuroinflammation and Apoptosis in Cerebral Ischemia in Rat Model
  1556. Effect of Pluchea lanceolata bioactives in LPS-induced neuroinflammation in C6 rat glial cells
  1557. Effect of Q-VD-OPh on neurodegeneration and neuroinflammation of sarin-exposed mice (877.6)
  1558. Effect of simvastatin on neuroinflammation in microglial cells via mitogen-activated protein kinase and nuclear factor κB pathways
  1559. Effect of stress on neuroinflammation in the substantia nigra and striatum of LRRK2 (R1441G) mouse model for Parkinson’s disease
  1560. Effect of systemic inflammation on rat attentional function and neuroinflammation: Possible protective role for food restriction
  1561. Effect of the Broad-Spectrum Caspase Inhibitor Q-VD-OPh on Neurodegeneration and neuroinflammation of Sarin Exposed Mice
  1562. Effect of the Lipid Peroxidation Product 4-Hydroxynonenal on neuroinflammation in Microglial Cells: Protective Role of Quercetin and …
  1563. Effect of Toxoplasma gondii on altering dopaminelevels and neuroinflammation contributing to an increased risk of developingschizophrenia
  1564. Effect of TRPC6 knock-out on the mouse neuroinflammation induced by MPTP
  1565. Effect of valerenic acid on neuroinflammation in a MPTP-induced mouse model of Parkinson’s disease
  1566. neuroinflammation_in_Experimental_Spinal_Cord_Injury/links/5d08bbc5a6fdcc35c155f41a/Effect-of-Whartons-Jelly-Derived-Mesenchymal-Stem-Cells-on-the-Expression-of-NLRP3-Receptor-and-neuroinflammation-in-Experimental-Spinal-Cord-Injury.pdf”>Effect of Wharton’s Jelly Derived Mesenchymal Stem Cells on the Expression of NLRP3 Receptor and neuroinflammation in Experimental Spinal Cord Injury.
  1567. Effects of 900 MHz radiofrequency on corticosterone, emotional memory and neuroinflammation in middle-aged rats
  1568. Effects of a High-Fat Diet on neuroinflammation and Apoptosis in Acute Stage After Moderate Traumatic Brain Injury in Rats
  1569. Effects of a high-fat diet on the cerebrovasculature and neuroinflammation in an experimental model of Alzheimer’s disease
  1570. Effects of a standardized phenolic-enriched maple syrup extract on β-amyloid aggregation, neuroinflammation in microglial and neuronal cells, and β-amyloid induced …
  1571. Effects of active immunisation with myelin basic protein and myelin-derived altered peptide ligand on pain hypersensitivity and neuroinflammation
  1572. Effects of bexarotene on neuroinflammation in an ad mouse model
  1573. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer’s disease
  1574. Effects of CDP-choline on macrophages and oligodendrocytes in neuroinflammation
  1575. Effects of chronic systemic treatment with peroxisome proliferator-activated receptor α activators on neuroinflammation induced by intracerebral injection of …
  1576. Effects of cigarette smoke on immunity, neuroinflammation and multiple sclerosis
  1577. Effects of Clinacanthus nutans leaf extract on lipopolysaccharide-induced neuroinflammation in rats: A behavioral and 1H NMR-based metabolomics study
  1578. Effects of curcumin on neuroinflammation in animal models and in patients with Alzheimer disease
  1579. Effects of curcumin on short-term spatial and recognition memory, adult neurogenesis and neuroinflammation in a streptozotocin-induced rat model of dementia of …
  1580. Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson’s …
  1581. Effects of estrogen on expression of P2X7 receptor and neuroinflammation after subarachnoid hemorrhage in rats
  1582. Effects of exercise on adolescent and adult hypothalamic and hippocampal neuroinflammation
  1583. Effects of glatiramer acetate in a spontaneous model of autoimmune neuroinflammation
  1584. EFFECTS OF GSK-3 INHIBITION ON LPS-INDUCED neuroinflammation AND IL-10 PRODUCTION IN MICROGLIA
  1585. Effects of human Adipose-derived Stem Cell and their secretome on neuropathic pain, neuroinflammation and peripheral cytokines in a preclinical model of diabetes
  1586. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-105″>Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease
  1587. neuroinflammation/E7FD461949EC62B6696A5898686D4AE5″>Effects of IDO1 and TDO2 inhibition on cognitive deficits and anxiety following LPS-induced neuroinflammation
  1588. Effects of intermittent alcohol exposure on emotion and cognition: a potential role for the endogenous cannabinoid system and neuroinflammation
  1589. Effects of leonurine on intracerebral haemorrhage by attenuation of perihematomal edema and neuroinflammation via the JNK pathway
  1590. Effects of levosimendan on hemodynamics, local cerebral blood flow, neuronal injury, and neuroinflammation after asphyctic cardiac arrest in rats
  1591. Effects of LPLI on microglial phagocytosis in LPS-induced neuroinflammation model
  1592. Effects of Macrophage Migration Inhibitory Factors'(MIF) Inhibition on Chronic neuroinflammation
  1593. Effects of Mild Traumatic Brain Injury on Ethanol Consumption and the Combined Effects on neuroinflammation, Cognition, and Behavior in Mice
  1594. Effects of nanoparticles on neuroinflammation in a mouse model of asthma
  1595. Effects of neuroinflammation on glia–glia gap junctional intercellular communication: a perspective
  1596. neuroinflammation_on_microcirculation.381.aspx”>Effects of neuroinflammation on microcirculation in the brain-Visualized by intravital microscopy: 7AP2–9
  1597. Effects of neuroinflammation on neural stem cells
  1598. Effects of neuroinflammation on the regenerative capacity of brain stem cells
  1599. Effects of neuroinflammation on vascular dysfunction in Alzheimer’s disease
  1600. Effects of Ocrelizumab on Neurofilament Light Chain and Other Biomarkers of neuroinflammation and Neurodegeneration in MS: OBOE Study Design (P6. 337)
  1601. Effects of oral dimethyl fumarate on intestinal immune regulation in autoimmune neuroinflammation (P1. 164)
  1602. Effects of oxytocin on fear memory and neuroinflammation in a rodent model of posttraumatic stress disorder
  1603. Effects of physical exercise on neuroinflammation, neuroplasticity, neurodegeneration, and behavior: what we can learn from animal models in clinical settings
  1604. Effects of prebiotic galacto-oligosaccharide on postoperative cognitive dysfunction and neuroinflammation through targeting of the gut-brain axis
  1605. Effects of Rhei Undulati Rhizoma on lipopolysaccharide‐induced neuroinflammation in vitro and in vivo
  1606. Effects of RO27-3225 on neurogenesis, PDGFRβ+ cells and neuroinflammation after cerebral infarction
  1607. Effects of S100B on serotonergic plasticity and neuroinflammation in the hippocampus in Down syndrome and Alzheimer’s disease: studies in an S100B …
  1608. Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammation
  1609. Effects of sucrose and high fructose corn syrup consumption on spatial memory function and hippocampal neuroinflammation in adolescent rats
  1610. Effects of syringic acid on chronic MPTP/probenecid induced motor dysfunction, dopaminergic markers expression and neuroinflammation in C57BL/6 mice
  1611. Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats …
  1612. Effects of the Saturated Fatty Acid Palmitate on neuroinflammation,ER Stress, and Pomc mRNA Expression in Hypothalamic mHypoA-POMC/GFPNeurons
  1613. EFFECTS OF TREATMENT WITH DOXYCYCLINE ON BEHAVIOR, neuroinflammation AND BRAIN PATHOLOGY IN THE RTG-4510 MOUSE MODEL
  1614. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1089-5″>Effects of umbilical cord blood cells, and subtypes, to reduce neuroinflammation following perinatal hypoxic-ischemic brain injury
  1615. Effects of α-lipoic acid on LPS-induced neuroinflammation and NLRP3 inflammasome activation through the regulation of BV-2 microglial cells activation
  1616. Efficacy of vitamin D in treating multiple sclerosis-like neuroinflammation depends on developmental stage
  1617. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0734-0?optIn=true”>EGFR transactivation contributes to neuroinflammation in Streptococcus suis meningitis
  1618. Electric stimulation of the vagus nerve reduced mouse neuroinflammation induced by lipopolysaccharide
  1619. Electro-acupuncture alleviates chronic unpredictable stress-induced depressive-and anxiety-like behavior and hippocampal neuroinflammation in rat model …
  1620. Electroacupunctre improves motor impairment via inhibition of microglia-mediated neuroinflammation in the sensorimotor cortex after ischemic stroke
  1621. Electroacupuncture alleviates postoperative cognitive dysfunction in aged rats by inhibiting hippocampal neuroinflammation activated via microglia/TLRs pathway
  1622. Electroacupuncture attenuated cerebral ischemic injury and neuroinflammation through α7nAChR-mediated inhibition of NLRP3 inflammasome in stroke rats
  1623. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1665-3″>Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer’s disease animal model
  1624. Electroacupuncture preconditioning and postconditioning inhibit apoptosis and neuroinflammation induced by spinal cord ischemia reperfusion injury through …
  1625. Electroacupuncture prevents cognitive impairment induced by lipopolysaccharide via inhibition of oxidative stress and neuroinflammation
  1626. Electroencephalography Findings in Autoimmune and neuroinflammation-Related Epilepsies
  1627. Elevated Brain MCP-1 Contributes to neuroinflammation in Hypertension
  1628. Elevated circulating TGFβ1 during acute liver failure activates TGFβR2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy …
  1629. Elevated microRNA-129-5p level ameliorates neuroinflammation and blood-spinal cord barrier damage after ischemia-reperfusion by inhibiting HMGB1 and …
  1630. Elevated Neuroglobin Lessens neuroinflammation and Alleviates Neurobehavioral Deficits Induced by Acute Inhalation of Combustion Smoke in the Mouse
  1631. Elevation of USP4 antagonizes oxygen glucose deprivation/reoxygenation-evoked microglia activation and neuroinflammation-mediated neurotoxicity via the …
  1632. Ellagic Acid Protects the Brain Against 6-Hydroxydopamine Induced neuroinflammation in a Rat Model of Parkinson’s
  1633. Ellagic acid protects the brain against 6-hydroxydopamine induced neuroinflammation in a rat model of Parkinson’s disease
  1634. Elucidating the link between the modifiable risk factors of Alzheimer’s disease and neuroinflammation
  1635. Elucidation of relevant neuroinflammation mechanisms using gene expression profiling in patients with amyotrophic lateral sclerosis
  1636. Emerging CSF biomarkers of neuroinflammation, neuronal injury and synaptic integrity in the ADNI cohort
  1637. Emerging PET radiotracers and targets for imaging of neuroinflammation in neurodegenerative diseases: outlook beyond TSPO
  1638. Emerging role of diet and microbiota interactions in neuroinflammation
  1639. neuroinflammation/F05306C0BDCE1C7D9A956B5A76DCAC7F”>Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation
  1640. Emerging roles of protein kinases in microglia-mediated neuroinflammation
  1641. Emerging targets in neuroinflammation-driven chronic pain
  1642. Endocannabinoid degradation inhibition improves neurobehavioral function, blood–brain barrier integrity, and neuroinflammation following mild traumatic brain injury
  1643. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation
  1644. Endocannabinoid modulation of TLR4-induced neuroinflammation: implications for autism spectrum disorders
  1645. Endocannabinoid regulation of amyloid-induced neuroinflammation
  1646. Endocrine influence on neuroinflammation: the use of reporter systems
  1647. Endogenous hydrogen sulphide attenuates NLRP3 inflammasome-mediated neuroinflammation by suppressing the P2X7 receptor after intracerebral …
  1648. Endogenous sex steroids dampen neuroinflammation and improve outcome of traumatic brain injury in mice
  1649. Endoplasmic Reticulum Stress and neuroinflammation in the RVLM: A Novel Mechanism Related to Sympathoexcitation in Preserved Ejection Fraction Heart Failure
  1650. Endoplasmic Reticulum Stress Contributes to Nociception via neuroinflammation in a Murine Bone Cancer Pain Model.
  1651. Endoplasmic reticulum stress induction by an endogenous retrovirus glycoprotein during neuroinflammation: regulation by a free radical scavenger
  1652. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0987-2″>Endothelial α6β4 integrin protects during experimental autoimmune encephalomyelitis-induced neuroinflammation by maintaining vascular integrity and tight …
  1653. Endothelin and Endothelin Receptors in Retinal neuroinflammation
  1654. Endotoxin-and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation
  1655. Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation
  1656. Enhanced network activity despite clinical recovery in experimental neuroinflammation using two-photon calcium imaging
  1657. neuroinflammation_and_oxidative_stress.8.aspx”>Enhanced neuroinflammation and oxidative stress are associated with altered hippocampal neurogenesis in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine treated …
  1658. Enhanced neuroinflammation and pain hypersensitivity after peripheral nerve injury in rats expressing mutated superoxide dismutase 1
  1659. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0782-5″>Enhanced neuroinflammation mediated by DNA methylation of the glucocorticoid receptor triggers cognitive dysfunction after sevoflurane anesthesia in adult …
  1660. Enhanced neuroprotection of anthocyanin-loaded PEG-gold nanoparticles against Aβ1-42-induced neuroinflammation and neurodegeneration via the NF-KB/JNK …
  1661. Enhanced susceptibility of S‐100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human β‐amyloid
  1662. Enlarged Perivascular Spaces Correlate With CSF Biomarkers for Abnormal Blood-brain Barrier Permeability and neuroinflammation in Patients With Vascular …
  1663. Enteric neuroinflammation Driven by Exposure to Pyridostigmine Bromide is a Possible Contributing Factor to Gulf War Illness
  1664. Environmental enrichment attenuates hippocampal neuroinflammation and improves cognitive function during influenza infection
  1665. Environmental enrichment potently prevents microglia-mediated neuroinflammation by human amyloid β-protein oligomers
  1666. Enzyme Selective Flim in Microglia: Studying the Role of NADPH Oxidase in Chronic neuroinflammation
  1667. Eomes-expressing T-helper cells as potential target of therapy in chronic neuroinflammation
  1668. Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation
  1669. Ephedra-Cinnamomi Attenuates Cerebral Ischemia-Induced neuroinflammation via TLR4/NF-κB Pathway
  1670. Epigenetic and pharmacological targeting of neuroinflammation as novel therapeutic interventions for epilepsy
  1671. Epigenetic modifications associated to neuroinflammation and neuropathic pain after neural trauma
  1672. Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration
  1673. Epigenetic regulation of neuroinflammation in the aged mouse brain
  1674. Epigenetics and the modulation of neuroinflammation
  1675. Epilepsy: neuroinflammation, neurodegeneration, and APOE genotype
  1676. Epstein–Barr virus-induced gene 3 negatively regulates neuroinflammation and T cell activation following coronavirus-induced encephalomyelitis
  1677. ER stress and neuroinflammation: connecting the unfolded protein response to JAK/STAT signaling (P5196)
  1678. ER stress: an initiator of neuroinflammation in Alzheimer’s disease?
  1679. Erigeron linifolius attenuates lipopolysachharide-induced depressive-like behavior in mice by impeding neuroinflammation, oxido-nitrosative stress, and …
  1680. Eriodictyol attenuates LPS-induced neuroinflammation, amyloidogenesis, and cognitive impairments via the inhibition of NF-κB in male C57BL/6J mice and BV2 …
  1681. Erratum to “Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults”[Alzheimer’s & Dementia 2018; 14: 1640-50.]
  1682. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0593-8″>Erratum to: A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
  1683. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0430-5″>Erratum to: A role for human brain pericytes in neuroinflammation
  1684. neuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-015-0321-9″>Erratum to: Insulin improves memory and reduces chronic neuroinflammation in the hippocampus of young but not aged brains
  1685. Erratum to: MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal …
  1686. Erratum to: Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat
  1687. Erratum: Corrigendum to “Parkinson’s disease: Autoimmunity and neuroinflammation”(Autoimmunity Reviews (2016) 15 (10)(1005–1011)(S1568997216301677) …
  1688. Erratum: Corrigendum: Toll-like receptor 2 and poly (ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE
  1689. Erratum: REAC technology modifies pathological neuroinflammation and motor behaviour in an Alzheimer’s disease mouse model
  1690. Erratum: USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation
  1691. Eruca sativa seed extract: A novel natural product able to counteract neuroinflammation
  1692. Erythrocytes’ antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation
  1693. Erythropoietin ameliorates neonatal hypoxia-ischemia-induced neurobehavioral deficits, neuroinflammation, and hippocampal injury in the juvenile rat
  1694. Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis
  1695. Erythropoietin and CCL3 antagonise their functional properties during neuroinflammation
  1696. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-10-156″>Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and …
  1697. Esculentoside A suppresses Aβ1–42-induced neuroinflammation by down-regulating MAPKs pathways in vivo
  1698. ESE1 is associated with neuronal apoptosis in lipopolysaccharide induced neuroinflammation
  1699. Essay: TNF in neuroinflammation; what can be learned from TNF research in non-neuronal autoimmune diseases
  1700. Estradiol inhibits astrocytic GFAP expression in an animal model of neuroinflammation.
  1701. Estradiol inhibits ongoing autoimmune neuroinflammation and NFκB-dependent CCL2 expression in reactive astrocytes
  1702. Estrogen and neuroinflammation
  1703. Estrogen deficiency exacerbates Aβ-induced memory impairment through enhancement of neuroinflammation, amyloidogenesis and NF-ĸB activation in …
  1704. Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration
  1705. Estrogen-dependent modulation of neuroinflammation in endometriosis
  1706. Estrogen, neuroinflammation and neuroprotection in Parkinson’s disease: glia dictates resistance versus vulnerability to neurodegeneration
  1707. Estrogen, neuroinflammation and neuroprotection in Parkinson’s disease: key role of neuron-glia crosstalk
  1708. neuroinflammation&ots=3lt36ZOC2i&sig=iTPAzZZ4WIFT5nywvWTRlFIdGbg”>Estrogenic Regulation of Glia and neuroinflammation
  1709. Estrogens, neuroinflammation, and neurodegeneration
  1710. Etanercept reduces neuroinflammation and lethality in mouse model of Japanese encephalitis
  1711. Etanercept restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in morphine-tolerant rats
  1712. Etazolate, an α-secretase activator, reduces neuroinflammation and offers persistent neuroprotection following traumatic brain injury in mice
  1713. Ethanol Exposure Induces Microglia Activation and neuroinflammation through TLR4 Activation and SENP6 Modulation in the Adolescent Rat Hippocampus
  1714. Ethanol extract of Bupleurum falcatum and saikosaponins inhibit neuroinflammation via inhibition of NF-κB
  1715. Ethanol extract of Scutellaria baicalensis Georgi prevents oxidative damage and neuroinflammation and memorial impairments in artificial senescense mice
  1716. Ethanol induced modulation of microglial P2X7 receptor expression and its role in neuroinflammation
  1717. Ethyl-acetate fraction of Trichilia catigua protects against oxidative stress and neuroinflammation after cerebral ischemia/reperfusion
  1718. Etidronate–zinc Complex Ameliorated Cognitive and Synaptic Plasticity Impairments in 2-Vessel Occlusion Model Rats by Reducing neuroinflammation
  1719. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0687-3″>Etifoxine improves sensorimotor deficits and reduces glial activation, neuronal degeneration, and neuroinflammation in a rat model of traumatic brain injury
  1720. Etiology is the key determinant of neuroinflammation in epilepsy: Elevation of cerebrospinal fluid cytokines and chemokines in febrile infection‐related epilepsy …
  1721. Euflammation attenuates peripheral inflammation-induced neuroinflammation and mitigates immune-to-brain signaling
  1722. Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis–osteopontin as a potential marker of clinical severity
  1723. Evaluating white matter changes and executive function in rat models of mediodorsal thalamic stroke and neuroinflammation
  1724. Evaluation of [11C]-DAA1106 for imaging and quantification of neuroinflammation in a rat model of herpes encephalitis
  1725. Evaluation of [123I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation
  1726. Evaluation of [18F] DPA-716 in a rat model of neuroinflammation: Comparison with [11C] DPA-713 and [18F] DPA-714 radiotracer for the TSPO 18 kDa
  1727. Evaluation of [18F] PBR111 in a rat model of neuroinflammation: A new radiotracer for the TSPO 18 kDa (peripheral benzodiazepine receptor)
  1728. Evaluation of a novel positron emission tomographic radioligand to measure cyclooxygenase-2 in a model of neuroinflammation in rhesus macaque
  1729. Evaluation Of Anti-Inflammatory Nutraceuticals In Lps-Induced Mouse neuroinflammation Model: An Update.
  1730. Evaluation of Antiinflammatory Activity of 4′-О-Methylhonokiol Derivatives in a neuroinflammation Model
  1731. Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation
  1732. Evaluation of neuroinflammation in amyotrophic lateral sclerosis with 18F-DPA-714
  1733. Evaluation of neuroinflammation in experimental autoimmune encephalomyelitis (EAE) mice with animal PET and MRI
  1734. Evaluation of neuroinflammation in X-linked adrenoleukodystrophy
  1735. Evaluation of neuroprotective activity of carvacrol against neuroinflammation induced by chronic stress in mice
  1736. Evaluation of nigrostriatal neurodegeneration and neuroinflammation following repeated intranasal 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) …
  1737. Evaluation of Novel PET ligands for Imaging neuroinflammation
  1738. Evaluation of Some Medicinal Plant Extracts against neuroinflammation Characterizing Alzheimer’s Disease in Experimental Rat Model
  1739. Evaluation of the effects of chlorpyrifos combined with lipopolysaccharide stress on neuroinflammation and spatial memory in neonatal rats
  1740. Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures
  1741. Evidence for neuroinflammation after myocardial infarction in a mouse model
  1742. Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy
  1743. Evidence for neuroinflammation in Alzheimer’s disease
  1744. Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal …
  1745. Evidence of diffuse cerebellar neuroinflammation in multiple sclerosis by 11C-PBR28 MR-PET
  1746. Evidence of neuroinflammation in subgroups of schizophrenia and mood disorder patients: a semiquantitative postmortem study of CD3 and CD20 immunoreactive …
  1747. EVIDENCE OF neuroinflammation IN THE RETINA IN PRESYMPTOMATIC ALZHEIMER’S DISEASE
  1748. Evidence of the impact of systemic inflammation on neuroinflammation from a non-bacterial endotoxin animal model
  1749. Evidence that erythropoietin modulates neuroinflammation through differential action on neurons, astrocytes, and microglia
  1750. Exacerbation of autoimmune neuroinflammation by dietary sodium is genetically controlled and sex specific
  1751. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system
  1752. Examining the Role of Gut Dysbiosis in neuroinflammation and Hypertension in a Model of Obstructive Sleep Apnea
  1753. Examining the role of neuroinflammation in major depression
  1754. Excess administration of miR-340-5p ameliorates spinal cord injury-induced neuroinflammation and apoptosis by modulating the P38-MAPK signaling pathway
  1755. Excitotoxicity, neuroinflammation and oxidant stress as molecular bases of epileptogenesis and epilepsy-derived neurodegeneration: The role of vitamin E
  1756. Exendin-4 attenuates pain-induced cognitive impairment by alleviating hippocampal neuroinflammation in a rat model of spinal nerve ligation
  1757. Exercise and neuroinflammation in health and disease
  1758. Exercise prevents enhanced postoperative neuroinflammation and cognitive decline and rectifies the gut microbiome in a rat model of metabolic syndrome
  1759. Exercise-induced modulation of neuroinflammation in models of Alzheimer’s disease
  1760. Exogenous melatonin restrains neuroinflammation in high fat diet induced diabetic rats through attenuating indoleamine 2, 3-dioxygenase 1 expression
  1761. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-11-68″>Exosomes as mediators of neuroinflammation
  1762. Exosomes as mediators of neuron-glia communication in neuroinflammation
  1763. Exosomes derived from umbilical cord mesenchymal stem cells reduce microglia-mediated neuroinflammation in perinatal brain injury
  1764. Exosomes Isolated From Human Umbilical Cord Mesenchymal Stem Cells Alleviate neuroinflammation and Reduce Amyloid-Beta Deposition by Modulating …
  1765. Experimental and clinical evidence for the protective role of progesterone in motoneuron degeneration and neuroinflammation
  1766. EXPERIMENTAL INTESTINAL DYSBIOSIS IN RATS INCREASES THE PERMEABILITY OF THE BLOOD-BRAIN BARRIER AND INDUCES neuroinflammation
  1767. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1481-9″>Experimental necrotizing enterocolitis induces neuroinflammation in the neonatal brain
  1768. Experimental neuroinflammation: a focus on mitochondria, oxygen and function
  1769. Experimental neuroinflammation: a study of hypoxia and protein translation
  1770. Experimental Pulmonary Hypertension Is Associated With neuroinflammation in the Spinal Cord
  1771. Exploration of Novel Ureidobenzothiazole Library Against neuroinflammation
  1772. Exploring COX-2 as a biomarker of microglia-dependent neuroinflammation
  1773. Exploring Glial Marker Activation and neuroinflammation in Schizophrenia: A multimodal Approach
  1774. Exploring neuroinflammation as a potential avenue to improve the clinical efficacy of opioids
  1775. Exploring the Effects of neuroinflammation on Microglial Cytoskeletal Proteins
  1776. Exploring the neuroprotective function of extracellular vesicles containing small heat-shock proteins (HSPB1 and HSPB8) upon neuroinflammation
  1777. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0382-9″>Exposure of neonatal rats to alcohol has differential effects on neuroinflammation and neuronal survival in the cerebellum and hippocampus
  1778. Exposure to a polluted urban environment and to chronic low doses of lipopolysaccharides produces neuroinflammation in mice, and is ameliorated by dark chocolate
  1779. Exposure to formaldehyde and diisononyl phthalate exacerbate neuroinflammation through NF-κB activation in a mouse asthma model
  1780. Exposure to gestational diabetes mellitus induces neuroinflammation, derangement of hippocampal neurons, and cognitive changes in rat offspring
  1781. Exposure to inflammatory cytokines IL-1β and TNFα induces compromise and death of astrocytes; implications for chronic neuroinflammation
  1782. Exposure to Inhalational Anaesthetics Causes neuroinflammation
  1783. Exposure to nanoscale diesel exhaust particles: Oxidative stress, neuroinflammation, anxiety and depression on adult male mice
  1784. Exposure to nerve agents: from status epilepticus to neuroinflammation, brain damage, neurogenesis and epilepsy
  1785. Expression of Ccl11 associates with immune response modulation and protection against neuroinflammation in rats
  1786. Expression of CD300lf by microglia contributes to resistance to cerebral malaria by impeding the neuroinflammation
  1787. Expression of metallothionein-I,-II, and-III in Alzheimer disease and animal models of neuroinflammation
  1788. Expression profile of Japanese encephalitis virus induced neuroinflammation and its implication in disease severity
  1789. Extinguishing neuroinflammation
  1790. Extracellular HSP70, neuroinflammation and Protection Against Viral Virulence
  1791. Extracellular interactions of alpha-synuclein with astrocytes and microglia linked to neuroinflammation and spread in multiple system atrophy
  1792. Extracellular matrix-degrading metalloproteinases and neuroinflammation in stroke
  1793. Extracellular vesicles containing IL-4 modulate neuroinflammation in a mouse model of multiple sclerosis
  1794. Extracellular vesicles from mesenchymal stem cells reduce microglial-mediated neuroinflammation after cortical injury in aged Rhesus monkeys
  1795. Extract of Fructus Schisandrae chinensis Inhibits neuroinflammation Mediator Production from Microglia via NF-κ B and MAPK Pathways
  1796. Extracts from Dendropanax morbifera Leaves Have Modulatory Effects on neuroinflammation in Microglia
  1797. Extrapituitary prolactin promotes generation of Eomes-positive helper T cells mediating neuroinflammation
  1798. Ezetimibe Attenuates Oxidative Stress and neuroinflammation via the AMPK/Nrf2/TXNIP Pathway after MCAO in Rats
  1799. EZH2 regulates spinal neuroinflammation in rats with neuropathic pain
  1800. neuroinflammation.40.aspx”>F-002 CYCLOOXYGENASE-2-DEPENDENT neuroinflammation AND OXIDATIVE STRESS IN ROSTRAL VENTROLATERAL MEDULLA CONTRIBUTE TO …
  1801. F235. DIFFERENTIAL EFFECTS OF ANTIPSYCHOTICS ON neuroinflammation AND ENERGY SENSING IN A HYPOTHALAMIC CELL LINE
  1802. FAAH-mediated modulation of TLR3-induced neuroinflammation in the rat hippocampus
  1803. Facile synthesis of carbon-11-labeled sEH/PDE4 dual inhibitors as new potential PET agents for imaging of sEH/PDE4 enzymes in neuroinflammation
  1804. Fast direct neuronal signaling via the IL-4 receptor as therapeutic target in neuroinflammation
  1805. Fatal neuroinflammation in a case of multiple sclerosis with anti-natalizumab antibodies
  1806. Fatigue sensation following peripheral viral infection is triggered by neuroinflammation: who will answer these questions?
  1807. Fatty acid and lipid profiles in models of neuroinflammation and mood disorders: application of high field NMR, gas chromotography and liquid chromotography …
  1808. Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity
  1809. FEATURES OF neuroinflammation IN TRANSGENIC RAT EXPRESSING MISFOLDED TAU PROTEIN VARY WITH GENETIC BACKGROUND AND INFLUENCE …
  1810. Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific
  1811. FGF21 Protects Dopaminergic Neurons in Parkinson’s Disease Models Via Repression of neuroinflammation
  1812. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer’s disease
  1813. Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration
  1814. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation
  1815. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation
  1816. Fibroblast growth factor 2 modulates hippocampal microglia activation in a neuroinflammation induced model of depression
  1817. Fighting Chronic neuroinflammation by Boosting Autoimmunity: The Distinction Between Neurodegenerative Diseases and Multiple Sclerosis
  1818. Finding our way through the ‘neuroinflammation‘fog
  1819. Finding the’ubiquitous’ threads in infection and autoimmune neuroinflammation
  1820. Fine-mapping resolves Eae23 into two QTLs and implicates ZEB1 as a candidate gene regulating experimental neuroinflammation in rat
  1821. Fingolimod (FTY720) attenuates social deficits, learning and memory impairments, neuronal loss and neuroinflammation in the rat model of autism
  1822. Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model
  1823. Fingolimod effects in neuroinflammation: Regulation of astroglial glutamate transporters?
  1824. Fingolimod up-regulates BDNF expression within the CNS and Down-regulates tissue pathology in a pre-clinical model of chronic neuroinflammation (P1. 159)
  1825. neuroinflammation_manuscript_docx/7819991/1″>Finnell et al LC-NE neuroinflammation manuscript. docx
  1826. Fisetin improves lead-induced neuroinflammation, apoptosis and synaptic dysfunction in mice associated with the AMPK/SIRT1 and autophagy pathway
  1827. Fisetin nanoparticles protect against PM2. 5 exposure-induced neuroinflammation by down-regulation of astrocytes activation related NF-κB signaling …
  1828. Fisetin protects against intracerebral hemorrhage-induced neuroinflammation in aged mice
  1829. Fish oil prevents lipopolysaccharide-induced depressive-like behavior by inhibiting neuroinflammation
  1830. Fish oil supplementation attenuates neuroinflammation and alleviates depressive-like behavior in rats submitted to repeated lipopolysaccharide
  1831. Fish oil–rich lipid emulsion modulates neuroinflammation and prevents long-term cognitive dysfunction after sepsis
  1832. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson’s disease
  1833. Flavonoid-Rich Ethanol Extract from the Leaves of Diospyros kaki Attenuates D-Galactose-Induced Oxidative Stress and neuroinflammation-Mediated Brain Aging in …
  1834. Flavonoids have modulatory effects on neuroinflammation in microglia
  1835. FLUID BIOMARKERS OF neuroinflammation
  1836. Fluoride induces neuroinflammation and alters Wnt signaling pathway in BV2 microglial cells
  1837. Fluoxetine attenuates neuroinflammation in early brain injury after subarachnoid hemorrhage: a possible role for the regulation of TLR4/MyD88/NF-κB …
  1838. FLZ attenuates learning and memory deficits via suppressing neuroinflammation induced by LPS in mice
  1839. Focusing on the Mitochondrial Expression of TSPO as a Marker and Promoter of neuroinflammation
  1840. Follistatin-like protein 1 suppressed pro-inflammatory cytokines expression during neuroinflammation induced by lipopolysaccharide
  1841. Forced Wakefulness Enhances neuroinflammation in Postoperative Mice
  1842. Formononetin Ameliorates Cognitive Disorder via PGC-1α Pathway in neuroinflammation Conditions in High-Fat Diet-Induced Mice
  1843. Formononetin inhibits neuroinflammation and increases estrogen receptor beta (ERβ) protein expression in BV2 microglia
  1844. Forsythiae fructus and its active component, arctigenin, provide neuroprotection by inhibiting neuroinflammation
  1845. Foxo3 controls CD4 T cells differentiation and severity to neuroinflammation (IRM15P. 604)
  1846. neuroinflammation-selective-agonists-with-synergistic-anti-oxidative-and-pro-resolving-effects”>Fpr2 and neuroinflammation: selective agonists with synergistic anti-oxidative and pro-resolving effects
  1847. Fractalkine Expression Is Suppressed During Hepatic Encephalopathy in Mice and Promotes neuroinflammation: 2495
  1848. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0674-8″>Fractalkine suppression during hepatic encephalopathy promotes neuroinflammation in mice
  1849. Fractionated whole brain radiation-induced behavioral changes in athymic nude mice is associated with sustained neuroinflammation and microglial M1-phenotype
  1850. Fragmented sleep enhances postoperative neuroinflammation but not cognitive dysfunction
  1851. Fragmented Sleep Enhances Postoperative neuroinflammation but Not Cognitive Dysfunction: Really?
  1852. neuroinflammation&ots=khsnwI4cF2&sig=-vfqXQzQvo-2tvxTzEjGNAo0Exs”>From adolescence to late aging: A comprehensive review of social behavior, alcohol, and neuroinflammation across the lifespan.
  1853. From classic aspects of the stress response to neuroinflammation and sickness: implications for individuals and offspring
  1854. From molecules to neural morphology: understanding neuroinflammation in autism spectrum condition
  1855. From systemic inflammation to neuroinflammation: the case of neurolupus
  1856. From the “little brain” gastrointestinal infection to the “big brain” neuroinflammation: a proposed fast axonal transport pathway involved in multiple sclerosis
  1857. Fructose-derived advanced glycation end products (AGEs) enhance neuroinflammation and alter immune function in the brain
  1858. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0308-6″>FTY720 attenuates excitotoxicity and neuroinflammation
  1859. FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple …
  1860. Full Recovery From Cocaine-Induced Toxic Leukoencephalopathy: Emphasizing the Role of neuroinflammation and Brain Edema
  1861. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
  1862. Function of Protein Kinase CK2 in Innate Immune Cells in neuroinflammation
  1863. Functional aspects of redox control during neuroinflammation
  1864. Functional polarization of neuroglia: implications in neuroinflammation and neurological disorders
  1865. Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke
  1866. Funding free and universal access to Journal of neuroinflammation
  1867. Furanodien-6-one from Commiphora erythraea inhibits the NF-κB signalling and attenuates LPS-induced neuroinflammation
  1868. Future Perspectives: New Strategies for Antagonism of Excitotoxicity, Oxidative Stress and neuroinflammation in Neurodegenerative Diseases
  1869. G-CSF attenuates neuroinflammation and stabilizes the blood–brain barrier via the PI3K/Akt/GSK-3β signaling pathway following neonatal hypoxia-ischemia in rats
  1870. G2019s LRRK2 promotes mitochondrial fission and increases TNFα-mediated neuroinflammation responses
  1871. GABA transport and neuroinflammation are coupled in multiple sclerosis: regulation of the GABA transporter-2 by ganaxolone
  1872. GABAB receptor mediate hippocampal neuroinflammation in adolescent male and female mice after cold expose
  1873. GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders
  1874. Gabrb2 knockout mice displayed schizophrenia-like and comorbid phenotypes with GABAergic interneuron-astrocyte-microglia dysregulation and neuroinflammation
  1875. Gadofluorine M-enhanced MRI shows involvement of circumventricular organs in neuroinflammation
  1876. Gal-3 is a potential biomarker for spinal cord injury and Gal-3 deficiency attenuates neuroinflammation through ROS/TXNIP/NLRP3 signaling pathway
  1877. Galectin-1 reduces neuroinflammation via modulation of nitric oxide-arginase signaling in HIV-1 transfected microglia: a gold nanoparticle-Galectin-1 “Nanoplex” a …
  1878. Galectin-1 suppresses methamphetamine induced neuroinflammation in human brain microvascular endothelial cells: neuroprotective role in maintaining blood brain …
  1879. Galectins and neuroinflammation
  1880. Gallic Acid Attenuated LPS-Induced neuroinflammation: Protein Aggregation and Necroptosis
  1881. Gallic acid, a histone acetyltransferase inhibitor, suppresses β‐amyloid neurotoxicity by inhibiting microglial‐mediated neuroinflammation
  1882. Gamisoyo-San Ameliorates neuroinflammation in the Spinal Cord of hSOD1G93A Transgenic Mice
  1883. Gamma Visual Stimulation Induces a Neuroimmune Signaling Profile Distinct from Acute neuroinflammation
  1884. Gamma-linolenic acid ameliorates Aβ-induced neuroinflammation through NF-κB and MAPK signalling pathways
  1885. Garcinia kola seeds may prevent cognitive and motor dysfunctions in a type 1 diabetes mellitus rat model partly by mitigating neuroinflammation
  1886. Gasdermin D in peripheral myeloid cells drives neuroinflammation in experimental autoimmune encephalomyelitis
  1887. Gastrodin attenuates neuroinflammation in DOI‐induce Tourette syndrome in rats
  1888. Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson’s disease model rats
  1889. Gastrodin protects retinal ganglion cells through inhibiting microglial-mediated neuroinflammation in an acute ocular hypertension model
  1890. Gatekeeper role of brain antigen‐presenting CD11c+ cells in neuroinflammation
  1891. Gender-specific brain regional variation of neurons, endogenous estrogen, neuroinflammation and glial cells during rotenone-induced mouse model of Parkinson’s …
  1892. Gene therapy with mesenchymal stem cells expressing IFN‐ß ameliorates neuroinflammation in experimental models of multiple sclerosis
  1893. General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammation
  1894. General physiology and pathophysiology of microglia during neuroinflammation
  1895. Generation of neuroinflammation in human African trypanosomiasis
  1896. Genetic and Immunological Regulation of neuroinflammation
  1897. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-7-64″>Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for …
  1898. Genetic background modulates outcome of therapeutic amyloid peptides in treatment of neuroinflammation
  1899. Genetic deletion of galectin-3 enhances neuroinflammation, affects microglial activation and contributes to sub-chronic injury in experimental neonatal focal stroke
  1900. Genetic knockout of myosin light chain kinase (MLCK210) prevents cerebral microhemorrhages and attenuates neuroinflammation in a mouse model of …
  1901. Genetic regulation of autoimmune neuroinflammation
  1902. Genetic regulation of autoimmunity in experimental neuroinflammation
  1903. Genetic regulation of neuroinflammation after infection and injury
  1904. Genetic suppression of IKK2/NF-κB in astrocytes inhibits neuroinflammation and reduces neuronal loss in the MPTP-Probenecid model of Parkinson’s disease
  1905. Genetic variability commonly affecting neurodegeneration and neuroinflammation
  1906. Genetically engineered resveratrol-enriched rice inhibits neuroinflammation in lipopolysaccharide-activated BV2 microglia via downregulating mitogen-activated …
  1907. Genetics of autoimmune neuroinflammation
  1908. Genetics of neuroinflammation in Alzheimer disease
  1909. Genetics of rat neuroinflammation
  1910. Geniposidic acid ameliorates spatial learning and memory deficits and alleviates neuroinflammation via inhibiting HMGB-1 and downregulating TLR4/2 signaling …
  1911. Genistein alleviates neuroinflammation and restores cognitive function in rat model of hepatic encephalopathy: underlying mechanisms
  1912. Gestational Diabetes Mellitus Induces neuroinflammation, Synaptic Reduction, Behavioural Changes, and Impaired Memory in the Offspring.
  1913. Gestational intermittent hypoxia increases susceptibility to neuroinflammation and alters respiratory motor control in neonatal rats
  1914. Gestational intermittent hypoxia induces neuroinflammation and impairs compensatory respiratory plasticity in adult offspring
  1915. Ghrelin attenuates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis involving NLRP3 inflammasome signaling pathway and …
  1916. neuroinflammation/”>Ghrelin: Friend or Foe for neuroinflammation?
  1917. Ginger Extract Reduces Chronic Morphine-Induced neuroinflammation and Glial Activation in Nucleus Accumbens of Rats
  1918. Ginkgetin aglycone attenuates neuroinflammation and neuronal injury in the rats with ischemic stroke by modulating STAT3/JAK2/SIRT1
  1919. Ginkgo biloba L. extract protects against chronic cerebral hypoperfusion by modulating neuroinflammation and the cholinergic system
  1920. Ginsenoside Rb1 Attenuates Isoflurane/surgery-induced Cognitive Dysfunction via Inhibiting neuroinflammation and Oxidative Stress
  1921. Ginsenoside Rd attenuates neuroinflammation of dopaminergic cells in culture
  1922. Ginsenoside Re attenuates neuroinflammation in a symptomatic ALS animal model
  1923. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model
  1924. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein …
  1925. Ginsenoside Rg1 attenuates neuroinflammation following systemic lipopolysaccharide treatment in mice
  1926. Ginsenoside Rg1 prevents chemotherapy-induced cognitive impairment: associations with microglia-mediated cytokines, neuroinflammation, and neuroplasticity
  1927. Ginsenoside Rg18 suppresses lipopolysaccharide-induced neuroinflammation in BV2 microglia and amyloid-β-induced oxidative stress in SH-SY5Y neurons via …
  1928. Ginsenoside Rg3 and Rh2 protect trimethyltin‐induced neurotoxicity via prevention on neuronal apoptosis and neuroinflammation
  1929. Glia as a link between neuroinflammation and neuropathic pain
  1930. Glia maturation factor and mast cell-dependent expression of inflammatory mediators and proteinase activated receptor-2 in neuroinflammation
  1931. Glia maturation factor-β: a potential therapeutic target in neurodegeneration and neuroinflammation
  1932. Glia-mediated retinal neuroinflammation as a biomarker in Alzheimer’s disease
  1933. Glia-neuron sandwich cocultures: an in vitro approach to evaluate cell-to-cell communication in neuroinflammation and neurotoxicity
  1934. Glial activation and synaptic neurotoxicity in Alzheimer’s disease: a focus on neuroinflammation
  1935. neuroinflammation-how-they-cause-centralized-pain?page=0,1″>Glial cell activation and neuroinflammation: How they cause centralized pain
  1936. Glial cell diversity and methamphetamine-induced neuroinflammation in human cerebral organoids
  1937. Glial communication via gap junction in neuroinflammation
  1938. Glial epigenetics in neuroinflammation and neurodegeneration
  1939. Glibenclamide mitigates cognitive impairment and hippocampal neuroinflammation in rats with type 2 diabetes and sporadic Alzheimer-like disease
  1940. Glimepiride prevents paraquat‐induced Parkinsonism in mice: involvement of oxidative stress and neuroinflammation
  1941. Gliotoxin Aggravates Experimental Autoimmune Encephalomyelitis by Triggering neuroinflammation
  1942. Global and 3D spatial assessment of neuroinflammation in rodent models of multiple sclerosis
  1943. Global neuroinflammation patterns in experimental neonatal hydrocephalus
  1944. Glucagon-like peptide-1 suppresses neuroinflammation and improves neural structure
  1945. Glucagon‐like peptide‐1 protects synaptic and learning functions from neuroinflammation in rodents
  1946. Glucocorticoid induced leucine zipper in lipopolysaccharide induced neuroinflammation
  1947. Glucocorticoid induced leucine zipper is inversely related with neuroinflammation in the brain
  1948. GLUCOCORTICOID-INDUCED LEUCINE ZIPPER ANALOGS SUPPRESS neuroinflammation IN ALZHEIMER’S DISEASE
  1949. Glucocorticoids in the control of neuroinflammation
  1950. Glucose-dependent insulinotropic polypeptide ameliorates mild traumatic brain injury-induced cognitive and sensorimotor deficits and neuroinflammation in rats
  1951. Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation
  1952. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1120-x”>Glutaminase 1 regulates the release of extracellular vesicles during neuroinflammation through key metabolic intermediate alpha-ketoglutarate
  1953. Glutaminase C overexpression in the brain induces learning deficits, synaptic dysfunctions, and neuroinflammation in mice
  1954. Glutaminyl cyclases: enzyme targets to treat Alzheimer’s disease and neuroinflammation
  1955. Glutathione depletion: Starting point of brain metabolic stress, neuroinflammation and cognitive impairment in rats
  1956. Glycine inhibits ethanol-induced oxidative stress, neuroinflammation and apoptotic neurodegeneration in postnatal rat brain
  1957. Glycyrrhizic acid attenuates neuroinflammation and oxidative stress in rotenone model of Parkinson’s disease
  1958. Glycyrrhizin alleviates neuroinflammation and memory deficit induced by systemic lipopolysaccharide treatment in mice
  1959. GM-CSF in neuroinflammation: licensing myeloid cells for tissue damage
  1960. GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
  1961. GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early-onset Tay-Sachs disease.
  1962. Going with the flow: neuroinflammation
  1963. Gold drug auranofin could reduce neuroinflammation by inhibiting microglia cytotoxic secretions and primed respiratory burst
  1964. Gonadal hormone modulation of chronic neuroinflammation
  1965. GPER agonist G1 attenuates neuroinflammation and dopaminergic neurodegeneration in Parkinson disease
  1966. Gracilin A Derivatives Target Early Events in Alzheimer’s Disease: in Vitro Effects on neuroinflammation and Oxidative Stress
  1967. Granulocyte colony-stimulating factor attenuates chronic neuroinflammation in the brain of amyloid precursor protein transgenic mice: an Alzheimer’s disease mouse …
  1968. Graphene Oxide Nanosheets and Neural System: From Synaptic Modulation to neuroinflammation
  1969. Graphene quantum dots inhibit T cell-mediated neuroinflammation in rats
  1970. Green Tea Polyphenol (−)-Epigallocatechin Gallate (EGCG) Attenuates neuroinflammation in Palmitic Acid-Stimulated BV-2 Microglia and High-Fat Diet-Induced …
  1971. GSK-3β inhibitors suppressed neuroinflammation in rat cortex by activating autophagy in ischemic brain injury
  1972. Guanabenz Reverses a Key Behavioral Change Caused by Latent Toxoplasmosis in Mice by Reducing neuroinflammation
  1973. Gut microbiota and neuroinflammation in pathogenesis of hypertension: A potential role for hydrogen sulfide
  1974. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease
  1975. Gut microbiota to counteract metabolic disorders and neuroinflammation
  1976. Gut microbiota to counteract metabolic disorders and neuroinflammation: Impact of dietary factors and their potential to prevent Alzheimer’s disease
  1977. Gut microbiota–brain axis in depression: The role of neuroinflammation
  1978. Gx-50 inhibits neuroinflammation via α7 nAChR activation of the JAK2/STAT3 and PI3K/AKT pathways
  1979. Gypenosides attenuate lipopolysaccharide-induced neuroinflammation and anxiety-like behaviors in rats
  1980. Gypenosides attenuate lipopolysaccharide-induced neuroinflammation and memory impairment in rats
  1981. Gypenosides reverses depressive behavior via inhibiting hippocampal neuroinflammation
  1982. Hashimoto’s thyroiditis induces neuroinflammation and emotional alterations in euthyroid mice
  1983. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1640-z”>HDAC2 hyperexpression alters hippocampal neuronal transcription and microglial activity in neuroinflammation-induced cognitive dysfunction
  1984. HDAC8 inhibitor WK2-16 therapeutically targets lipopolysaccharide-induced mouse model of neuroinflammation and microglial activation
  1985. HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation
  1986. Heat shock protein 70 suppresses neuroinflammation induced by α-synuclein in astrocytes
  1987. Heat Shock Proteins in neuroinflammation
  1988. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0324-6″>Heat stress-induced memory impairment is associated with neuroinflammation in mice
  1989. Heat stress-induced neuroinflammation and aberration in monoamine levels in hypothalamus are associated with temperature dysregulation
  1990. Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation
  1991. Helminth products potently modulate experimental autoimmune encephalomyelitis by downregulating neuroinflammation and promoting a suppressive …
  1992. Heme oxygenase-1 induction by carbon monoxide releasing molecule-3 suppresses interleukin-1β-mediated neuroinflammation
  1993. Heme oxygenase–1 and carbon monoxide suppress autoimmune neuroinflammation
  1994. Hemorrhage Associated Mechanisms of neuroinflammation in Experimental Traumatic Brain Injury
  1995. Heparan sulfate proteoglycans as relays of neuroinflammation
  1996. Heparin reduces neuroinflammation and transsynaptic neuronal apoptosis in a model of subarachnoid hemorrhage
  1997. Hepatocyte growth factor limits autoimmune neuroinflammation via glucocorticoid-induced leucine zipper expression in dendritic cells
  1998. Herbal Complement inhibitors in the treatment of neuroinflammation
  1999. Herbal compounds with special reference to gastrodin as potential therapeutic agents for microglia mediated neuroinflammation
  2000. Herbicide paraquat induces sex-specific variation of neuroinflammation and neurodegeneration in Drosophila melanogaster
  2001. neuroinflammation&ots=ayGh5CnMqE&sig=pgRuz2LA2s4VRe1YMpCM3px8gPo”>Herpes simplex virus type 1 neuronal infection elicits cellular and molecular mechanisms of neuroinflammation and neurodegeneration in in vitro and in vivo mice …
  2002. Herpes viruses and neuroinflammation
  2003. Herpesvirus trigger accelerates neuroinflammation in a nonhuman primate model of multiple sclerosis
  2004. HERV-W envelope is significantly expressed in Multiple Sclerosis and causes neuroinflammation in animal models with specific antibody inhibition
  2005. Hesperetin inhibits neuroinflammation on microglia by suppressing inflammatory cytokines and MAPK pathways
  2006. Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats
  2007. Hesperetin, a citrus flavonoid, attenuates LPS-induced neuroinflammation, apoptosis and memory impairments by modulating TLR4/NF-κB signaling
  2008. Hesperidin alleviates lipopolysaccharide-induced neuroinflammation in mice by promoting the miRNA-132 pathway
  2009. Hesperidin ameliorates functional and histological outcome and reduces neuroinflammation in experimental stroke
  2010. Hesperidin ameliorates immunological outcome and reduces neuroinflammation in the mouse model of multiple sclerosis
  2011. High and Low Molecular Weight Hyaluronic Acid Differentially Influences Oxylipins Synthesis in Course of neuroinflammation
  2012. High Ca2+ Influx During Traumatic Brain Injury Leads to Caspase-1-Dependent neuroinflammation and Cell Death
  2013. High cholesterol‐induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice
  2014. High CRMP2 expression in peripheral T lymphocytes is associated with recruitment to the brain during virus-induced neuroinflammation
  2015. High Dietary Salt Aggravates Experimental neuroinflammation in Mice Via Induction of Th17 Cells (S50. 003)
  2016. High dimensional cytometry of central nervous system leukocytes during neuroinflammation
  2017. High fat diet exacerbates neuroinflammation in an animal model of multiple sclerosis by activation of the renin angiotensin system
  2018. High fat diet increases cognitive decline and neuroinflammation in a model of orexin loss
  2019. High fat diet increases cognitive decline and neuroinflammation in a model of orexin loss
  2020. High fat diet increases neuroinflammation and alters behavior in mice latently-infected with HSV-1
  2021. HIGH GLUCOSE CONCENTRATIONS INCREASE LEUKOCYTE ADHESION TO ASTROCYTES IN A POST-TRAUMATIC neuroinflammation MODEL.: 144
  2022. High levels of cerebrospinal fluid chemokines point to the presence of neuroinflammation in peripheral neuropathic pain: a cross-sectional study of 2 cohorts …
  2023. High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis
  2024. High Pulsatile Pressure Promotes Cerebrovascular Damage and Endothelial Cell Death, Leading to Hypoperfusion, neuroinflammation and Cognitive Decline in Mice
  2025. High Sensitivity C-Reactive Protein as a Potential Biomarker of neuroinflammation in Major Psychiatric Disorders
  2026. High-energy diet consumption predisposes rats to cognitive impairments, neuroinflammation, and neurovascular damage
  2027. High-fat diet and aging interact to produce neuroinflammation and impair hippocampal-and amygdalar-dependent memory
  2028. High-Fat Diet Causes Increased neuroinflammation and Decreased Motor Function in a Rodent Model of Parkinson’s Disease
  2029. High-Fat Diet Induces neuroinflammation and Mitochondrial Impairment in Mice Cerebral Cortex and Synaptic Fraction
  2030. High-fat diet–induced dysbiosis as a cause of neuroinflammation
  2031. High-fructose diet during adolescent development increases neuroinflammation and depressive-like behavior without exacerbating outcomes after stroke
  2032. High-mobility group box1 protein promotes neuroinflammation after intracerebral hemorrhage in rats
  2033. High-refined carbohydrate diet consumption induces neuroinflammation and anxiety-like behavior in mice
  2034. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-020-1714-y”>High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathy
  2035. High-throughput automated image analysis of neuroinflammation and neurodegeneration enables quantitative assessment of virus neurovirulence
  2036. Higher-Resolution MR Elastography Reveals Early Mechanical Signatures of neuroinflammation in Patients with Clinically Isolated Syndrome
  2037. Higher‐resolution MR elastography reveals early mechanical signatures of neuroinflammation in patients with clinically isolated syndrome
  2038. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration
  2039. Highly selective activation of heat shock protein 70 by allosteric regulation provides an insight into efficient neuroinflammation inhibition
  2040. Highly selective cyclooxygenase-1 inhibitors P6 and Mofezolac counteract inflammatory state both in vitro and in vivo models of neuroinflammation
  2041. Hippo Signaling Pathway has a critical role in Zika Virus Replication and in the Pathogenesis of neuroinflammation
  2042. Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures
  2043. Hippocampal metabolomics using ultrahigh-resolution mass spectrometry reveals neuroinflammation from Alzheimer’s disease in CRND8 mice
  2044. Hippocampal Neurogenesis and neuroinflammation after Cranial Irradiation with 56Fe Particles
  2045. Hippocampal neurogenesis dysfunction linked to depressive-like behaviors in a neuroinflammation induced model of depression
  2046. Hippocampal neuroinflammation and depression: Relevance to multiple sclerosis and other neuropsychiatric illnesses
  2047. Hippocampal neuroinflammation, functional connectivity, and depressive symptoms in multiple sclerosis
  2048. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy
  2049. Histamine and neuroinflammation: insights from murine experimental autoimmune encephalomyelitis
  2050. Histamine H4 receptor agonist‐induced relief from painful peripheral neuropathy is mediated by inhibition of spinal neuroinflammation and oxidative stress
  2051. Histological and direct evidence for the role of complement in the neuroinflammation of AD
  2052. Histone deacetylase 2 inhibitor CAY10683 alleviates lipopolysaccharide induced neuroinflammation through attenuating TLR4/NF-κB signaling pathway
  2053. Histone Deacetylase Inhibitor MS-275 Alleviates Postoperative Cognitive Dysfunction in Rats by Inhibiting Hippocampal neuroinflammation
  2054. Histone deacetylase inhibitor trichostatin a ameliorated endotoxin-induced neuroinflammation and cognitive dysfunction
  2055. HIV gp120‐induced neuroinflammation potentiates NMDA receptors to overcome basal suppression of inhibitory synapses by p38 MAPK
  2056. HIV-1 associated neuroinflammation: effects of two complimentary medicines illustrated in an in vitro model of the blood-brain barrier
  2057. HIV-1 Envelope Glycoprotein 120 Induced neuroinflammation Does Not Result in Neurocognitive Impairment in An in vivo Rat Model
  2058. HIV-1 gp120-induced neuroinflammation: relationship to neuron loss and protection by rSV40-delivered antioxidant enzymes
  2059. HIV-1 Tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation
  2060. HIV-1 viral protein R activates NLRP3 inflammasome in microglia: implications for HIV-1 associated neuroinflammation
  2061. HIV-1, HCV and alcohol in the CNS: potential interactions and effects on neuroinflammation
  2062. HIV-induced neuroinflammation: impact of PAR1 and PAR2 processing by Furin
  2063. HMGB-1 AND ANNEXIN A1: IMPORTANT MEDIATORS OF neuroinflammation IN THE SYNDROME OF ALZHEIMER’S DEMENTIA WITH CONCOMITANT …
  2064. HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration
  2065. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0670-z”>HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in …
  2066. HMGB1 gene silencing inhibits neuroinflammation via down-regulation of NF-κB signaling in primary hippocampal neurons induced by Aβ25–35
  2067. HMGB1-mediated differential response on hippocampal neurotransmitter disorder and neuroinflammation in adolescent male and female mice following cold …
  2068. HMGB1-RAGE signaling plays a role in organic dust-induced microglial activation and neuroinflammation
  2069. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain
  2070. HMGB1: a common biomarker and potential target for TBI, neuroinflammation, epilepsy, and cognitive dysfunction
  2071. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1673-3″>HMGB1/RAGE axis mediates stress-induced RVLM neuroinflammation in mice via impairing mitophagy flux in microglia
  2072. Homocysteine exaggerates microglia activation and neuroinflammation through microglia localized STAT3 overactivation following ischemic stroke
  2073. Honokiol abrogates lipopolysaccharide-induced depressive like behavior by impeding neuroinflammation and oxido-nitrosative stress in mice
  2074. Honokiol ameliorates amyloidosis and neuroinflammation and improves cognitive impairment in Alzheimer’s disease transgenic mice
  2075. Honokiol ameliorates cognitive impairment by attenuating amyloidosis and neuroinflammation in a transgenic mouse model of Alzheimer’s disease
  2076. Honokiol Attenuates the Memory Impairments, Oxidative Stress, neuroinflammation, and GSK-3 β Activation in Vascular Dementia Rats
  2077. Hormesis, cellular stress response and neuroinflammation in schizophrenia: early onset versus late onset state
  2078. How air pollution alters brain development: the role of neuroinflammation
  2079. How can viruses influence the neuroinflammation and neurodegeneration in the aged human brain
  2080. How do statins control neuroinflammation?
  2081. How neuroinflammation contributes to neurodegeneration
  2082. HSPA12B regulates SSeCKS-mediated astrocyte inflammatory activation in neuroinflammation
  2083. Human amyloid β‐induced neuroinflammation is an early event in neurodegeneration
  2084. Human and mouse neuroinflammation markers in Niemann-Pick disease, type C1
  2085. Human antimicrobial peptide LL-37 induces glial-mediated neuroinflammation
  2086. Human bone marrow mesenchymal stem cell-derived extracellular vesicles attenuate neuroinflammation evoked by focal brain injury in rats
  2087. Human brain pericytes as mediators of neuroinflammation: Implications for disease and therapeutics
  2088. Human endogenous retrovirus and neuroinflammation in chronic inflammatory demyelinating polyradiculoneuropathy
  2089. neuroinflammation_in_Chronic_Inflammatory_Demyelinating_Polyradiculoneuropathy/links/56e9360008ae9bcb3e1e5571/Human-Endogenous-Retrovirus-and-neuroinflammation-in-Chronic-Inflammatory-Demyelinating-Polyradiculoneuropathy.pdf”>Human Endogenous Retrovirus and neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
  2090. Human herpesvirus 6 and neuroinflammation
  2091. Human immunodeficiency virus type 1 (HIV-1)-mediated neuroinflammation dysregulates neurogranin and induces synaptodendritic injury
  2092. Human iPSC-derived neurons and astrocytes as models of neurodegeneration, neuroinflammation and vesicular trafficking in Alzheimer’s disease
  2093. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic …
  2094. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson’s disease
  2095. Human TBK1: a gatekeeper of neuroinflammation
  2096. Human Umbilical Cord Mesenchymal Stem Cells Attenuate Ocular Hypertension-Induced Retinal neuroinflammation via Toll-Like Receptor 4 Pathway
  2097. Human Urinary Kallidinogenase Reduces Lipopolysaccharide-Induced neuroinflammation and Oxidative Stress in BV-2 Cells
  2098. Human whole-body biodistribution and dosimetry of a new PET tracer,[{sup 11} C] ketoprofen methyl ester, for imagings of neuroinflammation
  2099. Human whole-body biodistribution and dosimetry of a new PET tracer,[11C] ketoprofen methyl ester, for imagings of neuroinflammation
  2100. Huperzine A alleviates neuroinflammation, oxidative stress and improves cognitive function after repetitive traumatic brain injury
  2101. Huperzine A ameliorates cognitive dysfunction and neuroinflammation in kainic acid‐induced epileptic rats by antioxidant activity and NLRP 3/caspase‐1 pathway …
  2102. Hydrogen sulfide and neuroinflammation
  2103. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-202″>Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in beta-amyloid rat model of Alzheimer’s disease
  2104. Hydrogen sulfide inhibits ATP-induced neuroinflammation and Aβ1–42 synthesis by suppressing the activation of STAT3 and cathepsin S
  2105. Hydrogen sulfide protects against cognitive impairment induced by hepatic ischemia and reperfusion via attenuating neuroinflammation
  2106. Hydrogen sulfide protects hippocampal neurons against methamphetamine neurotoxicity via inhibition of apoptosis and neuroinflammation
  2107. Hydrogen sulfide‐releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation
  2108. Hydroxy-safflor yellow A inhibits neuroinflammation mediated by Aβ1–42 in BV-2 cells
  2109. Hydroxysafflor yellow A attenuates lipopolysaccharide-induced neurotoxicity and neuroinflammation in primary mesencephalic cultures
  2110. Hyperammonemia induces glial activation, neuroinflammation and alters neurotransmitter receptors in hippocampus, impairing spatial learning: reversal by …
  2111. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy
  2112. Hyperbaric oxygen effects on depression-like behavior and neuroinflammation in traumatic brain injury rats
  2113. Hyperbaric oxygen preconditioning attenuates neuroinflammation after intracerebral hemorrhage in rats by regulating microglia characteristics
  2114. Hyperbaric oxygen therapy ameliorates pathophysiology of 3xTg-AD mouse model by attenuating neuroinflammation
  2115. Hyperbaric oxygen therapy reduces neuroinflammation and expression of matrix metalloproteinase-9 in the rat model of traumatic brain injury.
  2116. Hyperbaric oxygen therapy reduces neuroinflammation and expression of matrix metalloproteinase‐9 in the rat model of traumatic brain injury
  2117. Hyperglycemia-driven neuroinflammation compromises BBB leading to memory loss in both diabetes mellitus (DM) type 1 and type 2 mouse models
  2118. Hyperpolarized 13C magnetic resonance spectroscopy detects toxin‐induced neuroinflammation in mice
  2119. Hyperpolarized 13C MR metabolic imaging can detect neuroinflammation in vivo in a multiple sclerosis murine model
  2120. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0455-9″>Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson’s disease
  2121. Hypothermia Attenuates Neuro-Glial Injury and neuroinflammation in Prolonged Status Epilepticus (S56. 004)
  2122. neuroinflammation&ots=IbFgxNnme9&sig=aLLdVUx5F7tXwBY2xBF8zTP_Ua8″>Hypoxia and neuroinflammation: Connections with Toll-Like Receptor Signaling in Brain Microglia
  2123. Hypoxia as an initiator of neuroinflammation: microglial connections
  2124. Hypoxia-induced neuroinflammation and learning–memory impairments in adult zebrafish are suppressed by glucosamine
  2125. Hypoxic preconditioning suppresses glial activation and neuroinflammation in neonatal brain insults
  2126. Hypoxic-conditioned medium from adipose tissue mesenchymal stem cells improved neuroinflammation through alternation of toll like receptor (TLR) 2 and TLR4 …
  2127. Ibuprofen inhibits neuroinflammation and attenuates white matter damage following hypoxia–ischemia in the immature rodent brain
  2128. Icariin and icaritin ameliorated hippocampus neuroinflammation via inhibiting HMGB1-related pro-inflammatory signals in lipopolysaccharide-induced inflammation …
  2129. Icariin and icaritin ameliorated hippocampus neuroinflammation via mediating HMGB1 expression in social defeat model in mice
  2130. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1472-x”>Icariin attenuates neuroinflammation and exerts dopamine neuroprotection via an Nrf2-dependent manner
  2131. Icariin targets Nrf2 signaling to inhibit microglia-mediated neuroinflammation
  2132. Icariside II attenuates lipopolysaccharide-induced neuroinflammation through inhibiting TLR4/MyD88/NF-κB pathway in rats
  2133. Idebenone alleviates neuroinflammation and modulates microglial polarization in LPS-stimulated BV2 cells and MPTP-induced Parkinson’s disease mice
  2134. Identification of a fatty acid binding protein4-UCP2 axis regulating microglial mediated neuroinflammation
  2135. Identification of ADAM proteinase substrates in neurodegeneration and neuroinflammation
  2136. Identification of brain regions predicting epileptogenesis by serial [18F] GE-180 positron emission tomography imaging of neuroinflammation in a rat model of …
  2137. Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation
  2138. Identification of novel candidate protein biomarkers for the post-polio syndrome—implications for diagnosis, neurodegeneration and neuroinflammation
  2139. Identification of target genes in neuroinflammation and neurodegeneration after traumatic brain injury in rats
  2140. Identifying the role of complement in triggering neuroinflammation after traumatic brain injury
  2141. Identifying the role of IL-1 in neuroinflammation of MPSIIIA
  2142. IFN-β induces IL-6 production by B cells to promote TH17-mediated neuroinflammation
  2143. IL-1-induced Bhlhe40 identifies pathogenic TH cells in a model of autoimmune neuroinflammation
  2144. IL-1–induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation
  2145. IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis
  2146. IL-11 antagonist suppresses Th17 cells-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis (P2. 406)
  2147. IL-12p35 inhibits neuroinflammation and ameliorates autoimmune encephalomyelitis
  2148. IL-13 ameliorates neuroinflammation and promotes functional recovery after traumatic brain injury
  2149. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson’s disease
  2150. IL-17A induces autophagy and promotes microglial neuroinflammation through ATG5 and ATG7 in intracerebral hemorrhage
  2151. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0394-5″>IL-17A is implicated in lipopolysaccharide-induced neuroinflammation and cognitive impairment in aged rats via microglial activation
  2152. IL-17A promotes microglial activation and neuroinflammation in mouse models of intracerebral haemorrhage
  2153. IL-17A promotes the neuroinflammation and cognitive function in sevoflurane anesthetized aged rats via activation of NF-κB signaling pathway
  2154. IL-18 is differently regulated in specific areas of rat brain during neuroinflammation: relevance for neurodegenerative disease
  2155. IL-18: a key player in neuroinflammation and neurodegeneration?
  2156. IL-1β-mediated changes in cerebral perfusion and neural activity in a rat model of neuroinflammation and excitotoxicity
  2157. IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammation
  2158. IL-27 and IL-35 as gene therapy of neuroinflammation
  2159. IL-27, but not IL-35, inhibits neuroinflammation through modulating GM-CSF expression
  2160. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1169-6″>IL-33/ST2 plays a critical role in endothelial cell activation and microglia-mediated neuroinflammation modulation
  2161. neuroinflammation_AFTER.282.aspx”>IL-8 IS A KEY MEDIATOR OF neuroinflammation AFTER TRAUMATIC BRAIN INJURY: 363
  2162. IL‐4 attenuates the neuroinflammation induced by amyloid‐β in vivo and in vitro
  2163. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0596-5″>IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo
  2164. Imaging Amnestic Mild Cognitive Impairment: neuroinflammation, Beta-Amyloid and Glutathione
  2165. Imaging biomarkers and the role of neuroinflammation in neuropathic pain
  2166. Imaging cellular markers of neuroinflammation in the brain of the rat model of amyotrophic lateral sclerosis
  2167. IMAGING MARKER OF neuroinflammation PREDICTS DISEASE PROGRESSION IN ALZHEIMER DISEASE
  2168. Imaging marker of neuroinflammation predicts progression in Alzheimer’s disease
  2169. Imaging microglial activation during neuroinflammation and Alzheimer’s disease
  2170. Imaging neuroinflammation after brain injuries by ultrasensitive MRI and two-photon laser-scanning microscopy
  2171. Imaging neuroinflammation after stroke: current status of cellular and molecular MRI strategies
  2172. Imaging neuroinflammation in Alzheimer disease with [1–11C] arachidonic acid and positron emission tomography
  2173. Imaging neuroinflammation in Alzheimer’s disease and other dementias: recent advances and future directions
  2174. Imaging neuroinflammation in Alzheimer’s disease with radiolabeled arachidonic acid and PET
  2175. IMAGING neuroinflammation IN AMNESTIC MILD COGNITIVE IMPAIRMENT (AMCI) USING A NOVEL PET RADIOLIGAND:[18F]-FEPPA
  2176. Imaging neuroinflammation in Gray and White Matter in Schizophrenia: An In-Vivo PET Study With [ 18 F]-FEPPA
  2177. Imaging neuroinflammation in ischemic stroke and in the atherosclerotic vascular disease
  2178. Imaging neuroinflammation in multiple sclerosis using TSPO-PET
  2179. Imaging neuroinflammation in neurodegenerative diseases (INMIND): Concepts and future directions
  2180. Imaging neuroinflammation in Post Traumatic Stress Disorder
  2181. Imaging neuroinflammation in Progressive Multiple Sclerosis
  2182. Imaging neuroinflammation in vivo in a neuropathic pain rat model with near-infrared fluorescence and 19F magnetic resonance
  2183. Imaging neuroinflammation using 18F-DPA-714 microPET after low intensity pulsed focused ultrasound treatment with microbubbles.
  2184. Imaging neuroinflammation using18F-DPA-714 PET after disrupting the blood brain barrier with pulsed focused ultrasound.
  2185. Imaging neuroinflammation–from bench to bedside
  2186. Imaging neuroinflammation: quantification of astrocytosis in a multitracer PET approach
  2187. Imaging neuroinflammation? A perspective from MR spectroscopy
  2188. Imaging of neuroinflammation
  2189. Imaging of neuroinflammation in Alzheimer’s disease, multiple sclerosis and stroke: Recent developments in positron emission tomography
  2190. Imaging of neuroinflammation in dementia: a review
  2191. Imaging of neuroinflammation in migraine with aura: A [11C] PBR28 PET/MRI study
  2192. Imaging of neuroinflammation in parkinsonian syndromes with positron emission tomography
  2193. Imaging of neuroinflammation with an ICAM-1 Specific Paramagnetic and Fluorescent Nanoparticle
  2194. Imaging of neuroinflammation: TSPO and beyond
  2195. Imaging Tau, neuroinflammation, and Aβ in Dementia With Lewy Bodies: A Deep‐Phenotyping Case Report
  2196. Imaging the Breakdown of the BBB and neuroinflammation in Models of Neurodegeneration
  2197. Imaging toxin-induced neuroinflammation in mice using hyperpolarized 13C magnetic resonance spectroscopy
  2198. Imaging translocator protein as a biomarker of neuroinflammation in dementia
  2199. Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune …
  2200. Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood–brain barrier integrity and by modulating the peripheral immune …
  2201. Immune activation and neuroinflammation in alcohol use and HIV infection: evidence for shared mechanisms
  2202. Immune dysfunction and neuroinflammation in autism spectrum disorder.
  2203. Immune heterogeneity in neuroinflammation: dendritic cells in the brain
  2204. IMMUNE MECHANISMS ASSOCIATED TO neuroinflammation IN ALZHEIMER¿ S DISEASE
  2205. Immune privilege as an intrinsic CNS property: astrocytes protect the CNS against T-cell-mediated neuroinflammation
  2206. Immune System in Acute and Chronic neuroinflammation
  2207. Immune System in Acute and Chronic neuroinflammation
  2208. Immune system markers of neuroinflammation in patients with clinical diagnose of neuromyelitis optica
  2209. Immunity, neuroglia and neuroinflammation in autism
  2210. Immunization with Bacillus Calmette-Guérin (BCG) alleviates neuroinflammation and cognitive deficits in APP/PS1 mice via the recruitment of inflammation-resolving …
  2211. Immunobiology of WNV-induced neuroinflammation
  2212. Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury
  2213. Immunoglobulin G: a potential treatment to attenuate neuroinflammation following spinal cord injury
  2214. Immunological Approaches to Prevent Neuronal Apoptosis During neuroinflammation
  2215. Immunomodulatory influence of bone marrow-derived mesenchymal stem cells on neuroinflammation in astrocyte cultures
  2216. Immunomodulatory properties of bone marrow-derived mesenchymal stem cells: influence on neuroinflammation
  2217. Immunomodulatory role of the extracellular matrix protein tenascin-C in neuroinflammation
  2218. Immunotherapy against APP β-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on …
  2219. Immunotherapy in Autoimmune and neuroinflammation-Related Epilepsies
  2220. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0954-y”>Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation
  2221. Impact of indomethacin on neuroinflammation and hippocampal neurogenesis in aged mice
  2222. Impact of long-term RF-EMF on oxidative stress and neuroinflammation in aging brains of C57BL/6 mice
  2223. Impact of metabolic syndrome on neuroinflammation and the blood–brain barrier
  2224. Impact of neuroinflammation on hippocampal neurogenesis: relevance to aging and Alzheimer’s disease
  2225. Impact of novel N-aryl piperamide NO donors on NF-κB translocation in neuroinflammation: rational drug-designing synthesis and biological evaluation
  2226. Impact of opiate addiction on neuroinflammation in HIV
  2227. neuroinflammation_and_disease/links/5c42205ba6fdccd6b5b6e83e/Impact-of-the-paracaspase-MALT1-on-rabies-virus-induced-neuroinflammation-and-disease.pdf”>Impact of the paracaspase MALT1 on rabies virus-induced neuroinflammation and disease
  2228. Impact of Titanium Dioxide Nanoparticles on neuroinflammation in a Mouse Model of Asthma
  2229. Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder
  2230. Impaired remission from autoimmune neuroinflammation upon T cell-specific knockout of the stress kinase GCN2
  2231. Impairment of blood brain barrier is related with the neuroinflammation induced peripheral immune status in intracerebroventricular colchicine injected rats: An …
  2232. Implications of heparan sulfate and heparanase in neuroinflammation
  2233. Improved 3D hydrogel cultures of primary glial cells for in vitro modelling of neuroinflammation
  2234. Improved brain insulin/IGF signaling and reduced neuroinflammation with T3D-959 in an experimental model of sporadic Alzheimer’s disease
  2235. In a Model of neuroinflammation Designed to Mimic Delirium, Quetiapine Reduces Cortisol Secretion and Preserves Reversal Learning in the Attentional Set Shifting …
  2236. In silico design of novel gold-phosphate containing compounds as selective inhibitors of cathepsin B in neuroinflammation
  2237. In vitro assessment of neurotoxicity and neuroinflammation of homemade MWCNTs
  2238. In Vitro Model of neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid
  2239. In vitro models to study insulin and glucocorticoids modulation of trimethyltin (TMT)-induced neuroinflammation and neurodegeneration, and in vivo validation in db/db …
  2240. In vivo analysis of neuroinflammation in the late chronic phase after experimental stroke
  2241. In vivo assessment of amyloid deposition, neuroinflammation, and metabolic changes in neurodegenerations of different origin
  2242. In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET
  2243. In vivo detection of age-and disease-related increases in neuroinflammation by 18F-GE180 TSPO microPET imaging in wild-type and Alzheimer’s transgenic mice
  2244. In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer’s disease
  2245. In vivo evaluation of” Meriva” curcumin, and apigenin as anti-inflammatory drugs in a mouse model of chronic neuroinflammation
  2246. In vivo evidence for pre‐symptomatic neuroinflammation in a MAPT mutation carrier
  2247. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-1038-8″>In vivo evidence for the contribution of peripheral circulating inflammatory exosomes to neuroinflammation
  2248. In vivo expression of cyclooxygenase-1 in activated microglia and macrophages during neuroinflammation visualized by PET with 11C-ketoprofen methyl ester
  2249. In vivo imaging biomarkers of neuroinflammation in the development and assessment of stroke therapies-towards clinical translation
  2250. In vivo imaging detects a transient increase in brain arachidonic acid metabolism: a potential marker of neuroinflammation
  2251. In vivo imaging of human neuroinflammation
  2252. In vivo imaging of neuroinflammation
  2253. In Vivo Imaging of neuroinflammation in Acute Brain Injury
  2254. In vivo imaging of neuroinflammation in Alzheimer’s disease
  2255. In vivo imaging of neuroinflammation in neurodegenerative diseases
  2256. In vivo imaging of neuroinflammation in schizophrenia
  2257. In vivo imaging of neuroinflammation in the rodent brain with [11C]SSR180575, a novel indoleacetamide radioligand of the translocator protein (18 kDa)
  2258. In vivo imaging of neuroinflammation: a comparative study between [18F]PBR111, [11C]CLINME and [11C]PK11195 in an acute rodent model
  2259. In vivo imaging of Α7 nicotinic receptors as a novel method to monitor neuroinflammation after cerebral ischemia
  2260. In vivo imaging of”neuroinflammation”. Principles and applications
  2261. In vivo imaging of”neuroinflammation”. Principles and applications; In-vivo-Darstellung”neuroinflammatorischer”Veraenderungen mit [{sup 11} C] PK11195-PET …
  2262. In vivo molecular imaging of neuroinflammation in Alzheimer’s disease
  2263. In vivo nanoneurotoxicity screening using oxidative stress and neuroinflammation paradigms
  2264. In vivo peptide biomarker screening for molecular imaging in eae neuroinflammation
  2265. In vivo PET imaging of neuroinflammation in Alzheimer’s disease
  2266. In Vivo Retinal Imaging of neuroinflammation in a Mouse Model of Traumatic Brain Injury
  2267. In vivo study of a PET radiotracer for imaging P2X7 receptors for neuroinflammation in animal model
  2268. In vivo targeting of Abeta and tau amyloidogeneses, neuroinflammation, calcium-mediated neurotoxicity and their interplays
  2269. In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke neuroinflammation in rats: a positron emission tomography study
  2270. neuroinflammation/links/55f6d2cc08aec948c462f6b8/In-Vitro-Ly6Chi-monocytes-and-their-role-in-neuroinflammation.pdf”>IN-VITRO Ly6C hi MONOCYTES AND THEIR ROLE IN neuroinflammation
  2271. In-vivo imaging of grey and white matter neuroinflammation in Alzheimer’s disease: a positron emission tomography study with a novel radioligand,[18 F]-FEPPA
  2272. In-vivo imaging of neuroinflammation in Veterans with Gulf War Illness
  2273. Incipient melanoma brain metastases instigate astrogliosis and neuroinflammation
  2274. Increase in core body temperature of Alzheimer’s disease patients as a possible indicator of chronic neuroinflammation: a meta-analysis
  2275. Increased brain docosahexaenoic acid has no effect on the resolution of neuroinflammation following intracerebroventricular lipopolysaccharide injection
  2276. Increased cerebral Tff1 expression in two murine models of neuroinflammation
  2277. Increased cortical infarction and neuroinflammation in ischemic stroke mice with experimental periodontitis
  2278. Increased expression of astrocyte markers in schizophrenia: association with neuroinflammation
  2279. Increased neuroinflammation in Asymptomatic LRRK2 Mutation Carriers: A Pilot PET Imaging Study (P4. 321)
  2280. Increased neuronal PreP activity reduces Aβ accumulation, attenuates neuroinflammation and improves mitochondrial and synaptic function in Alzheimer …
  2281. Increased neuronal PreP activity reduces Aβ accumulation, attenuates neuroinflammation and improves mitochondrial and synaptic function in Alzheimer disease’s …
  2282. Increased olfactory bulb volume due to treatment of chronic rhinosinusitis: neuroinflammation and adult neurogenesis
  2283. Increased P2X7 receptor binding is associated with neuroinflammation in acute but not chronic rodent models for Parkinson’s disease
  2284. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-5-10″>Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment
  2285. Increases in neuroinflammation and Astrocyte Activation in a Murine Model of Mixed Dementia
  2286. Increasing extracellular cGMP in cerebellum in vivo reduces neuroinflammation, GABAergic tone and motor in-coordination in hyperammonemic rats
  2287. Indirect effects of radiation induce apoptosis and neuroinflammation in neuronal SH-SY5Y cells
  2288. Indispensable role of CX3CR1+ dendritic cells in regulation of virus-induced neuroinflammation through rapid development of antiviral immunity in peripheral …
  2289. Indoxyl sulfate affects glial function increasing oxidative stress and neuroinflammation in chronic kidney disease: interaction between astrocytes and microglia
  2290. Inducible ablation of Cxcr2 in oligodendroglia attenuates autoimmune, but not viral, mediated neuroinflammation and demyelination
  2291. INDUCTION AND RESOLUTION OF neuroinflammation AND NEUROTOXICITY
  2292. Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation
  2293. Induction of neuroinflammation and Neurotoxicity by Synthetic Hemozoin
  2294. Induction of Nrf2/HO-1 pathway suppresses neuroinflammation in ischemic stroke
  2295. Induction of suppressor of cytokine signaling 3 via HSF-1-HSP70-TLR4 axis attenuates neuroinflammation and ameliorates postoperative pain
  2296. Infection with mosquito-borne alphavirus induces selective loss of dopaminergic neurons, neuroinflammation and widespread protein aggregation
  2297. Infiltrating macrophages contribute to age-related neuroinflammation in C57/BL6 mice
  2298. Infiltrating regulatory B cells control neuroinflammation following viral brain infection
  2299. neuroinflammation_and.2.aspx”>Inflamed in the Membrane: neuroinflammation and Perioperative Neurocognitive Disorders
  2300. Inflamed in vitro retina: cytotoxic neuroinflammation and galectin-3 expression
  2301. Inflammasomes in neuroinflammation and changes in brain function: a focused review
  2302. Inflammasomes link vascular disease with neuroinflammation and brain disorders
  2303. Inflammasomes, hormesis, and antioxidants in neuroinflammation: role of NRLP3 in Alzheimer disease
  2304. Inflammasomes: An emerging mechanism translating environmental toxicant exposure into neuroinflammation in Parkinson’s disease
  2305. Inflammatory cell populations in early neuroinflammation in the core and peri-ischemic lesions of rat brain after transient focal cerebral ischemia: A …
  2306. Inflammatory cells and cytokines in the olfactory bulb of a rat model of neuroinflammation; insights into neurodegeneration?
  2307. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0710-8″>Infliximab reduces peripheral inflammation, neuroinflammation, and extracellular GABA in the cerebellum and improves learning and motor coordination in …
  2308. Influence of caffeine on 3, 4‐methylenedioxymethamphetamine‐induced dopaminergic neuron degeneration and neuroinflammation is age‐dependent
  2309. Influence of chronic Helicobacter pylori infection on systemic and neuroinflammation and its impact on cognition
  2310. Influence of HAART on HIV-related CNS disease and neuroinflammation
  2311. Influence of LPS-induced neuroinflammation on acetylcholinesterase activity in rat brain
  2312. Influence of neuroinflammation on Neuronal Function in Neurodegenerative Diseases: An 11C-(R)-PK11195 and 18F-FDG PET Study (IN9-1.001)
  2313. Influence of neuroinflammation on Neuronal Function in Neurodegenerative Diseases: An 11C-(R)-PK11195 and 18F-FDG PET Study (S44. 003)
  2314. Influence of neuroinflammation on the regulation of glutamate handling in astrocytes, link with neuropathies
  2315. Influence of post-traumatic stress disorder on neuroinflammation and cell proliferation in a rat model of traumatic brain injury
  2316. Influenza infection induces neuroinflammation and impacts hippocampal structure and function
  2317. Influenza infection induces neuroinflammation, alters hippocampal neuron morphology, and impairs cognition in adult mice
  2318. Inhalation of hydrogen gas attenuates brain injury in mice with cecal ligation and puncture via inhibiting neuroinflammation, oxidative stress and neuronal apoptosis
  2319. Inhaled budesonide protects against chronic asthma-induced neuroinflammation in mouse brain
  2320. Inheritance of autoimmune neuroinflammation
  2321. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1271-9″>Inhibiting aberrant p53-PUMA feedback loop activation attenuates ischaemia reperfusion-induced neuroapoptosis and neuroinflammation in rats by …
  2322. Inhibiting neuroinflammation: the role and therapeutic potential of GABA in neuro-immune interactions
  2323. Inhibiting RIPK1 limits neuroinflammation and alleviates postoperative cognitive impairments in D-galactose-induced aged mice
  2324. Inhibition of 26S protease regulatory subunit 7 (MSS1) suppresses neuroinflammation
  2325. Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damage
  2326. Inhibition of activator protein 1 attenuates neuroinflammation and brain injury after experimental intracerebral hemorrhage
  2327. Inhibition of AGEs/RAGE/Rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-κB …
  2328. Inhibition of Amyloid-Beta Production, Associated neuroinflammation, and Histone Deacetylase 2-Mediated Epigenetic Modifications Prevent Neuropathology …
  2329. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1476-6″>Inhibition of apoptosis signal-regulating kinase by paeoniflorin attenuates neuroinflammation and ameliorates neuropathic pain
  2330. Inhibition of Aβ production, associated neuroinflammation, and HDAC2-mediated epigenetic modifications prevent neuropathology in Alzheimer’s disease in vitro …
  2331. Inhibition of cathepsin X reduces the strength of microglial-mediated neuroinflammation
  2332. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0875-9″>Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation
  2333. Inhibition of DNA methylation with zebularine alters lipopolysaccharide-induced neuroinflammation in mice
  2334. Inhibition of DNA methylation with zebularine alters lipopolysaccharide-induced sickness behavior and neuroinflammation in mice
  2335. Inhibition of Endocannabinoid Degradation Improves Recovery of Neurobehavioral Function and Resolution of neuroinflammation and Synaptic Hyperexcitability in a …
  2336. Inhibition of fibrin formation reduces neuroinflammation and improves long-term outcome after intracerebral hemorrhage
  2337. Inhibition of HDAC6 alleviating lipopolysaccharide-induced p38MAPK phosphorylation and neuroinflammation in mice
  2338. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke
  2339. Inhibition of MALT1 decreases neuroinflammation and pathogenicity of virulent rabies virus in mice
  2340. Inhibition of microRNA-155 Alleviates Cognitive Impairment in Alzheimer’s Disease and Involvement of neuroinflammation
  2341. Inhibition of microRNA-155 Alleviates Neurological Dysfunction Following Transient Global Ischemia and Contribution of neuroinflammation and Oxidative Stress in …
  2342. Inhibition of miR-155 limits neuroinflammation and improves functional recovery after experimental traumatic brain injury in mice
  2343. Inhibition of miR-429 improves neurological recovery of traumatic brain injury mice and attenuates microglial neuroinflammation
  2344. Inhibition of NADPH oxidase promotes alternative and anti‐inflammatory microglial activation during neuroinflammation
  2345. Inhibition of neuroinflammation and mitochondrial dysfunctions by carbenoxolone in the rotenone model of Parkinson’s disease
  2346. Inhibition of neuroinflammation by AIBP: spinal effects upon facilitated pain states
  2347. Inhibition of neuroinflammation by artemisinin and its derivatives
  2348. Inhibition of neuroinflammation by cinnamon and its main components
  2349. Inhibition of neuroinflammation by Synthetic Androstene Derivatives Incorporating Amino Acid Methyl Esters on Activated BV‐2 Microglia
  2350. Inhibition of neuroinflammation by thymoquinone requires activation of Nrf2/ARE signalling
  2351. Inhibition of neuroinflammation in BV2 microglia by the biflavonoid kolaviron is dependent on the Nrf2/ARE antioxidant protective mechanism
  2352. Inhibition of neuroinflammation in LPS-activated microglia by cryptolepine
  2353. Inhibition of neuroinflammation prevents injury to the serotonergic network after hypoxia-ischemia in the immature rat brain
  2354. INHIBITION OF neuroinflammation REDUCES DEGENERATION OF DOPAMINERGIC NEURONS IN THE SUBSTANTIANIGRA INDUCED BY …
  2355. Inhibition of NF-κB activity by aminoguanidine alleviates neuroinflammation induced by hyperglycemia
  2356. Inhibition of P2X7 receptor ameliorates nuclear factor-kappa B mediated neuroinflammation induced by status epilepticus in rat hippocampus
  2357. neuroinflammation.97515.aspx”>Inhibition of PAR-2 Attenuates neuroinflammation and Improves Short-Term Neurocognitive Functions via ERK1/2 Signaling Following Asphyxia-Induced Cardiac …
  2358. Inhibition of PDE5 attenuates streptozotocin-induced neuroinflammation and tau hyperphosphorylation in a streptozotocin-treated rat model
  2359. Inhibition of RAGE-Related Pathway Prevents Subarachnoid Hemorrhage (sah)-Associated neuroinflammation and Neurologic Dysfunction in Rats
  2360. Inhibition of semicarbazide‐sensitive amine oxidase/vascular adhesion protein‐1 reduces lipopolysaccharide‐induced neuroinflammation
  2361. Inhibition of SERPINA3N‐dependent neuroinflammation is essential for melatonin to ameliorate trimethyltin chloride–induced neurotoxicity
  2362. Inhibition of sPLA2-IIA Prevents LPS-Induced neuroinflammation by Suppressing ERK1/2-cPLA2α Pathway in Mice Cerebral Cortex
  2363. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson’s disease models
  2364. Inhibition of the JAK/STAT pathway protects against α-synuclein-induced neuroinflammation and dopaminergic neurodegeneration
  2365. Inhibition of the P2X7–PANX1 complex suppresses spreading depolarization and neuroinflammation
  2366. Inhibition of the receptor for advanced glycation end-products (RAGE) attenuates neuroinflammation while sensitizing cortical neurons towards death in experimental …
  2367. Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage
  2368. Inhibition of TNF-alpha protein synthesis restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation
  2369. Inhibitor of phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of …
  2370. Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer’s disease
  2371. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-35″>Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear …
  2372. Inhibitory effect of ethanol extract of Nannochloropsis oceanica on lipopolysaccharide-induced neuroinflammation, oxidative stress, amyloidogenesis and …
  2373. Inhibitory effect of ferulic acid on neuroinflammation in LPS-activated microglia
  2374. Inhibitory effect of INT-777 on lipopolysaccharide-induced cognitive impairment, neuroinflammation, apoptosis, and synaptic dysfunction in mice
  2375. Inhibitory effect of memantine on streptozotocin-induced insulin receptor dysfunction, neuroinflammation, amyloidogenesis, and neurotrophic factor decline in …
  2376. Inhibitory effect of Petalonia binghamiae on neuroinflammation in LPS-stimulated microglial cells
  2377. Inhibitory effect of punicalagin on lipopolysaccharide-induced neuroinflammation, oxidative stress and memory impairment via inhibition of nuclear factor-kappaB
  2378. Inhibitory effects of betulinic acid on LPS-induced neuroinflammation involve M2 microglial polarization via CaMKKβ-dependent AMPK activation
  2379. Inhibitory effects of ginsenoside Rb1 on neuroinflammation following systemic lipopolysaccharide treatment in mice
  2380. Inhibitory Effects of Myricetin on Lipopolysaccharide-Induced neuroinflammation
  2381. Inhibitory effects of walnut (Juglans regia) peptides on neuroinflammation and oxidative stress in lipopolysaccharide-induced cognitive impairment mice
  2382. Initial evaluation in healthy humans of [18F] DPA-714, a potential PET biomarker for neuroinflammation
  2383. Initial Parkinson’s and healthy control studies of 123-I CLINDE, a SPECT marker of the peripheral benzodiazepine receptor and neuroinflammation
  2384. Injecting mitochondria into mouse hippocampi induces neuroinflammation and raises app expression
  2385. INMiND: getting to the bottom of neuroinflammation
  2386. Innate and adaptive immune-mediated neuroinflammation and neurodegeneration in Parkinson’s disease
  2387. Innate immunity and neuroinflammation
  2388. Innate immunity and neuroinflammation
  2389. neuroinflammation-in-neuropsychiatric-conditions-including-autism-spectrum-disor?fbclid=IwAR3JgpmxalljKo8WI8Aa5iMW_xTEWKULZ7aeZtda6bqsG0iSYGCJ2_OLu6o”>Innate Immunity and neuroinflammation in Neuropsychiatric Conditions Including Autism Spectrum Disorders: Role of Innate Immune Memory
  2390. Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll‐like receptor‐mediated neuronal injury
  2391. Innate immunity and protective neuroinflammation: new emphasis on the role of neuroimmune regulatory proteins
  2392. Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication
  2393. Inosine improves cognitive function and decreases aging-induced oxidative stress and neuroinflammation in aged female rats
  2394. INSIGHTS FROM FLUID BIOMARKERS OF neuroinflammation
  2395. Insights into macrophage heterogeneity and cytokine-induced neuroinflammation in major depressive disorder
  2396. Insights into neuroinflammation in Parkinson’s disease: from biomarkers to anti-inflammatory based therapies
  2397. Insights into the Role of neuroinflammation in the Pathogenesis of Multiple Sclerosis
  2398. Insights on the pathophysiology of Alzheimer’s disease: the crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system
  2399. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0282-z”>Insulin improves memory and reduces chronic neuroinflammation in the hippocampus of young but not aged brains
  2400. Insulin resistance, neuroinflammation, and Alzheimer’s disease
  2401. Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice
  2402. Insulin Signaling Suppresses Virus Replication and neuroinflammation in HIV/AIDS (S53. 005)
  2403. Insulin treatment normalizes retinal neuroinflammation but not markers of synapse loss in diabetic rats
  2404. Insulin treatment prevents neuroinflammation and neuronal injury with restored neurobehavioral function in models of HIV/AIDS neurodegeneration
  2405. Insulin treatment protects the brain against neuroinflammation by reducing cerebral cytokines and modulating mitochondrial function
  2406. Insulin-like growth factor-1 and neuroinflammation
  2407. Integration of Th17-and lymphotoxin-derived signals initiates meningeal-resident stromal cell remodeling to propagate neuroinflammation
  2408. Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration
  2409. Integrin α5β1 inhibition by ATN-161 reduces neuroinflammation and is neuroprotective in ischemic stroke
  2410. Intensive Combination Immunotherapy and neuroinflammation Resolution in a Child With Anti-PCA-1 (Yo) Paraneoplastic Syndrome and 2 Malignancies
  2411. Interaction between CNS-resident cells and gut dysbiosis in multiple sclerosis: consequences on neuroinflammation
  2412. Interactions Between Neurons and Microglia During neuroinflammation
  2413. Interactions between the canonical WNT/beta-catenin pathway and PPAR gamma on neuroinflammation, demyelination, and remyelination in multiple sclerosis
  2414. Interactions of Aβ with endogenous anti-inflammatory agents: a basis for chronic neuroinflammation in Alzheimer’s disease
  2415. Interfering with the CCL2–glycosaminoglycan axis as a potential approach to modulate neuroinflammation
  2416. Interferon mediated neuroinflammation in polyglutamine disease is not caused by RNA toxicity
  2417. Interferon-β plays a detrimental role in experimental traumatic brain injury by enhancing neuroinflammation that drives chronic neurodegeneration
  2418. neuroinflammation&ots=hOgZ6fNPTZ&sig=6Z4oj6aRgr9HIlCQrN-Vvfs5bts”>Interleukin 1 Receptor and Alzheimer’s Disease-Related neuroinflammation
  2419. Interleukin 6 mediates neuroinflammation and motor coordination deficits after mild traumatic brain injury and brief hypoxia in mice
  2420. Interleukin-1, neuroinflammation, and Alzheimer’s disease
  2421. Interleukin-10 inhibits neuroinflammation-mediated apoptosis of ventral mesencephalic neurons via JAK-STAT3 pathway
  2422. Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice
  2423. Interleukin-18, from neuroinflammation to Alzheimer’s disease
  2424. INTERLEUKIN-1α AS PLEIOTROPIC BIOMARKER FOR neuroinflammation IN ALZHEIMER’S DISEASE
  2425. Interleukin-1β in neuroinflammation associated to Alzheimer disease
  2426. neuroinflammation_in_Autism/links/5a00c366aca2725286dfb2e0/Interleukin-1b-Interleukin10-Ratio-Produced-by-Monocytes-as-a-Biomarker-of-neuroinflammation-in-Autism.pdf”>Interleukin-1β/interleukin10 ratio produced by monocytes as a biomarker of neuroinflammation in autism
  2427. Interleukin-6 trans-signaling: implications for neuroinflammation and cognitive deficits in the aged
  2428. Interleukin-6: A Marker of neuroinflammation in Glaucoma
  2429. Interleukin-7 is required for CD4+ T cell activation and autoimmune neuroinflammation
  2430. neuroinflammation,_and_secondary.54.aspx”>Interleukin-8, neuroinflammation, and secondary brain injury
  2431. Interleukin‐1: A master regulator of neuroinflammation
  2432. Intermittent fasting attenuates lipopolysaccharide-induced neuroinflammation and memory impairment
  2433. Intermittent low-level lead exposure provokes anxiety, hypertension, autonomic dysfunction and neuroinflammation
  2434. Internalization of particulate delivery systems by activated microglia influenced the therapeutic efficacy of simvastatin repurposing for neuroinflammation
  2435. Interplay between age and neuroinflammation in multiple sclerosis: effects on motor and cognitive functions
  2436. INTERPLAY OF CELLULAR ADAPTIVE IMMUNITY AND INNATE neuroinflammation IN ALZHEIMER’S DISEASE
  2437. Intra-amniotic LPS causes acute neuroinflammation in preterm rhesus macaques
  2438. Intra-and intercellular functions of redoxins during neuroinflammation
  2439. Intracellular delivery of dendrimer-based nanoconjugates for cancer and neuroinflammation
  2440. Intracellular Effectors of Synaptic Dysfunction and neuroinflammation in Alzheimer’s and other Neurodegenerative Diseases
  2441. Intracerebral delivery of brain-derived neurotrophic factor using HyStem®-C hydrogel implants improves functional recovery and reduces neuroinflammation in a rat …
  2442. Intracerebral interleukin-10 injection modulates post-ischemic neuroinflammation: an experimental microarray study
  2443. Intracerebroventricular Aβ-Induced neuroinflammation Alters Peripheral Immune Responses in Rats
  2444. Intracerebroventricular streptozotocin impairs adult neurogenesis and cognitive functions via regulating neuroinflammation and insulin signaling in adult rats
  2445. Intracisternal delivery of NFκB-inducible scAAV2/9 reveals locoregional neuroinflammation induced by systemic kainic acid treatment
  2446. Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves …
  2447. Intracranial electrode implantation produces regional neuroinflammation and memory deficits in rats
  2448. Intracranial injection of LPS in rat as animal model of neuroinflammation
  2449. Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation
  2450. Intranasal delivery for peptide and siRNA to the brain using lipid-based nanocarriers for the treatment of neuroinflammation
  2451. Intranasal delivery of dexamethasone efficiently controls LPS‐induced murine neuroinflammation
  2452. Intranasal delivery of nerve growth factor attenuates neuroinflammation following traumatic brain injury in rats
  2453. Intranasal Exosomes for Treatment of neuroinflammation?: Prospects and Limitations
  2454. Intranasal insulin administration ameliorates streptozotocin (ICV)-induced insulin receptor dysfunction, neuroinflammation, amyloidogenesis, and memory impairment …
  2455. Intranasal insulin treatment alleviates methamphetamine induced anxiety-like behavior and neuroinflammation
  2456. Intranasal Methylprednisolone Effectively Reduces neuroinflammation in Mice With Experimental Autoimmune Encephalitis
  2457. Intranasal MMI-0100 attenuates Aβ1-42-and LPS-induced neuroinflammation and memory impairments via the MK2 signaling pathway
  2458. Intranasal post-cardiac arrest treatment with orexin-A facilitates arousal from coma and ameliorates neuroinflammation
  2459. Intranasally administered pitavastatin ameliorates pentylenetetrazol-induced neuroinflammation, oxidative stress and cognitive dysfunction
  2460. Intraperitoneal inoculation of Sandhoff mouse neonates with an HIV-1 based lentiviral vector exacerbates the attendant neuroinflammation and disease phenotype
  2461. Intrathecal application of the antimicrobial peptide CRAMP reduced mortality and neuroinflammation in an experimental model of pneumococcal meningitis
  2462. Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: equally diverse and compartmentalized, but more mutated, biased and …
  2463. Intrathecal curcumin attenuates pain hypersensitivity and decreases spinal neuroinflammation in rat model of monoarthritis
  2464. Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation
  2465. Intrauterine inflammation induces sex-specific effects on neuroinflammation, white matter, and behavior
  2466. Intravenously infusing the secretome of adipose-derived mesenchymal stem cells ameliorates neuroinflammation and neurological functioning after traumatic brain …
  2467. Intravital correlated microscopy reveals differential macrophage and microglial dynamics during resolution of neuroinflammation
  2468. Intravitreal injection of adenosine A 2A receptor antagonist reduces neuroinflammation, vascular leakage and cell death in the retina of diabetic mice
  2469. Introduction to a special issue on cytokines in neuroinflammation and immunity
  2470. INVESTIGATE THE RELATIONSHIP BETWEEN TAU AND neuroinflammation IN ALZHEIMER’S DISEASE USING PET AND REACTION RATE MODELLING
  2471. Investigating Imaging Biomarkers of neuroinflammation and Neurodegeneration in Rodent Models of Alzheimer’s Disease
  2472. Investigating neuroinflammation and demyelination in the nervous system of Twitcher mice by the use of immunohistochemistry
  2473. Investigating the contribution of astrocytes and neuroinflammation to pathological tau changes in Alzheimer’s disease
  2474. INVESTIGATING THE LINK BETWEEN PATHOLOGICAL TAU ACCUMULATION, neuroinflammation AND BRAIN ATROPHY IN A MODEL OF TAUOPATHY
  2475. Investigating the mechanistic link between neuroinflammation and biometal homeostasis in neurodegenerative diseases
  2476. Investigating the role of the locus coeruleus-noradrenergic system during social stress on neuroinflammation and resulting changes in serotonin
  2477. Investigation into RAGE as a biomarker of the LPS-induced murine model of neuroinflammation
  2478. investigation into the effects of tenilsetam on markers of neuroinflammation in GFAP-IL6 mice
  2479. Investigation of consequences of chronic neuroinflammation in the cerebellum and brainstem regions of young rats
  2480. Investigation of how endoplasmic reticulum stress causes insulin resistance and neuroinflammation
  2481. Investigation of the Effects of Image Signal-to-noise Ratio on TSPO PET Quantification of neuroinflammation
  2482. Investigation of the Nrf2-Mediated inhibition of neuroinflammation by diosgenin
  2483. INVESTIGATION OF THE RELATIONSHIP BETWEEN TAU AND neuroinflammation IN ALZHEIMER’S DISEASE USING PET AND REACTION MODELLING
  2484. Investigations into the role of 26S proteasome non-ATPase regulatory subunit 13 in neuroinflammation
  2485. Involvement of acute neuroinflammation in postoperative delirium-like cognitive deficits in rats
  2486. Involvement of AMP-activated protein kinase in neuroinflammation and neurodegeneration in the adult and developing brain
  2487. Involvement of bone marrow cells and neuroinflammation in hypertension
  2488. Involvement of early growth response-2 (Egr-2) in lipopolysaccharide-induced neuroinflammation
  2489. INVOLVEMENT OF ELEVATED neuroinflammation IN KEY REGIONS OF THE PAIN PATHWAY IN NOCICEPTIVE PROCESSING IN ALZHEIMER’S DISEASE
  2490. Involvement of neuroinflammation during brain development in social cognitive deficits in autism spectrum disorder and schizophrenia
  2491. Involvement of neuroinflammation in models of neurodegeneration
  2492. Involvement of neuroinflammation in the pathogenesis of monocrotaline-induced pulmonary hypertension
  2493. Involvement of NLRC4 inflammasome through caspase-1 and IL-1β augments neuroinflammation and contributes to memory impairment in an experimental model of …
  2494. Involvement of NMDA receptors in both MPTP-induced neuroinflammation and deficits in episodic-like memory in Wistar rats
  2495. Involvement of NMDA receptors in both MPTP-induced neuroinflammation and deficits in episodic-like memory in Wistar rats
  2496. Involvement of rat hippocampal astrocytes in β-amyloid-induced angiogenesis and neuroinflammation
  2497. Ion Transporters in Microglial Function: New Therapeutic Targets for neuroinflammation in Ischemic Stroke?
  2498. Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation
  2499. Irisin attenuates neuroinflammation and prevents the memory and cognitive deterioration in streptozotocin-induced diabetic mice
  2500. Iron, neuroinflammation, and Alzheimer’s disease
  2501. Irradiation of Mouse Brain Leads to neuroinflammation and Delayed Infiltration of Immune Cells: Role of Interleukin-1 and CCR2 Signaling
  2502. Is calprotectin a novel biomarker of neuroinflammation in diabetic periferal neuropathy?
  2503. Is neuroinflammation in the injured spinal cord different than in the brain? Examining intrinsic differences between the brain and spinal cord
  2504. Is neuroinflammation involved in the development of dementia in patients with Parkinson’s disease?
  2505. Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation?
  2506. Ischemia-induced neuroinflammation is associated with disrupted development of oligodendrocyte progenitors in a model of periventricular leukomalacia
  2507. Ischemia-reperfusion injury as a model of activation and resolution of retinal neuroinflammation and vascular permeability
  2508. Isoflurane‑induced postoperative cognitive dysfunction is mediated by hypoxia‑inducible factor‑1α‑dependent neuroinflammation in aged rats
  2509. Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease
  2510. Isolated spinal cord contusion in rats induces chronic brain neuroinflammation, neurodegeneration, and cognitive impairment: Involvement of cell cycle activation
  2511. Isoliquiritigenin attenuates neuroinflammation in traumatic brain injury in young rats
  2512. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic …
  2513. Isorhynchophylline exerts antidepressant-like effects in mice via modulating neuroinflammation and neurotrophins: involvement of the PI3K/Akt/GSK-3β signaling …
  2514. Isothiocyanates are promising compounds against oxidative stress, neuroinflammation and cell death that may benefit neurodegeneration in Parkinson’s disease
  2515. Isovitexin regulates microglia M1/M2 polarization in LPS-induced neuroinflammation via activation of CaMKKβ/AMPK-PGC-1α signaling axis
  2516. Isovitexin-Mediated Regulation of Microglial Polarization in Lipopolysaccharide-Induced neuroinflammation via Activation of the CaMKKβ/AMPK-PGC-1α …
  2517. Itk signals promote neuroinflammation by regulating CD4+ T-cell activation and trafficking
  2518. IκBα deficiency in brain leads to elevated basal neuroinflammation and attenuated response following traumatic brain injury: implications for functional …
  2519. Janus faces of amyloid proteins in neuroinflammation
  2520. Involvement of rat hippocampal astrocytes in β-amyloid-induced angiogenesis and neuroinflammation
  2521. Ion Transporters in Microglial Function: New Therapeutic Targets for neuroinflammation in Ischemic Stroke?
  2522. Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation
  2523. Irisin attenuates neuroinflammation and prevents the memory and cognitive deterioration in streptozotocin-induced diabetic mice
  2524. Iron, neuroinflammation, and Alzheimer’s disease
  2525. Irradiation of Mouse Brain Leads to neuroinflammation and Delayed Infiltration of Immune Cells: Role of Interleukin-1 and CCR2 Signaling
  2526. Is calprotectin a novel biomarker of neuroinflammation in diabetic periferal neuropathy?
  2527. Is neuroinflammation in the injured spinal cord different than in the brain? Examining intrinsic differences between the brain and spinal cord
  2528. Is neuroinflammation involved in the development of dementia in patients with Parkinson’s disease?
  2529. Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation?
  2530. Ischemia-induced neuroinflammation is associated with disrupted development of oligodendrocyte progenitors in a model of periventricular leukomalacia
  2531. Ischemia-reperfusion injury as a model of activation and resolution of retinal neuroinflammation and vascular permeability
  2532. Isoflurane‑induced postoperative cognitive dysfunction is mediated by hypoxia‑inducible factor‑1α‑dependent neuroinflammation in aged rats
  2533. Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease
  2534. Isolated spinal cord contusion in rats induces chronic brain neuroinflammation, neurodegeneration, and cognitive impairment: Involvement of cell cycle activation
  2535. Isoliquiritigenin attenuates neuroinflammation in traumatic brain injury in young rats
  2536. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic …
  2537. Isorhynchophylline exerts antidepressant-like effects in mice via modulating neuroinflammation and neurotrophins: involvement of the PI3K/Akt/GSK-3β signaling …
  2538. Isothiocyanates are promising compounds against oxidative stress, neuroinflammation and cell death that may benefit neurodegeneration in Parkinson’s disease
  2539. Isovitexin regulates microglia M1/M2 polarization in LPS-induced neuroinflammation via activation of CaMKKβ/AMPK-PGC-1α signaling axis
  2540. Isovitexin-Mediated Regulation of Microglial Polarization in Lipopolysaccharide-Induced neuroinflammation via Activation of the CaMKKβ/AMPK-PGC-1α …
  2541. Itk signals promote neuroinflammation by regulating CD4+ T-cell activation and trafficking
  2542. IκBα deficiency in brain leads to elevated basal neuroinflammation and attenuated response following traumatic brain injury: implications for functional …
  2543. Janus faces of amyloid proteins in neuroinflammation
  2544. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-175″>JNK signaling is the shared pathway linking neuroinflammation, blood–brain barrier disruption, and oligodendroglial apoptosis in the white matter injury of the …
  2545. JNK signaling pathway regulates the process of neuroinflammation and apoptosis of nigral cells in the MPTP mouse model of subacute Parkinson′ s disease [J]
  2546. JNK-IN-8, a c-Jun N-terminal kinase inhibitor, improves functional recovery through suppressing neuroinflammation in ischemic stroke
  2547. JNK‐IN‐8, ac‐Jun N‐terminal kinase inhibitor, improves functional recovery through suppressing neuroinflammation in ischemic stroke
  2548. JSH‐23 targets nuclear factor‐kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence
  2549. Juglanin ameliorates LPS-induced neuroinflammation in animal models of Parkinson’s disease and cell culture via inactivating TLR4/NF-κB pathway
  2550. Juglone prevents metabolic endotoxemia-induced hepatitis and neuroinflammation via suppressing TLR4/NF-κB signaling pathway in high-fat diet rats
  2551. Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation
  2552. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1269-3″>K284-6111 prevents the amyloid beta-induced neuroinflammation and impairment of recognition memory through inhibition of NF-κB-mediated CHI3L1 …
  2553. Kaempferol acts through mitogen‐activated protein kinases and protein kinase B/AKT to elicit protection in a model of neuroinflammation in BV2 microglial cells
  2554. Kaempferol alleviates LPS-induced neuroinflammation and BBB dysfunction in mice via inhibiting HMGB1 release and down-regulating TLR4/MyD88 pathway
  2555. Kaempferol attenuates cognitive deficit via regulating oxidative stress and neuroinflammation in an ovariectomized rat model of sporadic dementia
  2556. Kaempferol attenuates LPS-induced striatum injury in mice involving anti-neuroinflammation, maintaining BBB integrity, and down-regulating the HMGB1 …
  2557. Kaempferol attenuates neuroinflammation and blood brain barrier dysfunction to improve neurological deficits in cerebral ischemia/reperfusion rats
  2558. KCa3. 1 deficiency attenuates neuroinflammation by regulating an astrocyte phenotype switch involving the PI3K/AKT/GSK3β pathway
  2559. Ketamine-mediated alleviation of electroconvulsive shock-induced memory impairment is associated with the regulation of neuroinflammation and soluble amyloid …
  2560. Ketogenic diet-induced peroxisome proliferator-activated receptor-γ activation decreases neuroinflammation in the mouse hippocampus after kainic acid-induced …
  2561. Kinetics of the neuroinflammation-oxidative stress correlation in rat brain following the injection of fibrillar amyloid-β onto the hippocampus in vivo
  2562. Kinin B1 Receptor Blockade Prevents Angiotensin II-induced neuroinflammation and Oxidative Stress in Primary Hypothalamic Neurons
  2563. Kinins and microglial responses in bipolar disorder: a neuroinflammation hypothesis
  2564. Kinins and neuroinflammation: dual effect on prostaglandin synthesis
  2565. Knockdown of cathepsin D protects dopaminergic neurons against neuroinflammation‐mediated neurotoxicity through inhibition of NF‐κB signalling pathway in …
  2566. Knockdown of circulating C1 inhibitor induces neurovascular impairment, glial cell activation, neuroinflammation, and behavioral deficits
  2567. Knockdown of endogenous circulating C1 inhibitor induces neurovascular impairment, neuroinflammation and cognitive decline
  2568. Knockdown of hippocampal cysteinyl leukotriene receptor 1 prevents depressive behavior and neuroinflammation induced by chronic mild stress in mice
  2569. Knockdown of interleukin-1 receptor type-1 on endothelial cells attenuated stress-induced neuroinflammation and prevented anxiety-like behavior
  2570. Korean Red Ginseng alleviates neuroinflammation and promotes cell survival in the intermittent heat stress-induced rat brain by suppressing oxidative stress …
  2571. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0876-8″>Kososan, a Kampo medicine, prevents a social avoidance behavior and attenuates neuroinflammation in socially defeated mice
  2572. Koumine decreases astrocyte-mediated neuroinflammation and enhances autophagy, contributing to neuropathic pain from chronic constriction injury in rats
  2573. Krabbe disease: cytototicity and neuroinflammation
  2574. KRICT-9 inhibits neuroinflammation, amyloidogenesis and memory loss in Alzheimer’s disease models
  2575. Krüppel-like factor 4 regulates amyloid-β (Aβ)-induced neuroinflammation in Alzheimer’s disease
  2576. Krüppel-like factor 4, a novel transcription factor regulates microglial activation and subsequent neuroinflammation
  2577. Kukoamine A prevents radiation-induced neuroinflammation and preserves hippocampal neurogenesis in rats by inhibiting activation of NF-κB and AP-1
  2578. Kynurenine pathway metabolic balance influences microglia activity: targeting kynurenine monooxygenase to dampen neuroinflammation
  2579. Kynurenines, gender and neuroinflammation; showcase schizophrenia
  2580. L-8 is a key mediator of neuroinflammation in severe traumatic brain injuries
  2581. L-F001, a novel multifunctional ROCK inhibitor, suppresses neuroinflammation in vitro and in vivo: involvement of NF-κB inhibition and Nrf2 pathway activation
  2582. l‐DOPA‐induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?
  2583. l‐DOPA‐induced dyskinesia in Parkinson’s disease: Are neuroinflammation and astrocytes key elements?
  2584. Lack of chronic neuroinflammation in the absence of focal hemorrhage in a rat model of low-energy blast-induced TBI
  2585. Lack of Galectin-3 attenuates neuroinflammation and protects the retina and optic nerve of diabetic mice
  2586. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0390-9″>Lack of neuroinflammation in the HIV-1 transgenic rat: an [18 F]-DPA714 PET imaging study
  2587. Lack of Rhes increases MDMA-induced neuroinflammation and dopamine neuron degeneration: Role of gender and age
  2588. neuroinflammation-and-memory-impairment-in-vitro-and-in-vivo/28B25A5C3FE4186AC8F34EAED7C68458″>Lactobacilli-fermented cow’s milk attenuated lipopolysaccharide-induced neuroinflammation and memory impairment in vitro and in vivo
  2589. Lanthionine ketimine ester promotes locomotor recovery after spinal cord injury by reducing neuroinflammation and promoting axon growth
  2590. Laser Moxibustion Alleviates Knee Osteoarthritis Pain by Inhibiting Spinal Microglial Activation-Mediated neuroinflammation in Rats
  2591. Late aging–associated increases in L-DOPA–induced dyskinesia are accompanied by heightened neuroinflammation in the hemi-parkinsonian rat
  2592. Late anxiety-like behavior and neuroinflammation in mice subjected to sublethal polymicrobial sepsis
  2593. Late exercise reduces neuroinflammation and cognitive dysfunction after traumatic brain injury
  2594. Lateral cerebellar nucleus stimulation promotes motor recovery and suppresses neuroinflammation in a fluid percussion injury rodent model
  2595. Lateral fluid percussion brain injury in the mouse: regional and temporal characterization of neuroinflammation
  2596. Leishmania infection and neuroinflammation: Specific chemokine profile and absence of parasites in the brain of naturally-infected dogs
  2597. Lentivirus infection causes neuroinflammation and neuronal injury in dorsal root ganglia: pathogenic effects of STAT-1 and inducible nitric oxide synthase
  2598. Lentivirus-mediated downregulation of α-synuclein reduces neuroinflammation and promotes functional recovery in rats with spinal cord injury
  2599. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1117-5″>Lentivirus-mediated overexpression of OTULIN ameliorates microglia activation and neuroinflammation by depressing the activation of the NF-κB signaling …
  2600. Leonurine exerts antidepressant-like effects in the chronic mild stress-induced depression model in mice by inhibiting neuroinflammation
  2601. Leonurine suppresses neuroinflammation through promoting oligodendrocyte maturation
  2602. Leptin, neuroinflammation and obesity
  2603. Less estrogen, more neuroinflammation
  2604. Letter to the Editor. Impaired glymphatic pathway as potential contributing factor in amyloid beta accumulation and enhanced neuroinflammation after IVH
  2605. Leucine rich repeats and calponin homology domain containing 1 inhibits microglia-mediated neuroinflammation in a rat traumatic spinal cord injury model
  2606. Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders
  2607. Leukotriene-mediated neuroinflammation, toxic brain damage, and neurodegeneration in acute methanol poisoning
  2608. neuroinflammation_in_Disease_Development/links/5e30390a92851c7f7f05efb9/Lichen-Planus-Sparing-the-Extremity-Affected-by-Poliomyelitis-The-Profound-Role-of-neuroinflammation-in-Disease-Development.pdf”>Lichen Planus Sparing the Extremity Affected by Poliomyelitis: The Profound Role of neuroinflammation in Disease Development
  2609. Licofelone modulates neuroinflammation and attenuates mechanical hypersensitivity in the chronic phase of spinal cord injury
  2610. Lidocaine alleviates morphine tolerance via AMPK-SOCS3-dependent neuroinflammation suppression in the spinal cord
  2611. Lidocaine injection into the rat dorsal root ganglion causes neuroinflammation
  2612. Ligustilide ameliorates neuroinflammation and brain injury in focal cerebral ischemia/reperfusion rats: involvement of inhibition of TLR4/peroxiredoxin 6 signaling
  2613. Limiting Autoimmune neuroinflammation using Novel T Cell Suppressants & Investigating Overlapping Lysosomal Reductase Function in Macrophages and …
  2614. LIMITING FACTORS IN SELF-PACED EXERCISE TOLERANCE-THE ROLE OF neuroinflammation AND CENTRAL SENSITISATION
  2615. lincRNA-Cox2 regulates NLRP3 inflammasome and autophagy mediated neuroinflammation
  2616. Linking Gut Dysbiosis and neuroinflammation Observed in Individuals with Autism Spectrum Disorder and Possible Treatment with Bacteroides Fragilis
  2617. Linking neuroinflammation and Glial Phenotypic Changes in Neurological Diseases
  2618. Linking neuroinflammation and neurodegeneration in Parkinson’s disease
  2619. Lipid dynamics in LPS-induced neuroinflammation by DESI-MS imaging
  2620. Lipid metabolism and neuroinflammation in Alzheimer’s disease: a role for liver X receptors
  2621. Lipid rafts in glial cells: Role in neuroinflammation and pain processing
  2622. Lipid-core nanocapsules improve the effects of resveratrol against Aβ-induced neuroinflammation
  2623. Lipocalin-2 deficiency attenuates neuroinflammation and brain injury after transient middle cerebral artery occlusion in mice
  2624. Lipocalin-2: a new regulator of nonpathogen-associated neuroinflammation
  2625. Lipolysaccharide-induced neuroinflammation is associated with Alzheimer-like amyloidogenic axonal pathology and dendritic degeneration in rats
  2626. Lipopolysaccharide induces neuroinflammation in microglia by activating the MTOR pathway and downregulating Vps34 to inhibit autophagosome formation
  2627. Lipopolysaccharide preconditioning reduces neuroinflammation against hypoxic ischemia and provides long-term outcome of neuroprotection in neonatal rat
  2628. Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular …
  2629. neuroinflammation_leads_to_the_accumulation_of_ubiquitinated_proteins_and_increases_susceptibility_to_neurodegeneration_induced_by_proteasome_inhibition_in_rat_hippocampus/links/09e41506554324c6f5000000.pdf”>Lipopolysaccharide-induced neuroinflammation
  2630. Lipopolysaccharide-induced neuroinflammation as a bridge to understand neurodegeneration
  2631. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1490-8″>Lipopolysaccharide-induced neuroinflammation induces presynaptic disruption through a direct action on brain tissue involving microglia-derived interleukin …
  2632. Lipopolysaccharide-induced neuroinflammation leads to the accumulation of ubiquitinated proteins and increases susceptibility to neurodegeneration …
  2633. Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid β peptide in APPswe transgenic mice
  2634. Lipopolysacharide-induced neuroinflammation leads to the accumulation of ubiquitinated proteins and increases susceptibility to neurodegeneration induced …
  2635. Lipotoxicity, neuroinflammation, glial cells and oestrogenic compounds
  2636. Lipotoxicity, neuroinflammation, glial cells and oestrogenic compounds
  2637. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0540-8″>Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection
  2638. Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury
  2639. Lithium and memantine improve spatial memory impairment and neuroinflammation induced by β-amyloid 1-42 oligomers in rats
  2640. Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation
  2641. Live imaging of neuroinflammation reveals sex and estrogen effects on astrocyte response to ischemic injury
  2642. Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse
  2643. Liver X Receptor α Is Involved in Counteracting Mechanical Allodynia by Inhibiting neuroinflammation in the Spinal Dorsal Horn
  2644. Liver X receptors activation decreases neuroinflammation in Parkinson’s disease (846.5)
  2645. Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson’s disease
  2646. Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer’s disease
  2647. Lnhibitory effects of hua feng dan on microglia-mediated neuroinflammation
  2648. Loading into nanoparticles improves quercetin’s efficacy in preventing neuroinflammation induced by oxysterols
  2649. Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury
  2650. Local neuroinflammation and the progression of Alzheimer’s disease
  2651. Localized calcium accumulations prime synapses for phagocyte removal in cortical neuroinflammation
  2652. Locus coeruleus neurons are most sensitive to chronic neuroinflammation-induced neurodegeneration
  2653. Long Non-coding RNA MALAT1 Inhibits Neuron Apoptosis and neuroinflammation While Stimulates Neurite Outgrowth and Its Correlation With MiR-125b Mediates …
  2654. Long noncoding RNA H19 promotes neuroinflammation in ischemic stroke by driving histone deacetylase 1–dependent M1 microglial polarization
  2655. Long noncoding RNA SNHG1 promotes neuroinflammation in Parkinson’s disease via regulating miR-7/NLRP3 pathway
  2656. Long-term administration of melatonin attenuates neuroinflammation in the aged mouse brain
  2657. Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate …
  2658. Long-term dietary supplementation of pomegranates, figs and dates alleviate neuroinflammation in a transgenic mouse model of Alzheimer’s disease
  2659. Long-term impact of intrauterine neuroinflammation and treatment with magnesium sulphate and betamethasone: Sex-specific differences in a preterm labor …
  2660. Long-term neuroinflammation induced by influenza A virus infection and the impact on hippocampal neuron morphology and function
  2661. Long-term pain, neuroinflammation and glial activation
  2662. Long-term voluntary wheel running does not alter vascular amyloid burden but reduces neuroinflammation in the Tg-SwDI mouse model of cerebral amyloid …
  2663. Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6‐hydroxydopamine rat model of Parkinson’s disease
  2664. Longitudinal investigation of neuroinflammation and metabolite profiles in the APPswe×PS1Δe9 transgenic mouse model of Alzheimer’s disease
  2665. Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer’s disease enabled by positron …
  2666. Loss of brain norepinephrine elicits neuroinflammation-mediated oxidative injury and selective caudo-rostral neurodegeneration
  2667. Loss of function due to neuroinflammation: A role for oxygen therapy?
  2668. Loss of G as6 and A xl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone …
  2669. Loss of IGF1R from oligodendrocytes ameliorates neuroinflammation without affecting cell survival
  2670. Loss of microglial parkin inhibits necroptosis and contributes to neuroinflammation
  2671. Loss of PAFR prevents neuroinflammation and brain dysfunction after traumatic brain injury
  2672. Loss of tissue-nonspecific alkaline phosphatase (TNAP) enzyme activity in cerebral microvessels is coupled to persistent neuroinflammation and behavioral deficits in …
  2673. Low avidity CD8+ T cells in viral infection: From neuroinflammation to adoptive T cell therapy
  2674. Low cerebral blood flow is a non-invasive biomarker of neuroinflammation after repetitive mild traumatic brain injury
  2675. Low sucrose, omega-3 enriched diet has region-specific effects on neuroinflammation and synaptic function markers in a mouse model of doxorubicin-based …
  2676. Low-density lipoprotein receptor deficiency attenuates neuroinflammation through the induction of apolipoprotein E
  2677. Low-dose NSAIDs reduce pain via macrophage targeted nanoemulsion delivery to neuroinflammation of the sciatic nerve in rat
  2678. Low-Dose Subcutaneous Anti-CD20 Treatment Depletes Disease Relevant B Cell Subsets and Attenuates neuroinflammation
  2679. Low-grade neuroinflammation due to chronic sleep deprivation results in anxiety and learning and memory impairments
  2680. Low-intensity pulsed ultrasound attenuates LPS-induced neuroinflammation and memory impairment by modulation of TLR4/NF-κB signaling and CREB/BDNF …
  2681. Low-level primary blast induces neuroinflammation and neurodegeneration in rats
  2682. Low-Molecular Weight Metabolites from Polyphenols as Effectors for Attenuating neuroinflammation
  2683. Low, but not high, dose triptolide controls neuroinflammation and improves behavioral deficits in toxic model of multiple sclerosis by dampening of NF-κB activation …
  2684. LPS and neuroinflammation: a matter of timing
  2685. LPS induces mediators of neuroinflammation, cell proliferation, and GFAP expression in human astrocytoma cells U373MG: the anti-inflammatory and anti-proliferative …
  2686. LPS-induced murine neuroinflammation model: main features and suitability for pre-clinical assessment of nutraceuticals
  2687. LPS-induced proNGF synthesis and release in the N9 and BV2 microglial cells: a new pathway underling microglial toxicity in neuroinflammation
  2688. LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
  2689. LRRK2 kinase activity induces mitochondrial fission in microglia via Drp1 and modulates neuroinflammation
  2690. LRRK2 regulates innate immune responses and neuroinflammation during Mycobacterium tuberculosis infection
  2691. Lumbar nerve root injury induces central nervous system neuroimmune activation and neuroinflammation in the rat: relationship to painful radiculopathy
  2692. Lupeol inhibits LPS-induced neuroinflammation in cerebellar cultures and induces neuroprotection associated to the modulation of astrocyte response and expression …
  2693. Luteolin could improve cognitive dysfunction by inhibiting neuroinflammation
  2694. Luteolin reduces primary hippocampal neurons death induced by neuroinflammation
  2695. Luteoloside attenuates neuroinflammation in focal cerebral ischemia in rats via regulation of the PPARγ/Nrf2/NF-κB signaling pathway
  2696. LW-AFC Attenuates LPS-Induced neuroinflammation via Inhibiting Nuclear Factor-Kappa B Signaling
  2697. Lychee seed fraction inhibits Aβ (1-42)-induced neuroinflammation in BV-2 cells via NF-κB signaling pathway
  2698. Lycopene attenuates insulin signaling deficits, oxidative stress, neuroinflammation, and cognitive impairment in fructose-drinking insulin resistant rats
  2699. Lycopene supplementation attenuates oxidative stress, neuroinflammation, and cognitive impairment in aged CD-1 mice
  2700. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and neuroinflammation in a Rat Model of Parkinson’s Disease
  2701. Lymphatic Drainage of the CNS and Its Role in neuroinflammation and Neurodegenerative Disease
  2702. Lymphoid chemokines in chronic neuroinflammation
  2703. Lysosomal Dysfunction in Brain Aging and Neurodegeneration: Roles in Trophic Signaling and neuroinflammation
  2704. Macranthol attenuates lipopolysaccharide-induced depressive-like behaviors by inhibiting neuroinflammation in prefrontal cortex
  2705. Macrophage galactose-type lectin (MGL) is induced on M2 microglia and participates in the resolution phase of autoimmune neuroinflammation
  2706. Macrophage migration inhibitory factor (MIF) decreases neuroinflammation in the solitary tract nucleus (NTS) of spontaneously hypertensive rats (SHR).
  2707. Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation
  2708. Macrophage migration inhibitory factor promotes central nervous system pathology in a model of neuroinflammation (35.8)
  2709. Macrophage-derived extracellular succinate licenses neural stem cells to suppress chronic neuroinflammation
  2710. Macrophage-inducible C-type lectin/spleen tyrosine kinase signaling pathway contributes to neuroinflammation after subarachnoid hemorrhage in rats
  2711. Macrophages in neuroinflammation: role of the renin-angiotensin-system
  2712. Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation
  2713. Magnesium ion influx reduces neuroinflammation in Aβ precursor protein/Presenilin 1 transgenic mice by suppressing the expression of interleukin-1β
  2714. Magnesium lithospermate B suppresses lipopolysaccharide-induced neuroinflammation in BV2 microglial cells and attenuates neurodegeneration in …
  2715. Magnesium sulfate attenuates brain edema by lowering AQP4 expression and inhibits glia-mediated neuroinflammation in a rodent model of eclampsia
  2716. Magnesium sulfate provides neuroprotection in eclampsia-like seizure model by ameliorating neuroinflammation and brain edema
  2717. Magnesium sulfate treatment reverses seizure susceptibility and decreases neuroinflammation in a rat model of severe preeclampsia
  2718. Magnetic resonance imaging as a tool to image neuroinflammation in a rat model of P arkinson’s disease–phagocyte influx to the brain is promoted by bilberry …
  2719. Magnetic resonance imaging of glutamate in neuroinflammation
  2720. neuroinflammation_in.98491.aspx”>Magnetic resonance imaging of neuroinflammation in chronic pain: a role for astrogliosis?
  2721. Magnetic resonance molecular imaging of post‐stroke neuroinflammation with a P‐selectin targeted iron oxide nanoparticle
  2722. Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain
  2723. Magnolol abrogates chronic mild stress-induced depressive-like behaviors by inhibiting neuroinflammation and oxidative stress in the prefrontal cortex of mice
  2724. Mammary tumor and mastectomy synergistically promote neuroinflammation in a breast cancer survivor model
  2725. Mammary tumors induce neuroinflammation, but not behavioral deficits in Balb/C mice
  2726. Management of glia-mediated neuroinflammation and related patents
  2727. Manganese Exposure Induces neuroinflammation by Impairing Mitochondrial Dynamics in Astrocytes
  2728. Manganese exposure induces neuroinflammation by impairing mitochondrial dynamics in astrocytes
  2729. Manganese induces neuroinflammation via NF-κB/ROS NLRP3 pathway in rat brain striatum and HAPI cells
  2730. Manganese-induced neurotoxicity: new insights into protein misfolding, mitochondrial impairment and neuroinflammation
  2731. Manipulation of the Gut Microbiome: Influencing alcohol-induced neuroinflammation
  2732. neuroinflammation&ots=Nt1EPelELO&sig=3Pzjub43OxKfSGyj7YK64lYrFXc”>Many causes of delirium have been proposed, including neuroinflammation, neuronal aging, oxidative stress, neurotransmitter deficiency, neuroendocrinopathy …
  2733. MAPK-activated protein kinase 2 (MK2) in neuroinflammation, Hsp27 phosphorylation and cell cycle: Role and Targeting
  2734. MAPKAP kinase 2‐deficiency prevents neurons from cell death by reducing neuroinflammation–relevance in a mouse model of Parkinson’s disease
  2735. Mapping neuroinflammation in frontotemporal dementia with molecular PET imaging
  2736. Mapping neuroinflammation in vivo in healthy aging and Alzheimer’s disease: A PET study using a novel translocator protein 18kDA (TSPO) radioligand,[18F]-FEPPA
  2737. Maresin 1 attenuates neuroinflammation in a mouse model of perioperative neurocognitive disorders
  2738. Marine pharmacology: therapeutic targeting of matrix metalloproteinases in neuroinflammation
  2739. Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes
  2740. Markers of neuroinflammation associated with Alzheimer’s disease pathology in older adults
  2741. Markers of neuroinflammation influence measures of cortical thickness in bipolar depression
  2742. Mast cell–glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide
  2743. Mast cells and neuroinflammation
  2744. Mast Cells Augment neuroinflammation and Neurodegeneration
  2745. Mast cells in neuroinflammation and brain disorders
  2746. neuroinflammation&ots=nzdAElKJQb&sig=JGZ2QVVHUwTbKK_yo7hv77dQ3OM”>Mast Cells in Stress, Pain, Blood-Brain Barrier, neuroinflammation and Alzheimer’s
  2747. Mast cells in stress, pain, blood-brain barrier, neuroinflammation and Alzheimer’s disease
  2748. Mast cells, glia and neuroinflammation: partners in crime?
  2749. Mast Cells, neuroinflammation and Pain in Fibromyalgia Syndrome
  2750. Matairesinol suppresses neuroinflammation and migration associated with Src and ERK1/2-NF-κB pathway in activating BV2 microglia
  2751. Maternal alcohol binge drinking induces persistent neuroinflammation associated with myelin damage and behavioural dysfunctions in offspring mice
  2752. Maternal immune activation in late gestation increases neuroinflammation and aggravates experimental autoimmune encephalomyelitis in the offspring
  2753. Maternal immune activation increases neuroinflammation and aggravates EAE in adult offspring
  2754. Maternal separation induces neuroinflammation and long-lasting emotional alterations in mice
  2755. Matrine ameliorates anxiety and depression-like behaviour by targeting hyperammonemia-induced neuroinflammation and oxidative stress in CCl4 model of liver …
  2756. Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegeneration
  2757. Matrix metalloproteinase 9 in epilepsy: the role of neuroinflammation in seizure development
  2758. Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice
  2759. MATRIX METALLOPROTEINASE-12 ACTIVITY IN A NEUROPATHIC PAIN RODENT MODEL: IMPACT ON neuroinflammation RESPONSE: 29
  2760. Matrix metalloproteinase-12 contributes to neuroinflammation in the aged brain
  2761. Matrix metalloproteinase-8 plays a pivotal role in neuroinflammation by modulating TNF-α activation
  2762. Matrix metalloproteinase-mediated neuroinflammation in vascular cognitive impairment of the Binswanger type
  2763. Matrix metalloproteinases and neuroinflammation in multiple sclerosis
  2764. Matrix metalloproteinases and proteolytic opening of the blood-brain barrier in neuroinflammation
  2765. Matrix metalloproteinases in neuroinflammation
  2766. Matrix metalloproteinases in neuroinflammation and cerebral ischemia
  2767. MATRIX METALOPROTEINASE INHIBITOR PROTECTS FROM neuroinflammation AND PAIN.
  2768. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1589-y”>MCP1-CCR2 and neuroinflammation in the ALS motor cortex with TDP-43 pathology
  2769. MDA5-Associated neuroinflammation and the Singleton–Merten Syndrome: Two Faces of the Same Type I Interferonopathy Spectrum
  2770. MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex
  2771. Measuring neuroinflammation in hemiparkinsonian rhesus treated with iPSC-derived dopaminergic neuronal grafts using [18F] FEPPA PET
  2772. Mechanism of antrocytic connexin-43 autophagy degradation in oxygen-glucose deprivation and its effect on neuroinflammation
  2773. Mechanism of neuroinflammation: enhanced cytotoxicity and IL-17 production via CD46 binding
  2774. Mechanism of Non-receptor Tyrosine Kinase Src Regulating neuroinflammation Through Phosphatase and Tensin Homology Protein in Microglia.
  2775. Mechanisms and implications of regional sensitivity to neuroinflammation: in vivo and in vitro studies
  2776. Mechanisms behind T cell-mediated neuroinflammation
  2777. Mechanisms of dietary flavonoid action in neuronal function and neuroinflammation
  2778. Mechanisms of glucocorticoids in the control of neuroinflammation
  2779. neuroinflammation&ots=hOgZ6fNOSU&sig=tGJiamClvtlXoR8-6YkxDiivlFM”>Mechanisms of neuroinflammation
  2780. Mechanisms of neuroinflammation and inflammatory mediators involved in brain injury following subarachnoid hemorrhage.
  2781. Mechanisms of neuroinflammation and inflammatory neurodegeneration in acute brain injury
  2782. Mechanisms of stress-dependent neuroinflammation and their implications for understanding consequences of alcohol exposure
  2783. Mechanisms of Synaptic Alterations in a neuroinflammation Model of Autism
  2784. Mechanisms to prevent the toxicity of chronic neuroinflammation on forebrain cholinergic neurons
  2785. Mechanisms underlying select chemotherapeutic-agent-induced neuroinflammation and subsequent neurodegeneration
  2786. Mediators of neuroinflammation
  2787. Mediators of neuroinflammation
  2788. Mediators of neuroinflammation
  2789. Medicinal Chemistry: ARTICLE; Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation
  2790. Melanoma-secreted Amyloid Beta Supresses neuroinflammation and Promotes Brain Metastasis
  2791. Melastatin-related transient receptor potential 2 channel in Aβ42-induced neuroinflammation: implications to Alzheimer’s disease mechanism and …
  2792. Melatonin and oestrogen treatments were able to improve neuroinflammation and apoptotic processes in dentate gyrus of old ovariectomized female rats
  2793. Melatonin and Rapamycin Attenuate Isoflurane-Induced Cognitive Impairment Through Inhibition of neuroinflammation by Suppressing the mTOR Signaling …
  2794. Melatonin attenuated mediators of neuroinflammation and alpha-7 nicotinic acetylcholine receptor mRNA expression in lipopolysaccharide (LPS) stimulated rat …
  2795. Melatonin attenuates D‐galactose‐induced memory impairment, neuroinflammation and neurodegeneration via RAGE/NF‐KB/JNK signaling pathway in aging …
  2796. Melatonin attenuates methamphetamine-induced neuroinflammation through the melatonin receptor in the SH-SY5Y cell line
  2797. Melatonin attenuates pain hypersensitivity and decreases astrocyte-mediated spinal neuroinflammation in a rat model of oxaliplatin-induced pain
  2798. Melatonin inhibits neuronal dysfunction‐associated with neuroinflammation by atopic psychological stress in NC/Nga atopic‐like mouse models
  2799. Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF‐κB and Nrf2 cascades
  2800. Melatonin protects methamphetamine-induced neuroinflammation through NF-κB and Nrf2 pathways in glioma cell line
  2801. Melatonin reduced microglial activation and alleviated neuroinflammation induced neuron degeneration in experimental traumatic brain injury: possible involvement …
  2802. Melatonin regulates neuroinflammation ischemic stroke damage through interactions with microglia in reperfusion phase
  2803. Melatonin rescue oxidative stress-mediated neuroinflammation/neurodegeneration and memory impairment in scopolamine-induced amnesia mice model
  2804. Meloxicam blocks neuroinflammation, but not depressive-like behaviors, in HIV-1 transgenic female rats
  2805. Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat
  2806. Membrane damage induced by amyloid beta and a potential link with neuroinflammation
  2807. Menin deficiency leads to depressive-like behaviors in mice by modulating astrocyte-mediated neuroinflammation
  2808. Meningeal Lymphatic Network: the Middleman of neuroinflammation
  2809. Meningeal lymphatics, immunity and neuroinflammation
  2810. Mesenchymal Stem Cell Derived Exosomes as a Mediator of neuroinflammation and Neuronal Damage Following Cortical Injury
  2811. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the …
  2812. Mesenchymal stem cell transplantation modulates neuroinflammation in focal cerebral ischemia: contribution of fractalkine and IL-5
  2813. Mesenchymal stem cell-conditioned medium triggers neuroinflammation and reactive species generation in organotypic cultures of rat hippocampus
  2814. Mesenchymal stem cells alleviate Japanese encephalitis virus-induced neuroinflammation and mortality
  2815. Mesenchymal stem cells enhance microglia M2 polarization and attenuate neuroinflammation through TSG-6
  2816. Mesenchymal stem cells transplantation delays functional deterioration by inhibiting neuroinflammation response in aged mice.
  2817. Mesenchymal stem cells transplantation delays functional deteriorationby inhibiting neuroinflammation response in aged mice
  2818. Mesuagenin C mitigated LPS-induced neuroinflammation in BV-2 and NG108-15 cells through pMTOR-PI3K-Akt and ccl21 downregulation
  2819. Metabolic control of glia-mediated neuroinflammation
  2820. Metabolic endotoxemia promotes neuroinflammation after focal cerebral ischemia
  2821. Metabolomic signatures in peripheral blood associated with Alzheimer’s disease amyloid-β-induced neuroinflammation
  2822. Metabotropic glutamate receptor 5 ablation accelerates age-related neurodegeneration and neuroinflammation
  2823. Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients
  2824. Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation
  2825. Metal toxicity links to alzheimer’s disease and neuroinflammation
  2826. Metalloprotease Adam10 suppresses epilepsy through repression of hippocampal neuroinflammation
  2827. Metalloproteinases in neuroinflammation
  2828. Metallothionein and neuroinflammation
  2829. Metals and neuroinflammation
  2830. Metformin ameliorates sepsis-induced brain injury by inhibiting apoptosis, oxidative stress and neuroinflammation via the PI3K/Akt signaling pathway
  2831. Metformin attenuates neurological deficit after intracerebral hemorrhage by inhibiting apoptosis, oxidative stress and neuroinflammation in rats
  2832. Metformin reduces morphine tolerance by inhibiting microglial-mediated neuroinflammation
  2833. METH-induced neurotoxicity is alleviated by lactulose pretreatment through suppressing oxidative stress and neuroinflammation in rat striatum
  2834. Methadone diminishes neuroinflammation and disease severity in EAE through modulating T cell function
  2835. Methamphetamine induces neuroinflammation and neuronal dysfunction in the mice hippocampus
  2836. Methamphetamine neurotoxicity, microglia, and neuroinflammation
  2837. Methamphetamine-induced neuroinflammation and Neurotoxicity: a Role for Interleukin-1β
  2838. Methamphetamine‐induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin
  2839. Methionine Sulfoxide Reductase A Negatively Controls Microglia-Mediated neuroinflammation via Inhibiting ROS/MAPKs/NF-κB Signaling Pathways Through a …
  2840. Method of Passsive Immunization Against Disease or Disorder Charcterized by Amyloid Aggregation with Diminished Risk of neuroinflammation
  2841. Methods to assess neuroinflammation
  2842. Methyl jasmonate attenuates memory dysfunction and decreases brain levels of biomarkers of neuroinflammation induced by lipopolysaccharide in mice
  2843. Methylene blue attenuates neuroinflammation after subarachnoid hemorrhage in rats through the Akt/GSK-3β/MEF2D signaling pathway
  2844. Methylene blue attenuates traumatic brain injury-associated neuroinflammation and acute depressive-like behavior in mice
  2845. Methylene Blue Infusion for Treatment of Traumatic Brain Injury-associated neuroinflammation
  2846. Methylene blue inhibits Caspase-6 activity, and reverses Caspase-6-induced cognitive impairment and neuroinflammation in aged mice
  2847. Methylene blue mitigates acute neuroinflammation after spinal cord injury through inhibiting NLRP3 inflammasome activation in microglia
  2848. Methylene Blue Reduced Brain Edema, neuroinflammation, and Behavioral Deficits associated with a Moderate Traumatic Brain Injury
  2849. Methylene Blue: A Novel Disease-modifying Drug for neuroinflammation in Parkinson’s Disease
  2850. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-135″>Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors?
  2851. Mevalonate kinase deficiency and neuroinflammation: balance between apoptosis and pyroptosis
  2852. MFG-E8 mediates primary phagocytosis of viable neurons during neuroinflammation
  2853. MG17, A Novel Triazole Derivative Abrogated neuroinflammation and Related Neurodegenerative Symptoms in Rodents
  2854. MG53 attenuates lipopolysaccharide-induced neurotoxicity and neuroinflammation via inhibiting TLR4/NF-κB pathway in vitro and in vivo
  2855. Microarray analysis identifies the potential role of long non-coding RNA in regulating neuroinflammation during Japanese encephalitis virus infection
  2856. Microbial Translocation is associated with neuroinflammation in HIV-infected subjects on ART
  2857. Microdose Lithium NP03 Diminishes Pre-Plaque Oxidative Damage and neuroinflammation in a Rat Model of Alzheimer’s-Like Amyloidosis
  2858. Microglia Activated by Excess Cortisol Induce HMGB1 Acetylation and neuroinflammation in the Hippocampal DG Region of Mice Following Cold Exposure
  2859. Microglia and astroglia: the role of neuroinflammation in lead toxicity and neuronal injury in the brain
  2860. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
  2861. Microglia and calcium dysregulation during chronic neuroinflammation and aging: causes and consequences
  2862. Microglia and mast cells: two tracks on the road to neuroinflammation
  2863. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-1-14″>Microglia and neuroinflammation: a pathological perspective
  2864. Microglia contribute to the glia limitans around arteries, capillaries and veins under physiological conditions, in a model of neuroinflammation and in human brain …
  2865. Microglia in neurodegenerative disorders and neuroinflammation
  2866. Microglia Mediated neuroinflammation: Focus on PI3K Modulation
  2867. Microglia modulate Ang II induced neuronal activity and neuroinflammation
  2868. Microglia morphological categorization in a rat model of neuroinflammation by hierarchical cluster and principal components analysis
  2869. Microglia pre-activation and neurodegeneration precipitate neuroinflammation without exacerbating tissue injury in experimental autoimmune …
  2870. Microglia TREM2 is required for electroacupuncture to attenuate neuroinflammation in focal cerebral ischemia/reperfusion rats
  2871. Microglia-Based Phenotypic Screening Identifies a Novel Inhibitor of neuroinflammation Effective in Alzheimer’s Disease Models
  2872. Microglia-dependent presynaptic disruption in an organotypic hippocampal slice culture model of neuroinflammation
  2873. Microglia-mediated neuroinflammation and neurotrophic factor-induced protection in the MPTP mouse model of Parkinson’s disease-lessons from transgenic mice
  2874. Microglia-mediated neuroinflammation in neurodegenerative diseases
  2875. Microglia-mediated neuroinflammation is an amplifier of virus-induced neuropathology
  2876. neuroinflammation_and_Ab_in_Alzheimer’s_disease/links/567f699d08ae051f9ae6761d.pdf”>Microglia, neuroinflammation, and Aβ in Alzheimer’s disease
  2877. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease
  2878. Microglial activation and neuroinflammation in Alzheimer’s disease: a critical examination of recent history
  2879. Microglial activation in neuroinflammation: Implications for the etiology of neurodegeneration
  2880. Microglial activation is not equivalent to neuroinflammation in alcohol-induced neurodegeneration: The importance of microglia phenotype
  2881. Microglial CD14 activated by iNOS contributes to neuroinflammation in cerebral ischemia
  2882. Microglial genes regulating neuroinflammation in the progression of Alzheimer’s disease
  2883. Microglial immunoreceptor tyrosine-based activation and inhibition motif signaling in neuroinflammation
  2884. Microglial inhibitory effect of ginseng ameliorates cognitive deficits and neuroinflammation following traumatic head injury in rats
  2885. Microglial IRF5-IRF4 regulatory axis regulates neuroinflammation after cerebral ischemia and impacts stroke outcomes
  2886. Microglial Kv1. 3, a voltage-gated potassium channel, mediates neuroinflammation and neurodegeneration in cell culture and animal models of Parkinson’s disease
  2887. Microglial LOX-1 reacts with extracellular HSP60 to bridge neuroinflammation and neurotoxicity
  2888. Microglial LOX-1/MAPKs/NF-κB positive loop promotes the vicious cycle of neuroinflammation and neural injury
  2889. Microglial migration and interactions with dendrimer nanoparticles are altered in the presence of neuroinflammation
  2890. Microglial mitophagy mitigates neuroinflammation in Alzheimer’s disease
  2891. Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy
  2892. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0819-4″>Microglial-derived microparticles mediate neuroinflammation after traumatic brain injury
  2893. Microinjection of l-arginine into corpus callosum cause reduction in myelin concentration and neuroinflammation
  2894. MicroRNA 155 and viral-induced neuroinflammation
  2895. MicroRNA let-7c-5p improves neurological outcomes in a murine model of traumatic brain injury by suppressing neuroinflammation and regulating microglial …
  2896. MicroRNA-125b mimic inhibits ischemia reperfusion-induced neuroinflammation and aberrant p53 apoptotic signalling activation through targeting TP53INP1
  2897. MicroRNA-146a protects against cognitive decline induced by surgical trauma by suppressing hippocampal neuroinflammation in mice
  2898. MicroRNA-152 attenuates neuroinflammation in intracerebral hemorrhage by inhibiting thioredoxin interacting protein (TXNIP)-mediated NLRP3 inflammasome …
  2899. MicroRNA-155 negatively affects blood–brain barrier function during neuroinflammation
  2900. MicroRNA-181 variants regulate T cell phenotype in the context of autoimmune neuroinflammation
  2901. MicroRNA-181b-5p attenuates early postoperative cognitive dysfunction by suppressing hippocampal neuroinflammation in mice
  2902. MicroRNA-23b alleviates neuroinflammation and brain injury in intracerebral hemorrhage by targeting inositol polyphosphate multikinase
  2903. MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3
  2904. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease
  2905. MicroRNA‐190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP‐induced Parkinson’s disease mouse model
  2906. MicroRNA‑195 triggers neuroinflammation in Parkinson’s disease in a Rho‑associated kinase 1‑dependent manner
  2907. microRNA‐200b modulates microglia‐mediated neuroinflammation via the cJun/MAPK pathway
  2908. microRNA‐9‐5p alleviates blood‐brain barrier damage and neuroinflammation after traumatic brain injury
  2909. MicroRNAs and the genetic nexus of brain aging, neuroinflammation, neurodegeneration, and brain trauma
  2910. MicroRNAs as novel regulators of neuroinflammation
  2911. MicroRNAs in neuroinflammation: implications in disease pathogenesis, biomarker discovery and therapeutic applications
  2912. MicroRNAs in the brain: it’s regulatory role in neuroinflammation
  2913. MicroRNAs: roles in regulating neuroinflammation
  2914. MICROVESICLES: MESSENGERS AND MEDIATORS OF neuroinflammation
  2915. Midkine is a novel regulator of amphetamine-induced striatal gliosis and cognitive impairment: evidence for a stimulus-dependent regulation of neuroinflammation by …
  2916. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-1002-7″>Mild endoplasmic reticulum stress ameliorates lipopolysaccharide-induced neuroinflammation and cognitive impairment via regulation of microglial …
  2917. Mild Neurocognitive Impairment in HIV Infection Is Associated with neuroinflammation on Positron Emission Tomography (IN3-1.008)
  2918. Mild Neurocognitive Impairment in HIV Infection Is Associated with neuroinflammation on Positron Emission Tomography (S37. 003)
  2919. Mildronate and its neuroregulatory mechanisms: targeting the mitochondria, neuroinflammation, and protein expression
  2920. Mincle/Syk Signaling Pathway Contributes to neuroinflammation after Subarachnoid Hemorrhage in Rats
  2921. Mineralocorticoid receptors, neuroinflammation and hypertensive encephalopathy
  2922. Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder
  2923. Minocycline ameliorates anxiety-related self-grooming behaviors and alters hippocampal neuroinflammation, GABA and serum cholesterol levels in female Sprague …
  2924. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-5-15″>Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia
  2925. Minocycline attenuates neonatal germinal-matrix-hemorrhage-induced neuroinflammation and brain edema by activating cannabinoid receptor 2
  2926. Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE in a transgenic model of Alzheimer’s-like amyloid pathology
  2927. Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer’s disease-like amyloid pathology
  2928. MINOCYCLINE IMPROVES MEMORY AND REDUCES THE neuroinflammation OF MICE SUBJECT TO AMYLOID B (1-42) PEPTIDE ADMINISTRATION
  2929. neuroinflammation_and_enhances_vascular_endothelial_growth_factor_expression_in_a_cerebral_ischemiareperfusion_rat_model/links/567f6d1708aebccc4e05f9e9/Minocycline-inhibits-neuroinflammation-and-enhances-vascular-endothelial-growth-factor-expression-in-a-cerebral-ischemia-reperfusion-rat-model.pdf”>Minocycline inhibits neuroinflammation and enhances vascular endothelial growth factor expression in a cerebral ischemia/reperfusion rat model
  2930. Minocycline modulates neuroinflammation independently of its antimicrobial activity in staphylococcus aureus-induced brain abscess
  2931. Minocycline plus N-acteylcysteine induces remyelination, synergistically protects oligodendrocytes and modifies neuroinflammation in a rat model of mild traumatic …
  2932. Minocycline reduces astrocytic reactivation and neuroinflammation in the hippocampus of a vascular cognitive impairment rat model
  2933. Minocycline reduces neuroinflammation but does not ameliorate neuron loss in a mouse model of neurodegeneration
  2934. miR-140-5p Attenuates neuroinflammation and Brain Injury in Rats Following Intracerebral Hemorrhage by Targeting TLR4
  2935. miR-142-3p is a key regulator of IL-1β-dependent synaptopathy in neuroinflammation
  2936. miR‐194 relieve neuropathic pain and prevent neuroinflammation via targeting FOXA1
  2937. neuroinflammation_AND_APOPTOSIS_ASSOCIATED_WITH_ALZHEIMER’S_DISEASE_IN_EXPERIMENTAL_MODEL/links/544fa8ea0cf26dda08920a14.pdf”>Miracle enzymes serrapeptase and nattokinase mitigate neuroinflammation and apoptosis associated with Alzheimer’s disease in experimental model
  2938. MiRNA-210 induces microglial activation and regulates microglia-mediated neuroinflammation in neonatal hypoxic-ischemic encephalopathy
  2939. miRNA-3473b contributes to neuroinflammation following cerebral ischemia
  2940. Mitigating Role Of Chrysin Loaded Solid Lipid Nanoparticles Against Cognitive Decline neuroinflammation And Impaired Brain Aand# 946; Clearance In …
  2941. Mitigation effects of a novel herbal medicine, hepad, on neuroinflammation, neuroapoptosis, and neuro-oxidation
  2942. Mitigation of postnatal ethanol-induced neuroinflammation ameliorates trace fear memory deficits in juvenile rats
  2943. Mitoapocynin treatment protects against neuroinflammation and dopaminergic neurodegeneration in a preclinical animal model of Parkinson’s disease
  2944. Mitochondria and the link between neuroinflammation and neurodegeneration
  2945. Mitochondria as the core of neuroinflammation and neurodegeneration in models of neuronal and astrocytic dysfunction
  2946. Mitochondria at the interface between neurodegeneration and neuroinflammation
  2947. Mitochondria in neuroinflammation–Multiple sclerosis (MS), Leber hereditary optic neuropathy (LHON) and LHON-MS
  2948. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer’s disease
  2949. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1094-8″>Mitochondrial damage and “plugging” of transport selectively in myelinated, small-diameter axons are major early events in peripheral neuroinflammation
  2950. Mitochondrial damage and axon degeneration in chronic neuroinflammation
  2951. Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: novel therapeutic strategies for neurodegenerative disorders
  2952. Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration?
  2953. Mitochondrial dysfunctioning and neuroinflammation: Recent highlights on the possible mechanisms involved in Traumatic Brain Injury
  2954. Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuroinflammation and apoptosis after neonatal ischemic brain damage
  2955. Mitochondrial metabolism: a common link between neuroinflammation and neurodegeneration
  2956. Mitochondrial transcription factor A (TFAM) as a novel intercellular signaling molecule of the brain: its role in glial cell activation and neuroinflammation
  2957. Mitochondrial translocator protein (TSPO), astrocytes and neuroinflammation
  2958. Mitogen-activated protein kinase–activated protein kinase 2 in neuroinflammation, heat shock protein 27 phosphorylation, and cell cycle: role and targeting
  2959. MKP1 reduces neuroinflammation via inhibiting endoplasmic reticulum stress and mitochondrial dysfunction
  2960. MLKL mediated necroptosis accelerates JEV-induced neuroinflammation in mice
  2961. MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson’s disease
  2962. MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation …
  2963. Modafinil abrogates methamphetamine-induced neuroinflammation and apoptotic effects in the mouse striatum
  2964. MODELING AMYLOID-β INDUCED neuroinflammation IN ZEBRAFISH
  2965. Modeling cytokine regulatory network dynamics driving neuroinflammation in central nervous system disorders
  2966. Modeling HIV-1 induced neuroinflammation in mice: role of platelets in mediating blood-brain barrier dysfunction
  2967. Modeling neuroinflammation in Individuals with Parkinson’s
  2968. Modeling of TREX1-dependent autoimmune disease using human stem cells highlights L1 accumulation as a source of neuroinflammation
  2969. Modeling the Effect of HIV-1 Induced neuroinflammation on the Cerebral Vasculature: Acute Intracranial Exposure to HIV-1 Tat Leads to Dysregulation of …
  2970. Modelling neuroinflammation In Vitro: A Tool to Test the Potential
  2971. Modelling neuroinflammation in vitro: a tool to test the potential neuroprotective effect of anti-inflammatory agents
  2972. Modest reductions in BACE1 activity significantly reduce beta-amyloid plaque load and neuroinflammation in a mouse model of Alzheimer’s disease
  2973. Modifiable risk factors of Alzheimer’s disease and neuroinflammation: what are the links?
  2974. Modulating acute neuroinflammation in intracerebral hemorrhage: the potential promise of currently approved medications for multiple sclerosis
  2975. Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury
  2976. Modulating neuroinflammation to treat neuropsychiatric disorders
  2977. Modulating neuroinflammation with Porous Templated Scaffolds
  2978. Modulation by astrocytes of microglial cell-mediated neuroinflammation: effect on the activation of microglial signaling pathways
  2979. Modulation of adult hippocampal neurogenesis during myelin‐directed autoimmune neuroinflammation
  2980. Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation
  2981. Modulation of glutamate transmission during amyotrophic lateral sclerosis: regulation of glutamate transporters and implication of neuroinflammation
  2982. Modulation of ischemic brain injury and neuroinflammation by adenosine A2A receptors
  2983. Modulation of lipopolysaccharide-induced memory insult, γ-secretase, and neuroinflammation in triple transgenic mice by 5-lipoxygenase
  2984. Modulation of LPS-induced memory insult, γ-secretase and neuroinflammation in 3xTg mice by 5-Lipoxygenase
  2985. Modulation of LPS-stimulated neuroinflammation in BV-2 microglia by Gastrodia elata: 4-hydroxybenzyl alcohol is the bioactive candidate
  2986. Modulation of neuroimmune responses on glia in the central nervous system: implication in therapeutic intervention against neuroinflammation
  2987. Modulation of neuroinflammation and memory dysfunction using percutaneous vagus nerve stimulation in mice
  2988. Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer’s disease using a biased and selective beta-1 adrenergic receptor partial …
  2989. Modulation of neuroinflammation by cysteinyl leukotriene 1 and 2 receptors: Implications for cerebral ischemia and neurodegenerative diseases
  2990. Modulation of neuroinflammation by dietary flavonoids
  2991. neuroinflammation&ots=5kTGIOIBpw&sig=ub7C6qLj1OZlElnzmEHE1dXc1Ao”>MODULATION OF neuroinflammation BY MEDICINAL HERBS AND FLAVONOIDS
  2992. Modulation of neuroinflammation by Taklisodok-um in a Spinal Cord Injury Model
  2993. Modulation of neuroinflammation in Experimental Subarachnoid Hemorrhage
  2994. Modulation of neuroinflammation in the central nervous system: role of chemokines and sphingolipids
  2995. Modulation of neuroinflammation with the phytoestrogen, formononetin
  2996. Modulation of neuroinflammation: role and therapeutic potential of TRPV1 in the neuro-immune axis
  2997. Modulation of post-traumatic epilepsy by MIS416, a novel innate immune modulator for the treatment of neuroinflammation (P6. 232)
  2998. Modulation of pro-inflammatory response of retina by adenosinergic systems: neuroinflammation/neuroprotection
  2999. Modulation of the endocannabinoid system and PanX1-mediated neuroinflammation in an in vitro model of Alzheimer’s disease
  3000. Modulation of thrombin-induced neuroinflammation in BV-2 microglia by carbon monoxide-releasing molecule 3
  3001. Modulatory Effect of a Standardised Andrographis Paniculata Aqueous Extract on Urine Metabolomics in a Rat Model of neuroinflammation
  3002. Modulatory effects of neuropeptides on pentylenetetrazol-induced epileptic seizures and neuroinflammation in rats
  3003. Modulatory role of ketogenic diet on neuroinflammation; a possible drug naïve strategy to treatment of Parkinson’s disease
  3004. Molecular and cellular insights: neuroinflammation and amyotrophic lateral sclerosis
  3005. Molecular and Cellular Mechanisms of neuroinflammation
  3006. Molecular and Cellular Mechanisms of neuroinflammation
  3007. Molecular and Cellular Substrates of neuroinflammation in Alzheimer Disease and Depression
  3008. Molecular basis of etiological implications in Alzheimer’s disease: focus on neuroinflammation
  3009. Molecular chaperone α-crystallin prevents detrimental effects of neuroinflammation
  3010. Molecular cross-talk between Lrrk2 and NF-κ/INS; B in neuroinflammation in an/INS; animal model of Parkinson’s disease (PD)
  3011. Molecular hydrogen attenuates sepsis-induced neuroinflammation through regulation of microglia polarization through an mTOR-autophagy-dependent pathway
  3012. Molecular hydrogen reduces LPS-induced neuroinflammation and promotes recovery from sickness behaviour in mice
  3013. Molecular imaging of neuroinflammation in Alzheimer’s disease
  3014. Molecular imaging of neuroinflammation in Alzheimer’s disease and mild cognitive impairment
  3015. Molecular imaging of neuroinflammation in HIV
  3016. Molecular Imaging of neuroinflammation in Idiopathic Parkinson’s Disease
  3017. Molecular imaging of neuroinflammation in neurodegenerative dementias: the role of in vivo PET imaging
  3018. Molecular imaging of neuroinflammation in patients after mild traumatic brain injury: a longitudinal 123I‐CLINDE single photon emission computed tomography study
  3019. Molecular imaging of neuroinflammation in preclinical rodent models using positron emission tomography.
  3020. Molecular indicators of stress-induced neuroinflammation in a mouse model simulating features of post-traumatic stress disorder
  3021. Molecular Indicators of Stress-Induced neuroinflammation in a Mouse Model Simulating Features of Post-Traumatic Stress Disorder (Open Access)
  3022. Molecular insights into NR4A2 (Nurr1): an emerging target for neuroprotective therapy against neuroinflammation and neuronal cell death
  3023. Molecular mechanism of aluminum induced neuroinflammation
  3024. MOLECULAR MECHANISMS IN P25/CDK5-MEDIATED neuroinflammation AND SUBSEQUENT NEURODEGENERATION: THERAPEUTIC …
  3025. Molecular mechanisms linking neuroinflammation and neurodegeneration in MS
  3026. Molecular mechanisms of neuroinflammation and injury during acute viral encephalitis
  3027. Molecular Mechanisms Of neuroinflammation Following Global Cerebral Ischemia: The Role Of Hypothermia Therapy
  3028. Molecular mechanisms of synaptotoxicity and neuroinflammation in Alzheimer’s disease
  3029. Molecular mechanisms responsible for neuroinflammation and neurological impairments in mevalonate kinase deficiency
  3030. Molecular pathogenesis of neuroinflammation
  3031. Molecular Tipping Points in neuroinflammation
  3032. Molecular triggers of neuroinflammation in mouse models of demyelinating diseases
  3033. Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation
  3034. neuroinflammation_in_vivo_with_CEST_imaging/links/545d28ca0cf27487b44d4b1e.pdf”>Monitoring neuroinflammation in vivo with CEST imaging
  3035. monitoring the immune cell infiltration in the LPS-induced neuroinflammation region with simultaneous small animal PET/MR imaging using a TSPO-targeting probe
  3036. Monoacylglycerol lipase blockade impairs fine motor coordination and triggers cerebellar neuroinflammation through cyclooxygenase-2
  3037. Morin attenuates ifosfamide-induced neurotoxicity in rats via suppression of oxidative stress, neuroinflammation and neuronal apoptosis
  3038. Morin decreases cortical pyramidal neuron degeneration via inhibition of neuroinflammation in mouse model of schizophrenia
  3039. Morin exerts neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy
  3040. Morin mitigates chronic constriction injury (CCI)-induced peripheral neuropathy by inhibiting oxidative stress induced PARP over-activation and neuroinflammation
  3041. Moringa oleifera inhibit neuroinflammation in LPS activated BV2 microglia
  3042. Morphine activates neuroinflammation in a manner parallel to endotoxin
  3043. Morphine preconditioning protects against LPS-induced neuroinflammation and memory deficit
  3044. Motor neuron loss and neuroinflammation in a model of α-synuclein-induced neurodegeneration
  3045. MP47-04 CYCLOPHOSPHAMIDE-INDUCED CYSTITIS TRIGGERS NLRP3–DEPENDENT neuroinflammation IN THE HIPPOCAMPUS AND DEPRESSION IN …
  3046. MPTP lesion causes neuroinflammation and deficits in object recognition in Wistar rats.
  3047. MPTP-induced dopaminergic degeneration and deficits in object recognition in rats are accompanied by neuroinflammation in the hippocampus
  3048. MPTP-induced neuroinflammation increases the expression of pro-inflammatory cytokines and their receptors in mouse brain
  3049. neuroinflammation&ots=2C2HCDj5nS&sig=j6aV5d8hErsur7qEKrYaI-nLSnc”>MRI Assessment of Post-Ischemic neuroinflammation in Stroke: Experimental and Clinical Studies
  3050. MRI coupled with clinically-applicable iron oxide nanoparticles reveals choroid plexus involvement in a murine model of neuroinflammation
  3051. MRI monitoring of neuroinflammation in mouse focal ischemia
  3052. MRI of monocyte infiltration in an animal model of neuroinflammation using SPIO-labeled monocytes or free USPIO
  3053. MRI visualization of neuroinflammation using VCAM-1 targeted paramagnetic micelles
  3054. MRI/MRS in neuroinflammation: methodology and applications
  3055. MSCs-derived exosomes and neuroinflammation, neurogenesis and therapy of traumatic brain injury
  3056. MSP-dependent activation of CNS Ron Receptor Tyrosine Kinase signaling attenuates neuroinflammation through the physiological regulation of IL1B and NLRP3 …
  3057. mTOR and neuroinflammation
  3058. mTOR pathway inhibition prevents neuroinflammation and neuronal death in a mouse model of cerebral palsy
  3059. mTOR Pathway Inhibition Prevents neuroinflammation and Neuronal Death in a Mouse Model of Spinal Cord Injury
  3060. mTOR signaling inhibition modulates macrophage/microglia-mediated neuroinflammation and secondary injury via regulatory T cells after focal ischemia
  3061. mTORC1 pathway disruption abrogates the effects of the ciliary neurotrophic factor on energy balance and hypothalamic neuroinflammation
  3062. Mucopolysaccharide diseases: a complex interplay between neuroinflammation, microglial activation and adaptive immunity
  3063. Mucuna pruriens protects against MPTP Intoxicated neuroinflammation in Parkinson’s disease through NF-κB/pAKT signaling pathways
  3064. Müller Cell–Microglia Cross Talk Drives neuroinflammation in Diabetic Retinopathy
  3065. Multi-functional diarylurea small molecule inhibitors of TRPV1 with therapeutic potential for neuroinflammation
  3066. Multi-scale analyses of molecular network dynamics underlying neuronal excitability, neuroinflammation, and organismal homeostasis
  3067. Multifaces of neuropeptide Y in the brain–neuroprotection, neurogenesis and neuroinflammation
  3068. Multimodal approach to the evaluation of diffuse neuroinflammation in multiple sclerosis using positron emission tomography and diffusion tensor imaging
  3069. Multimodal evaluation of neuroinflammation-associated changes during epileptogenesis using small animal PET and MRI.
  3070. Multimodal molecular imaging demonstrates myeloperoxidase regulation of matrix metalloproteinase activity in neuroinflammation
  3071. Multiple loci comprising immune-related genes regulate experimental neuroinflammation
  3072. Multiple sclerosis and neuroinflammation: the overview of current and prospective therapies
  3073. Multiple Sclerosis is a Primary System of Neurodegeneration Permissive for neuroinflammation and Demyelination
  3074. Multiple sclerosis: Coagulation factors could mediate neuroinflammation in multiple sclerosis
  3075. Multiple sclerosis: implications of obesity in neuroinflammation
  3076. Multitarget Profiling of a Strigolactone Analog for Early Events of Alzheimer’s Disease: in Vitro Therapeutic Activities against neuroinflammation
  3077. Mumefural Ameliorates Cognitive Impairment in Chronic Cerebral Hypoperfusion via Regulating the Septohippocampal Cholinergic System and neuroinflammation
  3078. Murine K2P5. 1 deficiency has no impact on autoimmune neuroinflammation due to compensatory K2P3. 1-and KV1. 3-dependent mechanisms
  3079. Mutant huntingtin gene-dose impacts on aggregate deposition, DARPP32 expression and neuroinflammation in HdhQ150 mice
  3080. Mutated tau, amyloid and neuroinflammation in Alzheimer disease—A brief review
  3081. Mutations of complement factor I and potential mechanisms of neuroinflammation in acute hemorrhagic leukoencephalitis
  3082. Mycobacterium vaccae immunization protects aged rats from surgery-elicited neuroinflammation and cognitive dysfunction
  3083. MyD88 is dispensable for cerebral amyloid pathology and neuroinflammation in PSAPP transgenic mice
  3084. MyD88 is dispensable for cerebral amyloidosis and neuroinflammation in APP/PS1 transgenic mice
  3085. Myelin loss associated with neuroinflammation in hypertensive rats
  3086. Myeloid cell transmigration across the CNS vasculature triggers IL-1β–driven neuroinflammation during autoimmune encephalomyelitis in mice
  3087. Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil–platelet interactions
  3088. Myeloid Kruppel-like factor 2 deficiency exacerbates neurological dysfunction and neuroinflammation in a murine model of multiple sclerosis
  3089. Myeloid microvesicles are a marker and therapeutic target for neuroinflammation
  3090. Myeloid sphingosine-1-phosphate receptor 1 is important for CNS autoimmunity and neuroinflammation
  3091. Myeloid-derived suppressor cells infiltrate the brain and suppress neuroinflammation in a mouse model of focal traumatic brain injury
  3092. Myeloperoxidase Molecular MRI Reveals Synergistic Combination Therapy in Murine Experimental Autoimmune neuroinflammation
  3093. Myocardial infarction is associated with neuroinflammation-a systemic analysis using TSPO-targeted molecular imaging.
  3094. Myocardial inflammation predicts remodeling and neuroinflammation after myocardial infarction
  3095. Myosin1f-mediated neutrophil migration contributes to acute neuroinflammation and brain injury after stroke in mice
  3096. Myricetin prevents dopaminergic neurons from undergoing neuroinflammation-mediated degeneration in a lipopolysaccharide-induced Parkinson’s disease model
  3097. n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis
  3098. n-3 Fatty Acid-Derived Lipid Mediators against Neurological Oxidative Stress and neuroinflammation
  3099. N-3 polyunsaturated fatty acid and neuroinflammation in aging and Alzheimer’s disease
  3100. N-3 Polyunsaturated Fatty Acid and neuroinflammation in Aging: Role in Cognition
  3101. N-3 Polyunsaturated Fatty Acids and neuroinflammation in Alzheimer’s Disease
  3102. N-3 polyunsaturated fatty acids and the resolution of neuroinflammation
  3103. n-3 Polyunsaturated fatty acids in animal models with neuroinflammation
  3104. N-3 polyunsaturated fatty acids in animal models with neuroinflammation: An update
  3105. N-acetyl-L-leucine treatment attenuates neuronal cell death and suppresses neuroinflammation after traumatic brain injury in mice
  3106. N-acetylcysteine attenuates neuroinflammation associated depressive behavior induced by chronic unpredictable mild stress in rat
  3107. N-acetylcysteine Prevents Alcohol Related neuroinflammation in Rats
  3108. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0751-z”>N-Docosahexaenoylethanolamine ameliorates LPS-induced neuroinflammation via cAMP/PKA-dependent signaling
  3109. N-Palmitoylethanolamine and neuroinflammation: a Novel Therapeutic Strategy of Resolution
  3110. N-Palmitoylethanolamine-oxazoline (PEA-OXA): a new therapeutic strategy to reduce neuroinflammation and oxidative stress associated to vascular dementia
  3111. N-Palmitoylethanolamine-oxazoline (PEA-OXA): a new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an …
  3112. N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord …
  3113. N, N-disubstituted azines attenuate LPS-mediated neuroinflammation in microglia and neuronal apoptosis via inhibiting MAPK signaling pathways
  3114. Nafamostat mesilate improves function recovery after stroke by inhibiting neuroinflammation in rats
  3115. NAFLD induces neuroinflammation and accelerates Alzheimer’s disease
  3116. Naja sputatrix venom preconditioning attenuates neuroinflammation in a rat model of surgical brain injury via PLA2/5-LOX/LTB4 cascade activation
  3117. Nalmefene prevents alcohol‐induced neuroinflammation and alcohol drinking preference in adolescent female mice: role of TLR4
  3118. NAMPT inhibitor protects ischemic neuronal injury in rat brain via anti-neuroinflammation
  3119. Nano-size Particles Of Probiotics For Preventing And Treating neuroinflammation
  3120. Nanoliposome containing cyclosporine A reduced neuroinflammation responses and improved neurological activities in cerebral ischemia/reperfusion in rat
  3121. Nanomedicine and its application in treatment of microglia-mediated neuroinflammation
  3122. Nanoscale effects in dendrimer-mediated targeting of neuroinflammation
  3123. NanoString analysis of neuroinflammation in multiple system atrophy
  3124. Nanotherapeutics for gene modulation that prevents apoptosis in the brain and fatal neuroinflammation
  3125. Naringenin decreases α-synuclein expression and neuroinflammation in MPTP-induced Parkinson’s disease model in mice
  3126. Naringenin protects against 1-methyl-4-phenylpyridinium-induced neuroinflammation and resulting reactive oxygen species production in SH-SY5Y cell line …
  3127. Naringin attenuates autophagic stress and neuroinflammation in kainic acid-treated hippocampus in vivo
  3128. Narrative Review Article: neuroinflammation and Perioperative Neurocognitive Disorders
  3129. Natural AD-Like neuropathology in Octodon degus: impaired burrowing and neuroinflammation
  3130. Natural compound 2 provides neuroprotection and anti-neuroinflammation via Nrf2/AREdependent HO-1 expression through activation of the PI3K/AKT …
  3131. Natural compounds isolated from wild Alaska bog blueberries intervene with molecular targets of neuroinflammation
  3132. Natural flavone jaceosidin is a neuroinflammation inhibitor
  3133. Naturally occurring beta-secretase inhibitors mitigate behavioral impairment, cerebral amyloidosis and neuroinflammation in transgenic mice
  3134. NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson’s Disease
  3135. NDP-MSH binding melanocortin-1 receptor ameliorates neuroinflammation and BBB disruption through CREB/Nr4a1/NF-κB pathway after intracerebral …
  3136. Near-infrared photobiomodulation combined with coenzyme Q10 for depression in a mouse model of restraint stress: reduction in oxidative stress, neuroinflammation …
  3137. Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
  3138. Necroptosis in microglia contributes to neuroinflammation and retinal degeneration through TLR4 activation
  3139. NEIL1 stimulates neurogenesis and suppresses neuroinflammation after stress
  3140. NEK7 regulates NLRP3 inflammasome activation and neuroinflammation post-TBI
  3141. Neonatal Bacillus Calmette-Guerin vaccination alleviates lipopolysaccharide-induced neurobehavioral impairments and neuroinflammation in adult mice
  3142. Neonatal hydrocephalus leads to white matter neuroinflammation and injury in the corpus callosum of Ccdc39 hydrocephalic mice
  3143. Neonatal lipopolysaccharide treatment alters hippocampal neuroinflammation, microglia morphology and anxiety-like behavior in rats selectively bred for an infantile …
  3144. Nerolidol ameliorates cyclophosphamide-induced oxidative stress, neuroinflammation and cognitive dysfunction: Plausible role of Nrf2 and NF-κB
  3145. Nesfatin-1 Ameliorate Learning and Memory Deficit via Inhibiting Apoptosis and neuroinflammation Following Ethanol-Induced Neurotoxicity in Early Postnatal Rats
  3146. Netrin 1 regulates blood–brain barrier function and neuroinflammation
  3147. Netrin‐1 and multiple sclerosis: a new biomarker for neuroinflammation?
  3148. Network medicine in drug design: implications for neuroinflammation
  3149. Neural stem cell small extracellular vesicle-based delivery of 14-3-3t reduces apoptosis and neuroinflammation following traumatic spinal cord injury by …
  3150. Neural stem cell transplantation decreases neuroinflammation in a transgenic mouse model of Alzheimer’s disease
  3151. Neural Stem Cell Treatment Prevents neuroinflammation and Increases Hippocampal BDNF Levels in Genetic Absence Epileptic WAG/Rij Rats
  3152. Neural stem cell-derived small extracellular vesicles attenuate apoptosis and neuroinflammation after traumatic spinal cord injury by activating autophagy
  3153. Neural stem cells respond to extracellular succinate via SUCNR1/GPR91 to ameliorate chronic neuroinflammation
  3154. Neuraminidase-induced neuroinflammation is largely dependent on microglial TLR4 receptor
  3155. Neuregulin upregulates microglial α7 nicotinic acetylcholine receptor expression in immortalized cell lines: implications for regulating neuroinflammation
  3156. Neuregulin-1 protects mouse cerebellum against oxidative stress and neuroinflammation
  3157. Neuroactive Steroids and neuroinflammation
  3158. Neuroactive steroids, their metabolites, and neuroinflammation
  3159. Neurobehavioral performance in feline immunodeficiency virus infection: integrated analysis of viral burden, neuroinflammation, and neuronal injury in cortex
  3160. Neurocysticercosis and hippocampal damage: a causal link favored by epileptogenesis or neuroinflammation?
  3161. Neurodegeneration and neuroinflammation in a Mouse Model of Sarin Exposure
  3162. Neurodegeneration and neuroinflammation in cdk5/p25-inducible mice: a model for hippocampal sclerosis and neocortical degeneration
  3163. Neurodegeneration and neuroinflammation in diabetic retinopathy: potential approaches to delay neuronal loss
  3164. Neurodegeneration and neuroinflammation in Parkinson’s disease: reasearch of blood circulating biomarkers.
  3165. Neurodegeneration and neuroinflammation: two processes, one target
  3166. Neurodegeneration in Chronic Kidney Disease: role of neuroinflammation and uremic toxins
  3167. Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation.
  3168. Neurogenesis and neuroinflammation: the role of Wnt proteins
  3169. Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome
  3170. Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity
  3171. Neuroglial activation and neuroinflammation in the brain of patients with autism
  3172. Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
  3173. Neuroimaging in Autoimmune and neuroinflammation-Related Epilepsies
  3174. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia
  3175. Neuroimmune and Systemic Manifestations of neuroinflammation in the Temporomandibular Joint and Related Disorders
  3176. Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases
  3177. Neuroimmunity and neuroinflammation
  3178. Neuroimmunologic and neurotrophic interactions in autism spectrum disorders: relationship to neuroinflammation
  3179. Neuroimmunology and neuroinflammation in autoimmune, neurodegenerative and psychiatric disease
  3180. Neuroimmunology: What Role for Autoimmunity, neuroinflammation, and Small Fiber Neuropathy in Fibromyalgia, Chronic Fatigue Syndrome, and Adverse Events …
  3181. neuroinflammation&ots=-KoBSjGwXH&sig=fjjvr2jagzCoEcv7IEP9zwCo3VI”>neuroinflammation
  3182. neuroinflammation
  3183. neuroinflammation
  3184. neuroinflammation
  3185. neuroinflammation
  3186. neuroinflammation
  3187. neuroinflammation/links/5cdc0b7092851c4eaba0ac0c/Pentraxin-3-regulates-neutrophil-infiltration-to-the-brain-during-neuroinflammation.pdf”>neuroinflammation [version 1; peer review: awaiting peer review]
  3188. neuroinflammation & pre-mature aging in the context of chronic HIV infection and drug abuse: Role of dysregulated autophagy
  3189. neuroinflammation a Common Link in Neurodegenerative Neurological and Psychiatric Disorders
  3190. neuroinflammation activates Mdr1b efflux transport through NFκB: promoter analysis in BBB endothelia
  3191. neuroinflammation after acute brain injury: the role of interleukin-1 actions on non-neuronal cells
  3192. neuroinflammation after intracerebral hemorrhage
  3193. neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets
  3194. neuroinflammation after neonatal hypoxia–ischemia is associated with alterations in the purinergic system: adenosine deaminase 1 isoenzyme is the most …
  3195. neuroinflammation after Subarachnoid Hemorrhage: The Role of Microglia
  3196. neuroinflammation after traumatic brain injury is enhanced in activating transcription factor 3 mutant mice
  3197. neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention
  3198. neuroinflammation after traumatic injury to the developing brain
  3199. neuroinflammation alters cellular proteostasis by producing endoplasmic reticulum stress, autophagy activation and disrupting ERAD activation
  3200. neuroinflammation alters integrative properties of rat hippocampal pyramidal cells
  3201. neuroinflammation alters the hippocampal pattern of behaviorally induced Arc expression
  3202. neuroinflammation alters voltage-dependent conductance in striatal astrocytes
  3203. neuroinflammation AND 18F-AV-1451 PET FINDINGS IN SEMANTIC DEMENTIA
  3204. neuroinflammation and aberrant hippocampal plasticity in a mouse model of emotional stress evoked by exposure to ultrasound of alternating frequencies
  3205. neuroinflammation and activation of Zif-268 in dyskinetic 6-OHDA-lesioned rats is counteracted by association of a 5-HT1A/1B receptor agonist and an A2A receptor …
  3206. neuroinflammation and adult hippocampal neurogenesis in neuropathic pain and alkyl glycerol ethers treatment in aged mice
  3207. neuroinflammation and ageing: current theories and an overview of the data
  3208. neuroinflammation and aging: influence of dietary n-3 polyunsaturated fatty acid
  3209. neuroinflammation and aging: significance of declining circadian functions and melatonin
  3210. neuroinflammation and ALS: transcriptomic insights into molecular disease mechanisms and therapeutic targets
  3211. neuroinflammation&ots=LIP7KlYssk&sig=42pD9K5jqIRRd0t3Fj9CZyDMbso”>neuroinflammation and alteration of the blood-brain barrier in Alzheimers disease
  3212. neuroinflammation_and_Alzheimer_Disease__Clinical.9.aspx”>neuroinflammation and Alzheimer disease: clinical and therapeutic implications
  3213. neuroinflammation&ots=0X3DK28gT7&sig=dG0aSCnRosIxkjSKtogLGjlHVM4″>neuroinflammation AND ALZHEIMER’S
  3214. neuroinflammation and Alzheimer’s Disease
  3215. neuroinflammation and Alzheimer’s disease: implications for microglial activation
  3216. neuroinflammation and Alzheimer’s disease: implications of Abeta immunotherapy
  3217. neuroinflammation and Alzheimer’s disease: lessons learned from 5-lipoxygenase
  3218. neuroinflammation and amyloid deposition: Concurrent [11C] PBR28 and [11C] PIB PET imaging in patients with Alzheimer’s disease, mild cognitive impairment, and …
  3219. neuroinflammation AND AMYLOID PATHOLOGY AFTER TBI
  3220. neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s …
  3221. neuroinflammation and anti-inflammatory therapy for Alzheimer’s disease
  3222. neuroinflammation and astrocytic reaction in the course of Phoneutria nigriventer (armed-spider) blood–brain barrier (BBB) opening
  3223. neuroinflammation and autism spectrum disorder: a review
  3224. neuroinflammation and autism: toward mechanisms and treatments
  3225. neuroinflammation and Aβ accumulation linked to systemic inflammation are decreased by genetic PKR down-regulation
  3226. neuroinflammation and B-Cell Phenotypes in Cervical and Lumbosacral Regions of the Spinal Cord in Experimental Autoimmune Encephalomyelitis in the Absence …
  3227. neuroinflammation and behavior
  3228. neuroinflammation and behavior in HIV-1 transgenic rats exposed to chronic adolescent stress
  3229. neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism
  3230. neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy
  3231. neuroinflammation and blood–brain barrier disruption following traumatic brain injury: Pathophysiology and potential therapeutic targets
  3232. neuroinflammation and both cytotoxic and vasogenic edema are reduced in interleukin-1 type 1 receptor-deficient mice conferring neuroprotection
  3233. neuroinflammation and brain antioxidant levels in ethanol leaf extract of Nauclea latifolia and Artemisinin-combination therapy in Swiss mice infected with …
  3234. neuroinflammation and brain atrophy in former NFL players: an in vivo multimodal imaging pilot study
  3235. neuroinflammation and brain functional disconnection in Alzheimer’s disease
  3236. neuroinflammation and brain infections: historical context and current perspectives
  3237. neuroinflammation and Cannabinoid CB2 Receptor Expression in the Human Huntington’s Disease Brain and R6/1 Transgenic Mouse Model
  3238. neuroinflammation and cell therapy for Parkinson’s disease
  3239. neuroinflammation and central nervous system regeneration in vertebrates
  3240. neuroinflammation and central PI3K/Akt/mTOR signal pathway contribute to bone cancer pain
  3241. neuroinflammation and central sensitization in chronic and widespread pain
  3242. neuroinflammation and cerebrovascular disease in old age: a translational medicine perspective
  3243. neuroinflammation and Circuitry Changes in the Dorsal Raphe Nucleus with Depressive Phenotype after Spinal Cord Injury
  3244. neuroinflammation and CNS disorders
  3245. neuroinflammation AND COGNITION
  3246. neuroinflammation and Cognition
  3247. neuroinflammation-and-cognition-across-psychiatric-conditions/3F71B7A20C855994E45166E06561C0AB”>neuroinflammation and cognition across psychiatric conditions
  3248. neuroinflammation and cognitive aging
  3249. neuroinflammation and cognitive dysfunction in chronic disease and aging
  3250. neuroinflammation and cognitive function in aged mice following minor surgery
  3251. neuroinflammation and cognitive impairment in the aged: implications for nutritional intervention
  3252. neuroinflammation and cognitive plasticity following experimental stroke
  3253. neuroinflammation and common mechanism in Alzheimer’s disease and prion amyloidosis: amyloid-associated proteins, neuroinflammation and neurofibrillary …
  3254. neuroinflammation and comorbid depression: a role for interleukin-1 beta converting enzyme and indoleamine 2, 3-dioxygenase
  3255. neuroinflammation and comorbidities are frequently ignored factors in CNS pathology
  3256. neuroinflammation and comorbidity of pain and depression
  3257. neuroinflammation and Complexes of 17β-Hydroxysteroid Dehydrogenase type 10-Amyloid β in Alzheimer’s Disease
  3258. neuroinflammation and copper in Alzheimer’s disease
  3259. neuroinflammation and cytokine abnormality in major depression: cause or consequence in that illness?
  3260. neuroinflammation and cytokines in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a critical review of research methods
  3261. neuroinflammation AND DEFECTIVE MYELINATION IN POLYMICROGYRIA
  3262. neuroinflammation and defining gene therapy approaches for ovine CLN6 Batten disease
  3263. neuroinflammation and demyelination from the point of nitrosative stress as a new target for neuroprotection
  3264. neuroinflammation and demyelination in multiple sclerosis after allogeneic hematopoietic stem cell transplantation
  3265. neuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation
  3266. neuroinflammation_and_Depression___The_Role_of.2.aspx”>neuroinflammation and depression: the role of indoleamine 2, 3-dioxygenase (IDO) as a molecular pathway
  3267. neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system
  3268. neuroinflammation and EIF2 signaling persist in an HiPSC tri-culture model of HIV infection despite antiretroviral treatment
  3269. neuroinflammation and endoplasmic reticulum stress are coregulated by crocin to prevent demyelination and neurodegeneration
  3270. neuroinflammation and endoplasmic reticulum stress are coregulated by cyclo (His-Pro) to prevent LPS neurotoxicity
  3271. neuroinflammation and ER-stress are key mechanisms of acute bilirubin toxicity and hearing loss in a mouse model
  3272. neuroinflammation and excitatory symptoms in bipolar disorder
  3273. neuroinflammation and excitotoxicity in neurobiology of HIV-1 infection and AIDS: targets for neuroprotection
  3274. neuroinflammation and fatty acids
  3275. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1412-9″>neuroinflammation and fractalkine signaling in Alzheimer’s disease
  3276. neuroinflammation and Fragile X syndrome: regulation by glycogen synthase kinase-3
  3277. neuroinflammation and functional connectivity in Alzheimer’s disease: interactive influences on cognitive performance
  3278. neuroinflammation And Glial Cell Activation In Mental Disorders
  3279. neuroinflammation and glial cell activation in pathogenesis of chronic pain
  3280. neuroinflammation and glial phenotypic changes in alpha-synucleinopathies
  3281. neuroinflammation and Immune Regulation in Ischemic Stroke: Identification of New Pharmacological Targets
  3282. neuroinflammation and immunity: a new pharmacological target in depression
  3283. neuroinflammation and impairment of hippocampal neurogenesis underlies depressive-like behaviors of obese rats: Role of TNF-alpha inhibition
  3284. neuroinflammation_and_infection.6.aspx”>neuroinflammation and infection
  3285. neuroinflammation and infection: molecular mechanisms associated with dysfunction of neurovascular unit
  3286. neuroinflammation and inhibitory synaptic control of cultured premotor circuits
  3287. neuroinflammation and iron handling in animal models with brain iron overload
  3288. neuroinflammation and its modulation by flavonoids
  3289. neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis
  3290. neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration
  3291. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-11-98″>neuroinflammation and M2 microglia: the good, the bad, and the inflamed
  3292. neuroinflammation and mechanisms of neuropathic pain development
  3293. neuroinflammation and memory: the role of prostaglandins
  3294. neuroinflammation and microglia in glaucoma: time for a paradigm shift
  3295. neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment
  3296. neuroinflammation and Microvascular Dysfunction After Experimental Subarachnoid Hemorrhage: Emerging Components of Early Brain Injury Related to Outcome
  3297. neuroinflammation and mitochondrial dysfunction in Alzheimer’s and prion’s diseases
  3298. neuroinflammation and mitochondrial dysfunction in the pathogenesis of Alzheimer’s disease: modulation by Coriolus Versicolor (Yun-Zhi) nutritional …
  3299. neuroinflammation and MMPs: potential therapeutic targets in neonatal hypoxic-ischemic injury
  3300. neuroinflammation and myelin status in Alzheimer’s disease, Parkinson’s disease, and normal aging brains: A small sample study
  3301. neuroinflammation and neuroaxonal damage in multiple sclerosis: a cross-sectional cerebrospinal fluid-based proteomic study
  3302. neuroinflammation and neurodegeneration
  3303. neuroinflammation&ots=2HceOwx6ua&sig=GaEDXSrarKdo3HfEpB571nVgJeI”>neuroinflammation and neurodegeneration
  3304. neuroinflammation and neurodegeneration as mechanisms for worsened outcomes in elderly traumatic brain injury
  3305. neuroinflammation and neurodegeneration in adult rat brain from binge ethanol exposure: abrogation by docosahexaenoic acid
  3306. neuroinflammation and neurodegeneration in human brain at single-cell resolution
  3307. neuroinflammation and neurodegeneration in overnutrition-induced diseases
  3308. neuroinflammation and neurodegeneration: pinpointing pathological and pharmacological targets
  3309. neuroinflammation and Neurodegeneration: Pinpointing Pathological and Pharmacological Targets
  3310. neuroinflammation&ots=QyIFUBqwja&sig=3wkI8_bj8XEWNCkA13OyrH3J5ek”>neuroinflammation and Neurodegenerative Diseases
  3311. neuroinflammation and neurodegenerative diseases: a single subject analysis
  3312. neuroinflammation and Neurogenesis in Alzheimer’s Disease and Potential Therapeutic Approaches
  3313. neuroinflammation and neurogenesis in the choroid plexus
  3314. neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms
  3315. neuroinflammation and neuroimmune dysregulation after acute hypoxic-ischemic injury of developing brain
  3316. neuroinflammation and Neuroimmunomodulation in Alzheimer’s Disease
  3317. neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin
  3318. neuroinflammation and neurological alterations in chronic liver diseases
  3319. neuroinflammation and Neuromodulation in Neurological Diseases
  3320. neuroinflammation and neuronal autophagic death were suppressed via Rosiglitazone treatment: New evidence on neuroprotection in a rat model of global cerebral …
  3321. neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer’s disease
  3322. neuroinflammation and neuroplasticity in pain
  3323. neuroinflammation and neuroprotection in schizophrenia and autism spectrum disorder
  3324. neuroinflammation and neuroprotection: an update on (future) neurotrophin-related strategies in multiple sclerosis treatment
  3325. neuroinflammation and neuroprotective strategies in acute ischaemic stroke-from bench to bedside
  3326. neuroinflammation and neurosteroidogenesis: Reciprocal modulation during injury to the adult zebra finch brain
  3327. neuroinflammation and neurotoxicity contribute to neuroprogression in neurological and psychiatric disorders
  3328. neuroinflammation&ots=hOgZ6fNTNW&sig=NGRzjWIWFCmPOt3OptgV0YIqGTk”>neuroinflammation and Neurotransmission Mechanisms Involved in Neuropsychiatric Disorders
  3329. neuroinflammation and neurotrophic actions of chemokines during a cerebral ischemic process
  3330. neuroinflammation AND NEUROVASCULAR DYSFUNCTION IN CVN MICE AFTER ORTHOPEDIC SURGERY
  3331. neuroinflammation and non-motor symptoms: the dark passenger of Parkinson’s disease?
  3332. neuroinflammation and not tauopathy is a predominant pathological signature of nodding syndrome
  3333. neuroinflammation and optic nerve regeneration: where do we stand in elucidating underlying cellular and molecular players?
  3334. neuroinflammation and optic nerve regeneration: where do we stand in elucidating underlying cellular and molecular players?
  3335. neuroinflammation and oxidation/nitration of α-synuclein linked to dopaminergic neurodegeneration
  3336. neuroinflammation and oxidative injury in developmental neurotoxicity
  3337. neuroinflammation and oxidative stress act in concert to promote neurodegeneration in the diabetic retina and optic nerve: galectin-3 participation
  3338. neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets
  3339. neuroinflammation and oxidative stress in psychosis and psychosis risk
  3340. neuroinflammation and oxidative stress in rostral ventrolateral medulla contribute to neurogenic hypertension induced by systemic inflammation
  3341. neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson’s disease
  3342. neuroinflammation and pain
  3343. neuroinflammation and Parkinson disease: the silent battleground
  3344. neuroinflammation and Parkinson’s disease
  3345. neuroinflammation and Parkinson’s Disease: Understanding the Inflammatory Process Induced by Chronic Peripheral Injection of LPS in LRRK2 G2019S KI Mice in …
  3346. neuroinflammation and Pediatric Lupus
  3347. neuroinflammation and peripheral immune infiltration in Parkinson’s disease: an autoimmune hypothesis
  3348. neuroinflammation and physical exercise as modulators of adult hippocampal neural precursor cell behavior
  3349. neuroinflammation_and_postoperative_cognitive.2.aspx”>neuroinflammation and postoperative cognitive dysfunction: can anaesthesia be therapeutic?
  3350. neuroinflammation and postoperative cognitive dysfunction: what do we know?
  3351. neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum.
  3352. neuroinflammation and proteostasis are modulated by endogenously biosynthesized neuroprotectin D1
  3353. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-10-43″>neuroinflammation and psychiatric illness
  3354. neuroinflammation and Psychiatric Illness
  3355. neuroinflammation and psychosis; antipsychotic medication.
  3356. neuroinflammation and regeneration in the early stages of Alzheimer’s disease pathology
  3357. neuroinflammation and regulation of glial glutamate uptake in neurological disorders
  3358. neuroinflammation and related neuropathologies in APPSL mice: further value of this in vivomodel of Alzheimer’s disease
  3359. neuroinflammation and schizophrenia
  3360. neuroinflammation and Schizophrenia
  3361. neuroinflammation and Seizures After Pediatric Brain Injury: What a Headache!
  3362. neuroinflammation and sickness induced by lipopolysaccharide in adult and aged mice are not mitigated by dietary broccoli (134.4)
  3363. neuroinflammation and Sjogren’s Syndrome
  3364. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0492-z”>neuroinflammation and structural injury of the fetal ovine brain following intra-amniotic Candida albicans exposure
  3365. neuroinflammation and sympathetic overactivity: mechanisms and implications in hypertension
  3366. neuroinflammation and synaptic loss
  3367. neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders
  3368. neuroinflammation and tau interact with amyloid in predicting sleep problems in aging independently of atrophy
  3369. neuroinflammation and the APOε genotype: Implications for Alzheimer’s disease and modulation by dietary flavonoids and n-3 polyunsaturated fatty acids
  3370. neuroinflammation and the Behavioral Consequences of Air Pollution Over the Life Course
  3371. neuroinflammation and the blood‐brain‐interface: new findings in brain pathology
  3372. neuroinflammation and the blood–brain interface: New findings in brain pathology
  3373. neuroinflammation and the cGAS-STING pathway
  3374. neuroinflammation and the dynamic lesion in traumatic brain injury
  3375. neuroinflammation and the generation of neuropathic pain
  3376. neuroinflammation and the genetics of Alzheimer’s disease: the search for a pro-inflammatory phenotype
  3377. neuroinflammation and the glial endocannabinoid system
  3378. neuroinflammation and the Glial Response Contribute to Both Beneficial and Pathological Outcomes in Multiple Disease Models
  3379. neuroinflammation and the gut microbiota: possible alternative therapeutic targets to counteract Alzheimer’s disease?
  3380. neuroinflammation and the immune-kynurenine pathway in anxiety disorders
  3381. neuroinflammation and the plasticity-related immediate-early gene Arc
  3382. neuroinflammation and the prospects for anti-inflammatory treatment of Parkinson’s disease.
  3383. neuroinflammation and the role of glia: relevance for neurodegenerative and neurosupportive roles
  3384. neuroinflammation_and_Therapeutic_Potential_of.14.aspx”>neuroinflammation and Therapeutic Potential of Neuromediation in Pruritus and Inflammation
  3385. neuroinflammation and Toll-Like Receptors in the Skin
  3386. neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer’s disease
  3387. neuroinflammation and Virus Replication in the Spinal Cord of Simian Immunodeficiency Virus–Infected Macaques
  3388. neuroinflammation and White Matter Alterations in Obesity Assessed by Diffusion Basis Spectrum Imaging
  3389. neuroinflammation and white matter pathology in schizophrenia: systematic review
  3390. neuroinflammation and α-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction
  3391. neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other Driving Chronic Progression of Parkinson’s Disease
  3392. neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson’s disease
  3393. neuroinflammation and β amyloid deposition in Alzheimer’s disease: in vivo quantification with molecular imaging
  3394. neuroinflammation appears early on PET imaging and then plateaus in a mouse model of Alzheimer disease
  3395. neuroinflammation Appears Early on PET Imaging and Then Plateaus in a Mouse Model of Alzheimer Disease
  3396. neuroinflammation as a cause of chronic pain
  3397. neuroinflammation as a common feature of neurodegenerative disorders
  3398. neuroinflammation as a common mechanism associated with the modifiable risk factors for Alzheimer’s and Parkinson’s diseases
  3399. neuroinflammation as a factor of neurodegenerative disease: Thalidomide analogs as treatments
  3400. neuroinflammation as a mechanism for cardiovascular diseases
  3401. neuroinflammation as a neurotoxic mechanism in alcoholism: commentary on” Increased MCP-1 and microglia in various regions of human alcoholic brain”.
  3402. neuroinflammation-as-a-possible-link-between-cannabinoids-and-addiction/6983C95DD34F3DCDF29E4CC9796083AC”>neuroinflammation as a possible link between cannabinoids and addiction
  3403. neuroinflammation as a Potential Mechanism Underlying Parkinsons Disease
  3404. neuroinflammation as a potential therapeutic target in dementia with Lewy bodies
  3405. neuroinflammation as a risk factor for attention deficit hyperactivity disorder
  3406. neuroinflammation as a target for glaucoma therapy
  3407. neuroinflammation as a target for intervention in subarachnoid hemorrhage
  3408. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1571-8″>neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles
  3409. neuroinflammation as a therapeutic target in neurodegenerative diseases
  3410. neuroinflammation as an Early Event and Prime Mover in Alzheimer’s Pathobiology
  3411. neuroinflammation&ots=RMtS0vhQRl&sig=xazZeTqBhRhBVaf6W8Sn_zL2bQM”>neuroinflammation as an Important Pathogenic
  3412. neuroinflammation as an important pathogenic mechanism in spinal cord injury
  3413. neuroinflammation as fuel for axonal regeneration in the injured vertebrate central nervous system
  3414. neuroinflammation as fuel for axonal regeneration: unravelling the underlying players
  3415. neuroinflammation as modifier of genetically caused neurological disorders of the central nervous system: understanding pathogenesis and chances for treatment
  3416. neuroinflammation as the proximate cause of signature pathogenic pattern progression in amyotrophic lateral sclerosis, AIDS, and multiple sclerosis
  3417. neuroinflammation assessment of a mouse model of multiple sclerosis
  3418. neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress
  3419. neuroinflammation at the interface of depression and cardiovascular disease: Evidence from rodent models of social stress
  3420. neuroinflammation biomarkers
  3421. neuroinflammation by cytotoxic T-lymphocytes impairs retrograde axonal transport in an oligodendrocyte mutant mouse
  3422. neuroinflammation caused by mental stress: the effect of chronic restraint stress and acute repeated social defeat stress in mice
  3423. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0942-2″>neuroinflammation contributes to autophagy flux blockage in the neurons of rostral ventrolateral medulla in stress-induced hypertension rats
  3424. neuroinflammation contributes to high salt intake-augmented neuronal activation and active coping responses to acute stress
  3425. neuroinflammation contributes to hypokinesia in rats with hepatic encephalopathy: ibuprofen restores its motor activity
  3426. neuroinflammation disorders exacerbated by environmental stressors
  3427. neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis
  3428. neuroinflammation during Parkinson’s disease: key cells and molecules involved in it
  3429. neuroinflammation during RNA viral infections
  3430. neuroinflammation explains aspects of chronic pain and opens new avenues for therapeutic interventions
  3431. neuroinflammation Extends Brain Tissue at Risk to Vital Peri-Infarct Tissue: A Double Tracer [11C]PK11195- and [18F]FDG-PET Study
  3432. neuroinflammation facilitates LIF entry into brain: role of TNF
  3433. neuroinflammation follow-up in a quinolinic acid rat model of excitotoxicity by translocator protein (18 kDa) mapping with CLINDE
  3434. neuroinflammation following disease modifying therapy in multiple sclerosis: a pilot positron emission tomography study
  3435. neuroinflammation Following Sleep Fragmentation In A Pediatric Model
  3436. neuroinflammation functionally regulates CNS lymphatic vasculature and drainage
  3437. neuroinflammation imaging markers for epileptogenesis
  3438. neuroinflammation_impact_in_epileptogenesis_and.6.aspx”>neuroinflammation impact in epileptogenesis and new treatment strategy
  3439. neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer’s disease
  3440. neuroinflammation in a Forceps Compression Model of Spinal Cord Injury
  3441. neuroinflammation_in_a_mouse_model_of_colitis_cross-talk_between_the_gut_and_the_brain/links/5620c48408ae93a5c9244ec7.pdf”>neuroinflammation in a mouse model of colitis: cross-talk between the gut and the brain.
  3442. neuroinflammation IN A T-CELL TGF-β RECEPTOR DISRUPTED P301S MOUSE
  3443. neuroinflammation in acute hepatic encephalopathy rats: imaging and therapeutic effectiveness evaluation using 11C-PK11195 and 18F-DPA-714 micro-positron …
  3444. neuroinflammation in acute liver failure: mechanisms and novel therapeutic targets
  3445. neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies
  3446. neuroinflammation in advanced canine glaucoma
  3447. neuroinflammation in Age-Related Neurodegenerative Diseases
  3448. neuroinflammation in Aging
  3449. neuroinflammation in alcoholism using [11C] PBR28: from rat to human
  3450. neuroinflammation in Alzheimer’s
  3451. neuroinflammation in Alzheimer’s disease
  3452. neuroinflammation in Alzheimer’s disease
  3453. neuroinflammation in Alzheimer’s disease
  3454. neuroinflammation in Alzheimer’s disease and Down syndrome
  3455. neuroinflammation in Alzheimer’s disease and involvement of interleukin-1: a mechanistic view
  3456. neuroinflammation_in_Alzheimers_Disease20160416-27284-1tmcp5n.pdf”>neuroinflammation in Alzheimer’s disease and major depression
  3457. neuroinflammation in Alzheimer’s disease and mild cognitive impairment: a field in its infancy
  3458. neuroinflammation in Alzheimer’s disease and obesity
  3459. neuroinflammation in Alzheimer’s disease and Parkinson’s disease: are microglia pathogenic in either disorder?
  3460. neuroinflammation in Alzheimer’s disease and prion disease
  3461. neuroinflammation in Alzheimer’s Disease and Prion Disease
  3462. neuroinflammation in Alzheimer’s Disease and Vascular Cognitive Impairment
  3463. neuroinflammation IN ALZHEIMER’S DISEASE PATHOLOGY DECREASES WITH AGE
  3464. neuroinflammation in Alzheimer’s disease wanes with age
  3465. neuroinflammation-in-alzheimer-disease-a-review-manju-bhaskar.pdf”>neuroinflammation in Alzheimer’s disease-A review
  3466. neuroinflammation in Alzheimer’s disease; a source of heterogeneity and target for personalized therapy
  3467. neuroinflammation in Alzheimer’s disease: an understanding of physiology and pathology
  3468. neuroinflammation in Alzheimer’s disease: are NSAIDs and selective COX-2 inhibitors the next line of therapy?
  3469. neuroinflammation in Alzheimer’s disease: Characterization and modification of the response of transgenic mice to intrahippocampal lipopolysaccharide …
  3470. neuroinflammation in Alzheimer’s disease: chemokines produced by astrocytes and chemokine receptors
  3471. neuroinflammation in Alzheimer’s disease: current evidence and future directions
  3472. neuroinflammation in Alzheimer’s disease: different molecular targets and potential therapeutic agents including curcumin
  3473. neuroinflammation in Alzheimer’s disease: focus on NF-κB and C/EBP transcription factors
  3474. neuroinflammation in Alzheimer’s disease: from pathogenesis to a therapeutic target
  3475. neuroinflammation in Alzheimer’s disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation
  3476. neuroinflammation in Alzheimer’s Disease: Microglia, Molecular Participants and Therapeutic Choices
  3477. neuroinflammation in Alzheimer’s disease: pleiotropic roles for cytokines and neuronal pentraxins
  3478. neuroinflammation in Alzheimer’s Disease: Potential Targets for Disease-Modifying Drugs
  3479. neuroinflammation in Alzheimer’s disease: protector or promoter?
  3480. neuroinflammation in Alzheimer’s disease: the preventive and therapeutic potential of polyphenolic nutraceuticals
  3481. neuroinflammation in Alzheimer’s, Parkinson’s and Huntington’s Diseases
  3482. neuroinflammation in amyotrophic lateral sclerosis
  3483. neuroinflammation in amyotrophic lateral sclerosis: new targets for the treatment?
  3484. neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
  3485. neuroinflammation in amyotrophic lateral sclerosis: role of redox (dys) regulation
  3486. neuroinflammation in an Alzheimer’s disease animal model andthe effectiveness of selective suppression of glial activation
  3487. neuroinflammation in animal models of autism
  3488. neuroinflammation in animal models of fatigue
  3489. neuroinflammation in animal models of traumatic brain injury
  3490. neuroinflammation in autism spectrum disorders
  3491. neuroinflammation in autism spectrum disorders: Role of high mobility group box 1 protein
  3492. neuroinflammation in autism: plausible role of maternal inflammation, dietary omega 3, and microbiota
  3493. neuroinflammation in Bacterial Meningitis
  3494. neuroinflammation in bipolar disorder–A [11C]-(R)-PK11195 positron emission tomography study
  3495. neuroinflammation in bipolar disorders
  3496. neuroinflammation in CNS diseases: molecular mechanisms and the therapeutic potential of plant derived bioactive molecules
  3497. neuroinflammation in delirium: a postmortem case-control study
  3498. neuroinflammation in Demyelinating Diseases: Oxidative Stress as a Modulator of Glial Cross-Talk
  3499. neuroinflammation in depression
  3500. neuroinflammation in early and late onset Alzheimer´ s disease: a multimodal analysis
  3501. neuroinflammation in Early Stages of Alzheimer’s Disease and Parkinson’s Disease
  3502. neuroinflammation in epilepsy: an analysis of patients’ sera and its effect on microglia-like cells (S55. 007)
  3503. neuroinflammation in epileptogenesis: insights and translational perspectives from new models of epilepsy
  3504. neuroinflammation in fibromyalgia and CRPS is multifactorial
  3505. neuroinflammation in fibromyalgia and CRPS: top-down or bottom-up?
  3506. neuroinflammation in first episodes of psychosis
  3507. neuroinflammation in frontotemporal dementia
  3508. neuroinflammation in frontotemporal lobar degeneration revealed by 11C‐PBR28 PET
  3509. neuroinflammation in glaucoma and optic nerve damage
  3510. neuroinflammation in glaucoma: a new opportunity
  3511. neuroinflammation in glaucoma: soluble tumor necrosis factor alpha and the connection with excitotoxic damage
  3512. neuroinflammation in Gulf War Illness is linked with HMGB1 and complement activation, which can be discerned from brain-derived extracellular vesicles in the blood
  3513. neuroinflammation in hAPPSL transgenic mice
  3514. neuroinflammation in HCV-infection–Peril or protection?
  3515. neuroinflammation in healthy aging: A PET study using a novel Translocator Protein 18 kDa (TSPO) radioligand,[18F]-FEPPA
  3516. neuroinflammation in heart failure: new insights for an old disease
  3517. neuroinflammation in hepatic encephalopathy: mechanistic aspects
  3518. neuroinflammation in Huntington’s & Related Neurodegenerative Disorders
  3519. neuroinflammation in Huntington’s disease
  3520. neuroinflammation in Huntington’s disease
  3521. neuroinflammation in Huntington’s disease-effects of fractalkine on microglia in a mouse model R6/2 of Huntington’s disease
  3522. neuroinflammation in Huntington’s Disease: New Insights with 11C-PBR28 PET/MRI
  3523. neuroinflammation in hypertension: the renin-angiotensin system versus pro-resolution pathways
  3524. neuroinflammation in inflammatory bowel disease
  3525. neuroinflammation in intrauterine growth restriction
  3526. neuroinflammation in Ischaemic Stroke: Utilizing the Biphasic Niche of Neuroprotection and Neurotoxicity for Clinic
  3527. neuroinflammation in ischemic brain injury as an adaptive process
  3528. neuroinflammation in ischemic pediatric stroke
  3529. neuroinflammation in l-DOPA-induced dyskinesia: beyond the immune function
  3530. neuroinflammation in Lewy body dementia
  3531. neuroinflammation in liver disease: sessional talks from ISHEN
  3532. neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
  3533. neuroinflammation in Major Depressive Disorder and Schizophrenia: A PET Study
  3534. neuroinflammation in manganese neurotoxicity
  3535. neuroinflammation in mild cognitive impairment and Alzheimer’s disease: A meta-analysis
  3536. neuroinflammation in mood disorders: Mechanisms and drug targets
  3537. neuroinflammation in motor neuron disease
  3538. neuroinflammation in motor neuron disease
  3539. neuroinflammation in mouse models of Alzheimer’s disease
  3540. neuroinflammation in Movement Disorders
  3541. neuroinflammation in multiple sclerosis: evidence for autoimmune dysregulation, not simple autoimmune reaction
  3542. neuroinflammation in multiple system atrophy: response to and cause of α-synuclein aggregation
  3543. neuroinflammation in murine cirrhosis is dependent on the gut microbiome and is attenuated by fecal transplant
  3544. neuroinflammation in neocortical epilepsy measured by PET imaging of translocator protein
  3545. neuroinflammation in neurodegeneration: role in pathophysiology, therapeutic opportunities and clinical perspectives
  3546. neuroinflammation in neurodegenerative diseases: Current multi-modal imaging studies and future opportunities for hybrid PET/MRI
  3547. neuroinflammation in neurodegenerative disorders—a review
  3548. neuroinflammation in Neurodegenerative Disorders: Harmful or Helpful?
  3549. neuroinflammation in neurological disorders
  3550. neuroinflammation in Neurological Dysfunction and Degeneration
  3551. neuroinflammation in neuronal degeneration and repair
  3552. neuroinflammation in obesity: circulating lipopolysaccharide-binding protein associates with brain structure and cognitive performance
  3553. neuroinflammation in organophosphate-induced neurotoxicity
  3554. neuroinflammation in overnutrition-induced diseases
  3555. neuroinflammation in Parkinson’s disease
  3556. neuroinflammation in Parkinson’s disease
  3557. neuroinflammation in Parkinson’s disease and its potential as therapeutic target
  3558. neuroinflammation in Parkinson’s disease and related disorders: a lesson from genetically manipulated mouse models of-synucleinopathies
  3559. neuroinflammation in Parkinson’s disease animal models: a cell stress response or a step in neurodegeneration?
  3560. neuroinflammation in Parkinson’s disease: a target for neuroprotection?
  3561. neuroinflammation_in_Parkinson’s_disease_is_there_sufficient_evidence_for_mechanism-based_interventional_therapy/links/00463521f6198e15e3000000/neuroinflammation-in-Parkinsons-disease-is-there-sufficient-evidence-for-mechanism-based-interventional-therapy.pdf”>neuroinflammation in Parkinson’s disease: is there sufficient evidence for mechanism-based interventional therapy
  3562. neuroinflammation in Parkinson’s disease: its role in neuronal death and implications for therapeutic intervention
  3563. neuroinflammation in Parkinson’s disease: role in neurodegeneration and tissue repair
  3564. neuroinflammation in Parkinson’s patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 …
  3565. neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: an 11C-(R)-PK11195 PET study
  3566. neuroinflammation in plaque and vascular β-amyloid disorders: clinical and therapeutic implications
  3567. neuroinflammation in Post-Traumatic Epilepsy: Pathophysiology and Tractable Therapeutic Targets
  3568. neuroinflammation in preclinical Alzheimer’s disease is associated with parahippocampal pathology and memory deficits
  3569. neuroinflammation in preclinical Alzheimer’s disease: a review of current evidence
  3570. neuroinflammation in preterm babies and autism spectrum disorders
  3571. neuroinflammation in primary blast neurotrauma: Time course and prevention by torso shielding
  3572. neuroinflammation in prion diseases: concepts and targets for therapeutic intervention
  3573. neuroinflammation in pulmonary hypertension: concept, facts, and relevance
  3574. neuroinflammation in response to intracerebral injections of different HMGB1 redox isoforms
  3575. neuroinflammation in retinitis pigmentosa, diabetic retinopathy, and age-related macular degeneration: a minireview
  3576. neuroinflammation in schizophrenia and effects of antipsychotic medication-a PET study.
  3577. neuroinflammation in schizophrenia especially focused on the role of microglia
  3578. neuroinflammation_in_Schizophrenia_Focused_on_the_Pharmacological_and_Therapeutic_Evidence/links/562f1db108ae518e34838d55/neuroinflammation-in-Schizophrenia-Focused-on-the-Pharmacological-and-Therapeutic-Evidence.pdf”>neuroinflammation in schizophrenia focused on the pharmacological and therapeutic evidence
  3579. neuroinflammation in schizophrenia-related psychosis: a PET study
  3580. neuroinflammation in schizophrenia: a critical review and the future
  3581. neuroinflammation-in-schizophrenia-metaanalysis-of-in-vivo-microglial-imaging-studies/991843292F0212960314A007D052003F”>neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies
  3582. neuroinflammation in schizophrenia: meta-analysis of in-vivo microglial imaging studies
  3583. neuroinflammation in schizophrenic patients: a positron emission tomography study with [11C]-(R)-PK11195
  3584. neuroinflammation in sepsis: sepsis associated delirium
  3585. neuroinflammation in spinal cord injury: therapeutic targets for neuroprotection and regeneration
  3586. neuroinflammation&ots=aw4-RTfgp4&sig=7fUsbxpA1xQXUTvM18lu6YV5P9c”>neuroinflammation in stroke
  3587. neuroinflammation_in_Stroke.18.aspx”>neuroinflammation IN STROKE
  3588. neuroinflammation in suicide
  3589. neuroinflammation in suicide: too little may be just as bad as too much
  3590. neuroinflammation in suicide: Toward a comprehensive model
  3591. neuroinflammation in Survivors of Murine Pneumosepsis
  3592. neuroinflammation in synucleinopathies
  3593. neuroinflammation in systemic lupus erythematosus–a review
  3594. neuroinflammation in temporal lobe epilepsy measured using positron emission tomographic imaging of translocator protein
  3595. neuroinflammation in the aging down syndrome brain; lessons from Alzheimer’s disease
  3596. neuroinflammation in the Brain of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
  3597. neuroinflammation in the C1q/TNF-related over-expression mouse model of chronic ethanol exposure
  3598. neuroinflammation in the central nervous system: symphony of glial cells
  3599. neuroinflammation_in_the_Developing_Brain__Risk.17.aspx”>neuroinflammation in the developing brain: risk factors, involvement of microglial cells, and implication for early anesthesia
  3600. neuroinflammation in the dorsolateral prefrontal cortex in elderly chronic schizophrenia
  3601. neuroinflammation in the fetus exposed to maternal obsessive–compulsive disorder during pregnancy: A comparative study on cord blood tumor necrosis factor-alpha …
  3602. neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson’s disease
  3603. neuroinflammation in the living brain of Parkinson’s disease
  3604. neuroinflammation in the metabolic disorder X-adrenoleukodystrophy
  3605. neuroinflammation in the normal aging hippocampus
  3606. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1512-6″>neuroinflammation in the NTS is associated with changes in cardiovascular reflexes during systemic inflammation
  3607. neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches
  3608. neuroinflammation&ots=LplBmjj8BN&sig=dy8aVoPxS3SEQ9YU9ABEI9b1qKU”>neuroinflammation